Evaluating innovations in the delivery and organisation of gastroenterology services initiated directly or indirectly by the modernising endoscopy service of the NHS Modernisation Agency by Kym, Thorne
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa16155
_____________________________________________________________
 
Research report for external body :
Williams, J., Cheung, W., Cohen, D., Hutchings, H., Jerzembek, G., Rapport, F., Russell, I., Seagrove, A. & Thorne, K.
(2008).  Evaluating innovations in the delivery and organisation of gastroenterology services initiated directly or
indirectly by the modernising endoscopy service of the NHS Modernisation Agency.
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 The ENIGMA study 
©NCCSDO 2008 Page 1 
 
 
Evaluating innovations in the 
delivery and organisation of 
gastroenterology services 
initiated directly or indirectly 
by the Modernising Endoscopy 
Services programme of the 
NHS Modernisation Agency: 
(ENIGMA) 
Report for the National Co-ordinating Centre for 
NHS Service Delivery and Organisation R&D 
(NCCSDO) 
November 2008 
 
The ENIGMA study 
©NCCSDO 2008 Page 2 
 
Report for the National Co-ordinating Centre for 
NHS Service Delivery and Organisation R&D 
(NCCSDO) 
 
November 2008 
 
Prepared by  
 
Professor John G Williams 
 School of Medicine, Swansea University  
 
Dr Wai-Yee Cheung 
 School of Medicine, Swansea University  
 
Professor David Cohen 
 Faculty of Health, Sport and Science, University of Glamorgan 
 
Dr Hayley Hutchings 
 School of Medicine, Swansea University  
 
Mrs Gabi Jerzembek 
 School of Medicine, Swansea University 
 
Professor Frances Rapport 
 School of Medicine, Swansea University  
 
Professor Ian Russell 
 Institute for Medical & Social Care Research, Bangor University 
 
Mrs Anne Seagrove  
 School of Medicine, Swansea University  
 
Mrs Kymberley Thorne 
 School of Medicine, Swansea University  
 
 
Address for correspondence 
Professor John G Williams 
School of Medicine 
Swansea University 
Singleton Park 
Swansea, SA2 8PP 
E-mail: j.g.williams@swansea.ac.uk 
 
The ENIGMA study 
©NCCSDO 2008 Page 3 
Contents 
Contents ..................................................................... 3 
Acknowledgements .................................................. 11 
Foreword .................................................................. 12 
Abbreviations list ..................................................... 13 
Glossary ................................................................... 15 
1 Introduction ..................................................... 18 
1.1 Aims of the research ........................................................... 19 
1.2 Objectives ......................................................................... 20 
1.3 Methods of evaluation ......................................................... 20 
2 Overview of methods ....................................... 22 
2.1 Philosophy ......................................................................... 22 
2.2 Hospital recruitment ............................................................ 25 
2.3 Innovation history of participating sites ................................. 28 
2.4 Patient outcomes and waiting times ...................................... 28 
2.5 Endoscopy process data analysis .......................................... 28 
2.6 Health economics ............................................................... 29 
2.6.1 Health economics interviews ....................................... 29 
2.6.2 Health economics questionnaire ................................... 29 
2.7 Patient views ...................................................................... 30 
2.8 Professional views at study sites ........................................... 30 
2.9 Professional views at non-study sites .................................... 30 
2.9.1 Recruitment and sample ............................................. 30 
2.9.2 Method ..................................................................... 30 
2.10 GP views at study sites ............................................... 31 
2.11 The evaluation of the effects of modernisation using the 
Method for Aggregating the Reporting of Interventions in 
Complex Studies (MATRICS) ................................................ 31 
2.12 Ethics ....................................................................... 33 
3 The innovation histories of study sites ............. 34 
3.1 Executive summary ............................................................. 34 
3.2 Methods ............................................................................ 34 
3.2.1 Questionnaire design and allocation ............................. 34 
3.2.2 Analysis plan ............................................................. 35 
3.3 Results .............................................................................. 35 
3.3.1 Innovations introduced – a descriptive summary ........... 35 
3.3.2 Analysis of innovation scores ....................................... 39 
3.4 Discussion ......................................................................... 40 
The ENIGMA study 
©NCCSDO 2008 Page 4 
4 Patient outcomes and waiting times ................ 43 
4.1 Executive summary ............................................................. 43 
4.1.1 Objectives ................................................................ 43 
4.1.2 Methods ................................................................... 43 
4.1.3 Statistical analysis ..................................................... 43 
4.1.4 Results ..................................................................... 43 
4.2 Objectives ......................................................................... 44 
4.3 Methods ............................................................................ 44 
4.3.1 Participating patients ................................................. 44 
4.3.2 The pilot study .......................................................... 47 
4.3.3 Outcome measures .................................................... 47 
4.3.4 Statistical methods .................................................... 47 
4.4 Results .............................................................................. 49 
4.4.1 Participant recruitment and flow .................................. 49 
4.4.2 Questionnaire response rates ...................................... 53 
4.4.3 Patient demographics and sensitivity analysis ................ 53 
4.4.4 Disease specific HRQoL – GSRQ ................................... 56 
4.4.5 GSRQ baseline scores ................................................. 58 
4.4.6 GSRQ – changes in BQ, PPQ and 12m PPQ scores .......... 58 
4.4.7 GSRQ at 12 months – multilevel modelling ................... 61 
4.4.8 GSRQ at post procedure ............................................. 63 
4.4.9 SF-36 ....................................................................... 65 
4.4.10 EQ-5D .................................................................. 65 
4.4.11 SF-36 & EQ-5D – changes in BQ, PPQ and 12m PPQ 
scores ...................................................................... 65 
4.4.12 SF-36 – multilevel modelling.................................... 70 
4.4.13 EQ-5D  – Analysis of covariance ............................... 71 
4.4.14 Waiting times ........................................................ 72 
4.4.15 Patient Satisfaction ................................................. 73 
4.4.16 Patient comments .................................................. 77 
4.5 Discussion ......................................................................... 82 
4.5.1 Summary of results ................................................... 82 
4.5.2 Internal validity ......................................................... 83 
4.5.3 External validity ........................................................ 83 
4.5.4 Implications .............................................................. 83 
5 Hospital process data ....................................... 85 
5.1 Executive summary ............................................................. 85 
5.1.1 Aim.......................................................................... 85 
5.1.2 Methods ................................................................... 85 
5.1.3 Results ..................................................................... 85 
5.1.4 Conclusion ................................................................ 85 
5.2 Aims and objectives ............................................................ 86 
5.3 Methods ............................................................................ 86 
5.3.1 Details of the process data requested ........................... 86 
The ENIGMA study 
©NCCSDO 2008 Page 5 
5.3.2 Time periods of data collection .................................... 87 
5.3.3 The endoscopy unit data request ................................. 88 
5.3.4 The NHS Trust Information Services endoscopy data 
request .................................................................... 88 
5.3.5 Data collection forms ................................................. 89 
5.3.6 Formation of the final dataset...................................... 90 
5.3.7 The validation of the study datasets ............................. 91 
5.3.8 Intervention and Control site data analysis ................... 92 
5.3.9 Description of Intervention and Control group datasets 
split by procedure type ............................................... 92 
5.3.10 Correlation of outcome measures ............................. 92 
5.3.11 Two-way analysis of variance ................................... 92 
5.4 Results .............................................................................. 92 
5.4.1 The availability of process data from the endoscopy units 92 
5.4.2 The availability of process data from TIS departments .... 93 
5.4.3 The availability of process data from the ENIGMA study .. 94 
5.4.4 Categorisation of datasets .......................................... 96 
5.4.5 Exclusion of datasets .................................................. 97 
5.4.6 Formation of final datasets .......................................... 97 
5.4.7 Results of the data validation process ........................... 99 
5.4.8 Description of Intervention and Control site datasets .... 103 
5.4.9 Intervention and Control site data analysis ................. 103 
5.4.10 Description of Intervention and Control group data ... 112 
5.4.11 Correlation .......................................................... 123 
5.4.12 Two-way analysis of variance ................................. 124 
5.5 Discussion ....................................................................... 126 
5.5.1 The availability of routinely collected process data ....... 126 
5.5.2 The validation of the process data .............................. 129 
5.5.3 The analysis of the data ........................................... 130 
5.6 Implications ..................................................................... 133 
6 Health Economics ........................................... 136 
6.1 Executive summary ........................................................... 136 
6.1.1 Introduction ............................................................ 136 
6.1.2 Objectives .............................................................. 136 
6.1.3 Methods ................................................................. 136 
6.1.4 Results ................................................................... 137 
6.1.5 Discussion .............................................................. 138 
6.2 Introduction ..................................................................... 139 
6.3 Objectives ....................................................................... 140 
6.4 Methods .......................................................................... 140 
6.4.1 Cost of modernisation: ............................................. 140 
6.4.2 Other Health Service Costs ....................................... 141 
6.4.3 Quality of Life .......................................................... 142 
6.5 Results ............................................................................ 142 
The ENIGMA study 
©NCCSDO 2008 Page 6 
6.5.1 Modernisation costs ................................................. 142 
6.6 An illustration of the costs of modernisation: Site 19 ............. 147 
6.7 NHS Resource Use ............................................................ 148 
6.8 Missing data imputations ................................................... 148 
6.8.1 Imputation using last case carried forward method ...... 148 
6.8.2 Imputation of missing items as zero ........................... 153 
6.9 NHS Resource use and costs by wave .................................. 158 
6.10 Adjustments ........................................................... 169 
6.10.1 Clustering ........................................................... 169 
6.10.2 Differences in timing of questionnaires .................... 173 
6.10.3 Skewness ............................................................ 173 
6.11 Results of adjusted analyses ..................................... 174 
6.12 Lost Productivity ...................................................... 178 
6.13 Discussion .............................................................. 178 
7 Patient Views ................................................. 181 
7.1 Executive summary ........................................................... 181 
7.1.1 Waiting for an endoscopy.......................................... 181 
7.1.2 Information provision ............................................... 181 
7.1.3 Staff ...................................................................... 182 
7.1.4 Differences in experience of endoscopy services over a 
period of time ......................................................... 182 
7.1.5 Suggestions for improvement .................................... 182 
7.1.6 Summary - Differences between Intervention and Control 
sites....................................................................... 183 
7.1.7 Major issues arising ................................................. 183 
7.2 Aims 184 
7.3 Objectives ....................................................................... 184 
7.4 Method ............................................................................ 184 
7.4.1 Telephone interviews ............................................... 185 
7.4.2 Interview schedule ................................................... 185 
7.4.3 Pilot study .............................................................. 185 
7.4.4 Sampling strategy and recruitment ............................ 186 
7.5 Data collection and analysis ............................................... 188 
7.6 Findings first and second round interviews ........................... 189 
7.7 Differences between Intervention and Control sites ............... 190 
7.8 Examination of findings in detail ......................................... 191 
7.8.1 Theme 1 – Waiting for an endoscopy .......................... 191 
7.8.2 Theme 2 – Information provision ............................... 193 
7.8.3 Theme 3 – Staff ...................................................... 196 
7.8.4 Theme 4 – Differences in experience of endoscopy 
services over time.................................................... 198 
7.8.5 Theme 5 – Suggestions for improvement .................... 200 
8 Professional views at study sites ................... 202 
8.1 Executive summary ........................................................... 202 
The ENIGMA study 
©NCCSDO 2008 Page 7 
8.1.1 Theme 1 – Drivers for change ................................... 202 
8.1.2 Theme 2 – The human dimension of endoscopy units ... 203 
8.1.3 Theme 3 – Financial resources................................... 203 
8.1.4 Major issues arising from the interviews ..................... 205 
8.2 Aims 209 
8.3 Objectives ....................................................................... 209 
8.4 Method ............................................................................ 209 
8.4.1 Interview schedule first round interviews .................... 209 
8.4.2 Pilot study .............................................................. 209 
8.4.3 Interview schedule second round interviews ................ 210 
8.4.4 Sampling strategy ................................................... 210 
8.5 Data collection and analysis ............................................... 210 
8.6 Findings: First round of interviews ...................................... 211 
8.6.1 Differences between Intervention and Control sites and 
their responses to modernisation ............................... 212 
8.7 Findings in detail – First round of interviews ......................... 214 
8.7.1 Theme 1 – Drivers for change ................................... 214 
8.7.2 Theme 2 – The human dimension of endoscopy units ... 220 
8.7.3 Theme 3 – Financial resources................................... 229 
8.8 Findings: Second round of interviews .................................. 231 
8.8.1 Differences between Intervention and Control sites  and 
their responses to modernisation ............................... 233 
8.8.2 Recommendations from second round interviews ......... 234 
8.9 Findings in detail – second round of interviews ..................... 236 
8.9.1 Theme 1 – Drivers for change ................................... 236 
8.9.2 Theme 2 – The human dimension of endoscopy units ... 242 
8.9.3 Theme 3 – Financial resources................................... 252 
9 Professional views at non-study sites ............ 255 
9.1 Executive summary ........................................................... 255 
9.1.1 Aim........................................................................ 255 
9.1.2 Participant groupings ............................................... 255 
9.1.3 Method ................................................................... 255 
9.1.4 Analysis.................................................................. 256 
9.1.5 Findings ................................................................. 256 
9.2 PART 1 - Focus Group 1: Non-participant endoscopy specialists 
in England ....................................................................... 257 
9.2.1 Focus group 1: Background....................................... 258 
9.2.2 Method ................................................................... 258 
9.2.3 Analysis.................................................................. 258 
9.2.4 FG1 ....................................................................... 259 
9.2.5 FG1 Summary of results ........................................... 259 
9.2.6 FG1 Results in detail: main themes arising .................. 260 
9.2.7 Additional points of note ........................................... 263 
9.3 Part 2 - Three focus groups with endoscopy specialists in Wales264 
The ENIGMA study 
©NCCSDO 2008 Page 8 
9.3.1 Focus groups 2-4: Background .................................. 264 
9.3.2 Method ................................................................... 264 
9.3.3 Analysis.................................................................. 265 
9.3.4 FG2 ....................................................................... 265 
9.3.5 FG2 Summary of results ........................................... 265 
9.3.6 FG2 Results in detail: Main themes arising .................. 266 
9.3.7 FG3 ....................................................................... 267 
9.3.8 FG3 Summary of results ........................................... 268 
9.3.9 FG3 Results in detail: Main themes arising .................. 268 
9.3.10 FG4 .................................................................... 271 
9.3.11 FG4 Summary of results ........................................ 271 
9.3.12 Results in detail: Major themes arising .................... 272 
9.4 Summary ........................................................................ 274 
10 GP views at study sites .................................. 275 
10.1 Executive summary.................................................. 275 
10.1.1 Objectives ........................................................... 275 
10.1.2 Methods .............................................................. 275 
10.1.3 Results ............................................................... 275 
10.1.4 Implications ......................................................... 275 
10.2 Introduction ............................................................ 275 
10.3 Objectives .............................................................. 276 
10.4 Method ................................................................... 276 
10.4.1 Population ........................................................... 276 
10.4.2 Survey Design ..................................................... 276 
10.4.3 Development of the questionnaire .......................... 276 
10.5 Analysis.................................................................. 277 
10.5.1 Non-respondent analysis ....................................... 277 
10.5.2 Quantitative analysis of questionnaire response ....... 277 
10.5.3 Qualitative analysis of questionnaire response .......... 277 
10.6 Results ................................................................... 277 
10.6.1 Findings from non-respondent analysis ................... 278 
10.6.2 Findings from quantitative analysis of questionnaire 
response ................................................................ 279 
10.6.3 Findings from qualitative analysis of questionnaire 
response ................................................................ 282 
10.6.4 Accessing endoscopy services ................................ 283 
10.6.5 Waiting times ...................................................... 283 
10.6.6 Communication .................................................... 284 
10.6.7 GP views of endoscopy service overall ..................... 284 
10.7 Discussion .............................................................. 285 
10.7.1 Summary of findings............................................. 285 
10.7.2 Internal validity ................................................... 286 
10.7.3 External validity ................................................... 286 
10.7.4 Implications ......................................................... 286 
The ENIGMA study 
©NCCSDO 2008 Page 9 
11 Discussion ...................................................... 288 
11.1 Summary of findings ................................................ 288 
11.2 Internal validity ....................................................... 294 
11.3 External validity ...................................................... 296 
11.4 Wider implications ................................................... 296 
11.5 Learning Points ....................................................... 296 
11.5.1 Policy makers ...................................................... 296 
11.5.2 NHS Trusts .......................................................... 297 
11.5.3 Professionals........................................................ 297 
11.5.4 Research funders ................................................. 297 
11.6 Need for further research .......................................... 297 
12 Conclusion ..................................................... 299 
12.1 There were substantial changes in the services delivered 
by endoscopy units during the timescale of this study ........... 299 
12.2 Small financial incentives do not themselves trigger 
innovation in services ........................................................ 299 
12.3 Modernisation to reduce endoscopy waiting lists does not 
improve patient outcomes .................................................. 299 
12.4 Endoscopy activity and process data needs substantial 
improvement ................................................................... 299 
12.5 Patients are largely content with services .................... 299 
12.6 Endoscopy staff must be at the heart of improvement .. 299 
12.7 Modernisation should be more patient-focused ............ 300 
12.8 A mixed method approach which includes a quasi-
experimental component is feasible and valuable in the 
evaluation of the delivery of services ................................... 300 
References ............................................................. 301 
Appendix 1 – Full Proposal ..................................... 304 
Appendix 2 – Innovation form proforma ................ 318 
Appendix 3 – Baseline Questionnaire ..................... 322 
Appendix 4 – Post Procedure Questionnaire ........... 346 
Appendix 5 – 12 month Post Procedure 
Questionnaire ......................................................... 374 
Appendix 6 – 12 month Post Referral Questionnaire396 
Appendix 7 – The TIS Form proforma ..................... 420 
Appendix 8 – Total procedures data submitted by 
highest ranking source for each site ...................... 422 
Appendix 9 – Data submitted from highest ranking 
source for FS procedures only ................................ 424 
Appendix 10 – Data submitted from highest ranking 
source for Colonoscopy procedures only ................ 426 
The ENIGMA study 
©NCCSDO 2008 Page 10 
Appendix 11 – Data submitted from highest ranking 
source for UGE procedures only ............................. 428 
Appendix 12 – Costing assumptions and unit costs 430 
Appendix 13 – Patient Interview Schedule ............. 433 
Appendix 14 – Clinician / Key person first round 
interview schedule ................................................. 434 
Appendix 15 – Clinician / Key person second round 
interview schedule ................................................. 436 
Appendix 16 – Individual analysts’ summative 
paragraphs for all four focus groups ...................... 437 
Appendix 17 - Focus group schedule ...................... 449 
Appendix 18 – GP Questionnaire ............................ 450 
  
 
The ENIGMA study 
©NCCSDO 2008 Page 11 
Acknowledgements 
We gratefully acknowledge the contribution of the following to the conduct 
of this study, and the preparation of the report: 
 
 Addenbrookes NHS Trust 
 Brighton & Sussex University Hospitals 
 County Durham & Darlington Acute Hospitals NHS Trust 
 East & North Hertfordshire Trust 
 East Kent Hospitals NHS Trust 
 Elizabeth Allen – formerly NHS Modernisation Agency 
 Emma Riordan – School of Medicine, Swansea University  
 Gaynor Demery – School of Medicine, Swansea University  
 George Eliot Hospital NHS Trust 
 Harrogate Healthcare NHS Trust 
 Heatherwood & Wexham Park Hospitals NHS Trust 
 Ian Greenwood - Director of Strategic and Service 
Development, Doncaster and Bassetlaw Hospitals NHS 
Foundation Trust, formerly NHS Modernisation Agency 
 Isle of Wight Healthcare Trust 
 Judy Williams – School of Medicine, Swansea University  
 Lancashire Teaching Hospitals NHS 
 Mayday Healthcare/Croydon PCT 
 Mid Staffordshire General Hospitals 
 North Hampshire Hospital 
 Oxford Radcliffe Hospital Trust 
 Peterborough Hospitals NHS Trust 
 Professor Anne Williams – School of Nursing and Midwifery 
studies, Cardiff University 
 Professor Glyn Elwyn – Department of Primary Care and 
Public Health - Cardiff University  
 Roland Valori – National Clinical Lead for endoscopy 
services 
 Royal Bolton Hospital 
 SDO Programme 
 Shrewsbury & Telford NHS Trust (formerly Royal 
Shrewsbury   Hospital) 
 South Tyneside Health Care Trust 
 Southern Derbyshire Acute Hospitals NHS Trust 
 St Marys NHS Trust 
 Susan Myles – formerly University of Glamorgan 
 Singleton Hospital 
 Neath Port Talbot Hospital 
 Princess of Wales Hospital, Bridgend 
The ENIGMA study 
©NCCSDO 2008 Page 12 
Foreword 
 
This report describes a four year study of the effects of an important 
modernisation initiative on patients, endoscopy services and the wider NHS. 
Methodologically it breaks new ground in the evaluation of delivery of 
services, applying a quasi-experimental approach in the context of mixed 
methods to evaluate a diffuse intervention, and integrating the results to 
paint a cohesive picture of the impact of change, and the facilitators and 
barriers to progress. It demonstrates that such an evaluation is possible, 
and we would like to acknowledge the courage of the SDO Programme in 
commissioning such a large and complex project. 
 
On page 11 there is an impersonal list of people and organisations that have 
helped us. The task was huge and the list does not do justice to the volume 
of effort. I and the ENIGMA team pay tribute to the support and 
collaboration we have received. We would also like to thank the 3818 
patients who completed questionnaires and gave us their views. Without 
this support the study this report would not have been possible. 
 
John Williams 
Swansea University 
April 2008 
The ENIGMA study 
©NCCSDO 2008 Page 13 
Abbreviations list 
Abbreviation Full term 
  
12m PPQ 12 month Post Procedure Questionnaire  
12m PRQ 12 month Post Referral Questionnaire  
ANOVA Analysis of Variance 
BPR Business Process Reengineering 
BQ Baseline Questionnaire  
BSG British Society of Gastroenterology  
CD Crohn’s disease 
CI Confidence Interval 
CNS Clinical Nurse Specialist 
CRC  Colorectal cancer 
CT Computerised Tomography 
DNA Did not attend 
DoH Department of Health 
DOU Degree of urgency 
EDA Exploratory Data Analysis 
ENIGMA Evaluating Innovations in Gastroenterology by the 
NHS Modernisation Agency 
EQ-5D EuroQol – 5D (QoL Questionnaire) 
ERCP Endoscopic Retrograde Cholangiopancreatography 
EUS Endoscopic Ultrasound 
FOBT Faecal Occult Blood Test 
FS Flexible sigmoidoscopy  
FT Foundation Trust  
GDP Gross Domestic Product 
GERD Gastroesophageal Reflux Disease 
GESQ Gastrointestinal Endoscopy Satisfaction 
Questionnaire  
GI Gastrointestinal 
GP General practitioner 
GRS* Global Rating Scale 
GSRQ Gastrointestinal Symptom Rating Questionnaire  
HA Health Authority 
HES* Hospital Episode Statistics 
HIRU Health Information Research Unit 
HRQoL Health-related Quality of Life 
IBD Inflammatory Bowel Disease 
IBS Irritable Bowel Syndrome 
ICC Intraclass Correlation Coefficient  
ID Identification 
IHI Institute of Health Improvement  
IT Information Technology 
JAG Joint Advisory Group on Gastrointestinal 
Endoscopy  
LGE Lower Gastrointestinal Endoscopy  
LREC Local Research Ethics Committee 
MDT Multidisciplinary Team 
MES* Modernising Endoscopy Services  
MeSH Medical Subject Headings 
MESPT MES programme Team 
MLM Multilevel Model 
MRC Medical Research Council 
The ENIGMA study 
©NCCSDO 2008 Page 14 
MREC Multi-centre Research Ethics Committee 
NBCSP* NHS Bowel Cancer Screening Programme  
NE Nurse Endoscopist 
NHS  National Health Service 
NHS SDO National Health Service Service Delivery and 
Organisation 
NHSMA* NHS Modernisation Agency 
NICE National Institute for Clinical Excellence 
NIHR SDO National Institute for Health Research Service 
Delivery and Organisation R&D Programme 
NPfIT National Programme for Information Technology 
OA Open access 
OGD Oesophageal-gastro-duodenoscopy  
OPCS Office for Population Censuses and Surveys 
PAS Patient Administration System  
PPQ Post Procedure Questionnaire  
PSG Project Steering Group 
R&D Research and Development  
RCT Randomised Controlled Trial 
SDO Service Delivery & Organisation  
SF-36 Short Form – 36 (QoL Questionnaire) 
Sig. Significance 
T Time 
TIS Trust Information Services  
TWR Two Week Rule 
UGE Upper Gastrointestinal Endoscopy  
UK United Kingdom 
y Years 
* Also included in Glossary 
The ENIGMA study 
©NCCSDO 2008 Page 15 
Glossary 
Activity The number of procedures performed by the endoscopy 
unit 
 
Change Referred to as changes to layout, equipment, 
management structures and working procedures within 
the units. In this context they were positive, neutral or 
negative. ‘Changes’ had sometimes been used 
interchangeably or together with ‘Innovations’, 
generally referring to anything that has been 
implemented or changed within the service. 
 
Cluster randomised trial 
(CRT) 
An epidemiological experiment in which clusters of 
participants (e.g. all those receiving an endoscopy in a 
specific hospital) are allocated at random between the 
experimental intervention and the control intervention. 
This may be the best research design to evaluate 
whether a cluster-wide intervention is effective (Last 
2001). 
 
Control sites The Control sites had unsuccessfully applied to 
participate in the MES programme but had noted an 
intention to redesign their services independently.  
 
Endoscopist A skilled person who is qualified to perform 
endoscopies. Endoscopists can be clinicians / 
consultants, nurses or GPs with special interests. 
 
Gastrointestinal 
endoscopy 
A procedure whereby a fibre optic camera is inserted 
into a natural orifice with the purpose of visualising the 
gastrointestinal tract. 
 
Global Rating Scale 
(GRS)* 
A web-based assessment tool that makes a series of 
statements requiring a yes or no answer. From the 
answers it automatically calculates the GRS scores, 
which provide a summary view of your service. It 
enables units to assess how well they provide a 
patient-centred service. 
 
Hospital Episode 
Statistics (HES)* 
The national statistical data warehouse for England of 
the care provided by NHS hospitals and for NHS 
hospital patients treated elsewhere. HES is the data 
source for a wide range of healthcare analysis for the 
NHS, Government and many other organisations and 
individuals 
 
Improvement A change to services that makes things better in 
structure, process or outcome. 
 
Innovation A change to the way services were run as part of a 
redesign programme that could be positive, neutral or 
negative in outcome.  
 
Innovations form Forms completed by endoscopy staff to describe the 
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types of innovations introduced into their services at 
specific time points. 
 
Intervention sites The Intervention sites had successfully applied to 
participate in the MES programme and redesigned their 
services over a period of 12 months beginning Jan 
2003. 
 
Key Person Someone who had led or played a key role in 
modernising an endoscopy unit. 
 
Lost slots The number of lost appointment slots due to DNAs or 
cancellations by the patient or the hospital. 
 
Modernisation  
 
Adopting new ways of doing things. 
 
Modernising Endoscopy 
Services (MES) 
The MES programme was set up by the NHSMA in 2002 
to facilitate the redesign of 26 endoscopy units in 
England during 2003. 
 
NHS Bowel Cancer 
Screening Programme 
Bowel cancer screening aims to detect bowel cancer at 
an early stage (in people with no symptoms), when 
treatment is more likely to be effective. The NHS Bowel 
Cancer Screening Programme is now being rolled out 
nationally and will achieve nationwide coverage by 
2009. 
 
NHS Breast Screening 
Programme 
The NHS Breast Screening Programme provides free 
breast screening every three years for all women in the 
UK aged 50 and over. Around one-and-a-half million 
women are screened in the UK each year. 
 
NHS Modernisation 
Agency (NHSMA) 
Established in April 2001, but closed in March 2005, the 
NHS Modernisation Agency was designed to support the 
NHS and its partners in modernising services and 
improving outcomes for patients. The Agency focused 
on four areas: improving access, increasing local 
support, raising standards of care, and capturing and 
sharing knowledge widely. 
 
Process data The term applied to service-related measures including 
Referral numbers, Wait >3m, Snapshot, Lost slots and 
Activity. 
 
Quasi-experiment An epidemiological study in which the investigators lack 
full control over the allocation of interventions but 
conduct the study as if it were a randomised controlled 
trial or a cluster randomised trial (Last 2001). 
 
Randomised controlled 
trial (RCT) 
An epidemiological experiment in which individual 
participants are allocated at random between an 
intervention group receiving the experimental 
intervention and a control group receiving an 
alternative intervention. Under most circumstances this 
is the best research design to evaluate whether an 
intervention is effective (Last 2001). 
Referral numbers The number of referrals for an upper or lower GI 
endoscopy made to the endoscopy unit. 
The ENIGMA study 
©NCCSDO 2008 Page 17 
 
Snapshot The total number of patients waiting at a specific point 
in time, irrespective of how long they waited. 
 
Wait >3m The number of patients waiting more than three 
months for an endoscopy. 
 
* Also included in the list of abbreviations 
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The Report  
1   Introduction 
This project started in 2003, at a time when the NHS was changing in 
response to political, social and economic pressures. As with many other 
secondary care diagnostic services, referrals for endoscopy were increasing, 
and waiting lists lengthened. There was a heavy demand for rapid access to 
diagnostic facilities for patients with symptoms that raise the possibility of 
gastrointestinal cancer (oesophagus, stomach, pancreas, colon and rectum), 
which are commoner than in any other organ system and most need 
endoscopy of the upper or lower gut for diagnosis. Endoscopy also has a 
major role in the diagnosis and treatment of benign disease. As a result 
gastroenterology units were having increasing difficulty maintaining 
appropriate, timely assessment of all patients. 
 
In response to these pressures, gastroenterology services in general and 
gastrointestinal (GI) endoscopy in particular, were starting to modernise.  
Many improvement initiatives have been implemented as a result of the 
NHS Plan (Department of Health 2000(b)), NHS Cancer Plan (Department of 
Health 2000(a)) and NHS Improvement Plan (Department of Health 2004), 
all of which specify the need for service modernisation to be patient-centred, 
and for patients to be seen within strict timeframes.  For example, all 
patients with a suspected GI cancer must be seen in the secondary care 
setting within a maximum of 14 days following referral from their GP. Since 
2001 NHS gastroenterology services have also had to implement full and 
partial booking (NHS Modernisation Agency 2003).  
 
In 2002, the NHS Modernisation Agency (NHSMA) had embarked on a 
Modernising Endoscopy Services (MES) programme to support the 
modernisation of NHS endoscopy services in England to facilitate target 
attainment in terms of waiting times, booking and patient satisfaction. The 
MES programme had a number of aims and objectives to achieve in order to 
modernise and improve NHS endoscopy services in England [Ref NHSMA 
report of 2nd wave 2004].  These were: 
 
 To redesign endoscopy services with the patient at its centre. 
 To demonstrate that improvements can be made by a systematic 
approach to service redesign. 
 To implement booking and choice. 
 To identify examples of good practice to help other teams 
redesign their service. 
 To demonstrate that Modernising Endoscopy Services – A 
Practical Guide to Redesign (MES) could work for a wider and 
more diverse range of endoscopy units and truly supported day-
to-day service management. 
 
Specific programme targets were listed as follows : 
 
 No patient to wait over 3 months 
 Increase in effective use of capacity 
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 DNAs below 2% 
 Cancellations below 5% 
 Booking implemented – full 
 Booking implemented - partial 
 No cancer patient to wait more than 31 days from GP referral to 
diagnosis 
 4 patient led changes 
 Locally derived measures 
 
The MES programme encouraged and supported detailed analysis of demand 
and supply in 169 collaborating endoscopy departments, and gave £10,000 
to twenty-nine selected pilot sites to help them use a MES ToolkitTM to 
analyse their endoscopy services over the last three months of 2002, 
together with training and support from the MES itself. The ToolkitTM used 
the principles of service improvement and redesign to enable pilot sites to 
assess current services in response to seven ‘challenges’ (Investing for 
Health). These were as follows: 
 
Challenge 1: Inequalities Widening 
Challenge 2: Variable Quality & Safety 
Challenge 3: Complex Services Difficult to Navigate 
Challenge 4: Lack of Public Confidence in Services 
Challenge 5: Lack of Upstream Investment 
Challenge 6: Buying things that don’t work 
Challenge 7: Costs Increasing Faster than Income 
 
Of those pilot sites which used the ToolkitTM, twenty-six successfully applied 
for further funding of £30,000 to support redesign of their services over the 
calendar year 2003 in response to the eighth and final ‘challenge’ – that of 
promoting new ways of working.  
 
The 70 unsuccessful sites which received no funding were eligible to use the 
ToolkitTM outside the remit of the MES programme. They were also able to 
attend a one-day training course in the autumn of 2002 and thereafter 
receive support in kind from the NHSMA.  
 
The ENIGMA project set out to evaluate the impact of the NHSMA’s MES 
programme on services, patients and professionals. We selected 10 sites 
which received funding to modernise (Intervention sites), and 10 Control 
sites that did not receive funding, but had access to support from the MES 
programme. We focussed our research on these 20 sites and followed them 
over five waves from April 2004 to April 2006. We also sought views from 
sites in England and Wales who had no engagement with the MES 
programme. 
 
It should be noted that further policies emerged after the start of the 
ENIGMA study, in particular the introduction of the Global Rating Scale 
(Valori 2005) in 2005 and the Bowel Cancer Screening programme in 2007 
(Weller, Moss, Butler, Campbell and Coleman 2006), both of which have 
added to the burden of modernising endoscopy services.  We will discuss the 
impact of these in chapter 11. 
 
1.1   Aims of the research 
 
We set out to: 
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1. Evaluate innovations in service delivery and organisation initiated by the 
MES programme of the NHS Modernisation Agency. 
 
2. Compare the accessibility and acceptability of the resulting models of 
service delivery with other new models. 
 
3. Compare effectiveness and cost-effectiveness in improving outcomes 
assessed by patients and professionals. 
1.2   Objectives 
As we embarked on this multi-faceted study of complex innovations and 
changes introduced haphazardly in 20 sites over a period of years, with or 
without financial support from the MES programme, we found it necessary 
to refine our objectives set out in the original protocol (see Appendix 1), as 
follows: 
 
1. To describe new models of service delivery designed to improve the 
endoscopic assessment of patients with new and continuing gastrointestinal 
(GI) disorders (chapter 3); 
 
2. To compare the impact on patient outcome in those sites which received 
MES funding, with those that did not (chapter 4); 
 
3. To evaluate changes in endoscopic activity and compare those sites which 
received MES funding, with those that did not (chapter 5); 
 
4. To compare resources consumed by the NHS and by patients, and the 
impact on patient outcomes in those sites which received MES funding, with 
those that did not (chapter 6); 
 
5. To assess the views of patients on the changes they experienced, and 
compare those sites which received MES funding, with those that did not 
(chapter 7); 
 
6. To assess the views of professionals working in endoscopy units, on 
drivers and facilitators of change, and compare these views of professionals 
at sites which received MES funding, with those that did not (chapters 8 and 
9); 
 
7. To assess the views of general practitioners on the impact of change and 
compare those referring to sites which received MES funding, with those 
that did not (chapter 10); 
 
8. To assess the value of our approach to the evaluation of ill-defined and 
heterogeneous change in the NHS (discussed in chapters 2 and 11). 
1.3   Methods of evaluation 
We used a mixed method approach, comprising: 
 
1. Interviews with study sites, and a questionnaire, to document their 
innovation history; 
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2. A quasi-experimental design to measure impact on patient outcomes over 
two years; 
 
3. Analysis of data from study sites to assess the impact of change on 
endoscopy activity; 
 
4. Health economics to determine the costs of modernisation and patients’ 
use of other NHS resources and assess these against the impact of 
modernisation on patient health status; 
 
5. A qualitative approach to obtain the views of patients and professionals, 
using questionnaires, interviews and focus groups. 
 
These methods are summarised in chapter 2, and described in detail in 
chapters 3-10. In order to simplify the presentation of the effects we looked 
for and the methods we used, we have also developed a ‘matrix’ approach, 
which is described at the end of chapter 2. It is then used again to 
summarise the results in chapter 11. 
 
The refinement of our objectives reflected a pragmatic approach to the 
complexity of the NHS environment in which we were working and the 
changes we were seeking to evaluate. Thus we added an analysis of 
endoscopic activity data (which was not in our original proposal – see 
Appendix 1) and also included focus groups with representatives of Welsh 
sites entirely independent of the NHSMA, as well as five English sites who 
did not access MES support in any way. We worked in collaboration with the 
NHSMA until it was disbanded in 2005. At that time the MES programme 
changed and began to focus more on quality of services than endoscopic 
activity. The catalyst for change became the development and introduction 
of the Global Rating Scale (GRS), which our project did not seek to evaluate, 
but which clearly began to have a major impact towards the end of our 
study. We discuss this further in chapter 11. 
 
In summary, this report is set out as follows: 
 
Chapter 2: Overview of methods 
Chapter 3: Innovation histories of study sites 
Chapter 4: Patient outcomes and waiting times 
Chapter 5: Hospital process data 
Chapter 6: Health economics 
Chapter 7: Patient views 
Chapter 8: Professional views at study sites 
Chapter 9: Professional views at non-study sites 
Chapter 10: GP views at study sites 
Chapter 11: Discussion 
Chapter 12: Conclusions 
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2   Overview of methods 
This chapter discusses the philosophy of our approach before summarising 
the methods we used to collect and analyse quantitative, qualitative and 
health economic data separately. A more detailed description of method is 
provided within the subsequent chapters.  
2.1   Philosophy  
Evaluation Framework 
 
Evaluative health research in health and health care can be perceived as a 
continuum with individual clinical treatments at one end and health policy at 
the other. Interventions at the clinical end are increasingly being evaluated 
by Randomised Controlled Trials (RCTs) while policy evaluations tend to 
eschew experimental designs and adopt more context-dependent 
approaches such as “realistic evaluation” (Pawson and Tilley 1997) and the 
mixed methods used to evaluate total fundholding (Goodwin, Mays, McLeod, 
Malbon and Raftery 1998). The ENIGMA project lies between the two ends of 
this continuum. 
 
In recent years, however, there have been efforts to apply the rigour of the 
RCT to clinical interventions that are more complex than single treatments 
such as drugs. The term ‘complex intervention’ describes an intervention 
made up of separate elements where it is difficult to tease out the ‘active 
ingredients’. They can include interventions in the form of organisational or 
service modifications (i.e. SDO research) as well as those at the level of the 
individual patients (Medical Research Council 2000). The Medical Research 
Council’s (MRC) framework for the design and evaluation of complex 
interventions includes a definitive RCT as phase 3 of the development and 
evaluation process, while recognising that modifications are likely to be 
required due to the complex nature of these interventions (Campbell, 
Fitzpatrick, Haines, Kinmonth, Sandercock, Spiegelhalter et al. 2000). 
 
More recently, one of the authors has developed PHAIME – a manual for 
evaluating “area wide interventions” (Westley and Russell 2008). These are 
arguably even more difficult to evaluate than ‘complex interventions’, for 
three main reasons. First it is more difficult to achieve consensus about the 
nature of an intervention across independent areas than across collegial 
teams. Second it is more difficult to randomise individual areas for the 
purpose of rigorous evaluation than individual patients. Thirdly the Cluster 
Randomised Trial (CRT), which randomises areas, is even more difficult to 
implement rigorously than the RCT, which randomises patients. So, while 
Westley and Russell (2008) recommend using CRTs where feasible, they 
recognise that modification is often necessary to take account of the political 
circumstances in which area wide interventions are implemented. These 
often prevent the random allocation of treatments and lead to a quasi-
experimental approach that opportunistically treats the political allocation of 
interventions ‘as if’ it were random. 
 
In these terms ENIGMA has treated the modernisation of endoscopy services 
as an ‘area-wide intervention’. It meets the definition of a complex 
intervention since modernisation includes many elements, some of which 
will be more ‘active’ than others in improving patient outcomes. Though 
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endoscopy services are hospital-based, they are intended to affect care 
throughout the catchment area of a hospital and are thus area-wide. Though 
we accept modernisation as a policy initiative, we have adopted a quasi-
experimental approach by extending experimental methods to an unusual 
application.  
 
Extending rigorous evaluation principles to new applications is consistent 
with the way in which research guidance is often introduced with strict 
requirements which are later relaxed. For example the RCT principles 
originally applied to fastidious (i.e. strictly controlled) trials were later 
extended to pragmatic studies; and the CONSORT statement (Moher, Schulz 
and Altman 2001) which was initially intended for trials with individual 
patient randomisation, was later extended to CRT trials. By describing how 
such extensions were applied in the ENIGMA study, we shall identify where 
this has proved difficult and offer guidance for future research. The following 
sections outline the issues which complicate this extension. 
 
Defining the intervention 
 
ENIGMA is evaluating an intervention which involved the extra financial and 
non-financial support provided by the NHS Modernisation Agency (NHSMA) 
to selected hospital sites to assist them in modernising their endoscopy 
services through the Modernisation Endoscopy Services project. During the 
period of study, however, all parts of the National Health Service (NHS) 
were operating in a climate where modernisation was an explicit overarching 
philosophy of the Department of Health (DoH). Moreover, it was evident that 
many sites had started the process of modernising before the MES 
programme began and the extent to which endoscopy services were already 
‘modern’ varied between sites. The intervention was thus intended to be a 
catalyst to the modernisation activities that all NHS sites were, to one 
extent or another, already undergoing or being planned.  
 
Design of the Intervention 
 
The MRC framework on complex interventions encompasses design as well 
as evaluation issues, arguing that problems in evaluating complex 
interventions often arise because “researchers have not fully defined and 
developed the intervention” (Campbell, Fitzpatrick, Haines, Kinmonth, 
Sandercock, Spiegelhalter et al. 2000). It advocates a pre-clinical phase to 
ensure that the intervention is grounded in theory and a modelling phase to 
ensure that the intervention includes the relevant components – although it 
will be evaluated as a whole intervention.  
 
The implication is that the intervention will be evaluated by the same people 
who are responsible for its design and development. While this may be 
reasonable in certain cases, there will clearly be circumstances where the 
two elements of the framework cannot be undertaken by the same teams. 
In these circumstances an ideal model would have separate design and 
evaluation teams but with good channels of communication between them 
and each taking independent decisions.  
 
While the NHSMA was in a position to take forward the MES programme at a 
rapid pace, the evaluation team were constrained by the slower processes 
involved in designing the evaluation and then applying for and securing 
funding. By the time the latter was achieved the intervention was already 
being introduced which meant that the opportunity to establish 
communications with the NHSMA with regard to the early phases of the MRC 
framework were lost.  
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Identifying the start date for the intervention 
 
The start date for intervention was taken as the first day that sites 
implemented their 12 month re-design programme – 1st January 2003. It 
was always anticipated, however, that many sites in the Intervention arm of 
the study would inevitably find it difficult to disentangle the modernisation 
efforts that were catalysed by the intervention from those that were already 
planned or taking place anyway. Thus, while a specific start date for the 
intervention can be identified, its catalysing features inevitably introduce 
complications not seen with the evaluation of many other complex Service 
Delivery & Organisation (SDO) interventions such as stroke clinics.  
 
Selection of Intervention and Control sites 
 
A quasi-experimental design was necessary inter alia because it was not 
possible to randomly allocate hospitals to Intervention or Control groups. 
The sampling frame was made up of all ninety-nine hospitals which had 
applied to take part in the second phase of the MES programme. Of these, 
twenty-six of the twenty-nine who piloted the ToolkitTM were chosen by the 
MA to receive the intervention leaving seventy which were not. Selection of 
Intervention and Control sites for the evaluation thus had to be made from 
within the already chosen groups rather than by random allocation. (Details 
of selection and recruitment of study sites are given in section 2.2).  
 
This meant that allocation to Intervention and Control arms of the study was 
subject to the effects of the earlier NHSMA selection which raises the 
possibility that outcomes could be influenced by confounding factors which 
could not be controlled for. For example, if the NHSMA selected those sites 
that they felt were most likely to successfully modernise, then the end 
results could be due at least in part to the NHSMA’s ability to predict the 
‘winners’ as opposed, or in addition to, the effects of the intervention. The 
mixed-method approach taken in the ENIGMA study attempts to gain an 
understanding of these effects through its qualitative enquiries.  
 
Pre-intervention preparation 
 
A potential complicating factor was the fact that all participating sites had 
applied for phase 2 MES support. This meant that from the outset each had 
declared an interest in modernising its endoscopy service and had already 
gone through an in-house inspection of their services with a view to 
preparing the relevant documentation and supporting evidence. While it 
could be argued that this resulted in sites not being representative of all 
endoscopy services in England, such ‘preparation for modernisation’ was 
regarded here as analogous to the way that patients in a clinical trial will be 
worked up in the same way to the point where the clinician determines that 
they are suitable candidates for randomisation.  
 
Table 1 illustrates the similarities and the differences between the 
Intervention and the Control sites based on their involvement or lack thereof 
in the MES programme. 
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Table 1.   MES-related activities in Intervention and Control sites  
 
Intervention Controls 
Application for MES programme 
developed 
Application for MES programme 
developed 
Advice and guidance from NHSMA and 
MES programme lead 
Advice and guidance from NHSMA and 
MES programme lead 
Access to Improvement Guides on 
NHSMA website 
Access to Improvement Guides on 
NHSMA website 
Compulsory Toolkit™ use and training Optional Toolkit™ use and training 
£30,000 from the MES programme to 
fund pre-approved redesign plans 
No MES programme funding available 
Focussed redesign plans based on pilot 
data collection and redesign plan 
Ad hoc redesign plans 
Strict data collection regime No compulsory MES-directed data 
collection regime 
Buddy events to disseminate and learn 
good practice from other MES 
programme sites 
No formal environment to disseminate 
or learn good practice 
Site visits by MES personnel for 
problem solving 
No face to face contact with MES 
personnel 
NHSMA one day conferences No invitation to NHSMA conferences 
 
In a further attempt to address this issue, it had originally been intended to 
include a third study group of genuinely independent sites (i.e. non-MES 
applicants) identified through the British Society of Gastroenterology (BSG), 
to act as a more ‘pure’ Control group while bearing in mind the climate of 
modernisation that was in place at the time. In the event these were not 
included within the experimental design as not enough sites could be 
identified. However, we did not drop this concept as a source of data and 
instead focus groups were held with representatives of non-participating 
BSG sites from both England and Wales which are reported in chapter 9. 
 
Defining modernisation 
 
Though the MES programme aimed to modernise endoscopy services, the 
NHSMA did not provide a precise definition of the term ‘modernisation’ or 
specify what was to be considered a modernisation activity or investment. 
Nevertheless this study has used the term ‘modernisation’ because that was 
the term used by the NHSMA and partly because unlike related terms such 
as ‘improvement’, it carries fewer connotations i.e. it is possible to assess 
whether or not modernisation led to an improved service. 
2.2   Hospital recruitment 
 
The twenty-six sites selected by the NHSMA for the MES programme were 
ranked by bed numbers and ten were selected using an assigned random 
number. These sites were designated “Intervention” sites. Replacements for 
sites declining to participate were selected by allocation of one before and 
one after systematic interval sampling.  
 
Of the seventy sites that were unsuccessful in their application for the MES 
programme (but who were offered access to the data collection Toolkit™ 
software along with training and support to encourage their own data 
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collection), twenty-seven sites had indicated their intention to redesign 
independently of the NHSMA. Ten of these sites were selected using the 
same method as for the Intervention sites, as were the replacement sites. 
These sites were designated “Control” sites.  
 
The 20 randomly selected sites were invited by letter to participate in the 
study and were offered £5,000 as an incentive to participate and to cover 
postage and other costs. Two researchers visited ten endoscopy units each 
in order to introduce the study, agree the key contact person and assess the 
current method of service delivery within the unit. Following an agreement 
to participate, an appropriate method of distributing the patient recruitment 
packs was agreed by each site.  
 
Of the 20 sites originally consenting to take part in the study, one 
Intervention site withdrew prior to the study beginning, citing excessive 
workloads and was replaced by the first site on the Intervention 
replacement list. None of the original Control sites withdrew prior to the 
study commencing. 
 
To ensure anonymity, all 20 sites were given a unique identification number 
that will be presented within brackets throughout the report when referring 
to a particular site in order to preserve anonymity. A more detailed 
description of each site is shown in Table 2. 
 
After the first wave of patient recruitment, two sites, one Intervention and 
one Control, were withdrawn from the study after full agreement of the 
Project Steering Group (PSG) because they were unable to comply with the 
strict patient recruitment criteria. These sites were not replaced because the 
study had already begun. The Control site indicated that they were willing to 
participate in all other aspects of the study while the Intervention site chose 
to withdraw completely. 
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Table 2.   Characteristics of participating endoscopy units 
 
Site 
ID 
Site status Site type 
Unit 
type 
† 
(at 
first 
visit) 
Population 
served by 
the Trust 
No. 
hospital 
beds 
No. 
endoscopy 
rooms in 
unit in … 
2003 2006 
8 
Full 
participation 
Intervention 1, 4 1,500,000 1048 2 2 
18 
Withdrew 
completely 
Intervention 1, 4 350,000 720 3 3 
1 
Full 
participation 
Intervention 1, 4 250,000 547 2 2 
13 
Full 
participation 
Intervention 2, 3 500,000 519 3 4 
4 
Full 
participation 
Intervention 1, 4 500,000 512 2 2 
19 
Full 
participation 
Intervention 2, 4 157,000 453 2 2 
7 
Full 
participation 
Intervention 1, 3 250,000 413 2 2 
6 
Full 
participation 
Intervention 1, 4 183,000 396 1 2 
16 
Full 
participation 
Intervention 1, 4 138,500 320 2 2 
11 
Full 
participation 
Intervention 1, 3 400,000 203 2 2 
 
2 
Full 
participation 
Control 1, 4 500,000 1100 2 2 
9 
Full 
participation 
Control 2, 3 265,000 968 2 2 
17 
Full 
participation 
Control 1, 3 750,000 650 3 3 
10 
Excluded 
from patient 
recruitment 
Control 1, 4 600,000 610 4 4 
5 
Full 
participation 
Control 2, 4 500,000 520 2 2 
12 
Full 
participation 
Control 2, 4 300,000 450 1 2 
15 
Full 
participation 
Control 1, 4 350,000 430 3 3 
20 
Full 
participation 
Control 1, 3 550,000 427 3 3 
14 
Full 
participation 
Control 1, 4 640,000 368 1 2 
3 
Full 
participation 
Control 1, 3 300,000 357 2 2 
 
†Key: 1 = self-contained; 2 = part of another specialty; 3 = modern/new 
unit; 4 = older/original unit. 
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2.3   Innovation history of participating sites 
 
Qualitative interviews were used to compile the innovation history of each 
participating site, supplemented by subsequent completion of an innovation 
form by each site. 
 
2.4   Patient outcomes and waiting times 
 
Patient outcomes data were obtained by postal questionnaires (see 
Appendices 3-6), in five waves over two years. In each of the five waves of 
the study, a total of 100 sequential patients at each site who had been 
newly referred by their GP or via an outpatient clinic for either upper or 
lower GI endoscopies were invited to complete health related quality of life 
(HRQoL) questionnaires on three occasions: at baseline (Baseline 
Questionnaire - BQ), after the planned procedure (Post Procedure 
Questionnaire – PPQ) and 12 months after the procedure (12 month Post 
Procedure Questionnaires - 12m PPQ). If the patient had not been sent an 
appointment for a procedure by 12 months they were sent a 12 month Post 
Referral Questionnaire (12m PRQ). Recruitment of patients took place in 
April and November 2004, April and October 2005 and April 2006.  
 
The primary outcome measure was GSRQ (Williams, Russell, Durai, Cheung, 
Farrin, Bloor et al. 2006). Secondary outcome measures were the Short 
Form 36 (SF-36) (www.sf-36.org); EQ-5D (EuroQol Group) and GESQ 
(Williams, Russell, Durai, Cheung, Farrin, Bloor et al. 2006).  
 
The data variables collected at BQ were: 
 
 Patient refusal or non-response. 
 Patient demographic details (age, gender, degree of urgency 
(DOU), procedure type, waiting time). 
 GSRQ, SF-36, EQ5D, patient comments. 
 
Repeat GSRQ, SF-36, EQ5D and patient comments were collected PPQ and 
12 months after procedure data collection. The GESQ was collected post 
procedure only. 
 
The waiting times for patients were compared for Intervention and Control 
sites at each wave of recruitment. Additionally a literature review was 
conducted to determine the impact of the two-week rule (TWR) for referral 
(Thorne, Hutchings and Elwyn 2006). 
2.5   Endoscopy process data analysis 
 
Endoscopy process data were collected from all 20 Intervention and Control 
sites to evaluate the impact of the MES programme on five outcome 
measures including Referral numbers, Number of patients waiting more than 
three months, Total number of patients waiting, Lost appointment slots and 
Activity over time. These five measures were compared between 
Intervention and Control sites at specific points in time. We also explored 
the availability of these data from all 20 endoscopy units and validated the 
data collected based on a comparative analysis using Hospital Episode 
Statistics (HES) data. 
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2.6     Health economics 
 
This study is evaluating an intervention which involved extra financial and 
non-financial support by the NHSMA to selected hospital sites to assist them 
in modernising their endoscopy services. Given the underlying climate of 
modernisation which prevailed during the period of the study, the economics 
of ENIGMA can be seen more generally as being concerned with the costs 
and effects of modernising endoscopy services and the extent to which the 
intervention acted as a catalyst toward modernisation. 
 
The economics component of ENIGMA addressed the following five 
questions; 
 
1. What has been the cost of modernisation in each of the ENIGMA sites?    
 
2. Did modernisation costs differ between Intervention and Control sites? 
 
3. Was there a difference in other NHS resource use between Intervention 
site patients and Control site patients? 
 
4. Was there a difference in time off work between patients in Intervention 
and Control sites? 
 
5. Was there a difference in health outcomes (as measured by EQ-5D) 
between Intervention and Control site patients?  
 
6. If results are non-dominant, what are the extra costs (+ or -) per Quality 
Adjusted Life Year (QALY) and per unit of GSRQ of Intervention versus 
Control site patients? 
2.6.1   Health economics interviews 
 
Two semi-structured interviews were held one year apart with key personnel 
at each study site to identify the resources which had been deployed to 
facilitate modernisation of the endoscopy service. Identified incremental 
resources were classified as investments which produce a flow of benefits 
over time, one off activities and recurring revenue costs. These were valued 
using standard methods. Marginal costs per patient were derived by dividing 
the total cost of modernisation at each site by its endoscopy Activity. 
2.6.2   Health economics questionnaire  
 
NHS resource use data and patients time off work were obtained from 
patients via the BQ, PPQ and 12M PPQ. These data were multiplied by unit 
costs to assess primary care, secondary care, drug and total NHS costs. 
Costs were adjusted to account for baseline effects, group effects, and 
variations in length of time between baseline and subsequent 
questionnaires. Bootstrapping methods were applied to account for skewed 
cost data. Patients reported time off work was also examined. 
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2.7   Patient views 
 
Telephone interviews were undertaken with consenting patients referred 
either as urgent or non-urgent, to the nine Intervention and nine Control 
sites, to elicit responses on their experience of the referral process to enable 
an understanding of their views of the accessibility and accessibility of 
service provision. Semi-structured interviews took place after the second 
and fifth waves of patient recruitment. The interviews were recorded and 
transcribed and analysed using content analysis. 
2.8     Professional views at study sites  
 
Semi-structured interviews were undertaken with clinicians and key people 
based in the 10 Intervention and 10 Control sites, who had played a role in 
modernising endoscopy units, To enable an understanding of the impact of 
the MES programme, the interviews aimed to capture the views of clinicians 
and key people on innovations in service organisation and delivery, 
clarifying their perceptions of the accessibility and acceptability of the 
innovations and exploring how each unit functioned to consider what 
innovations had been made or were planned. A second round of interviews 
was conducted two years later, with the same clinicians and key people to 
clarify what had taken place in the intervening two years and capture 
changes in the perceptions of participants. The interviews were recorded 
and transcribed and analysed using thematic content analysis. 
2.9   Professional views at non-study sites 
2.9.1   Recruitment and sample 
 
We were unable to identify enough study sites to be an independent group.  
Instead, we ran focus groups in England and Wales.  Focus group 
participants were accessed through the British Society of Gastroenterology’s 
(BSG) list of all registered gastroenterologists in the UK. Key figures in 
gastroenterology, including surgeons, physicians, nurse managers and nurse 
leaders were sent details of the study asking those who were committed to 
genuinely independent redesign of their gastroenterology services, to 
contribute to the study by taking part in a qualitative focus group.  
2.9.2   Method 
 
Following written consent of participants, each focus group followed a 
similar procedure, lasted approximately one hour and was tape recorded 
and transcribed. Focus groups were facilitated by the ENIGMA qualitative 
research lead (FR) and one of the two senior research officers working on 
the qualitative elements of the study (AS, GJ). In each case an observer was 
present to take notes, manage the tape recording equipment and discuss 
their overall impression of the focus group with the facilitator at the end of 
the session. The focus groups were facilitated according to a pre-designed 
interview schedule. The same schedule was used for all focus groups with 
the Welsh groups having one additional question regarding the NHSMA’s 
support for English units in terms of the impact of the NHSMA work on 
English units and impressions of the rate and extent of modernisation across 
England and Wales. The interview schedule was devised in keeping with the 
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research literature and to respond to the study aims and objectives and 
other qualitative datasets – patient and professional interviews. 
Consequently, the interview schedule concentrated on issues relating to: 
staffing, funding, impact, extent and rate of change and changes 
undertaken across units.  
 
The focus groups encouraged all participants to have an equal say in 
discussions and many questions were directed to each participant in turn. In 
recognition of their contribution, on the day of the focus group, participants 
were reimbursed for their time. 
2.10   GP views at study sites 
 
All GPs with patients in the study were sent a questionnaire at the end of 
Wave 5 asking for their perceptions of the impact of the changes that had 
occurred in the endoscopy unit participating in the study. The questionnaire 
asked GPs to complete “yes or no” to indicate whether they perceived that 
specific changes had occurred during the last two years, accompanied by a 
three-point Likert rating scale to reflect their opinion on the impact of the 
change as either better, neither better nor worse, or worse. GPs were also 
invited to make specific comments for qualitative analysis. 
2.11   The evaluation of the effects of 
modernisation using the Method for Aggregating 
the Reporting of Interventions in Complex 
Studies (MATRICS) 
 
In view of the complexity of this study we developed a matrix approach to 
summarising the effects we were seeing, the methods used and the 
findings. The first two layers of this matrix are shown in Tables 3 and 4 
(layer 1 – effects sought and layer 2 – methods used). Each effect is 
numbered and cross referenced to the appropriate method(s) using this 
number. The resultant alpha-numeric code is then cross referenced to the 
findings in layer three, which are summarised in Table 71 (a, b and c) in 
chapter 11. We have designated this approach MATRICS (Method for 
Aggregating The Reporting of Interventions in Complex Studies). 
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Table 3.   Effects1 that were sought (MATRICS layer 1) 
 
 
1Outcomes defined specifically for each perspective, according to Aims and 
Objectives. 
 
Table 4.   Methods used (MATRICS layer 2) 
 
 
 
 
Effects on patients Effects on endoscopy 
services 
Effects on the rest of 
the NHS and society 
1 -  Patient Quality of Life  
[B,D] 
6 - Cost of modernisation 
[H] 
 
14 – Patients’ time off 
work [I] 
2 - Total health benefit 
[C] 
7 – Service performance 
[A] 
 
3 - Patient experience of 
referral process  
[E] 
8 – Organisation, 
function and process of 
service delivery [E, F, G, 
J] 
4 – Patient satisfaction 
with endoscopy [L] 
9 – Accessibility to 
services [E, F, K] 
5 – Waiting times [E, M] 10 – Appropriateness and 
acceptability of services 
[F, G, K] 
 11 – Reliability and 
availability of routinely 
collected process data 
[A] 
12 – Patient use of drugs 
[I] 
13 – Patient use of 
primary and secondary 
care resources [I] 
Code Method 
A [7, 11] Process data analysis 
B [1] Analysis of SF36 scores  
C [2] Analysis of EQ-5D scores 
D [1] Analysis of GSRQ scores 
E [3, 5, 8, 10] Semi-structured patient interviews 
F[8, 9, 10] Interviews with professionals and key people 
G[8, 10] Focus groups 
H [6] Health economic site visits 
I [12, 13, 14] Health economic patient reported resource use 
J [8] Innovations form 
K [9, 10] GP questionnaire 
L [4] GESQ (patient satisfaction questionnaire) 
M [5] Analysis of time difference between referral and procedure 
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2.12 Ethics 
 
Ethical approval from the Multi-Centre Research Ethics Committee (MREC) 
for Wales (reference number 03/09/74) was received in November 2003 and 
Local Research Ethics Committees (LRECs) of the corresponding study sites 
were informed of the study accordingly. The Research and Development 
(R&D) departments in all the NHS Trusts involved in the study each granted 
approval prior to the commencement of the study. Both researchers 
obtained honorary contracts from all 20 Trusts. 
 
The time taken for R&D approval varied in each site, with a minimum of one 
day and a maximum of 150 days (Elwyn, Seagrove, Thorne and Cheung 
2005).  
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3   The innovation histories of study sites 
3.1   Executive summary  
 
This part of the evaluation sought to identify which innovations each site 
had implemented and to compare the number of innovations introduced by 
Intervention and Control sites. The innovations documented in this chapter 
include any changes made to the way the service was run, whether they 
were completely new ways of working, or simply “doing more of the same”, 
so long as the change was made with a view to improving the service or the 
patient experience. 
 
An Innovations Form with a comprehensive list of possible innovations was 
sent to all endoscopy units, and that asked them to indicate whether they 
had introduced any of the changes and if so, when they first implemented 
them (2000/02, 2003 or 2004/06) to indicate which were introduced prior 
to, during and after the MES programme. Each site was given a score to 
reflect any proactive modernisation plans with innovations introduced in 
2000/02 scoring most highly and those introduced in 2004/06 scoring 
lowest. Mean scores were analysed using two-way Analysis of Variance 
(ANOVA) to determine whether there was any significant difference in their 
scores over time and between Site types (Intervention and Control).  
 
Nineteen of 20 sites completed the form. Results indicated that on average, 
the Intervention sites had implemented more innovations than the Control 
sites although the difference was not statistically significant. Two-way 
ANOVA indicated that the scores differed significantly over time within 
Intervention sites but not in Control sites. Scores did not significantly differ 
between site types at any of the three time points tested. 
3.2   Methods 
3.2.1   Questionnaire design and allocation 
 
A list of innovations occurring in the study sites since 2000 was compiled by 
the researcher in the course of the first round of qualitative interviews with 
clinicians and key people working in the 19 participating endoscopy units 
(see chapter 8). From this data, an “Innovations Form” (see Appendix 2) 
was designed asking respondents to tick “Yes” or “No” to whether they had 
implemented each innovation listed and to tick one box under the 
Timeframe column (“2000/02”, “2003” or “2004/05”) to indicate when it 
was first implemented. A section was added at the end for the addition of 
innovations not listed on the form and for any comments.  
 
The form was piloted at Singleton Hospital in Swansea before being sent to 
the ENIGMA contact of all endoscopy units except Hospital 18 (which had 
withdrawn from any active participation in the ENIGMA study) during July 
2005. Where a response had not been received after eight weeks, a 
reminder letter and form was sent.  
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The form was revised with an additional 2006 column and resent to the 
original respondents in May 2006 to update the entries as far as April 2006. 
A third reminder and revised form was sent to sites who had not returned an 
Innovations Form at that time. 
3.2.2    Analysis plan 
 
A description of the most commonly implemented innovations was drawn up 
according to Site type. An independent samples t-test was used to 
determine whether there were any significant differences in the number of 
innovations implemented by Intervention and Control sites. 
 
Each innovation listed on the Innovation Form was scored according to 
whether it had been implemented or not and if so, when. The scoring 
system was devised to reflect any proactive redesign plans in each site by 
scoring innovations implemented earlier in the Timeframe more highly:  
Innovations implemented in 2000/02 scored “3”; innovations implemented 
during 2003 scored “2”; innovations implemented during 2004/06 scored 
“1”. Where the “Yes” column had been ticked but no specific Timeframe was 
indicated, no score was given. Any additional innovations added by 
respondents were either integrated into the existing framework where 
appropriate or were included as an additional innovation.  
 
Each site was given a score for each Timeframe and a total score that was 
used to assign a rank (1 to 19) to all study sites, irrespective of Site type. 
The scores from the three Timeframes were analysed using a two-way 
Analysis of Variance (ANOVA) to determine whether there was any 
significant difference between Site type and between Timeframes and 
whether there was a significant interaction effect. P-values ≥ 0.05 were 
considered to be statistically significant.  
3.3   Results 
 
Of the 19 endoscopy units sent the Innovations Form, all returned it 
completed for 2005 and only two did not return the updated form with 2006 
scores, both of which were Intervention sites (1 and 16). These forms were 
included in the analysis irrespective of the 2006 missing data, since any 
missing data would not have scored highly and therefore would probably not 
have had a significant impact on the final scores. Of the additional 
comments entered by respondents, all could be reclassified as one of the 
innovations already listed.  
3.3.1   Innovations introduced – a descriptive summary 
 
Of the innovations listed on the questionnaire, all were implemented by a 
minimum of two sites in each Site type out of a maximum of nine for the 
Intervention sites and 10 for the Control sites. Table 5 illustrates how many 
Intervention and Control sites implemented each innovation, split according 
to when they were first implemented. 
 
There was no significant difference between the Intervention and Control 
sites with regard to the overall number (mean 91.7 ± 37.1 vs 81.3 ± 19, p 
= 0.446) or in the types of innovation introduced. 
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Table 5.   The number of Intervention and Control sites implementing any of the 65 innovations listed between 2000 and 
2006. 
 
Innovation 
category 
Innovation type 
Number of Intervention and Control sites implementing 
innovations during… 
Intervention  (n = 9) Control (n = 10) 
2000/02 2003 2004/06 2000/02 2003 2004/06 
New / additional 
staff 
Nurse endoscopists 4 2 1 5 1 3 
GP endoscopists 1 1 0 5 1 0 
Consultants 2 1 2 4 3 3 
Link / escort nurses 2 0 2 2 1 0 
Health care assistants 2 1 1 3 0 4 
Receptionist / other clerical staff 2 1 1 3 3 2 
New management / leadership 3 0 2 0 3 2 
Data collection staff 1 0 1 0 1 2 
Alteration of 
roles 
Changing roles of medical staff 0 1 1 0 1 1 
Changing roles of clerical staff 1 2 2 1 1 5 
Clerical duties taken from nurses 1 2 2 0 0 5 
New nurse 
responsibilities 
Nurse led clinic(s) 2 0 3 3 0 3 
Nurse led consent 3 1 2 1 1 2 
Nurses performing cannulations 4 1 2 2 1 4 
PEG nurses 4 1 2 1 0 3 
Training nurses to be nurse endoscopists 2 2 1 5 1 3 
New working 
practices 
New referral procedure(s) into the unit 2 0 3 2 2 5 
Validation of referrals 2 2 2 2 2 4 
New guideline(s) / protocols 1 3 2 4 0 5 
Triage of emergency patients 2 0 3 1 0 5 
Pre-assessment clinics 1 1 1 0 0 2 
DNA strategies 2 2 1 1 4 3 
Cancellation strategies 2 2 1 1 3 4 
“6-week notice period for leave” policy 3 2 3 2 4 3 
New procedure(s) performed 3 2 1 3 1 4 
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One-stop clinics / dedicated training lists 1 0 4 2 0 5 
Increasing 
activity 
Extra slots for emergency bleeds, etc 1 0 4 3 1 4 
Scheduling extra list(s) (Mon to Fri) 0 0 5 0 5 4 
Increasing the length of the working day 0 0 4 0 0 4 
Weekend / out of hours working 2 2 2 0 0 4 
Waiting list 
management 
Validation of waiting lists 2 1 4 2 1 6 
Pooling waiting lists 3 1 2 4 1 3 
Waiting list initiative sessions 1 1 1 2 2 4 
Booking 
Open access booking 2 0 2 2 2 1 
Full booking 2 1 2 1 4 3 
Partial booking 2 4 2 2 3 4 
Structural 
changes 
New hospital / unit 1 1 1 1 1 3 
Structural alterations to current unit 1 2 1 1 1 2 
Increasing capacity in recovery area 0 1 1 1 0 4 
Centralising admin in one place 1 2 0 3 0 3 
Moving some endoscopy externally 1 1 1 0 1 3 
Refurbishment of reception / endoscopy 
suite 
2 3 1 1 0 3 
Analysis of 
working 
practices 
New / improved in-house data collection 1 3 0 2 3 4 
Demand and capacity studies 3 3 2 5 2 2 
Audits 5 1 2 3 3 4 
Process mapping 2 4 0 3 2 3 
Patient surveys 4 2 1 3 2 5 
Patient 
experience 
New information leaflets for patients 3 2 2 3 1 5 
Improving patient privacy & dignity 1 3 1 1 1 6 
Home bowel preps 5 1 1 8 2 0 
Improving experience of inpatients 1 1 3 1 1 4 
Improving experience of diabetic patients 1 1 4 1 1 6 
Improving experience of patients with 
other comorbidities 
1 0 4 1 0 2 
Staff experience 
Staff training / development 4 2 0 3 2 3 
“Protected time” for staff to meet / train 1 1 2 2 2 1 
Surveying staff on changes wanted 0 2 2 3 1 3 
The ENIGMA study 
©NCCSDO 2008 Page 38 
New / improved staffroom 2 3 0 0 0 4 
Endoscopy groups / staff meetings 3 1 1 5 2 3 
Improving staff communication 2 2 1 2 2 5 
Miscellaneous 
New medical equipment 3 2 2 3 4 3 
New IT equipment / software 1 3 2 1 3 4 
Raising the profile of endoscopy 0 4 2 2 2 2 
Advice or help from within the Trust 1 3 1 3 4 2 
Advice or help from external agencies 1 2 0 1 3 2 
Open days for hospital staff / patients 3 3 0 2 0 3 
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All nine Intervention sites had implemented the following: a six week notice 
period for leave policy, partial booking, demand and capacity studies and 
audits, while all 10 Control sites had implemented the following: additional 
consultants, audits, patient surveys, home bowel preparations, endoscopy 
groups / staff meetings and new medical equipment. 
3.3.2   Analysis of innovation scores 
 
All sites were scored as previously described. All scores and ranks are 
described for each Intervention and Control site in Table 5. The distribution 
of the Site types were fairly evenly spaced throughout the ranks, with an 
Intervention site as the top scoring site and the highest position for a 
Control site at third place. However, the lowest two ranks were also 
Intervention sites.  
 
Of the 19 sites returning a completed form, 13 had their highest score 
corresponding to 2000/02. This was to be expected, since the scoring 
framework rewarded a more proactive approach to modernisation (pre-MES 
programme innovations) more highly. Of these, seven were Intervention 
sites (1, 4, 7, 11, 13, 16 and 19) with scores ranging from 27 to 129, while 
the other six were Control sites (2, 5, 9, 15, 17 and 20), with scores ranging 
from 30 to 84. 
 
The remaining six sites had their highest scores in either 2003 (6, 8, 10 and 
12) or 2004/06 (3 and 14). Of these, two were Intervention sites (6 and 8) 
and the remaining four were Control sites (3, 10, 12 and 14). The 2003 
scores ranged from 16 to 50 for the Intervention sites and from 36 to 42 for 
the Control sites while the 2004/06 scores ranged from 30 to 44 for the 
Control sites (no Intervention sites scored more highly for 2004/06). 
 
When the scores for each Timeframe for both Site types were analysed using 
two-way ANOVA (see Table 6), there was no significant difference between 
Intervention and Control groups but there was a significant difference in the 
scores within each site at each Timeframe (F (1, 17) = 8.031, p = 0.008). 
Post hoc analysis within each Site type found that the significant difference 
for Intervention sites was between 2000/02 Vs. 2003 (p = 0.048) and 
2000/02 Vs 2004/06 (p = 0.009), but not between 2003 Vs 2004/06 (p = 
1). There were no significant differences in scores for Control sites over 
time. 
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Table 6.   A breakdown of the Innovation Form scores for each 
Timeframe and the Total Innovation scores achieved by each 
Intervention and Control site, listed according to rank.  
 
Site 
ID 
Site type 
Timeframe Total 
score 
Rank 
2000/02 2003 2004/06 
19 Intervention   129 6 14 149 1 
4 Intervention   111 20 7 138 2 
15 Control  84 18 10 112 3 
20 Control  90 8 11 109 4 
7 Intervention    48 30 29 107 5 
13 Intervention   66 22 12 100 6 
12 Control  18 42 33 93 7 
11 Intervention   66 18 7 91 8 
10 Control  24 36 22 82 9 
17 Control  45 26 10 81 10 = 
6 Intervention   3 50 28 81 10 = 
5 Control  42 16 21 79 12 
9 Control  45 18 12 75 13 
16 Intervention   36 30 6 72 14 
14 Control  18 4 44 66 15 
2 Control  30 12 20 62 16 
3 Control  6 18 30 54 17 
1 Intervention   27 12 12 51 18 
8 Intervention   9 16 11 36 19 
18 Intervention   No form sent 
 
 
Table 7.   Illustration of the results of the two-way ANOVA for the 
innovation scores from Intervention and Control groups. Significant 
values are highlighted in bold. 
 
Intervention 
group means for 
2000/02, 2003, 
2004/06 
 
Control group 
means for 
2000/02,  
2003, 2004/06 
Within-
subject 
effects  
(F ratio, 
sig.) 
Between-
subject 
effects  
(F ratio, 
sig.) 
Interaction 
effects  
(F ratio, 
sig.) 
 
55, 22.7, 14  
(n = 9) 
 
 
40.2, 19.8, 21.3 
(n = 10) 
 
8.031, 
0.008 
 
0.608,  
0.446 
 
0.918,  
0.365 
3.4   Discussion 
 
The most striking conclusion from these data was that there was no 
difference between the Intervention and Control sites in the level of 
innovation they achieved, though it is clear that for both groups the greatest 
innovation activity occurred early in the study timeframe. 
 
While not statistically significant there were however on average more 
innovations implemented by Intervention sites than by Control sites 
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suggesting that the MES programme may have encouraged the 
implementation of more innovations not only during the course of the 
project but after the project had ended.  
 
Closer examination of the types of innovations implemented by all nine 
Intervention sites - six week notice period for leave policy, partial booking, 
demand and capacity studies and audits - revealed that they were closely 
tied in with the targets allocated and the advice given by the MES 
programme team (MESPT), as described in chapter 1. The only innovation to 
be implemented by all nine Intervention sites and all 10 Control sites was 
audit. Of those innovations implemented by the Control sites, two were 
considered not to be innovations per se as they may have happened 
irrespective of any modernisation plans due to the evolution of the service – 
additional consultants and new medical equipment. However, the other 
innovations were considered to be new ways of working.  
 
When exploring the difference in Intervention and Control sites in terms of 
the number implementing each innovation type, there were 11 innovations 
that were implemented in higher numbers by the Control sites than the 
Intervention sites. Conversely only four innovations were implemented in 
higher numbers by the Intervention sites than the Control sites. This was 
surprising, since some of these innovations were considered by the 
researcher to be expensive, although it is feasible that the increases in staff 
were funded by the Trust and would have happened anyway, irrespective of 
any modernisation drive (or lack thereof) occurring within the units. It is 
interesting that more Control sites were keen to introduce or enhance 
methods of communication, both internal and external, than the 
Intervention sites. They also appeared to be more amenable to data 
collection than the Intervention sites, a finding borne out in chapter 5 of this 
report. This issue is discussed more comprehensively in that chapter.  
 
The financial implications of implementing innovations may have reduced 
the number of innovations introduced by the Control sites. Some would have 
had significant budget implications (additional staff and new equipment) 
and while funding in Control sites may have been secured from other 
sources (e.g. charitable donations, business plans), the majority would not 
have had a large amount of money with which to implement changes. They 
also would not have had the same access to advice from the MESPT 
regarding how best to analyse and modernise their services. Many changes 
implemented by the Intervention sites were very simple and were cost-
neutral and involved only changing the way a process was done, usually by 
reducing the number of resources or by transferring the responsibility of a 
process to a qualified but less expensive member of staff, freeing up the 
more specialist staff to provide their expertise more effectively. However, 
the same point can be made for the Control sites, possibly because they had 
no additional MES funding and needed to find inexpensive solutions to 
improving their services. 
 
It is clear from the forms submitted for this study that many of the Control 
sites were equally as proactive in their attempts to modernise their 
endoscopy services as those sites chosen to be MES programme sites by the 
NHSMA. Discussions with NHSMA personnel via the ENIGMA study confirmed 
that the sites were chosen based on their application form and were not 
chosen as either good sites who would inevitably do well in the project, or 
poor sites who would show significant differences in their services that 
would be attributed to the MES programme, thereby artificially 
overestimating the impact of the MES programme. The analysis of the 
Innovation Forms confirms that the Intervention and Control sites did not 
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appear to be extremely different in their pre-MES programme redesign 
plans. 
 
The ranking of the sites based on their scores revealed that Intervention 
sites held the two top and bottom spaces on the one to 19 scale. Overall, 
there were marginally more Intervention sites than Control sites populating 
the top ten spaces. This was not surprising, considering that the 
Intervention group implemented more innovations on average than the 
Control group. This result suggests that these Intervention sites were more 
proactive in their modernisation programmes, implementing changes at an 
earlier point in time than the Control sites which would have been reflected 
in their scores in earlier Timeframes.  
 
The analysis of the innovation scores from each site grouped according to 
Site type identified a significant difference in the innovation scores of both 
Site types over the three Timeframes analysed due to a large decrease in 
the scores from 2000/02 to 2004/06. Post hoc analysis confirmed a 
statistically significant difference between 2000/02 and both 2003 and 
2004/06. This implies that most sites were proactive in their modernisation 
initiatives, but that over time the number of new innovations introduced 
declined. This may have been due to the fact that the researcher only scored 
the innovation when it was first implemented so the innovation would not 
have been scored for the subsequent Timeframes if the innovation had been 
re-introduced as either a repeated or an improved version of the innovation. 
This finding would also have been affected by the nature of the scoring 
system, which gave a higher rating to those sites implementing innovations 
earlier on. 
 
When the innovation forms were returned, only four of the Intervention sites 
(4, 7, 13 and 19) had ticked the box indicating that they had “help or advice 
from external agencies”. This meant that five Intervention sites did not 
acknowledge the role of the MES programme in their modernisation 
programmes. Five Intervention sites and nine Control sites had ticked the 
box indicating that they had “new / improved in-house data collection”, a 
finding not reflected in the collection of routine data for this study. Both of 
these issues are discussed in more detail in Chapter 5. 
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4   Patient outcomes and waiting times 
4.1   Executive summary 
4.1.1   Objectives 
 
To assess the effect of modernisation implemented at each study site on 
patients Health-related Quality of Life (HRQoL) and waiting time. 
4.1.2   Methods 
 
We used a quasi-experimental design. Patients aged over 18 years referred 
for a upper gastrointestinal endoscopy (UGE) (gastroscopy or oesophago-
gastro-duodenoscopy) flexible sigmoidoscopy (FS) or colonoscopy for the 
investigation of GI symptoms were recruited from 18 study sites in five 
waves from April 2004 until April 2006. In each wave patient HRQoL scores 
were assessed at three points in time: at the time of the patients’ referral 
using the Baseline Questionnaire (BQ), immediately after their procedure 
using the Post Procedure Questionnaire (PPQ) and 12 months after the 
procedure using the 12 month Post Procedure Questionnaire (12m PPQ). The 
questionnaire process was piloted in October 2003. Patient waiting times 
were calculated by comparing the date the PPQ was completed with the date 
of referral from the study register.  
4.1.3   Statistical analysis 
 
Analysis of Variance (ANOVA) was conducted to determine whether there 
were any significant differences between the HRQoL scores reported by 
patients having a UGE, FS or colonoscopy. Differences in HRQoL scores over 
time were assessed by Repeated Measures ANOVA.  Multilevel modelling 
was conducted to determine if there were any significant differences 
between the Control and Intervention sites with respect to the GSRQ 
(Gastrointestinal Symptom Rating Questionnaire), the two Short Form 36 
(SF-36) summary measures (the Physical Component Summary (PCS) and 
the Mental Component Summary (MCS)) and the GESQ (Gastrointestinal 
Endoscopy Satisfaction Questionnaire). One way between-groups analysis of 
covariance comparisons were conducted to determine if there were any 
significant differences between the Control and Intervention sites with 
respect to the Euroqol-5D (EQ-5D). Independent samples t-tests were used 
to determine whether there were any differences between the Intervention 
and Control sites in waiting time.  
4.1.4   Results 
 
9154 patients were assessed for eligibility, 7974 were invited, and 3818 
consented to take part. Non-respondent analysis showed some differences in 
age and procedure types between the consenters and the non-consenters. 
Data were adjusted to take account of these differences in analysis of 
patient outcomes. There was a significant improvement in both disease 
specific (GSRQ) and generic (SF-36) and (EQ-5D) HRQoL following all types 
The ENIGMA study 
©NCCSDO 2008 Page 44 
of endoscopy procedure. There was no difference between the Intervention 
and Control groups in any of the HRQoL measures. Intervention patients 
waited on average seven days less than the Control patients for their 
Endoscopy procedure, but this was not translated into improvements in 
patient outcomes. There was no overall change in waiting times between 
April 2004 and January 2007. 
4.2   Objectives   
 
The primary objective of this part of the study was to assess the effect of 
innovations implemented at each study site on patient HRQoL and waiting 
times, taking into account factors which might also have an impact (gender, 
age, type of procedure, degree of urgency (DOU), time at follow-up and 
study site). The effect of the MES programme on patient waiting times was 
also assessed. 
4.3 Methods 
 
Patient HRQoL scores were assessed at three points in time: at the time of 
the patients’ referral using the BQ, immediately after their procedure using 
the PPQ and 12 months after the procedure using the 12m PPQ. If a 
procedure had not taken place within one year of referral, a 12 month Post 
Referral Questionnaire (12m PRQ) was sent. 
 
Each of the study questionnaires contained the following sub-sections: the 
Medical Outcomes Study (SF-36 v2) questionnaire (purchased from www.sf-
36.org/), the EQ-5D questionnaire (located at www.euroqol.org) and the 
GSRQ (Williams, Russell, Durai, Cheung, Farrin, Bloor et al. 2006). A fourth 
questionnaire, the GESQ (Williams, Russell, Durai, Cheung, Farrin, Bloor et 
al. 2006), was included in the PPQ. In addition to completion of the 
quantitative HRQoL sections, patients were also given the option to make 
comments regarding specific aspects of their treatment. 
 
Patient HRQoL scores were collected from the questionnaires of all 
consenting patients from five waves of recruitment. The questionnaires were 
scanned using a Canon DR5020 scanner and the scores were downloaded 
into SPSSTM v13.0 (Lead Technologies Inc. 2004, USA) for analysis. 
Individual HRQoL sub-scale scores for each of the scales were calculated 
according to the developer’s guidelines. The effect of study sites were 
analysed with SPSS and confirmed with MLwiN v2.0 (Rasbash, Steele, 
Browne and Prosser 2004). 
 
Patient waiting times were calculated by comparing the date the PPQ was 
completed with the date of referral from the study register. 
4.3.1   Participating patients 
 
Only those patients over the age of 18 years who were referred for a UGE 
(gastroscopy or Oesophageal-Gastro-Duodenoscopy (OGD)) or Lower 
Gastrointestinal Endoscopy (LGE) (Flexible sigmoidoscopy or colonoscopy) 
for the investigation of GI symptoms and did not exhibit any of the 
exclusion criteria (outlined in Section 2.4) were considered for the study.  
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Following the withdrawal of two sites from the patient recruitment aspect of 
the study, a total of 9,000 patients were invited to take part. Units were 
limited to recruiting a maximum of 20 patients per day to ensure a fair 
allocation of patient types throughout a week.  
 
Exclusion criteria for patients were issued to all staff responsible for 
allocating the study questionnaire packs, which were: 
 
1. Patients aged under 18y 
2. Patients with a learning disability 
3. Patients who are severely ill or have a terminal illness 
4. Patients in emergency situations 
5. Patients with a mental illness 
6. Prisoners or young offenders 
7. Patients already participating in a research study 
8. Patients who were undergoing repeat or surveillance procedures 
9. Patients who do not speak English 
 
On receipt of the referral documentation, the endoscopy staff posted the 
study questionnaire packs to the home address of eligible patients, and 
completed a study register with the patients’ contact and referral details. 
The register was updated and returned to the study team on a regular basis.  
 
Patients wishing to participate in the study were asked to complete a BQ at 
home and sign the consent form before returning it to the study team using 
the Freepost envelope provided. Patients refusing to participate were asked 
to return the blank BQ and in doing so, were not contacted again.  
 
A system of reminders was set up to encourage patients to complete the BQ. 
If a patient did not return the BQ within two weeks of the hospital sending 
it, the study team sent a reminder letter and a second, identically numbered 
BQ, using the information provided by the study register. A reminder 
telephone call was made a minimum of two weeks after the reminder letter 
was sent. A postcard was sent as a final reminder when no contact was 
made by phone, or if contact was made but the questionnaire was not still 
returned after a further two weeks. Following the reminders, if a patient still 
did not respond, they were designated “non-responders” and were not 
pursued any further. Reminders were not sent to patients whose 
appointment date had passed. 
 
Patient outcomes were measured at the time of patient referral, immediately 
after procedure and 12 months after procedure using the generic health 
questionnaires SF-36 Version 2 and EQ-5D, and a GI symptom-specific 
questionnaire called the GRSQ. The PPQ contained an additional 
questionnaire called the GESQ. This was a patient satisfaction questionnaire 
that addressed how the patient rated the hospital, skills of the team, pain 
and discomfort and information received before and after their procedure. 
 
These questionnaires were used to obtain patients’ HRQoL scores, use of 
NHS resources including drugs and time off work (reported in Chapter 6). 
The HRQoL sections elicited patients’ assessment of their health status for 
both GI-specific conditions and general health at the time of referral, 
immediately after the procedure, and one year after the procedure. All three 
questionnaires were completed by the patient at home. The format of all 
questionnaires was designed in-house using TELEform™ version 10 
(Teleform Enterprise 2003, USA) and professionally printed by Zenith Media 
(Cardiff, Wales).  
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BQ 
 
12M PRQ 
 
PPQ 
 
12M PPQ 
 
24M PRQ 
 
 
The first pack to be sent contained the BQ previously described. The second 
pack contained the PPQ which was sent to patients by the study team once 
they had had their procedure. The last pack contained the 12M PPQ and was 
sent by the study team a year after their procedure date (see Figure 1).  
 
Additional questionnaire packs were sent to patients who had not had their 
procedures more than 12 months and 24 months after their referral date. 
These contained the 12 month Post Referral Questionnaire (12M PRQ) and in 
some cases, the 24 month Post Referral Questionnaire (24M PRQ). Once the 
patient had attended their procedure, they were sent the second pack 
containing the PPQ (see Figure 2). 
 
Figure 1.   Allocation of all study questionnaires when the patient has 
their appointment within 12 months of being referred. 
 
 
 
 
 
Figure 2.   Allocation of all study questionnaires when the patient has 
their appointment more than 12 months, and possibly 24 months, 
after being referred. 
 
 
 
 
 
 
 
All study packs were pre-packed by the study team and were uniquely 
numbered using a five-digit system whereby the first two numbers ran from 
1-20 and represented the hospital identification number. The last three 
numbers ran from 1-500 and identified each patient and which wave of 
recruitment they were from.  
 
The first study pack posted to the patient by the hospital contained the BQ, 
a letter to the patient on hospital headed notepaper with the signature of 
the local hospital consultant affiliated with the study on the bottom, a 
“Frequently Asked Questions” sheet containing contact numbers, a Freepost 
envelope and a green postcard, which patients were asked to complete with 
the date of their endoscopy appointment and return the day after they had 
attended their procedure. On the outside of the pack were two blue hospital 
postcards that were removed prior to posting the pack to the patient and 
attached to the patients’ notes or referral letter by the endoscopy staff. On 
the day that the patient attended for their procedure, one of the postcards 
was returned to the study team to inform them whether the patient had 
attended or, if not, of the outcome (if the patient was given a second 
appointment or was discharged back to the GP). The second postcard was 
returned to the study team if they attended a subsequent appointment.  
PPQ  12M PPQ  BQ  
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4.3.2   The pilot study  
 
The questionnaire process was piloted in October 2003 in the endoscopy 
unit of Singleton Hospital, Swansea (not one of the ENIGMA study sites) 
with 160 packs over a period of two months. The pilot indicated a response 
rate of only 38%, a refusal rate of 27% and a non-responder rate of 35%.  
 
The documentation was amended and a system of following up patients who 
did not return the BQ was established before a second phase was initiated 
with 50 packs in March 2004. The response rate increased to 59%. The 
refusal rate was still 27%, but the number of non-responders had reduced 
to 14%. The main study began with all changes implemented in the second 
pilot as standard. 
4.3.3   Outcome measures 
The primary outcome measure was GSRQ, secondary outcome measures 
were the SF-36, EQ-5D and GESQ. 
4.3.4   Statistical methods 
 
The primary analysis was by intention to treat, i.e. all patients who were 
properly recruited were included even if they did not follow their intended 
pathway, and all significance tests were two-sided and set at a significance 
level of 0.05. Correction tests were not applied to the data because they are 
highly conservative and were likely to mask any significant results (Perneger 
1998). Instead we examined the proportion of significant tests in relation to 
the number of tests performed to determine if the results represented true 
differences or mere chance. For example in applying a significance level of 
0.05 we would expect at least one in 20 tests to be significant by chance. If 
a greater proportion than this were significant this would represent a true 
difference in outcomes. 
 
In addition, ANOVA plus post-hoc tests comparisons were carried out to 
determine if there were any significant differences between the consenter, 
responder and non-responder groups at recruitment. Prior to any statistical 
comparisons between the Intervention and Control groups being carried out, 
a sensitivity analysis was undertaken whereby the proportion of consenters, 
refusers and non-responders were compared for their demographic 
characteristics including age, gender, DOU, procedure type and waiting 
time, split according to the corresponding wave of patient recruitment. The 
generalisability of the consenting group of patients to the general population 
was tested by a comparison of the consenters and non-consenters using 
Chi-squared tests for categorical data variables and independent samples t-
tests for continuous data variables. Where a 2x2 contingency table was 
analysed, the Yate’s continuity correction was used.  
 
Post hoc analysis was done to determine the source of any significant 
differences.  
 
The refusers and non-responders were later merged into a non-consenter 
group and any baseline characteristics that were found to be significantly 
different between the consenting and non-consenting groups were 
subsequently weighted in the consenting group to ensure that it was 
representative of the whole patient population. 
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Missing items within individual outcome measures were treated according to 
the scale developer’s instructions for that particular measure. Where data 
were missing for the 12M PPQ values, the last case carried forward policy 
was adopted. For example where the BQ (time point 0) and PPQ (time point 
1) data were present but the 12m PPQ (time point 2) data were missing, 
data were carried forward from the PPQ. A further weighting of the carried 
forward PPQ, based on the relative relationship of the PPQ to the 12m PPQ 
data, was not adopted in this instance as it was anticipated that it was 
unlikely to have any major impact on the results. Mean substitution was 
used for other missing items. 
 
Independent samples t-tests were used to determine whether there were 
any differences between the Intervention and Control groups in waiting 
time. In addition the difference between the study groups was assessed 
within each of the five waves of recruitment. 
 
Baseline scores were analysed using Analysis of Variance (ANOVA) and post 
hoc tests with data split according to procedure type to determine whether 
there were any significant differences between the scores reported by 
patients having a UGE, FS or colonoscopy. 
 
Data were also analysed to determine whether there were any significant 
differences in HRQoL scores over time using a repeated measures analysis 
and post hoc analysis with the data split according to procedure type to 
determine whether the mean HRQoL of patients having UGEs, FS or 
colonoscopies improved significantly from the time of referral to the time at 
12 months post procedure. 
 
Multilevel modelling was conducted to determine if there were any 
significant differences between the Control and Intervention sites with 
respect to the subscales on the GSRQ, the two SF-36 summary measures 
(the Physical Component Summary (PCS) and the Mental Component 
Summary (MCS)). The resultant models would take account of site effects, 
in particular of systematic differences between the models of service 
delivery adopted by each centre. The primary dependent variable was the 
12m PPQ scores (for each of the three outcome questionnaires). Patient-
level covariates included: the site type (Intervention or Control), BQ scores, 
adjusted age, gender, adjusted procedure type, DOU, time to 12m PPQ, and 
waves of recruitment. Site-level covariates included: innovation score, 
teaching hospital status and bed size. Multilevel modelling was also 
performed on the patient satisfaction (GESQ) data with each of the sub-
scale scores as the dependent variable, with a similar set of covariates. As 
this measure was only used in the PPQ, BQ scores were not included and 
time to PPQ was used instead of time to 12m PPQ. 
 
Where more comprehensive models were slow or failed to converge, the 
findings from a less complex model were reported. Similarly, when the final 
Hessian matrices were negative, the findings from a less complex, flat 
model were reported. The speed of convergence and the final Hessian 
matrix were checked to ascertain the validity of the fitted models. Goodness 
of fit tests based on maximum log likelihood were used to assess how well 
the models fitted the data. 
 
The size and the direction of the effect of individual covariate on the 
dependent variable would be estimated by the size and the sign on the 
coefficient (positive or negative). The coefficient showed how much the 
dependent variable was expected to increase (if the coefficient was positive) 
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or decrease (if the coefficient was negative) when that covariate increased 
by one, holding all the other covariates constant. 
 
One way between-groups analysis of covariance comparisons were 
conducted to determine if there were any significant differences between the 
Control and Intervention sites with respect to the EQ-5D outcomes. The 
independent variable was the assigned group (Intervention or Control) and 
the primary dependent variable was the 12m PPQ scores. BQ scores, age, 
gender, procedure type, DOU, time to 12m PPQ, teaching hospital status, 
bed size, wave of recruitment and innovation scores were used as covariates 
in the analysis. Preliminary checks were conducted to ensure that there was 
no violation of the assumptions of normality, linearity, homogeneity of 
variances, homogeneity of regression slopes, and reliable measurement of 
the covariate. 
 
The number and types of comments made in each of the three 
questionnaires (BQ, PPQ, 12m PPQ) were examined to determine if there 
were any differences between the Intervention and Control groups in each of 
the five waves. Chi-squared tests were carried out to determine if any of the 
differences were significant and a significance level of 0.05 was regarded as 
statistically significant. 
4.4   Results  
 
Patient outcomes data were available for 18 of the original 20 recruited 
hospitals. One hospital withdrew its involvement completely and a second 
was unable to manage the questionnaire distribution within the defined time 
period. Patients were recruited into the study from 19th April 2004 to 26th 
January 2007. Returned questionnaires were accepted until 31st December 
2007. 
4.4.1   Participant recruitment and flow  
 
There was a significant difference between all three patient types in terms of 
age at recruitment, gender, DOU, waiting time and procedure type. Post hoc 
analysis for age and waiting time revealed that for age, all three groups 
were statistically different from each other, whilst for waiting time the non-
responders were significantly different from both the refusers and the 
consenters but the waiting time for consenters and refusers was not 
significantly different.  
 
Details of the participant recruitment and flow through the study is 
summarised in Figure 3.  
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Patients considered (n=4611) Patients considered (n=4630) 
Figure 3. Consort diagram 
Intervention sites           Control sites 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Non study patients* (n=81)     Non study patients* (n=6) 
Assessed for eligibility (n=4530) Assessed for eligibility (n=4624) 
 
Excluded (hospital) (n=48) 
Excluded (study) (n=36) 
Excluded in error** (n=8) 
Patients lost to follow up (n=16) 
Included in error (n=66) 
Procedure date passed (n=360) 
 Excluded (hospital) (n=78) 
Excluded (study) (n=43) 
Excluded in error** (n=7) 
Patients lost to follow up (n=6) 
Included in error (n=49) 
Procedure date passed (n=462) 
Consented patients (n=1885) Consented patients (n=1933) 
Eligible patients (n=3996) Eligible patients (n=3979) 
 
Actively refused to participate 
(n=1207) 
Did not respond to invitation 
(n=904) 
 
 Actively refused to participate 
(n=1219) 
Did not respond to invitation 
(n=827) 
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Patients lost to follow up (n=22) 
Patients not having a procedure 
(withdrawn patients)*** (n=64) 
Patient withdrawal after consent 
(n=35) 
Unable to send PPQ – no proc date 
available (n=17) 
Excluded in error** (n=2) 
No PPQ sent**** - 12M PPQ sent 
out (n=4) 
Patients not completing PPQ 
(n=276) 
 
Patients returning a 
PPQ (n=1465) 
Patients lost to follow up (n=29) 
Patient withdrawal after consent 
(n=22) 
Patients with 12MPPQ to be sent 
>01/01/08 (n=19) 
Patients not completing 12M PPQ 
(n=416) 
 
Patients lost to follow up (n=13) 
Patients not having a procedure 
(withdrawn patients)*** (n=47) 
Patient withdrawal after consent 
(n=56) 
Unable to send PPQ – no proc 
date available (n=41) 
Excluded in error** (n=4) 
No PPQ sent**** - 12M PPQ sent 
out (n=43) 
Patients not completing PPQ 
(n=259) 
Patients returning a 
PPQ (n=1470) 
Patients lost to follow up (n=31) 
Patient withdrawal after consent 
(n=21) 
Patients with 12MPPQ to be sent 
>01/01/08 (n=23) 
Patients not completing 12M PPQ 
(n=370) 
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*   Non study patients – no information available on these patients from the hospital 
**  Excluded in error – patients originally excluded as ‘other’ (e.g. patient went private, patient having exploratory proc etc).   
  Some patients from waves 4 and 5 were subsequently re-instated and followed up. 
*** Patients not having procedure (withdrawn patients) – patients originally not followed up due to hospital/patient withdrawal  
  from  procedure. Some patients from waves 4 and 5 were subsequently re-instated and followed up.  
**** No PPQ sent out – due to the time lapse between the actual procedure being carried out and the hospital notifying ENIGMA  
  of the procedure date, the PPQ was not sent out. However, 12M PPQ was still sent out if applicable. 
Patients returning a 
12m PPQ (n=1260) 
Patients returning a 
12m PPQ (n=1327) 
Patients 
returning a 
12m PRQ 
(n=5) 
Patients 
returning a 
12m PRQ 
(n=23) 
Patients not sent 12M PRQ as 
excluded in error due to being 
withdrawn (W1-4) (n=48) 
Patients not sent 12M PRQ due to 
unavailable information from hospital 
(n=11) 
Patient withdrawal after consent 
(n=0) 
Patients not completing 12M PRQ 
(n=16) 
Patients returning 12M PRQ and 
eligible for PPQ / 12M PPQ (n=0) 
 
 
Patients not sent 12M PRQ as 
excluded in error due to being 
withdrawn (W1-4) (n=40) 
Patients not sent 12M PRQ due to 
unavailable information from 
hospital (n=14) 
Patient withdrawal after consent 
(n=1) 
Patients not completing 12M PRQ 
(n=14) 
Patients returning 12M PRQ and 
eligible for PPQ / 12M PPQ (n=5) 
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In total 3818 patients were enrolled in the study, 1885 (49.4%) to the 
Intervention group and 1933 (50.6%) to the Control group.  
4.4.2   Questionnaire response rates 
 
Of the 3818 patients completing the BQ, a further 2935 (76.9%) returned 
the PPQ and 2587 (67.8%) returned the 12m PPQ (Table 8). There was no 
significant difference in response rates for each questionnaire type between 
Intervention and Control patients (Chi-squared = 0.806, p = 0.668). 
 
Table 8.   Questionnaire response rates 
 
 Total  Intervention  Control  
BQ (%) 3818 1885 (49.4%) 1933 (50.6%) 
PPQ (%) 2935 1465 (49.9%) 1470 (50.1%) 
12m PPQ (%) 2587 1260 (48.7%) 1327 (51.3%) 
4.4.3   Patient demographics and sensitivity analysis  
 
Those returning a completed BQ were classified as Consenters, whilst those 
actively refusing to participate, both verbally and in writing were classified 
as Refusers. Those patients who did not respond to any attempts to contact 
them by post and by telephone were classified as Non-responders. The 
baseline characteristics of the three patient groups invited to participate in 
the ENIGMA study are shown in Table 9. When the three groups were 
compared, there were significant differences for age, gender, DOU, waiting 
time and procedure type. Post hoc analysis determined that the differences 
for aged all three groups were statistically different from each other, whilst 
for waiting time the Non-responders were significantly different from both 
the Refusers and the Consenters but the waiting time for Consenters and 
Refusers was not significantly different.  
 
Table 9.   Baseline characteristics of patients invited to participate in 
the study. The significance level is 0.05 
 
Characteristics Consenters 
N=3818 
Refusers 
N=2426 
Non-
responders 
N=1731 
P-value 
Age at recruitment (y) 
Mean (SD) 
Range 
 
55.5 (15.24) 
18.1 – 97.1 
 
62.6 (14.8) 
18.5 – 96.5 
 
48 (15.9) 
18.1 – 95.5 
 
<0.001 
Gender (%) 
Number of males  
Number of females 
 
1708 (48) 
2110 (47.9) 
 
955 (26.8) 
1463 (33.2) 
 
897 (25.2) 
834 (18.9) 
 
<0.001 
Wave (%) 
1 
2 
3 
4 
5 
 
820 (47.3) 
742 (48.2) 
781 (49.2) 
769 (47.7) 
706 (46.9) 
 
538 (31.1) 
473 (30.7) 
468 (29.5) 
473 (29.3) 
474 (31.5) 
 
374 (21.6) 
326 (21.2) 
337 (21.2) 
370 (23) 
324 (21.5) 
 
0.81 
 
(Cont…)
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(Cont…) 
 
DOU (%) 
Two Week Rule (TWR) 
Urgent 
Soon 
Routine 
 
139 (52.9) 
1140 (48.6) 
811 (49.3) 
1688 (46.5) 
 
92 (35) 
790 (33.7) 
460 (28) 
1045 (28.8) 
 
32 (12.2) 
417 (17.8) 
373 (22.7) 
899 (24.8) 
 
<0.001 
Site type (%) 
Intervention  
Control  
 
1885 (47.2) 
1933 (48.6) 
 
1207 (30.2) 
1219 (30.6) 
 
904 (22.6) 
827 (20.8) 
 
0.132 
Waiting time (days) 
Mean (SD) 
Range 
 
56.44 (60.46) 
-14 – 654 
 
52.77 (61.89) 
-7 – 844 
 
62.35 (66.04) 
-7 – 690 
 
<0.001 
Procedure type (%) 
Upper GIs † 
FS 
Colonoscopy 
Combination 
 
2030 (46.2) 
753 (49) 
838 (50.7) 
179 (50.6) 
 
1369 (31.1) 
444 (28.9) 
494 (29.9) 
107 (30.2) 
 
996 (22.7) 
341 (22.2) 
322 (19.5) 
68 (19.2) 
 
0.019 
Procedure type (%) 
Upper GIs † 
Lower GIs ‡ 
 
2030 (46.2) 
1591 (49.8) 
 
1369 (31.1) 
938 (29.4) 
 
996 (22.7) 
663 (20.8) 
 
0.006 
 
Key: † Gastroscopies and OGDs combined; ‡ FS and colonoscopy combined. 
 
Examination of the Refuser and Non-responder groups highlighted the 
differences of these two groups with the Consenters. However, the 
differences between the Refuser and the Non-responder group were in 
opposite directions. Since weighting of the HRQoL data was to be based on 
the completed patient questionnaire, the demographics of the Refuser and 
Non-responder groups were aggregated into one group to become a “Non-
consenters” group. Consequently, the effect of those differences were 
cancelled out when the two groups were aggregated. The baseline 
characteristics of Consenters and Non-consenters are shown in Table 10. 
 
Table 10.   Baseline characteristics of patients who consented to the 
study and those patients who did not (refusers and non-responders 
combined). The significance level is 0.05. 
 
Characteristics Consenters 
N=3818 
Non-consenters 
N= 4157 
P-value 
Age at recruitment (y) 
Mean (SD) 
Range 
 
55.52 (15.24) 
18.1 – 97.1 
 
56.49 (16.89) 
18.1 – 96.5 
 
0.007 
Gender (%) 
Number of males  
Number of females 
 
1708 (48) 
2110 (47.9) 
 
1852 (52) 
2297 (52.1) 
 
0.948 
Wave (%) 
1 
2 
3 
4 
5 
 
820 (47.3) 
742 (48.2) 
781 (49.2) 
769 (47.7) 
706 (46.9) 
 
912 (52.7) 
799 (51.8) 
805 (50.8) 
843 (52.3) 
798 (53.1) 
 
0.74 
(Cont…)
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DOU (%) 
TWR 
Urgent 
Soon 
Routine 
 
139 (52.9) 
1140 (48.6) 
811 (49.3) 
1688 (46.5) 
 
124 (47.1) 
1207 (51.4) 
833 (50.7) 
1944 (53.5) 
 
0.063 
 
Site type (%) 
Intervention  
Control  
 
1885 (47.2) 
1933 (48.6) 
 
2111 (52.8) 
2046 (51.4) 
 
0.216 
Waiting time (days) 
Mean (SD) 
Range 
 
56.44 (60.46) 
0 – 661 
 
56.76 (63.82) 
0 – 1841 
 
0.823 
Procedure type (%) 
Upper GIs † 
FS 
Colonoscopy 
Combination 
 
2030 (46.2) 
753 (49) 
838 (50.7) 
179 (50.6) 
 
2365 (53.8) 
785 (51) 
816 (49.3) 
175 (49.4) 
 
0.008 
Procedure type (%) 
Upper GIs † 
Lower GIs ‡ 
 
2030 (46.2) 
1591 (49.8) 
 
2365 (53.8) 
1601 (50.2) 
 
0.002 
  
Key: † Gastroscopies and OGDs combined; ‡ FS and colonoscopy combined.  
 
There were significant differences between the Consenters and Non-
consenters for age and procedure type. Consequently, the age and 
procedure type of the Consenters have been weighted accordingly in all 
subsequent analyses. 
 
The baseline characteristics of the Consenters split according to whether 
they were recruited from Intervention or Control sites are shown in Table 
11. There were significant differences between Consenters from the 
Intervention and Control sites for age, DOU, waiting time and procedure 
type. 
 
Table 11.   Baseline characteristics of consenting patients from 
Intervention and Control sites.  
 
Characteristics Intervention 
N=3979 
Control 
N=3996 
p-value 
Age at recruitment (y) 
Mean (SD) 
Range 
 
55.63 (16.17) 
18.1 – 97.1 
 
56.43 (16.08) 
18.1 – 94.5 
 
0.026 
Gender (%) 
Number of males  
Number of females 
 
1769 (49.7) 
2219 (50.4) 
 
1791 (50.3) 
2188 (49.6) 
 
0.558 
Wave (%) 
1 
2 
3 
4 
5 
 
832 (48) 
767 (49.8) 
801 (50.5) 
816 (50.6) 
780 (51.9) 
 
900 (52) 
774 (50.2) 
785 (49.5) 
796 (49.4) 
724 (48.1) 
 
0.271 
 
(Cont…)
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DOU (%) 
TWR 
Urgent 
Soon 
Routine 
 
25 (9.5) 
958 (40.8) 
898 (54.6) 
2076 (57.2) 
 
238 (90.5) 
1389 (59.2) 
746 (45.4) 
1556 (42.8) 
 
<0.001 
Waiting time (days) 
Mean (SD) 
Range 
 
54.65 (54.86) 
-13 – 690 
 
58.58 (68.81) 
-14 – 844 
 
0.006 
Procedure type (%) 
Upper GIs † 
FS 
Colonoscopy 
Combination 
 
2173 (49.4) 
976 (63.5) 
673 (40.7) 
147 (41.5) 
 
2222 (50.6) 
562 (36.5) 
981 (59.3) 
207 (58.5) 
 
<0.001 
Procedure type (%) * 
Upper GIs † 
Lower GIs ‡ 
 
2173 (49.4) 
1649 (51.7) 
 
2222 (50.6) 
1543 (48.3) 
 
0.06 
 
* combinations of procedures not included. 
4.4.4   Disease specific HRQoL – GSRQ 
Patients in both groups in each of the five waves reported a decrease in 
each of the four GSRQ subscales from BQ to PPQ, with a further decrease in 
scores from PPQ to 12m PPQ. This indicated fewer symptoms following a 
procedure which was maintained 12 months later (see Table 12). 
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Table 12.   The mean unadjusted GSRQ scores for patients for each questionnaire split according to Site type and Wave.  
Mean Score (SE) Intervention Control 
BQ 
Max n=385 
PPQ 
Max n=302 
12m PPQ 
Max n=272 
BQ 
Max n=399 
PPQ 
Max n=302 
12m PPQ 
Max n=276 
GSRQ Factor 1: Upper GI 
Scored 0 (no symptoms) – 100 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
23.46 (1.1) 
25.26 (1.11) 
22.54 (1.07) 
23.66 (1.06) 
21.79 (1.07) 
 
 
19.51 (1.15) 
20.82 (1.17) 
17.89 (1.1) 
19.98 (1.12) 
16.89 (1) 
 
 
15.96 (1.11) 
15.75 (1.16) 
12.38 (0.93) 
14.1 (0.99) 
13.06 (1.03) 
 
 
22.52 (0.98) 
23.68 (1.07) 
22.53 (0.95) 
22.9 (1.06) 
22.95 (1.11) 
 
 
19.56 (1.11) 
20.79 (1.18) 
17.71 (0.99) 
19.47 (1.22) 
19.71 (1.14) 
 
 
16.13 (1.13) 
16.96 (1.17) 
14.46 (0.96) 
13.68 (1) 
12.6 (0.99) 
GSRQ Factor 2: Lower GI   
Scored 0 (no symptoms) – 100 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
30.57 (1.56) 
30.05 (1.56) 
27.89 (1.52) 
34.91 (1.61) 
32.5 (1.6) 
 
 
26.47 (1.61) 
25.85 (1.53) 
22.95 (1.65) 
27.59 (1.68) 
28.86 (1.77) 
 
 
22.31 (1.58) 
24.38 (1.64) 
22.13 (1.66) 
23.77 (1.58) 
22.29 (1.81) 
 
 
33.22 (1.61) 
32.26 (1.63) 
33.19 (1.57) 
30.96 (1.56) 
29.04 (1.53) 
 
 
26.82 (1.66) 
29.8 (1.75) 
29.47 (1.76) 
26.15 (1.71) 
24.59 (1.67) 
 
 
24.2 (1.63) 
27.69 (1.72) 
27.87 (1.74) 
22.54 (1.62) 
19.63 (1.52) 
GSRQ Factor 3: Wind 
Scored 0 (no symptoms) – 100 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
45.3 (1.38) 
47.65 (1.42) 
44.06 (1.44) 
49.12 (1.35) 
43.92 (1.38) 
 
 
41.08 (1.54) 
41.84 (1.56) 
41.02 (1.57) 
43.2 (1.46) 
41.22 (1.47) 
 
 
35.33 (1.57) 
34.88 (1.57) 
33.68 (1.68) 
34.34 (1.4) 
34.48 (1.65) 
 
 
45.25 (1.34) 
46.64 (1.38) 
44.05 (1.34) 
44.39 (1.43) 
45.34 (1.42) 
 
 
41.75 (1.55) 
43.12 (1.65) 
39.85 (1.54) 
42.42 (1.74) 
41.26 (1.58) 
 
 
35.09 (1.54) 
37.19 (1.56) 
35.82 (1.51) 
34.37 (1.56) 
32.26 (1.54) 
GSRQ Factor 4: Defaecation 
Scored 0 (no symptoms) – 100 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
25.84 (1.27) 
26.44 (1.31) 
24.21 (1.26) 
23.8 (1.13) 
22.18 (1.13) 
 
 
23.56 (1.37) 
23.51 (1.46) 
21.87 (1.4) 
22.19 (1.23) 
19.93 (1.21) 
 
 
19.88 (1.23) 
22.87 (1.51) 
19.5 (1.34) 
20.64 (1.29) 
18.84 (1.41) 
 
 
24.09 (1.21) 
24.8 (1.23) 
24.58 (1.16) 
24.03 (1.24) 
22.9 (1.2) 
 
 
22.85 (1.43) 
21.3 (1.28) 
21.5 (1.21) 
22.91 (1.44) 
22.28 (1.41) 
 
 
19.89 (1.33) 
20.18 (1.41) 
20.29 (1.3) 
19.5 (1.38) 
17.95 (1.42) 
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4.4.5   GSRQ baseline scores  
 
There were significant differences in the baseline scores of the four GSRQ 
measures (Upper GI and lower GI symptoms, wind and defaecation) 
according to UGE, FS or colonoscopy. Post hoc analysis was done to 
determine which of the three procedures were significantly different to the 
others using a Bonferroni adjustment. The results of this analysis are shown 
in Table 13. 
 
Post hoc tests highlighted at baseline UGE patients had significantly worse 
symptoms than FS and colonoscopy patients in relation to the GSRQ factors 
of upper GI symptoms and wind but significantly better symptoms than FS 
and colonoscopy patients in relation to wind. UGE patients had significantly 
better symptoms than colonoscopy patients in relation to defaecation 
symptoms. 
 
4.4.6   GSRQ – changes in BQ, PPQ and 12m PPQ scores 
 
All three procedure types showed a statistically significant improvement in 
all four GSRQ scores from BQ to 12m PPQ. Most of the sub-scales also 
showed a statistically significant improvement from BQ to PPQ (see Table 
13). 
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Table 13.   Illustration of the differences in baseline scores according to each procedure type using ANOVA and post hoc 
tests. 
 
 Analysis by ANOVA Post hoc tests 
GSRQ factor Mean 
Baseline UGE 
score (SE) 
[n] 
Mean 
Baseline FS 
score (SE) 
[n] 
 
Mean Baseline 
Colonoscopy 
score (SE) [n] 
P-value Mean Difference 
UGE - FS  
(p-value) 
Mean Difference 
UGE - 
colonoscopy  
(p-value) 
Mean Difference 
FS - colonoscopy  
(p-value) 
 
1 (Upper GI) 
 
 
29.13 (20.15) 
[1902] 
 
 
14.5 (16.32) 
[705] 
 
16.59 (16.77) 
[788] 
 
<0.001 
 
14.628 
(<0.001) 
 
12.54 (<0.001) 
 
-2.09 (0.093) 
 
2 (Lower GI) 
 
 
24.36 (26.52) 
[1947] 
 
 
38.4 (31.66) 
[725] 
 
41.11 (32.46) 
[812] 
 
<0.001 
 
-14.04 (<0.001) 
 
-16.75 (<0.001) 
 
-2.71 (0.206) 
 
3 (Wind) 
 
 
49.31 (26.03) 
[1923] 
 
 
39.2 (25.35) 
[710] 
 
42.33 (26.01) 
[800] 
 
<0.001 
 
10.11 (<0.001) 
 
6.98 (<0.001) 
 
-3.13 (0.058) 
 
4 (Defaecation) 
 
 
22.75 (23.17) 
[1952] 
 
 
24.88 (22.46) 
[718] 
 
26.34 (22.8) 
[809] 
 
<0.001 
 
-2.13 (0.099) 
 
-3.59 (0.001) 
 
-1.46 (0.648) 
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Table 14.   Table of the mean GSRQ scores from each questionnaire split according to procedure type, along with the 
mean difference between each procedure type 
 
GSRQ factor Procedure 
type 
Mean BQ 
score (SE) 
Mean 
PPQ 
score 
(SE) 
Mean 12m 
PPQ score 
(SE) 
P-value Mean 
Difference BQ 
- PPQ (p-
value) 
Mean 
Difference BQ - 
12m PPQ (p-
value) 
Mean 
Difference 
PPQ - 12m 
PPQ (p-value) 
 
1 (Upper GI) UGE 
[n=1139] 
27.31 (0.57) 22.66 
(0.57) 
16.22 (0.51) <0.001 4.64 (<0.001) 11.09 (<0.001) 6.44 (<0.001) 
FS 
[n = 432] 
12.7 (0.73) 11.75 
(0.68) 
10.23 (0.66) <0.001 0.96 (0.1) 2.47 (<0.001) 1.51 (0.008) 
Colonoscopy 
[n = 497]  
16.16 (0.74) 15.32 
(0.74) 
13.76 (0.73) <0.001 0.84 (0.168) 2.389 (<0.001) 1.55 (0.014) 
2 (Lower GI) UGE 
[n = 1206] 
22.49 (0.74) 20.51 
(0.72) 
19.39 (0.69) <0.001 1.98 (0.001) 3.1 (<0.001) 1.12 (0.216) 
FS 
[n = 456] 
37.19 (1.47) 32.05 
(1.36) 
25.36 (1.24) <0.001 5.14 (<0.001) 11.82 (<0.001) 6.69 (<0.001) 
Colonoscopy 
[n = 521]  
41.57 (1.42) 35.97 
(1.36) 
30.93 (1.28) <0.001 5.6 (<0.001) 10.64 (<0.001) 5.04 (<0.001) 
3 (Wind) UGE 
[n = 1151] 
48.26 (0.76) 43.29 
(0.78) 
35.69 (0.73) <0.001 4.97 (<0.001) 12.58 (<0.001) 7.6 (<0.001) 
FS 
[n = 442] 
37.24 (1.15) 35.57 
(1.11) 
30.76 (1.1) <0.001 1.67 (0.103) 6.48 (<0.001) 4.81 (<0.001) 
Colonoscopy 
[n = 506]  
42.19 (1.14) 40.5 
(1.14) 
35.96 (1.13) <0.001 1.69 (0.047) 6.24 (<0.001) 4.55 (<0.001) 
4 (Defaecation) UGE 
[n = 1199] 
21.87 (0.66) 20.97 
(0.66) 
19.42 (0.63) <0.001 0.9 (0.215) 2.45 (<0.001) 1.55 (0.015) 
FS 
[n = 455] 
23.92 (1.06) 22.22 
(0.96) 
20.97 (0.99) 0.006 1.7 (0.096) 2.95 (0.007) 1.25 (0.554) 
Colonoscopy 
[n = 517]  
25.89 (1) 22.78 
(0.97) 
20.04 (0.92) <0.001 3.11 (<0.001) 5.85 (<0.001) 2.74 (0.003) 
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4.4.7   GSRQ at 12 months – multilevel modelling 
 
Random intercept models (which assumed random site effects and common 
linear effect of the covariates) and random slope models (which assumed 
random site effects and differing covariate effect between sites) were fitted. 
The findings were similar but the random slope models were slow to 
converge. Therefore, only the random intercept models were reported.  
 
There were no statistically significant differences between the study groups 
in the four GSRQ subscales (see Table 15). Baseline scores were found to 
have significant effects on all the GSRQ subscales, i.e. if patients were more 
ill at Baseline they had worse symptoms at 12m. Males were found to have 
better outcomes as measured by GSRQ3 and GSRQ4. If a patient was male 
their GSRQ scores were 1.61 and 2.49 point better on the GSRQ3 and 
GSRQ4 respectively. Those patients having a colonoscopy (scores worse by 
3.25 units) and those who waited longer (scores worse by 0.013 units) were 
found to have worse outcome for GSRQ1 and patients recruited at later 
waves were found to have better outcome (0.53 units better) at 12 month 
follow up as measured by GSRQ1. 
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Table 15.  Effects of covariates on primary outcome measure (12 months GSRQ scores) 
Effect size (SE) [sig] GSRQ1 
Upper GI 
GSRQ2 
Lower GI 
GSRQ3 
Wind 
GSRQ4 
Defaecation 
Gender  -0.74 (0.53) 
[0.16] 
-1.36 (0.86) 
[0.12] 
-1.61 (0.78) 
[0.04] 
-2.49 (0.71) 
[<0.001] 
Age  0.005 (0.019) 
[0.78] 
-0.055 (0.03) 
[0.08] 
-0.04 (0.028) 
[0.12] 
-0.034 (0.025) 
[0.18] 
Upper GI  0.67 (1.21) 
[0.58] 
1.18 (1.96) 
[0.55] 
0.033 (1.75) 
[0.99] 
1.54 (1.6) 
[0.38] 
FS  2.11 (1.36) 
[0.12] 
0.11 (2.21) 
[0.96] 
2.2 (1.98) 
[0.27] 
2.03 (1.81) 
[0.26] 
Colonoscopy  3.25 (1.38) 
[0.02] 
2.84 (2.25) 
[0.21] 
3.74 (2.01) 
[0.063] 
-0.52 (1.84) 
[0.78] 
Urgency of referral  0.0.14 (0.31) 
[0.66] 
0.93 (0.51) 
[0.07] 
-0.07 (0.47) 
[0.88] 
-0.5 (0.42) 
[0.23] 
Baseline scores  0.58 (0.015) 
[<0.001] 
0.52 (0.014) 
[<0.001] 
0.61 (0.015) 
[<0.001] 
0.55 (0.015) 
[<0.001] 
Time to 12m PPQ  0.013 (0.004) 
[0.005] 
0.008 (0.007) 
[0.26] 
0.012 (0.007) 
[0.077] 
0.012 (0.006) 
[0.06] 
Innovation score  -0.003 (0.01) 
[0.754] 
0.009 (0.017) 
[0.60] 
0.015 (0.017) 
[0.39] 
0.15 (0.014) 
[0.31] 
No of beds  0.0004 (0.002) 
[0.785] 
0.003 (0.002) 
[0.26] 
0.0007 (0.002) 
[0.76] 
0.0001 (0.002) 
[0.96] 
Teaching hospital  -0.15 (0.799) 
[0.85] 
0.001 (1.27) 
[0.99] 
-0.14 (1.28) 
[0.91] 
1.65 (1.06) 
[0.14] 
Wave  -0.53 (0.19) 
[0.004] 
-0.47 (0.31) 
[0.12] 
-0.2 (0.28) 
[0.48] 
0.05 (0.25) 
[0.86] 
Intervention/Control  -0.20 (0.59) 
[0.74] 
-0.61 (0.94) 
[0.52] 
-0.71 (0.94) 
[0.46] 
0.009 (0.79) 
[0.99] 
N 2395 2468 2414 2456 
-2 Log Likelihood 18932.60 22048.58 21029.50 20958.93 
N.B. GSRQ Score 0 (no symptom) to 100
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4.4.8   GSRQ at post procedure 
 
Multilevel models were fitted but the final Hessian matrices were not 
positive. Therefore, findings from flat models were reported. See Table 16. 
 
There were no statistically significant differences between the study groups 
in the four GSRQ subscales (see Table 16). Baseline scores were found to 
have significant effects on all the GSRQ subscales, i.e. if patients were more 
ill at baseline they had worse symptoms at PPQ. Males were found to have 
better outcomes as measured by GSRQ1, GSRQ3 and GSRQ4. Older patients 
had fewer defaecation symptoms as measured by the GRSQ4. Those 
patients having a UGE or a FS had fewer symptoms on the GRSQ1. Those 
patients that were regarded as urgent had worse symptoms and those 
patients who waited less time for their procedure had fewer symptoms on 
the GSRQ4. Those patients treated in a hospital with a higher innovation 
score had more symptoms on the GSRQ3. 
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Table 16.   Effects of Covariates on Primary outcome measure (post procedure GSRQ scores). Significance was at 0.05 
Effect size (SE) [sig] GSRQ1 
Upper GI 
GSRQ2 
Lower GI 
GSRQ3 
Wind 
GSRQ4 
Defaecation 
Gender  -2.20 (0.47) 
[<0.001] 
-1.26 (0.70) 
[0.073] 
-2.82 (0.67) 
[<0.001] 
-1.73 (0.62) 
[0.006] 
Age  -0.015 (0.017) 
[0.36] 
-0.037 (0.025) 
[0.13] 
-0.038 (0.024) 
[0.11] 
-0.044 (0.021) 
[0.04] 
Upper GI  -2.25 (1.08) 
[0.037] 
-0.52 (1.62) 
[0.75] 
-0.94 (1.52) 
[0.54] 
-0.78 (1.40) 
[0.58] 
FS  -3.01 (1.22) 
[0.013] 
0.13 (1.81) 
[0.94] 
-0.59 (1.72) 
[0.73] 
-1.99 (1.58) 
[0.21] 
Colonoscopy  -1.70 (1.24) 
[0.17] 
1.26 (1.85) 
[0.50] 
0.64 (1.76) 
[0.71] 
-2.34 (1.61) 
[0.15] 
Urgency of referral  -0.05 (0.27) 
[0.84] 
0.21 (0.41) 
[0.62] 
-0.091 (0.39) 
[0.82] 
-0.81 (0.36) 
[0.025] 
Baseline scores  0.74 (0.013) 
[<0.001] 
0.71 (0.012) 
[<0.001] 
0.75 (0.013) 
[<0.001] 
0.69 (0.013) 
[<0.001] 
Time to PPQ  0.0055 (0.0037) 
[0.13] 
-0.0064 (0.0056) 
[0.26] 
0.0025 (0.0054) 
[0.64] 
0.014 (0.005) 
[0.004] 
Innovation score  0.012 (0.0090) 
[0.18] 
-0.0085 (0.014) 
[0.53] 
0.026 (0.013) 
[0.045] 
0.019 (0.012) 
[0.12] 
No of beds  -0.00050 (0.0012) 
[0.69] 
-0.0030 (0.0019) 
[0.11] 
0.0010 (0.0018) 
[0.18] 
0.0011 (0.0016) 
[0.50] 
Teaching hospital  -0.07 (0.66) 
[0.97] 
1.85 (1.0009) 
[0.064] 
0.34 (0.95) 
[0.72] 
0.27 (0.87) 
[0.75] 
Wave  -0.0066 (0.16) 
[0.97] 
0.13 (0.25) 
[0.49] 
0.24 (0.24) 
[0.31] 
0.13 (0.22) 
[0.55] 
Intervention/Control  -0.016 (0.50) 
[0.97] 
-0.38 (0.75) 
[0.61] 
0.58 (0.72) 
[0.44] 
0.36 (0.66) 
[0.58] 
N 2614 2778 2669 2766 
-2 Log Likelihood 20289.78 24029.54 22732.15 23178.45 
N.B. GSRQ Score 0 (no symptom) to 100
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4.4.9   SF-36 
 
Patients in both groups in each of the five waves reported improvements in 
each of the eight SF-36 subscales and the physical and mental component 
summary scores from baseline to post-procedure indicating improved overall 
health. Although the scores at 12 months were still greater than baseline 
scores, only minor changes (positive or negative) were exhibited in the PPQ 
to the 12m PPQ scores. This indicated only minor changes in the perceived 
health of the patient from PPQ to 12m PPQ. The largest differences were 
apparent in the subscales social functioning, pain and role limitation 
physical (Table 17).  
 
There were significant differences in the baseline scores of the two SF-36 
summary measures (PCS and MCS) according to UGE, FS or colonoscopy. 
The results of this analysis are shown in Table 18. Post hoc analysis 
illustrated that for the SF-36 summary measures UGE patients exhibited 
significantly worse health than FS patients on both the PCS and MCS scales 
and significantly worse health than colonoscopy patients on the PCS scale. 
FS patients had significantly better health than colonoscopy patients. 
4.4.10   EQ-5D  
 
Patients in both groups in each of the five waves reported improvements in 
the EQ-5D scores from baseline to post-procedure indicating improved 
health. Although the scores at 12 months were still greater than BQ scores, 
only minor changes (positive or negative) were exhibited in the PPQ to the 
12m PPQ scores. This indicated only minor changes in the perceived health 
of the patient from PPQ to 12m PPQ (Table 17). 
 
There were significant differences in the baseline scores for the EQ-5D 
according to procedure type (see Table 18). Post hoc analysis highlighted 
that UGE patients exhibited significantly worse health than FS and 
colonoscopy patients.  
4.4.11   SF-36 & EQ-5D – changes in BQ, PPQ and 12m PPQ 
scores 
 
All three procedure types showed a statistically significant improvement in 
both the SF-36 summary measures and the EQ-5D from baseline to 12m 
PPQ. The SF-36 summary scores and EQ-5D similarly showed a significant 
improvement from baseline to PPQ for all procedures, with the exception of 
colonoscopy patients on the SF-36 PCS summary score and the EQ-5D. 
Although not significant the colonoscopy patients did exhibit and overall 
improvement in this period (see Table 19).  
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Table 17.   Secondary outcome measures (EQ-5D, SF-36) – unadjusted figures, split by wave 
 
 Intervention Control 
Mean Score (SE) BQ 
Max n=376 
PPQ 
Max n=309 
12m PPQ 
Max n=319 
BQ 
Max n=405 
PPQ 
Max n=360 
12m PPQ 
Max n=331 
EQ-5D   
Scored -0.594 (the worst 
imaginable health state) to 1 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
 
0.66 (0.01) 
0.64 (0.02) 
0.66 (0.02) 
0.67 (0.01) 
0.67 (0.01) 
 
 
 
0.7 (0.2) 
0.68 (0.02) 
0.75 (0.02) 
0.72 (0.01) 
0.74 (0.01) 
 
 
 
0.7 (0.02) 
0.67 (0.02) 
0.73 (0.02) 
0.7 (0.01) 
0.72 (0.02) 
 
 
 
0.65 (0.02) 
0.64 (0.02) 
0.68 (0.01) 
0.66 (0.02) 
0.65 (0.02) 
 
 
 
0.69 (0.02) 
0.67 (0.02) 
0.71 (0.02) 
0.71 (0.02) 
0.7 (0.02) 
 
 
 
0.69 (0.02) 
0.68 (0.02) 
0.7 (0.02) 
0.7 (0.02) 
0.7 (0.02) 
SF-36 - Physical Functioning  
Scored 0 (worse health) – 100 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
70.28 (1.59) 
70.33 (1.52) 
71.35 (1.57) 
72.33 (1.39) 
71.88 (1.55) 
 
 
71.32 (1.67) 
70.16 (1.77) 
75.97 (1.67) 
72.86 (1.57) 
74.42 (1.68) 
 
 
70.95 (1.68) 
70.28 (1.76) 
73.66 (1.76) 
73.66 (1.58) 
74.37 (1.66) 
 
 
68.61 (1.57) 
69.36 (1.54) 
71.08 (1.46) 
70.59 (1.43) 
69.87 (1.57) 
 
 
68.71 (1.78) 
68.35 (1.77) 
71.79 (1.71) 
71.35 (1.75) 
72.03 (1.73) 
 
 
67.82 (1.78) 
67.75 (1.8) 
71.04 (1.68) 
71.06 (1.65) 
72.26 (1.73) 
SF-36 - Social Functioning  
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
65.3 (1.54) 
65.87 (1.62) 
69.02 (1.55) 
67.17 (1.41) 
67.69 (1.48) 
 
73.26 (1.69) 
71.97 (1.84) 
78.51 (1.61) 
73.62 (1.63) 
75.42 (1.63) 
 
70.05 (1.71) 
68.75 (1.87) 
74.96 (1.73) 
71.73 (1.7) 
72.7 (1.74) 
 
66.95 (1.49) 
64.36 (1.57) 
65.25 (1.48) 
66.25 (1.47) 
65.43 (1.57) 
 
71.33 (1.79) 
70.46 (1.81) 
72.1 (1.8) 
73.36 (1.83) 
72.12 (1.76) 
 
71.69 (1.76) 
69.82 (1.75) 
71.36 (1.76) 
73.36 (1.7) 
71.49 (1.72) 
SF-36 - Role limitation – 
Physical 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
63.81 (1.75) 
62.95 (1.72) 
67.27 (1.78) 
65.2 (1.65) 
65.06 (1.63) 
 
 
69.07 (1.85) 
68.19 (1.93) 
75.56 (1.79) 
70.45 (1.75) 
71.86 (1.83) 
 
 
68.31 (1.84) 
67.68 (1.86) 
72.07 (1.9) 
69.92 (1.71) 
72 (1.83) 
 
 
62.16 (1.7) 
62.31 (1.72) 
63.64 (1.64) 
63.55 (1.68) 
62.3 (1.75) 
 
 
67.35 (1.94) 
66.02 (1.97) 
68.19 (1.86) 
69.33 (1.98) 
66.16 (2) 
 
 
65.57 (1.95) 
64.05 (1.92) 
66.9 (1.91) 
68.95 (1.87) 
67.52 (1.89) 
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SF-36 - Role limitation - 
Mental 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
71.83 (1.62) 
70.62 (1.7) 
74.98 (1.61) 
71.5 (1.49) 
74 (1.52) 
 
 
74.79 (1.68) 
73.21 (1.88) 
80.42 (1.55) 
75.72 (1.62) 
78.26 (1.62) 
 
 
75.17 (1.68) 
75.24 (1.77) 
77.97 (1.68) 
76.9 (1.64) 
76.31 (1.7) 
 
 
71.51 (1.66) 
70.38 (1.65) 
70.13 (1.55) 
74.7 (1.52) 
72.92 (1.65) 
 
 
71.89 (1.9) 
73.69 (1.8) 
73.96 (1.74) 
79.47 (1.68) 
72.53 (1.96) 
 
 
71.85 (1.84) 
71.62 (1.87) 
74.53 (1.69) 
78.4 (1.63) 
73.43 (1.85) 
SF-36 - Mental Health  
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
63.6 (0.71) 
62.97 (0.73) 
67.51 (0.98) 
63.62 (1.1) 
65.77 (1.08) 
 
68.26 (1.29) 
67.8 (1.3) 
72.7 (1.19) 
69.59 (1.19) 
70.26 (1.26) 
 
68.2 (1.26) 
67.69 (1.28) 
72.8 (1.15) 
68.29 (1.21) 
68.18 (1.2) 
 
64.74 (0.67) 
63.29 (0.77) 
64.27 (0.86) 
66.22 (1.1) 
64.15 (1.25) 
 
67.9 (1.3) 
67.82 (1.33) 
69.4 (1.18) 
70.72 (1.29) 
67.35 (1.4) 
 
67.5 (1.25) 
66.11 (1.31) 
69.05 (1.19) 
69.42 (1.25) 
68.16 (1.29) 
SF-36 – Vitality 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
49.35 (1.13) 
46.22 (1.24) 
48.31 (1.25) 
41.88 (1.2) 
43.88 (1.17) 
 
47.6 (1.35) 
45.1 (1.45) 
50.91 (1.46) 
47.59 (1.34) 
48.25 (1.42) 
 
47.24 (1.34) 
44.67 (1.4) 
50.76 (1.38) 
46.4 (1.3) 
47.61 (1.31) 
 
48.47 (1.17) 
46.15 (1.19) 
45.64 (1.15) 
42.65 (1.23) 
42.23 (1.25) 
 
46.29 (1.51) 
44.28 (1.5) 
48.04 (1.44) 
46.44 (1.47) 
46.65 (1.55) 
 
45.83 (1.4) 
43.69 (1.39) 
47.27 (1.34) 
46.66 (1.32) 
47 (1.4) 
SF-36 – Pain 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
57.81 (1.27) 
55.71 (1.37) 
60.36 (1.41) 
60.37 (1.28) 
57.17 (1.27) 
 
68.66 (1.36) 
65.4 (1.54) 
71.41 (1.49) 
69.36 (1.37) 
68.48 (1.39) 
 
66.19 (1.5) 
63.73 (1.59) 
67.59 (1.63) 
64.83 (1.48) 
66.45 (1.51) 
 
59.73 (1.41) 
55.42 (1.34) 
57.55 (1.26) 
58.84 (1.33) 
56.23 (1.4) 
 
69.19 (1.5) 
66.13 (1.52) 
68.89 (1.5) 
66.47 (1.61) 
67.78 (1.57) 
 
67.19 (1.56) 
66.26 (1.57) 
66.48 (1.5) 
65.68 (1.56) 
65.14 (1.56) 
SF-36 - General Health  
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
58.02 (0.95) 
58.04 (1) 
60.36 (0.99) 
58.79 (0.94) 
58.52 (0.94) 
 
59.51 (1.21) 
58.42 (1.3) 
62.61 (1.32) 
60.1 (1.2)  
60.48 (1.28) 
 
58.89 (1.25) 
57.49 (1.31) 
63.07 (1.3) 
58.56 (1.28) 
60.13 (1.28) 
 
58.31 (0.97) 
57.21 (0.94) 
58.51 (0.93) 
57.1 (0.92) 
57.39 (0.99) 
 
58.32 (1.31) 
57.22 (1.36) 
61.2 (1.3) 
58.67 (1.36) 
57.76 (1.34) 
 
58.47 (1.31) 
56.04 (1.32) 
59.68 (1.29) 
58.22 (1.33) 
56.99 (1.23) 
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SF-36 - Physical Component 
Summary (PCS) 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
45.45 (0.56) 
45.08 (0.55) 
45.97 (0.54) 
46.17 (0.46) 
47.08 (0.5) 
 
 
46.49 (0.55) 
45.8 (0.59) 
47.8 (0.6) 
46.73 (0.54) 
46.82 (0.56) 
 
 
46.34 (0.61) 
46.3 (0.62) 
47.21 (0.67) 
46.77 (0.58) 
47.11 (0.6) 
 
 
45.3 (0.6) 
45.08 (0.56) 
45.42 (0.52) 
45.1 (0.5) 
44.27 (0.54) 
 
 
46.34 (0.62) 
45.12 (0.61) 
46.67 (0.58) 
45.92 (0.63) 
46.34 (0.59) 
 
 
46.53 (0.65) 
45.17 (0.65) 
47.08 (0.61) 
45.79 (0.67) 
46.76 (0.61) 
SF-36 - Mental Component 
Summary (MCS) 
Wave 1  
Wave 2  
Wave 3  
Wave 4 
Wave 5 
 
 
44.03 (0.42) 
43.65 (0.48) 
46.04 (0.54) 
43.61 (0.57) 
44.27 (0.57) 
 
 
46.12 (0.65) 
45.12 (0.71) 
48.12 (0.63) 
46.08 (0.63) 
46.44 (0.66) 
 
 
46.12 (0.66) 
45.63 (0.68) 
48.08 (0.62) 
46.15 (0.62) 
45.72 (0.66) 
 
 
44.19 (0.42) 
43.47 (0.46) 
43.75 (0.48) 
44.59 (0.55) 
43.35 (0.62) 
 
 
45.79 (0.69) 
45.08 (0.68) 
46.14 (0.67) 
46.85 (0.66) 
45.07 (0.74) 
 
 
45.97 (0.68) 
44.94 (0.67) 
46.8 (0.68) 
47 (0.61) 
45.84 (0.72) 
 
Table 18.   Illustration of the differences in baseline scores for the SF-36 PCS and MCS and the EQ-5D according to each 
procedure type. Significance was at 0.05. 
 
Secondary 
outcome 
measure 
Mean 
Baseline UGE 
score (SE) 
[n] 
Mean 
Baseline FS 
score (SE) 
[n] 
Mean Baseline 
Colonoscopy 
score (SE) [n] 
P-value Mean Difference 
UGE - FS (p-
value) 
Mean Difference 
UGE - 
colonoscopy (p-
value) 
Mean Difference 
FS - colonoscopy  
(p-value) 
SF-36 PCS 44.53 (0.22) 
[1741] 
47.08 (0.37) 
[663] 
45.72 (0.37) 
[746] 
<0.001 -2.55 (<0.001) -1.19 (0.013) 1.36 (0.024) 
SF-36 MCS 43.85 (0.22) 
[1741] 
45 (0.37) 
[663] 
44.16 (0.34) 
[746] 
0.026 -1.15 (0.02) -0.31 (1) 0.84 (0.273) 
EQ-5D 0.64 (0.01) 
[1952] 
0.69 (0.01) 
[719] 
0.68 (0.01) 
[813] 
<0.001 -0.05 (0.001) -0.04 (0.009) 0.01 (1) 
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Table 19.   Table of the mean GSRQ scores from the SF-36 PCS and MCS and the EQ-5D split according to procedure type, 
along with the mean difference between each procedure type. Significance was at 0.05. 
 
Outcome 
measure 
Procedure 
type 
Mean 
Baseline 
score (SE) 
Mean PPQ 
score (SE) 
Mean 12m 
PPQ score 
(SE) 
P-value Mean 
Difference BQ - 
PPQ (p-value) 
Mean 
Difference BQ - 
12m PPQ (p-
value) 
Mean 
Difference 
PPQ - 12m 
PPQ (p-value) 
SF-36 PCS UGE 
[n = 1219] 
45.23 (0.26) 46.92 (0.25) 46.64 (0.28) <0.001 -1.69 (<0.001) -1.41 (<0.001) 0.28 (0.291) 
FS 
 [n = 480] 
47.32 (0.41) 48.87 (0.38) 48.44 (0.4) <0.001 -1.55 (<0.001) -1.12 (<0.001)  0.43 (0.238) 
Colonoscopy 
[n = 524]  
46.54 (0.43) 47.75 (0.4) 46.73 (0.43) <0.001 -1.21 (<0.001) -0.19 (1) 1.02 (<0.001) 
SF-36 MCS UGE 
[n = 1219] 
44.55 (0.26) 46.23 (0.31) 45.96 (0.3) <0.001 -1.68 (<0.001) -1.41 (<0.001)  0.27 (0.706) 
FS 
 [n = 480] 
45.66 (0.43) 48.49 (0.47) 47.67 (0.46) <0.001 -2.84 (<0.001) -2.01 (<0.001) 0.82 (0.068) 
Colonoscopy 
[n = 524]  
45.01 (0.39) 47.11 (0.46) 47.05 (0.44) <0.001 -2.09 (<0.001) -2.04 (<0.001) 0.05 (1) 
EQ-5D UGE 
[n = 1465] 
0.66 (0.01) 0.69 (0.01) 0.69 (0.01) <0.001 -0.03 (<0.001) -0.03 (<0.001) 0 (1) 
FS 
[n = 554] 
0.7 (0.01) 0.74 (0.01) 0.74 (0.01) <0.001 -0.04 (<0.001) -0.04 (<0.001) 0 (1) 
Colonoscopy 
[n = 614]  
0.7 (0.01) 0.71 (0.01) 0.71 (0.01) 0.042 -0.02 (0.036) -0.01 (0.811) 0.01 (0.599) 
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4.4.12   SF-36 – multilevel modelling 
 
Multilevel models were fitted but the final Hessian matrices were not 
positive. Therefore, findings from flat models were reported.  
See Table 20. 
 
At 12m PPQ, there were no statistically significant differences between the 
study groups in the SF-36 summary scores (see Table 20). Baseline scores 
were found to have significant effects on the SF-36 scores with patients that 
had worse health at baseline having worse health at 12m. Males were found 
to have better health as measured by the SF-36 MCS. Younger patients had 
worse health as measured by the SF-36 PCS. Those patients having a UGE 
had worse health as measured by the SF-36 MCS. The waiting time had a 
significant impact on outcome with those patients waiting longer exhibiting 
worse health on the SF-36 PCS. 
 
Table 20.   Effects of covariates on SF-36 PCS and SF-36 MCS (12m 
PPQ scores) 
 
Effect size (SE) [sig] 
 
SF36 PCS 
Scored 0  (poor health) 
– 100 
SF36 MCS 
Scored 0 (poor health) – 
100 
Gender  0.07 (0.26) 
[0.78] 
0.87 (0.34) 
[0.011] 
Age  -0.094 (0.0094) 
[<0.001] 
-0.00072 (0.012) 
[0.95] 
UGE  0.16 (0.62) 
[0.80] 
-2.10 (0.82) 
[0.010] 
FS  0.23 (0.70) 
[0.75] 
-1.20 (0.91) 
[0.19] 
Colonoscopy  -0.46 (0.71) 
[0.52] 
-1.49 (0.93) 
[0.11] 
DOU  0.25 (0.15) 
[0.10] 
-0.26 (0.20) 
[0.20] 
Baseline scores  0.75 (0.014) 
[<0.001] 
0.69 (0.019) 
[<0.001] 
Time to 12m PPQ  -0.0050 (0.0024) 
[0.034] 
-0.0049 (0.0031) 
[0.12] 
Innovation score  0.0053 (0.0050) 
[0.30] 
-0.011 (0.0066) 
[0.11] 
No of beds  0.00022 (0.00069) 
[0.75] 
0.0017 (0.00091) 
[0.064] 
Teaching hospital  -0.028 (0.37) 
[0.94] 
-0.83 (0.48) 
[0.084] 
Wave  0.091 (0.092) 
[0.32] 
-0.050 (0.12) 
[0.68] 
Intervention/Control  0.026 (0.28) 
[0.92] 
0.29 (0.36) 
[0.42] 
N 2317 2317 
-2 Log Likelihood 15008.54 16263.50 
P < 0.05 
 
Multilevel models were fitted at PPQ but the final Hessian matrices were not 
positive. Therefore, findings from flat models were reported. See Table 20. 
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At PPQ, there were no statistically significant differences between the study 
groups in the SF-36 summary scores (see Table 21). BQ scores were found 
to have significant effects on the SF-36 scores with patients that had worse 
health at BQ having worse health at PPQ. Males were found to have better 
health as measured by the SF-36 MCS. Younger patients had worse health 
as measured by the SF-36 PCS. Those patients classified as urgent and 
those waiting longer for their procedure exhibited significantly worse health 
as measured by the SF-36 PCS. The number of hospital beds in a unit also 
had an impact on patient outcome with more hospital beds leading to worse 
patient health on the SF-36 MCS. 
 
Table 21.   Effects of covariates on SF-36 PCS SF-36 MCS (PPQ scores) 
 
Effect size (SE) [sig] SF36 PCS 
Scored 0 (poor health) 
– 100 
SF36 MCS 
Scored 0 (poor health) – 
100 
Gender  0.33 (0.22) 
[0.13] 
0.92 (0.32) 
[0.004] 
Age  -0.037 (0.0078) 
[<0.001] 
0.012 (0.011) 
[0.29] 
UGE  0.29 (0.51) 
[0.57] 
-0.26 (0.75) 
[0.73] 
FS  0.64 (0.58) 
[0.27] 
1.22 (0.85) 
[0.15] 
Colonoscopy  0.39 (0.59) 
[0.51] 
0.44 (0.86) 
[0.61] 
DOU  0.36 (0.13) 
[0.004] 
0.32 (0.19) 
[0.086] 
Baseline scores  0.75 (0.012) 
[<0.001] 
0.81 (0.017) 
[<0.001] 
Time to PPQ  -0.0050 (0.0018) 
[0.005] 
-0.004 (0.0026) 
[0.101] 
Innovation score  0.0036 (0.0042) 
[0.40] 
0.00016 (0.0062) 
[0.98] 
No of beds  0.00024 (0.00058) 
[0.68] 
0.0018 (0.00085) 
[0.038] 
Teaching hospital  0.039 (0.31) 
[0.90] 
-0.35 (0.45) 
[0.4] 
Wave  0.052 (0.076) 
[0.50] 
-0.096 (0.11) 
[0.39] 
Intervention/Control  0.049 (0.23) 
[0.83] 
0.041 (0.38) 
[0.90] 
N 2415 2415 
-2 Log Likelihood 14871.30 16709.15 
 
P < 0.05 
4.4.13   EQ-5D  – Analysis of covariance 
 
After adjusting for BQ score, type of procedure, DOU, adjusted age, gender, 
waiting time, time elapsed between BQ and 12m PPQ sent, hospital bed 
size, innovation scores, wave of recruitment and whether the hospital was a 
teaching hospital using analysis of covariance (ANCOVA), there were no 
statistically significant differences between the Intervention and Control 
group for the EQ-5D at 12 month post-procedure.  
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Similarly the ANCOVA comparison at post-procedure (adjusting for the same 
covariates) showed no statistical significance between the Intervention and 
Control group.  
4.4.14   Waiting times 
 
On average patients waited 63.52 (SD 67.08) days for their procedure. 
There was a significant difference between the Intervention and Control 
groups in waiting times (Intervention- 60.04d, Control- 66.96d, p= 0.002). 
When each wave was examined, the first four waves showed a difference in 
favour of the Intervention group (Wave 1: Intervention- 53.93d, Control- 
58.95d, Wave 2: Intervention- 67.32d, Control- 78.37, Wave 3: 
Intervention- 59.25d, Control- 70.27d, Wave 4: Intervention- 58.25, 
Control- 76.21d). This was reversed in the final wave with the Control group 
exhibiting shorter waiting times than the Intervention sites (Intervention- 
62.18, Control- 45.26d) see Figure 4. There was no overall change in 
waiting times from April 2004 to January 2007. 
 
Figure 4.   Mean number of days waited from referral to procedure for 
each wave of recruitment split by Intervention and Control group. 
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This overall picture does not change when the analysis is confined to 
referrals categorised as routine (see Figure 5) except that differences are no 
longer significant in Waves 1 and 5 (see Table 22). 
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Figure 5.   Mean number of days waited from referral to procedure for 
patients classified as ‘Routine’ for each wave of recruitment split 
by Intervention and Control group. 
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Table 22. Mean waiting times (SE) for patients classified as ‘routine’ 
split by Intervention and Control 
 
Wave Intervention 
(days) 
Control  
(days) 
p-value 
1 64.97 (5.24) 82.31 (7.61) 0.062 
2 74.74 (4.19) 118.53 (8.30) 0.000 
3 64.28 (3.08) 105.05 (6.02) 0.000 
4 60.17 (3.78) 100.43 (7.00) 0.000 
5 66.63 (4.98) 61.88 (4.99) 0.503 
   
 
4.4.15   Patient Satisfaction 
Patient satisfaction: GESQ (one day post endoscopy) 
 
With the exception of the sub-scale information quality before endoscopy 
(Wave 2), there were no significant differences between the Intervention 
and Control group in any of the four sub-scales (see Table 23). Accounting 
for the number of tests performed (n=20), this significant result is likely to 
have arisen by chance. 
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Multilevel models were fitted to the GESQ data but the final Hessian 
matrices were not positive. Therefore, findings from flat models were 
reported. See Table 23. 
 
There were no statistically significant differences between the study groups 
in any of GESQ scores (see Table 24). Males were found to be more satisfied 
with the skills and the hospital and were less likely to suffer pain and 
discomfort following treatment. Older patients were more satisfied with the 
skills and hospital, had more pain and discomfort but were happier with the 
information before and after endoscopy. UGE patients exhibited more pain 
and discomfort following procedure. Those patients that had to wait less 
time for their procedure were more satisfied with skills and hospital. 
 
Table 23.  Mean scores (SE) for the GESQ in the Intervention and 
Control groups, split by wave 
 
Mean Score (SE) 
 
Intervention 
Max N= 304 
Control 
Max N=302 
p-value 
GESQ  
Scored 0 (satisfied) – 100 (unsatisfied) 
Factor 1: Skills & Hospital 
Wave 1 
Wave 2 
Wave 3 
Wave 4 
Wave 5 
 
 
 
10.74 (0.23) 
11.04 (0.25) 
10.74 (0.24) 
10.81 (0.23) 
10.59 (0.24) 
 
 
 
10.70 (0.24) 
10.63 (0.23) 
10.77 (0.23) 
10.18 (0.23) 
10.59 (0.24) 
 
 
 
0.89 
0.23 
0.93 
0.06 
0.99 
Factor 2: Pain & Discomfort 
Wave 1 
Wave 2 
Wave 3 
Wave 4 
Wave 5 
 
8.23 (0.19) 
8.63 (0.21) 
7.99 (0.20) 
8.44 (0.20) 
8.69 (0.21) 
 
7.94 (0.20) 
8.16 (0.20) 
8.15 (0.19) 
8.00 (0.21) 
8.18 (0.20) 
 
0.30 
0.10 
0.55 
0.12 
0.09 
Factor 3: Information quality 
before endoscopy 
Wave 1 
Wave 2 
Wave 3 
Wave 4 
Wave 5 
 
 
12.53 (0.20) 
12.94 (0.22) 
12.47 (0.20) 
12.24 (0.18) 
12.39 (0.19) 
 
 
12.26 (0.20) 
12.01 (0.18) 
12.17 (0.19) 
12.13 (0.21) 
12.36 (0.20) 
 
 
0.32 
0.001 
0.28 
0.66 
0.92 
Factor 4: Information after 
endoscopy 
Wave 1 
Wave 2 
Wave 3 
Wave 4 
Wave 5 
 
 
10.04 (0.18) 
9.92 (0.19) 
9.68 (0.20) 
9.92 (0.17) 
9.94 (0.19) 
 
 
9.64 (0.17) 
9.67 (0.17) 
9.92 (0.18) 
10.10 (0.19) 
9.87 (0.20) 
 
 
0.10 
0.33 
0.37 
0.47 
0.82 
GESQ multilevel modelling 
 
Random intercept models (which assumed random site effects and common 
linear effect of the covariates) and random slope models (which assumed 
random site effects and differing covariate effect between sites) were fitted. 
The findings were similar but the random slope models were slow to 
converge. Therefore, only the random intercept models were reported.  
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Table 24.   Effects of covariates on SF-36 PCF SF-36 MCF and EQ-5D  
 
Effect size (SE) [sig] Factor 1: 
Skills & Hospital 
Factor 2: 
Pain & Discomfort 
Factor 3: 
Information quality 
before endoscopy 
Factor 4: 
Information after 
endoscopy 
 
Gender  -0.37 
(0.15) 
[0.001] 
-0.57 
(0.12) 
[<0.001] 
0.014 
(0.12) 
[0.91] 
-0.22 
(0.12) 
[0.056] 
Age  -0.060 
(0.0051) 
[<0.001] 
-0.050 
(0.0042) 
[<0.001] 
-0.014 
(0.0043) 
[0.001] 
-0.033 
(0.0040) 
[<0.001] 
UGE  0.25 
(0.34) 
[0.46] 
-0.98 
(0.28) 
[0.001] 
-0.14 
(0.29) 
[0.63] 
-0.62 
(0.27) 
[0.024] 
FS  0.50 
(0.38) 
[0.19] 
0.46 
(0.32) 
[0.15] 
0.40 
(0.32) 
[0.21] 
-0.57 
(0.31) 
[0.064] 
Colonoscopy  0.144 
(0.39) 
[0.71] 
-0.48 
(0.32) 
[0.14] 
0.080 
(0.33) 
[0.81] 
-0.16 
(0.31) 
[0.61] 
DOU  -0.044 
(0.095) 
[0.65] 
-0.13 
(0.08) 
[0.11] 
-0.065 
(0.081) 
[0.42] 
-0.063 
(0.080) 
[0.41] 
Time to PPQ  0.0031  
(0.0013) 
[0.013] 
0.0010 
(0.0011) 
[0.34] 
0.0019 
(0.0011) 
[0.084] 
0.0016 
(0.0010) 
[0.12] 
Innovation score  0.0010  
(0.0061) 
[0.12] 
0.0059 
(0.0057) 
[0.32] 
0.0086 
(0.0056) 
[0.15] 
0.0062 
(0.0052) 
[0.26] 
No of beds  -0.000047 
(0.00083) 
[0.96] 
0.00031 
(0.00071) 
[0.70] 
-0.00020 
(0.00077) 
[0.86] 
-0.00014 
(0.00071) 
[0.85] 
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Teaching hospital  -0.095 
(0.45) 
[0.84] 
-0.10 
(0.42) 
[0.81] 
-0.031 
(0.41) 
[0.94] 
-0.10 
(0.38) 
[0.79] 
Wave  -0.083 
(0.052) 
[0.11] 
0.024 
(0.043) 
[0.57] 
-0.050 
(0.044) 
[0.26] 
0.027 
(0.040) 
[0.50] 
Intervention/Control  0.067 
(0.33) 
[0.84] 
0.24 
(0.31) 
[0.46] 
0.22 
(0.31) 
[0.49] 
0.084 
(0.28) 
[0.77] 
N 2804 2818 2798 2516 
-2 Log Likelihood 15536.20 14604.18 14576.56 12479.25 
 
N.B. GESQ Scored 0 (satisfied) – 100 (unsatisfied) 
p < 0.05 
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4.4.16   Patient comments 
 
There were no significant differences between the Intervention and Control 
group in each wave with respect to the number and types of comments 
made in each of the three questionnaires (see Table 25). 
 
Table 25. Counts of the number of comments made by patients split by 
site type, wave and comment type 
 
Questionnaire 
 
Intervention (N) Control (N) 
 
p-value 
BQ 
Total comments 
Wave 1 (n=820) 
Wave 2 (n=742) 
Wave 3 (n=781) 
Wave 4 (n=769) 
Wave 5 (n=706) 
 
Describing 
symptoms 
Wave 1 (n=158) 
Wave 2 (n=165) 
Wave 3 (n=167) 
Wave 4 (n=138) 
Wave 5 (n=137) 
 
Other problems 
impacting on 
questionnaire 
answers 
Wave 1 (n=158) 
Wave 2 (n=165) 
Wave 3 (n=167) 
Wave 4 (n=138) 
Wave 5 (n=137) 
 
Long wait for 
appointment 
Wave 1 (n=158) 
Wave 2 (n=165) 
Wave 3 (n=167) 
Wave 4 (n=138) 
Wave 5 (n=137) 
 
 
75 
70 
80 
63 
71 
 
 
 
44 
32 
32 
27 
29 
 
 
 
 
 
14 
20 
12 
4 
9 
 
 
 
5 
1 
2 
5 
2 
 
 
 
83 
95 
87 
75 
66 
 
 
 
46 
40 
34 
30 
24 
 
 
 
 
 
14 
22 
25 
8 
9 
 
 
 
6 
7 
2 
4 
3 
 
 
0.90 
0.22 
0.91 
0.18 
0.95 
 
 
 
0.68 
0.64 
0.93 
0.73 
0.59 
 
 
 
 
 
0.77 
0.43 
0.033 
0.37 
0.87 
 
 
 
0.89 
0.08 
0.93 
0.54 
0.59 
PPQ  
Any Other 
Comments 1 
Total comments 
Wave 1 (n=659) 
Wave 2 (n=577) 
Wave 3 (n=591) 
Wave 4 (n=572) 
Wave 5 (n=536) 
 
 
 
 
 
136 
123 
142 
142 
137 
 
 
 
 
 
158 
153 
157 
113 
140 
 
 
 
 
 
0.48 
0.021 
0.85 
0.39 
0.51 
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Good treatment 
Wave 1 (n= 294) 
Wave 2 (n=276) 
Wave 3 (n=299) 
Wave 4 (n=255) 
Wave 5 (n=277) 
 
Sedation issues 
Wave 1 (n= 294) 
Wave 2 (n=276) 
Wave 3 (n=299) 
Wave 4 (n=255) 
Wave 5 (n=277) 
 
Complaints 
about treatment 
Wave 1 (n= 294) 
Wave 2 (n=276) 
Wave 3 (n=299) 
Wave 4 (n=255) 
Wave 5 (n=277) 
 
 
18 
97 
124 
129 
120 
 
 
3 
2 
1 
7 
1 
 
 
 
2 
3 
1 
2 
3 
 
131 
135 
146 
105 
128 
 
 
7 
2 
6 
3 
3 
 
 
 
3 
3 
4 
0 
1 
 
 
0.36 
0.034 
0.10 
0.55 
0.30 
 
 
0.29 
0.83 
0.08 
0.35 
0.32 
 
 
 
0.78 
0.79 
0.21 
0.21 
0.30 
 
PPQ  
Any Other 
Comments 2 
Total comments 
Wave 1 (n=659) 
Wave 2 (n=577) 
Wave 3 (n=591) 
Wave 4 (n=572) 
Wave 5 (n=536) 
 
Suggestions 
Wave 1 (n=154) 
Wave 2 (n=137) 
Wave 3 (n=171) 
Wave 4 (n=151) 
Wave 5 (n=150) 
 
Better sedation 
Wave 1 (n=154) 
Wave 2 (n=137) 
Wave 3 (n=171) 
Wave 4 (n=151) 
Wave 5 (n=150) 
 
More information 
before/after 
Wave 1 (n=154) 
Wave 2 (n=137) 
Wave 3 (n=171) 
Wave 4 (n=151) 
Wave 5 (n=150) 
 
 
 
 
 
 
 
 
 
70 
52 
81 
83 
78 
 
 
50 
32 
53 
58 
48 
 
 
6 
6 
4 
9 
10 
 
 
 
5 
6 
13 
14 
10 
 
 
 
 
 
 
 
 
 
84 
85 
90 
68 
72 
 
 
49 
55 
57 
41 
48 
 
 
11 
7 
5 
2 
5 
 
 
 
12 
11 
16 
15 
16 
 
 
 
 
 
 
 
 
 
0.51 
0.002 
0.87 
0.71 
0.80 
 
 
0.090 
0.71 
0.69 
0.22 
0.51 
 
 
0.37 
0.52 
0.87 
0.06 
0.23 
 
 
 
0.16 
0.81 
0.81 
0.42 
0.13 
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Difficulty 
remembering 
results because 
of sedation 
Wave 1 (n=154) 
Wave 2 (n=137) 
Wave 3 (n=171) 
Wave 4 (n=151) 
Wave 5 (n=150) 
 
Lack of privacy 
Wave 1 (n=154) 
Wave 2 (n=137) 
Wave 3 (n=171) 
Wave 4 (n=151) 
Wave 5 (n=150) 
 
 
 
 
 
4 
1 
1 
2 
2 
 
 
6 
1 
6 
1 
4 
 
 
 
 
3 
2 
4 
1 
2 
 
 
4 
2 
4 
1 
4 
 
 
 
 
0.53 
0.87 
0.21 
0.68 
0.94 
 
 
0.34 
0.88 
0.53 
0.89 
0.91 
 
PPQ  
Any Other 
Comments 3 
Total comments 
Wave 1 (n=659) 
Wave 2 (n=577) 
Wave 3 (n=591) 
Wave 4 (n=572) 
Wave 5 (n=536) 
 
Follow-up issues 
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
Endoscopy who 
did it/how it 
went 
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
Good treatment 
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
Delay in unit 
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
 
 
 
 
 
104 
89 
91 
99 
87 
 
 
9 
12 
6 
10 
11 
 
 
 
 
13 
13 
26 
19 
23 
 
 
19 
15 
23 
24 
14 
 
 
2 
1 
1 
2 
0 
 
 
 
 
 
 
100 
112 
90 
98 
76 
 
 
9 
2 
14 
4 
8 
 
 
 
 
14 
21 
21 
19 
25 
 
 
12 
21 
17 
17 
16 
 
 
1 
3 
9 
1 
0 
 
 
 
 
 
 
0.40 
0.06 
0.44 
0.24 
0.49 
 
 
0.93 
0.001 
0.054 
0.10 
0.72 
 
 
 
 
0.75 
0.44 
0.42 
0.97 
0.37 
 
 
0.21 
0.26 
0.51 
0.39 
0.69 
 
 
0.59 
0.31 
0.009 
0.56 
No data 
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General 
comments re: 
too long for 
appointments  
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
General 
comments re: 
getting 
appointments  
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
NHS in general -
negative 
comments 
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
Other problems - 
impacting on 
questionnaire 
answers  
Wave 1 (n=204) 
Wave 2 (n=200) 
Wave 3 (n=181) 
Wave 4 (n=187) 
Wave 5 (n=163) 
 
 
 
 
4 
4 
2 
2 
2 
 
 
 
 
 
1 
2 
2 
1 
3 
 
 
 
 
0 
2 
1 
0 
0 
 
 
 
 
 
10 
19 
17 
20 
23 
 
 
 
 
 
4 
4 
3 
3 
1 
 
 
 
 
 
0 
0 
2 
1 
1 
 
 
 
 
1 
7 
4 
0 
0 
 
 
 
 
 
13 
20 
15 
23 
18 
 
 
 
 
0.96 
0.74 
0.99 
0.64 
0.64 
 
 
 
 
 
0.33 
0.11 
0.99 
0.99 
0.38 
 
 
 
 
0.31 
0.17 
0.17 
No data 
No data 
 
 
 
 
 
0.39 
0.53 
0.72 
0.58 
0.69 
 
12m PPQ  
Total comments 
Wave 1 (n=585) 
Wave 2 (n=503) 
Wave 3 (n=531) 
Wave 4 (n=520) 
Wave 5 (n=448) 
 
Changes made to 
diet/weight that 
helped condition 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Good treatment 
Wave 1 (n=156) 
 
 
67 
73 
69 
68 
57 
 
 
 
 
9 
5 
9 
2 
7 
 
 
6 
 
 
89 
86 
73 
72 
49 
 
 
 
 
15 
4 
4 
4 
3 
 
 
6 
 
 
0.17 
0.46 
0.67 
0.51 
0.35 
 
 
 
 
0.56 
0.55 
0.12 
0.45 
0.28 
 
 
0.61 
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Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Issues relating 
to how 
endoscopy went 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Now know cause 
of symptoms 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Sense of ‘who 
cares?’ 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Asking for advice 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Other problems 
impacting on 
answers  
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Describing 
ongoing 
problems 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Follow-up issues 
Wave 1 (n=156) 
Wave 2 (n=159) 
7 
6 
4 
5 
 
 
 
 
3 
2 
0 
2 
1 
 
 
 
9 
1 
2 
5 
5 
 
 
 
0 
0 
0 
0 
0 
 
 
0 
1 
0 
0 
1 
 
 
 
 
10 
16 
10 
16 
12 
 
 
 
 
20 
25 
20 
23 
20 
 
 
2 
2 
9 
3 
7 
6 
 
 
 
 
2 
1 
2 
4 
2 
 
 
 
5 
4 
6 
4 
4 
 
 
 
2 
2 
0 
0 
0 
 
 
2 
1 
0 
0 
0 
 
 
 
 
19 
22 
14 
18 
13 
 
 
 
 
33 
26 
32 
22 
11 
 
 
4 
4 
0.86 
0.26 
0.37 
0.56 
 
 
 
 
0.43 
0.47 
0.052 
0.45 
0.47 
 
 
 
0.09 
0.24 
0.17 
0.67 
0.91 
 
 
 
0.22 
0.19 
No data 
No data 
No data 
 
 
0.22 
0.91 
No data 
No data 
0.35 
 
 
 
 
0.31 
0.59 
0.46 
0.13 
0.51 
 
 
 
 
0.35 
0.59 
0.07 
0.88 
0.15 
 
 
0.30 
0.53 
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Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
NHS general 
negative 
comments 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Everything just 
takes too long 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Talking about 
IBS 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
 
Diet-would have 
liked more 
advice 
Wave 1 (n=156) 
Wave 2 (n=159) 
Wave 3 (n=142) 
Wave 4 (n=140) 
Wave 5 (n=106) 
5 
9 
4 
 
 
 
 
1 
3 
2 
1 
0 
 
 
 
3 
2 
1 
1 
2 
 
 
 
3 
0 
3 
9 
2 
 
 
 
 
1 
1 
2 
1 
4 
3 
4 
0 
 
 
 
 
2 
0 
3 
1 
0 
 
 
 
3 
0 
2 
0 
1 
 
 
 
2 
13 
6 
3 
2 
 
 
 
 
0 
0 
1 
2 
1 
0.42 
0.12 
0.06 
 
 
 
 
0.73 
0.06 
0.70 
0.97 
No data 
 
 
 
0.72 
0.12 
0.59 
0.30 
0.65 
 
 
 
0.43 
0.001 
0.34 
0.055 
0.88 
 
 
 
 
0.25 
0.28 
0.53 
0.59 
0.23 
 
4.5   Discussion 
4.5.1   Summary of results 
 
• Intervention patients waited on average seven days less than 
the Control patients. On a wave by wave basis the difference in 
waiting time between the Intervention and Control groups 
increased from Wave 1 (5d) to Wave 4 (18d) in favour of the 
Intervention group. This trend was reversed at Wave 5 with the 
Control group exhibiting a smaller waiting time than the 
Intervention group (17 days). 
 The differences in the second, third and fourth waves reflected 
an increase in waiting times in the Control group. They did not 
decrease in the Intervention group, and overall waiting times 
did not shorten from April 2004 to early 2007. 
The ENIGMA study 
©NCCSDO 2008 Page 83 
• Important covariates that had an impact on patient HRQoL were 
BQ scores, age, gender, procedure type and waiting time to 
procedure.  
• There was a significant improvement in both disease specific 
(GSRQ) and generic (SF-36 and EQ-5D) HRQoL following all 
types of endoscopy procedure for both Intervention and Control 
groups. 
• There was no difference between the Intervention and Control 
groups in any of the HRQoL measures. 
• There was no significant difference in HRQoL across any of the 
five waves of recruitment with the exception of the GSRQ-upper 
GI symptoms (at 12m PPQ). 
• There were no significant differences in the number or types of 
issues raised by patients in their written comments. 
4.5.2   Internal validity 
 
• Although patient recruitment rates were low (~40%), they were 
consistent over the five waves of recruitment.  
• The study recruited 3818 patients for HRQoL score analysis. 
This was 818 patients more than the 3000 specified by the 
initial power calculation for this study. 
• All covariates that could have affected the modelling were 
incorporated into the model, reducing the potential for 
confounders. 
• Results from the modelling were shown to be consistent when 
tested using different models (random intercept and random 
slope model, random intercept and fixed slope model and fixed 
intercept and fixed slope model) and when employing different 
software (MLWin and SPSS). 
4.5.3   External validity  
 
• The sites participating in the ENIGMA study were randomly 
selected from a cohort of sites applying to participate in the 
MES programme. The sites were stratified according to bed 
number prior to sampling to ensure that there was a mixture of 
different hospital types included in the study. 
• The patients were recruited from each site using strict criteria 
so that there was no over-representation of a specific patient 
type or procedure type per wave per site. 
• The scores reported by the consenting patients were weighted 
accordingly to ensure that the adjusted scores were more 
representative of the population of patients referred for GI 
endoscopy. 
4.5.4   Implications  
 
• Endoscopy has been shown to be an effective procedure as 
patients have better health related quality of life following 
endoscopy procedures. This supports previous studies 
(Williams, Russell, Durai, Cheung, Farrin, Bloor et al. 2006) that 
have also illustrated this benefit. 
• Modernisation through the MES programme significantly 
affected patient waiting times, with the Intervention group 
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exhibiting shorter waiting times than the Control group for the 
second, third and fourth waves of the study. 
 Overall waiting times did not decrease in either group over 
time. 
• Although differences were seen in patient waiting times in the 
Intervention group, this did not translate into any added 
improvement in disease specific or generic patient health 
related quality of life. 
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5   Hospital process data 
5.1   Executive summary 
5.1.1   Aim 
 
To evaluate the MES programme using routinely collected, service-related 
endoscopy data. 
5.1.2   Methods 
 
One aspect of the ENIGMA study involved comparing service-related data 
collected from Intervention and Control sites for eight specific time points in 
order to (1) determine whether the services in both Intervention and Control 
sites had changed over time and (2) identify whether there were any 
significant differences between the Intervention and Control sites at specific 
points in time. All 20 study sites were asked to submit service-related data 
pertaining to Referral numbers, Number of patients waiting more than three 
months (Wait >3m), Total number of patients waiting (Snapshot), Number 
of lost appointment slots (Lost slots) and Activity for eight time points: Jan, 
Jun & Dec 03, Apr & Nov 04, Apr & Oct 05 and Apr 06. Where endoscopy 
units did not provide data, Trust data was obtained. Data was aggregated 
into years (2003, 2004, 2005/06) and by site type (Intervention and Control 
groups) for statistical analysis using a two-way ANOVA. 
5.1.3   Results 
 
Analysable data was obtained from only eight sites (three Intervention and 
five Controls). There were no significant differences in the data over time for 
Referral numbers, Wait >3m, Snapshot, Lost slots or Activity within either 
the Intervention or the Control group. There was also no significant 
difference between Intervention and Control group data at any point in time 
for Referral numbers, Wait >3m or Lost slots. However, there was a 
significant difference in the data from the Intervention and Control groups 
for (1) Snapshot for 2004 and 2005/06 due to a decrease in the 
Intervention group matched by an increase in the Control group, and for (2) 
Activity for 2003 due to significant differences in data at the start of the 
study for the Intervention and Control groups.  
5.1.4   Conclusion 
 
The MES programme had no significant impact on the services of 
participating endoscopy units as a whole, and had limited benefits when 
compared to the Control site endoscopy units. Only the waiting lists of the 
Intervention sites benefited from the project, although that improvement 
was sustained long after the project closed. It appears that while the MES 
programme may have been a focus for thinking about redesigning services 
for both Intervention and Control sites during the application phase in 2002, 
the project itself did not appear to significantly improve endoscopy services 
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overall in the Intervention sites over and above what could have been 
achieved independently. 
5.2   Aims and objectives 
The aim of this aspect of the study was to evaluate the impact of the MES 
programme by comparing routine collected data relating to demand, activity 
and waiting times in each study site. The data encompassed Referral 
numbers, Referral source, Number of patients waiting, Number of lost 
appointment slots and Number of procedures performed. These outcome 
measures were referred to collectively as “process data”.  
 
More specifically, the aims of this study were: 
 To make an assessment of the impact of the MES programme 
based on the comparative analysis of process data from 
Intervention and Control sites. 
 To determine the availability and the accuracy of routinely 
collected process data from National Health Service (NHS) 
endoscopy units and their corresponding Trust Information 
Departments. 
 
This would be achieved by fulfilling the following objectives: 
a) To retrieve routinely collected process data from all 20 study sites. 
b) To determine whether there were any significant improvements in 
process data in both the Intervention sites and the Control sites 
over time. 
c) To explore whether there were any significant differences in process 
data between Intervention and Control sites at specific points in 
time.  
d) To measure the extent of any changes (in terms of time) in process 
data from both Intervention and Control sites. 
5.3   Methods  
5.3.1   Details of the process data requested 
 
The selection of the 20 study sites ensured that all had access to the MES 
ToolkitTM. The Intervention sites were bound to its compulsory data 
collection regime while the Control sites, which had attended NHSMA 
workshops and indicated their intention to redesign independently, were 
able to use the data collection software as they wished.  
 
The process data variables used in this study were all based on measures 
collected and analysed by the MES ToolkitTM as it was considered to be a 
fundamental part of the redesign process as an invaluable tool for analysing 
processes and measuring changes following modernisation. The NHSMA 
advocated the need for high quality data collection and so, the ENIGMA 
study opted to use these datasets as outcome measures with which to 
evaluate the MES programme. 
 
Referral numbers - This was the number of referrals received by the 
endoscopy unit for diagnostic or therapeutic UGE, FS or colonoscopy 
procedures made to the endoscopy unit during a specified time period. We 
requested the data be split where possible into referral types, including day 
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cases (outpatients), Two Week Rule (TWR) referrals, inpatients, follow-ups 
and emergencies. 
 
Referral sources - This was the number of referrals from a specific source 
for diagnostic or therapeutic UGE, FS or colonoscopy procedures made to 
the endoscopy unit during a specified time period. It was split where 
possible into numbers of referrals from GPs, consultants and private 
sources. 
 
Number of patients waiting (No patients waiting) - This was the 
number of patients waiting for diagnostic or therapeutic UGE, FS or 
colonoscopy procedures on the active waiting list for more than one month, 
three months, six months and 12 months during a specified time period. 
The number of patients waiting more than three months (designated “Wait 
>3m”) was used for all subsequent analyses because it was a Government 
target that all NHS patients in England should be seen within 13 weeks of a 
referral by their GP. The total number of patients waiting on the active 
waiting list for diagnostic or therapeutic UGE, FS or colonoscopy procedures 
at a specific point each month during a specified time period, irrespective of 
how long they had been waiting, was also requested (designated 
“Snapshot”). Sites were asked to provide both data types where possible. 
 
Number of lost appointment slots (Lost slots) - This was the total 
number of individual diagnostic or therapeutic endoscopy appointment slots 
“lost” due to patient DNAs and cancellations by both hospital and patient 
during a specified time period. This data was not requested split by 
procedure type as the datasets were not routinely compiled in this way. 
 
Number of procedures performed (Activity) - This was the total number 
of diagnostic or therapeutic UGE, FS and colonoscopy procedures performed 
within the endoscopy unit by endoscopy staff during a specified time period. 
The request did not include any procedures done within an outpatient clinic 
or theatre unless they were done within the remit of the endoscopy unit. 
 
The total number of UGEs was requested as opposed to the numbers of 
gastroscopies and oesophageal-gastro-duodenoscopies (OGDs) separately 
because the terminology differed between study sites: some differentiated 
between the two while others grouped them into “upper GIs”. 
5.3.2   Time periods of data collection 
 
All process data were requested for specific calendar months to get a better 
idea of the performance of the service over a long period of time. A total of 
eight separate months were chosen. The months falling in 2003 
corresponded to the start, middle and end of the MES programme, while all 
other months corresponded to the five waves of patient recruitment of the 
ENIGMA study. Where these dates were not available, data was accepted if 
± one month.  
 
The calendar months for which data was requested were: January 2003 
(T0), June 2003 (T1), December 2003 (T2), April 2004 (T3), November 
2004 (T4), April 2005 (T5), October 2005 (T6) and April 2006 (T7). The T 
value is the time lapsed in months since the start of the ENIGMA study. The 
T0 data was to be used as a baseline measurement against which all 
subsequent data would be compared. Where T0 data were not available, the 
next time point with data were used instead. Data was retrospectively 
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requested in two phases, the first to cover T0 to T4 and the second to cover 
T5 to T7. 
5.3.3   The endoscopy unit data request 
 
The data were supplied by the endoscopy units themselves. All participating 
endoscopy units were approached by phone or email in January 2005 to 
provide copies, either electronic or hard copy, of any process endoscopy 
data that had been routinely collected for the calendar months specified. 
The purpose of the data request was twofold: firstly to find out what type of 
data was collected by the endoscopy unit, if any, and secondly to provide 
datasets at their rawest (and probably their truest) levels, free from 
manipulation or misinterpretation by Trust Information Departments. Units 
sending in-house datasets were asked to provide detailed descriptions of the 
data and any definitions used to make sure the data were suitable for 
analysis. The initial data request in January 2005 retrospectively collected 
data pertaining to T0 to T4. Follow-up datasets to cover T5 to T7 were 
retrospectively requested in June 2006. The deadline for final data collection 
was January 2007. 
 
Routinely collected data was specified for five reasons: (1) The ENIGMA 
sites had not originally agreed to collect any process data for this study as it 
was not part of the study’s original remit, (2) the retrospective nature of the 
data request, (3) the fact that no financial incentive was made available to 
the units to fund the collection of these datasets if they were not routinely 
available, (4) it allowed the quantification of the availability of routinely 
collected process data and (5) to assess the quality of the data being 
collected in terms of detail and relevance to the analysis of the service over 
time.  
 
Mann-Whitney U Tests were used to analyse the time taken to return these 
datasets to determine whether there was a significant difference in the time 
taken by the endoscopy units of Intervention and Control sites. 
5.3.4   The NHS Trust Information Services endoscopy data 
request 
 
In April 2005, managers of the Trust Information Services (TIS) of all 20 
study sites were contacted by letter to ask whether they would be prepared 
to release copies of any process data that they routinely collected 
corresponding to the endoscopy unit of the hospital involved in ENIGMA 
within the Trust. Where no response to the original data collection request 
was received after six weeks, a second letter was sent. This time, the letter 
was addressed to a specific person in the TIS department identified by a 
contact based at the NHS wide clearing service for Hospital Episode 
Statistics (HES). Where no response was received to the second letter, 
efforts were made to communicate with the person by email and telephone 
on a minimum of five separate occasions before the request was abandoned. 
Where other Trust sources of data were identified by the ENIGMA contact, 
such as IT departments, the named contact was approached by email or 
phone in the same way. The initial data request in April 2005 asked for data 
for periods T0 to T4. Follow-up datasets to cover T5 to T7 were requested in 
June 2006. The deadline for final data collection was January 2007. 
 
Since TIS datasets were likely to be extensive if collected at the patient-
level, a proforma was made available for completion. The proforma was 
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designed as an Excel-based “TIS form” (see Appendix 7) that consisted of 
five pages requesting data on Referral numbers (Form A), Referral sources 
(Form B), No patients waiting (Form C), No Lost slots (Form D) and Activity 
(Form E) respectively, with the sub-variables described earlier incorporated 
within the form. The TIS form was accompanied by a comprehensive 
instruction sheet to ensure its completion was accurate, comparable and 
related only to the hospital specified, not the Trust as a whole. The 
instructions also asked for the data request to be completed using the Office 
for Population Censuses and Surveys-4 (OPCS-4) coding system used by the 
Department of Health (DoH): 
 
 Endoscopic operations on the oesophagus (G16 to G19) using 
Oesophageal-Gastro-Duodenoscopy (OGD) or gastroscopy. 
 Endoscopic operations on the upper GI tract (G43 to G45) using 
OGD or gastroscopy. 
 Endoscopic operations on the colon using colonoscopy (H20 to 
H22). 
 Endoscopic operations on lower bowel using FS (H23 to H25).  
 
TIS departments sending their own in-house datasets were asked to provide 
a detailed description of the data types and definitions used to ensure they 
were comparable with TIS form datasets. The TIS form was piloted in one 
study site endoscopy unit prior to being sent to those TIS contacts 
requesting a proforma. 
 
Mann-Whitney U tests were used to analyse the time taken to return these 
datasets to determine whether there was a significant difference in the time 
taken by the TIS contacts from both Intervention and Control site Trusts.  
5.3.5   Data collection forms 
 
The process described replaced the unsuccessful attempt to obtain data, in 
which each endoscopy unit was contacted early on in the ENIGMA study to 
determine whether they could provide basic demand, Activity and waiting 
list data. For those sites able to collect the data, forms requesting data for 
the five calendar months coinciding with the five waves of patient 
recruitment were posted to endoscopy units immediately following those 
months. A reminder form was sent by email if there was no response after 
one month. For the data corresponding to T0 to T3, all four forms were sent 
in one go and all subsequent forms were sent singularly on the month 
immediately following the month specified on the data request.  
 
The ENIGMA data collection form asked for the following counts for a specific 
calendar month, split by procedure type (FS, colonoscopy and UGE), and by 
degree of urgency (urgent or non-urgent):   
 
1.  The number of patients waiting more than 13 weeks for their  
  endoscopy. 
2.  The % Did Not Attend (DNA) rate. 
3.  The average time from GP referral to procedure. 
4.  The number of referrals made to the unit. 
 
Retrospective data were also requested for the calendar months of January 
03, June 03, and December 03, to coincide with the start, middle and end of 
the MES programme. 
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Unfortunately, this aspect of data collection was not particularly successful 
in most sites, with low response rates and even lower sustained responses 
over time. As a result, this aspect of the ENIGMA study was abandoned in 
favour of the data collection and analysis procedure described in this 
chapter. However, the data accumulated within these early forms was 
available for analysis, if necessary.  
5.3.6   Formation of the final dataset 
 
All data received were assessed following discussions with site contacts 
(endoscopy unit and/or TIS contacts), using the definitions provided and by 
using observational comparisons to determine their accuracy and 
comparability with other datasets submitted. The TIS forms were used as a 
proforma for the extraction of in-house routinely collected data provided by 
both endoscopy units and the Trust to structure comparable datasets.  
 
During the data extraction process, the data were assessed for their 
compliance to strict specifications and in accordance with the instruction 
sheet accompanying the TIS Form. Where a dataset did not conform to the 
request in either content or output style (e.g. Trust-wide data, planned and 
active waiting list data combined, percentages, etc), it was excluded from 
any analyses. Data were also excluded when it was not split according to 
procedure type because it was likely to include additional endoscopic 
procedures, albeit small, that would artificially inflate the totals and make 
the dataset inaccurate for comparison.  
 
The exclusion criteria were imposed following the first data request (T0 to 
T4) and where data were not suitable, it was not requested for T5 to T7. 
More suitable replacement datasets were requested where possible.  
 
Where data were extracted from routinely collected in-house data to 
complete the TIS forms, they were validated by selecting approximately 
20% of the datasets by randomising site numbers and TIS forms using SPSS 
v13.0 (Chicago, USA) software and re-completing them based on the 
original data. Any inconsistencies were amended and a further 20% of all 
sites and forms were validated until no errors occurred.  
 
Following this, all data from the verified TIS forms were input into SPSS. 
Data entry was validated by selecting 20% of the data in the file for re-
entry. Any discrepancies resulted in another 20% of the data being 
validated until no errors occurred. 
 
The datasets for this study were categorised according to whether they 
corresponded to “total procedures” data (all three procedure types – UGEs, 
FS and colonoscopy - combined) or “split procedures” data (UGEs, FS and 
Colonoscopies separately). The total procedures data was calculated from 
the sum of the data provided for all three procedure types.  
 
The data from the individual time periods were aggregated according to the 
corresponding year (2003, 2004 and 2005/06) for further analysis to 
improve the accuracy of the mean values from each site by providing a 
larger sample number from which the mean was taken. This would provide a 
truer reflection of the data for that period in time if missing data became a 
problem. Since there was only one time period for 2006, the data for 2005 
and 2006 was merged to become 2005/06. Two time scales (T0 - T7 and 
2003 - 2005/06) were used to contend with any missing data at the early 
and late time points. By presenting analyses using both time scales, any 
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changes in the outcome measures over time would be captured more 
effectively.  
5.3.7   The validation of the study datasets 
 
Since the data compiled for this study used up to three separate data 
sources (the endoscopy unit, the NHS Trust of each study site or the early 
ENIGMA data collection request), it was necessary to validate the final study 
datasets to ensure that any significant findings could be reported with 
confidence.  
 
HES data is the national statistical data warehouse for England of the care 
provided by NHS hospitals and for NHS hospital patients treated elsewhere. 
While tailor-made requests can be made at a cost, there are also freely 
available datasets online (www.hesonline.org.uk/). Since HES data is 
collected at the Trust-level, it contains data combined from each endoscopy 
unit within a Trust. Hence, it was not appropriate to include all 20 study 
sites in a comparative analysis, since all study sites had submitted data to 
us corresponding to one endoscopy unit and not for the Trust as a whole. 
Where there were two or more endoscopy units within a Trust, the study 
data could not be compared with the HES data. Only those sites with a 
single endoscopy unit in the Trust were eligible for comparison. Of the 20 
sites in this study, eight had just one endoscopy unit in the Trust. Of these 
eight, there were equal proportions of Intervention (6, 16, 18 and 19) and 
Control (2, 3, 9 and 12) sites. 
 
The most complete dataset collected that would be comparable with a HES 
dataset was for Activity. Details of the source of the Activity data for each of 
the eight study sites can be found in Table 28, while the actual data can be 
found in Appendices 8-11.  
 
A written request was sent to the Health Information Research Unit (HIRU) 
based at Swansea University for Activity data split according to procedure 
type using OPCS-4 codes G16-G19, G43-G45 and H20-H25 for the following 
time periods: Jan 03, Jun 03, Dec 03, Apr 04, Nov 04, Apr 05, Oct 05 and 
Apr 06. 
 
Where both study data and HES data were available, the differences 
between the two datasets were calculated using formula A to determine the 
Difference and formula B to determine the % Difference between them. 
 
 
Formula A:  STUDYdataHESdataDifference   
 
 
Formula B:  
STUDYdata
STUDYdataHESdata
Difference

%  
 
 
The datasets were then compared using Wilcoxon Sign Rank test (given that 
the data was not normally distributed) to identify whether there were any 
statistically significant differences between them. Both datasets were 
compared initially according to procedure type (UGEs, FS and colonoscopies) 
at each time point before being further split according to Site type. A p-
value of ≤ 0.05 was considered to be statistically significant.  
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5.3.8   Intervention and Control site data analysis 
 
Exploratory data analysis (EDA) was performed on the data submitted by 
each study site to identify any outlying data and to explore any site-level 
data trends. This involved plotting the data from each site over time on a 
line graph according to Site type (Intervention and Control) and outcome 
measure. The Intervention and Control group means were also plotted and 
any sites with data deviating from the corresponding group mean were 
described.  
5.3.9  Description of Intervention and Control group datasets 
split by procedure type 
 
The data from the Intervention sites and Control sites were merged to 
become Intervention group and Control group datasets for use in all 
subsequent analyses. Stacked bar graphs were used to describe split 
procedures data for the Intervention and Control groups to identify outlying 
data and to examine data trends at individual time points (T0 to T7) and for 
data aggregated according to year (2003, 2004 and 2005/06).  
5.3.10   Correlation of outcome measures 
 
Correlation was used to determine whether there were any significant linear 
relationships between any of the five outcome measures and if so, to 
identify their strength and direction. Spearman’s correlation was chosen as 
the best test due to low sample numbers, since this test was based on ranks 
rather than the actual data. This analysis was done using total procedures 
data for data aggregated according to the corresponding year, split 
according to Site type.  
5.3.11   Two-way analysis of variance  
 
A two-way analysis of variance (ANOVA), also known as a mixed between-
within groups ANOVA, was performed to determine the impact of Site type 
(Intervention and Control) and Time (2003, 2004 and 2005/06) on Referral 
numbers, Wait >3m, Snapshot, Lost slots and Activity using total 
procedures data. The test also identified any significant interaction effects 
between Site type and Time, which would indicate whether there was the 
same type of change in scores over time for the two different Site types. As 
well as a significant p-value, a significant interaction effect can be illustrated 
graphically whereby the two lines plotted for the means of each Site type 
are not parallel.  
5.4   Results  
5.4.1   The availability of process data from the endoscopy 
units 
 
Only eight of the 19 endoscopy units were able to provide copies of any 
process data for any of the time periods requested, of which three were 
Intervention sites and five were Control sites. The data submitted by these 
eight sites consisted of seven Excel files (5, 7, 10, 12, 17 and 19), two 
internal written reports (10 and 19) and two Excel-based MES ToolkitTM files 
The ENIGMA study 
©NCCSDO 2008 Page 93 
(1, 2). One of the ToolkitTM files had been submitted by a Control site that 
had attended an NHSMA workshop and were keen to use the data collection 
software. Closer examination of the dataset contained within the ToolkitTM 
file confirmed that they were only interested in completing specific aspects 
of the ToolkitTM as some tabs were left blank. One site (1) agreed to pilot 
the TIS form and searched Patient Administration System (PAS) to extract 
the necessary data. Since the completed form held data of superior quality, 
it was used for further analysis, replacing the original dataset submitted - a 
printout of part of the ToolkitTM for January 2003 only.  
 
Of the remaining 11 sites, two submitted the TIS forms originally sent to the 
TIS contact because they had liaised with them for their completion but 
returned it themselves (4 and 6) and so, were classified as “mixed source” 
datasets. A further two sites claimed that they collected their own data but 
it was not submitted for this study due to excessive staff workloads (9 and 
15). The remaining seven stated that they did not routinely collect any 
process data within the unit and relied on the Trust to extract and compile 
data whenever necessary (3, 8, 11, 13, 14, 16 and 20). When asked for 
copies of data collated following these requests, they had either not been 
kept or they were not relevant to this data request. In sites with no data, 
this was documented and no further requests were made unless, during the 
course of the study, they mentioned their intention to initiate data 
collection.  
 
Of the eight sites providing routinely collected process data, not all of the 
outcome measures were collected. When examining the data from 
Intervention and Control sites, the Control sites provided more of the 
outcome measures requested than the Intervention sites. When looking at 
all six outcome measures in this study (number of patients waiting was split 
into Wait >3m and Snapshot), one Intervention site provided four data 
types (1), while the other two were only able to provide one (7 and 19). 
One Control site provided five data types (2), one provided four (5), two 
provided three (12 and 17) and only one provided just one data type (10). A 
breakdown of the actual data provided by each endoscopy unit is illustrated 
in Table 26.  
 
Table 27 shows the time taken for the endoscopy units to return the process 
endoscopy data in response to the first data request (T0 to T4), which 
varied for each site from zero to 38 weeks (median 3). This figure did not 
include the two occasions when forms had been jointly completed by the 
endoscopy unit and TIS department (4 and 6). No significant differences 
were found between Intervention and Control sites in their response times 
(p ≤ 0.05, Mann-Whitney). 
 
This study hypothesised that all NHS endoscopy units would routinely collect 
some degree of process endoscopy data that would be available to this 
study for independent analysis. However, this soon proved to be untrue, 
with a number of sites reporting that they did not routinely collect any 
process endoscopy data. With this in mind, the methodology of the study 
was altered to capture sufficient data from as few sources as possible to 
reduce the variation in the data and allow a tentative comparison, so long as 
any conclusions would bear in mind the different sources of the data making 
up the datasets being analysed.  
5.4.2   The availability of process data from TIS departments 
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Of the 20 Trust sources contacted to provide data files, responses were 
received from 19, including one IT department (3), with the one non-
responder (7) not responding to any attempts to make contact by email, 
phone or letter. Ten Trusts were able to send electronic copies of their data 
or reports (2, 5, 9, 10, 12, 14, 16, 17, 18 and 19), while six sites completed 
the TIS forms and returned them electronically or by post (3, 8, 11, 13, 15 
and 20). Another two TIS contacts liaised closely with the endoscopy unit for 
TIS form completion but the forms were submitted ultimately by the 
endoscopy unit so they were included as endoscopy unit data sources (4 and 
6).  
 
One TIS contact (12) sent the exact same file as was submitted by the 
corresponding endoscopy unit, while another TIS contact (1) sent a report 
but advised the researcher to consult with the corresponding endoscopy 
unit, commenting that they deferred to the endoscopy staff for accurate 
data collection from PAS.  
 
Table 27 shows the time taken for the TIS contacts to return the process 
endoscopy data in response to the first data request (T0 to T4), which 
varied for each site from three to 67 weeks (median 22). This figure did not 
include the two occasions when forms had been jointly completed in sites 4 
and 6. No significant differences were found between Intervention and 
Control sites in their response times (p ≤ 0.05, Mann-Whitney). 
5.4.3   The availability of process data from the ENIGMA 
study  
 
A total of 14 of the 19 ENIGMA sites returned at least one form to 
correspond to a time point (T0 to T7) requested (1, 2, 3, 4, 6, 7, 8, 11, 12, 
13, 14, 16, 17 and 20). A further two indicated early on that the data was 
not routinely collected and they were not pursued any further during the 
ENIGMA study (5 and 10). Three sites reported that they collected data but 
did not complete the forms due to time and resource constraints (9, 15 and 
19). Of the 14 sites with forms, five stopped returning them for T6 (4, 6, 7, 
8 and 14) and a further three did not return the final form corresponding to 
T7 (2, 13 and 16).  
 
This may have been because sites had been asked to submit their routine 
datasets at this time and did not wish to continue with completing the forms 
as well. Completed forms were not of particularly high quality, with many 
sites unable to split data by procedure type or degree of urgency. They also 
found it extremely difficult to complete the average time from GP referral to 
procedure.  
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Table 26.   The availability of the six outcome measures provided by the eight endoscopy units submitting routinely 
collected process data for this study. 
 
Site ID Site type Referral 
Numbers 
Referral 
source 
Wait 
>3m 
Snapshot Lost 
slots 
Activity Earliest time 
period with data 
1 Intervention Yes No No Yes Yes Yes Jan 2003 
7 Intervention No No No Yes No No Jan 2003 
19 Intervention No No No No No Yes Jan 2003 
2 Control Yes Yes Yes Yes Yes No Dec 2003 
5 Control Yes Yes No No Yes Yes Apr 2004 
10 Control No No No Yes No No Apr 2004 
12 Control Yes No No Yes No Yes Dec 2003 
17 Control Yes Yes No No No Yes Dec 2003 
 
The ENIGMA study 
©NCCSDO 2008 Page 96 
Table 27.   Description of the time taken in weeks to receive data 
pertaining to T0 to T4 from the endoscopy units and the 
corresponding Trusts of all sites. Data from sites 4 and 6 were 
completed jointly by the endoscopy unit and Trust. Data from 
Hospital 18 was not requested from the endoscopy unit. 
 
Site ID Site type Time (weeks) taken by… 
Endoscopy unit Trust 
1 Intervention 35 No data submitted 
2 Control 3 12 
3 Control No data submitted 31 
4 Intervention 66 
5 Control 3 10 
6 Intervention 52 
7 Intervention 3 No data submitted 
8 Intervention No data submitted 67 
9 Control No data submitted 4 
10 Control 1 5 
11 Intervention 0 32 
12 Control 1 8 
13 Intervention No data submitted 19 
14 Control No data submitted 24 
15 Control No data submitted 22 
16 Intervention No data submitted 46 
17 Control 3 22 
18 Intervention Not requested 3 
19 Intervention 38 3 
20 Control No data submitted 46 
Median (range) 3 (0 to 38) 22 (3 to 67) 
5.4.4   Categorisation of datasets 
 
Based on discussions with site contacts (endoscopy unit and/or TIS 
contacts), definitions provided and observational comparisons, data from 
endoscopy units was used in preference to Trust data because some TIS 
contacts had commented that they were often unable to discriminate 
between endoscopies performed within and outside the endoscopy unit.  
 
There were also issues from a few Trusts concerning a change in coding 
practices for endoscopies, making the data from these sites less accurate 
when analysing for trends over time, although there was no published 
evidence of this occurring. Trust data was only used in the complete 
absence of any endoscopy data and where possible, the TIS data submitted 
was the same as the data that would have been sent to the endoscopy unit 
on request. 
 
In all, four types of data were available from three sources for this study. 
Each was ranked according to its accuracy, then by its availability. While 
data completed by the endoscopy unit was considered to be most accurate, 
the ENIGMA data collection forms completed by each endoscopy unit were 
not completed very rigorously and were not used unless all other data 
sources were exhausted. The final data rankings used for this study were: 
 
1.  Routinely collected in-house endoscopy unit data. 
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2.  TIS forms completed by the Trust. 
3.  Routinely collected Trust in-house data.  
4.  ENIGMA data collection forms. 
 
Where possible, the same data source was used for all five TIS forms to 
allow consistency and enhance comparability. Data sources were allowed to 
vary between TIS forms where absolutely necessary, but not within the TIS 
forms or else it would not be feasible to compare the data.  
5.4.5   Exclusion of datasets 
 
In most cases, data from sites was excluded because it did not conform to 
the request made, either in format or in the specification for it to be split 
according to procedure type. In one site (15), the datasets had to be 
excluded because there was doubt cast upon their accuracy because they 
included a number of zeros. When this was queried with the TIS contact, 
she commented on changes in coding practices over the time period 
requested that, in her opinion, made the dataset unsuitable for analysis over 
time. All Site 15 datasets were subsequently completely excluded from all 
analyses.  
 
Referral numbers data was excluded from Sites 14, 15 and 19. In two of 
these sites, the data was not split according to referral type (14) or 
procedure type (19). The request for Referral source data (TIS Form B) was 
poorly collected in the majority of sites and so, this outcome measure was 
excluded from any analyses.  
 
Number of patients waiting data was excluded from sites 5, 11, 13, 15 and 
17. One site did not split their waiting list data according to procedure type 
(5), one site provided waiting list data but it was recorded in minutes rather 
than counts (17), and two sites submitted waiting list datasets that included 
both their active and planned waiting lists (11 and 13).  
 
Lost slots data was excluded from Sites 14, 15, 16, 17 and 19 because Lost 
slots data needed to include DNAs, patient and hospital cancellations data to 
compute an accurate total for comparison with other sites. Two sites did not 
include hospital cancellations (14 and 16), one site did not include patient 
cancellations (17) and one site submitted only DNA counts (19). 
 
Activity data was excluded from 7, 14 and 15, two of which did not split 
their data according to procedure type (7 and 14). 
5.4.6   Formation of final datasets 
 
The final datasets used for analyses in this study used a mixture of 
endoscopy unit data, Trust data and ENIGMA data of varying types and 
subsequent ranking of data according to its source. Table 28 shows the 
breakdown of the best sources of each dataset provided and which datasets 
were subsequently excluded to produce the final dataset used by this study 
split according to Site ID, Time and outcome measure.  
 
The numbers within the Table correspond to a key identifying the source of 
that data item based on the final rankings. Grey-shaded cells highlight those 
data items where the exclusion criteria meant that it had to be excluded for 
one of the reasons stated previously. Black cells indicate that no data was 
available from any source. 
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Table 28.   Description of sources of data for the final dataset split 
according to site ID, site type (I = Intervention; C = Control), time 
point (T0 to T7) and data type based on TIS form completion (A = 
Referral numbers; B = Referral sources; C = Waiting lists; D = Lost 
slots and E = Activity).  
 
Site … Jan-03 (T0) Jun-03 (T1) Dec-03 (T2) Apr-04 (T3) 
ID Type 
TIS Forms TIS Forms TIS Forms TIS Forms 
A B C D E A B C D E A B C D E A B C D E 
1 I  1   1 1 1 1   1 1 1 1   1 1 1 1   1 1 1 
2 C         3         3 1   1 1 3 1   1 1 3 
3 C 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
4 I 4   4   4 4   4   4 4   4   4 4   4   4 
5 C     3         3         3     1 1 3 1 1 
6 I 5   5 4 4 5   5 4 4 5   5 4 4 5   5 4 4 
7 I 5   1   3 5   1   3 5   1   3 5   1   3 
8 I 3   3  3 3   3  3 3   3  3 3   3  3 
9 C 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
10 C         3         3         3     1   3 
11 I 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
12 C                     1   1   1 1   1   1 
13 I 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
14 C 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
15 C 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
16 I       3 3       3 3 5     3 3 5     3 3 
17 C                     1 1 1 1 1 1 1 1 1 1 
18 I 3   3 3 3 3   3 3 3 3   3 3 3 3   3 3 3 
19 I 3   3 3 1 3   3 3 1 3   3 3 1 3   3 3 1 
20 C         2         2         2         2 
(Cont’d…) 
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(…Cont’d) 
 
Site … Nov-04 (T4) Apr-05 (T5) Oct-05 (T6) Apr-06 (T7) 
ID Type 
TIS Forms TIS Forms TIS Forms TIS Forms 
A B C D E A B C D E A B C D E A B C D E 
1 I  1   1 1 1 1   1 1 1 1   1 1 1 1   1 1 1 
2 C 1   1 1 3 1   1 1 3 1   1 1   1   1 1   
3 C 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
4 I 4   4   4 4   4   4 4   4   4 4   4 4 4 
5 C 1 1 3 1 1 1 1 3 1 1 1 1 3 1 1   1 3 1 1 
6 I 5   5 4 4 5   5 4 4       4 4 5     4 4 
7 I 5   1   3 5   1   3     1   3     1   3 
8 I 3   3   3 3   3   3 3   3   3 3   3   3 
9 C 3 3 3 3 3     3 3 3     3 3 3     3 3 3 
10 C     1   3     1   3         3         3 
11 I 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2   2 2 
12 C 1   1   1 1   1   1 1   1   1           
13 I 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
14 C 3 3 3 3 3 3 3 3 3 3                     
15 C 2 2 2 2 2 2 2 2 2 2                     
16 I 5     3 3 5         5                   
17 C 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1   1 1 
18 I 3   3 3 3 3   3 3 3 3   3 3 3 3   3 3 3 
19 I 3   3 3 1 3   3 3 1 3   3 3       3     
20 C 5   5   2 5   5   2 5   5     5   5     
 
 
Table key: 1 = Endoscopy unit in-house data; 2 =Trust-completed TIS forms; 3 
= Trust in-house data; 4 = Endoscopy unit and Trust jointly-completed TIS forms 
(mixed source); 5 = ENIGMA data collection forms. The grey-shaded cells indicate 
that the data was excluded and the black cells indicate that no data was available 
from any source.  
 
5.4.7   Results of the data validation process 
 
HIRU were able to provide all HES datasets requested at a cost of £315. The 
results of applying formulae A and B to the datasets are shown in Table 29 
for the Intervention sites and Table 30 for the Control sites. Any % 
Difference values ≥ 50% are illustrated in bold.  
 
It was clear from the table that Sites 16 and 18 had extremely large 
differences between their HES data and the data collected for this study (see 
Table 31) whereby the HES data was a gross under-estimate of the study 
data, with % Difference between the HES data and study data reaching as 
high as -96%. 
 
When the actual Difference values are examined for these two sites, it is 
clear that for procedure 3 (FS) the counts are low anyway so the % 
Difference appears large. However, when looking at each procedure type, 
the actual Difference values are also high, indicating a true large % 
Difference between the two datasets. 
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Closer examination of the actual HES data from Sites 16 and 18, shown in 
Table 28 below, revealed extremely low counts for UGEs and colonoscopies 
during the calendar months specified as T0 to T7, so low as to cause serious 
concerns regarding their accuracy, especially when comparing the data to 
that received for this study (see Appendices 8-11). 
 
Further interrogation of the HES database in collaboration with a HIRU data 
analyst revealed that the error was “true” and was not the fault of any 
incorrect queries. It became apparent that it was the number of day cases 
being reported that was problematic, with Site 16 reporting three endoscopy 
day cases in total for 2003/04 and six for 2005/06, while Site 18 reported 
21 endoscopy day cases in total for 2003/04 and 30 day cases for 2005/06.  
 
The reason for this discrepancy was not obvious, since the study datasets 
from these two sites had both come from the Trust. The researcher pursued 
the matter further with both TIS contacts and found that they tended to 
record their endoscopies as outpatient procedures instead of day cases. This 
meant that they were not reported to HES, since the HES database did not 
include outpatient procedures until more recently. 
 
Given the non-normal distribution of the Activity data, non-parametric tests 
were used to analyse the data.  We used the Wilcoxon signed rank test to 
determine whether there was a significant difference between HES and 
Study data, split according to procedure type and time point of data 
capture.  Data from all eight sites were used in the first instance, followed 
by the exclusion of the data from Sites 16 and 18 for more accurate 
analysis.   
First-stage analysis – all datasets 
 
When examining the two sets of eight datasets split according to procedure 
type and time, there was no significant difference between HES data and 
Study data value. The same was true when data was split according to 
Intervention and Control sites. 
Second-stage analysis – edited datasets 
 
Following the exclusion of the split procedures datasets from Sites 16 and 
18 from the analysis, there were significant differences between the HES 
data and Study data for UGEs at T0 (Z = -2.023, p = 0.043), T1 (Z = -
2.023), T2 (Z = -2.023), for Colonoscopies at T0 (Z = -2.023, p = 0.043) 
and for FS at T0 (Z = -2.023, p = 0.043), T1 (Z = -2.023, p = 0.043), T2, 
(Z = -2.201, p = 0.028), T4 (Z = -2.201, p = 0.028) and T5 (Z = -1.997, p 
= 0.046). 
 
When the analysis was split according to Site type, there was no significant 
difference between HES data and study data. 
The ENIGMA study 
©NCCSDO 2008 Page 101 
Table 29.   Difference (Diff) and % Difference (% Diff) between HES data and study data for the four eligible Intervention 
sites.  
 
Site 
ID 
Proc. 
type 
T0 T1 T2 T3 T4 T5 T6 T7 
Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff 
6 1 9 4 71 61 0 0 -2 -1 -5 -3 -2 -1 16 8 -12 -9 
6 2 -7 -15 3 5 -3 -5 0 0 1 2 1 1 0 0 4 8 
6 3 7 11 6 13 3 5 1 3 2 4 8 8 -9 -14 -22 -34 
16 1 -31 -52 -101 -80 -101 -73 -143 -85 -146 -85 
 
 
 
 
 
 
 
 
 
16 2 -140 -93 -338 -95 -342 -96 -350 -96 -316 -96 
16 3 4 400 -9 -75 6 200 -1 -9 -24 -83 
18 1 -290 -85 -351 -89 -272 -84 -291 -85 -358 -90 -334 -87 -319 -89 -137 -71 
18 2 -278 -95 -334 -94 -354 -94 -334 -92 -334 -92 -403 -92 -474 -96 -213 -93 
18 3 -44 -90 -60 -92 -21 -91 -13 -81 3 300 -7 -70 -6 -55 2 100 
19 1 21 11 6 3 9 5 110 169 14 6 24 12 
 
 
 
 
 
 
19 2 4 11 2 4 6 14 -45 -53 0 0 15 23 
19 3 11 9 5 4 6 8 -122 -58 10 10 16 21 
 
Figures in bold illustrate a % Difference ≥ 50%. Procedure types: 1 = UGEs; 2 = FS and 3 = Colonoscopy. Shaded areas indicate that no 
data was available from this study. 
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Table 30.   Difference (Diff) and % Difference (% Diff) between HES data and study data for the four eligible Control 
sites. Figures in bold illustrate a % Difference ≥ 50%. Procedure types: 1 = UGEs; 2 = FS and 3 = Colonoscopy. 
Shaded areas indicate that no data was available from this study. 
 
Site 
ID 
Proc. 
type 
T0 T1 T2 T3 T4 T5 T6 T7 
Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff Diff 
% 
Diff 
2 1 53 15 89 23 41 11 55 15 38 10 58 16  
 
 
 
 
 
2 2 38 39 35 37 37 34 36 46 52 59 25 21 
2 3 15 42 25 89 11 37 0 0 18 30 4 7 
3 1 22 7 19 7 22 7 27 9 21 7 22 8 24 9 96 54 
3 2 18 33 16 18 19 34 17 26 27 32 21 25 21 21 26 43 
3 3 1 4 2 6 3 7 0 0 9 20 2 5 5 11 10 33 
9 1 128 44 99 30 120 42 -129 -51 -115 -49 -119 -48 -106 -44 110 57 
9 2 47 42 42 39 57 65 -51 -61 -35 -41 -63 -71 -31 -39 45 56 
9 3 4 80 10 333 10 91 6 86 -1 -8 -6 -38 9 69 27 169 
12 1 
 
  
57 66 64 49 53 48 36 32 45 34 
 
 
 
12 2 -13 -11 0 0 7 6 17 17 -8 -6 
12 3 17 39 7 13 10 11 8 12 17 31 
 
Table 31.   Actual data provided from HES for Sites 16 and 18 for UGEs and colonoscopy. 
 
 
Hospital ID Procedure type T0 T1 T2 T3 T4 T5 T6 T7 
16 UGEs 29 25 37 26 25 22 34 19 
16 Colonoscopy 10 16 16 14 14 21 25 13 
18 UGEs 50 43 51 53 42 48 38 55 
18 Colonoscopy 15 23 22 29 28 33 20 17 
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5.4.8   Description of Intervention and Control site datasets 
 
In the case of total procedures data: Referral numbers were available for 
nine Intervention sites and seven Control sites; Wait >3m data was 
available for six Intervention sites and four Control sites; Snapshot data was 
available for four Intervention sites and five Control sites; Lost slots data 
was available for five Intervention sites and four Control sites and Activity 
data was available for nine Intervention sites and eight Control sites. 
Availability of the Split procedures data was identical, since it was calculated 
from the data for all three procedure types. The actual datasets used for this 
study can be found in Appendices 8-11, split according to total procedures 
data and split procedures data, namely UGE, FS and colonoscopy datasets. 
5.4.9   Intervention and Control site data analysis 
 
The following section describes the data for each outcome measure from 
each study site, split according to Site type. The data is represented 
graphically according to Site type using total procedures data at individual 
time points, with individual sites’ data plotted using different coloured lines. 
The Intervention and Control group mean was also included for comparative 
purposes. The Intervention site and Control site graphs did not have 
matching scales because the data was better illustrated this way and also, 
because they were not meant for comparative purposes at this point. This 
will be dealt with later in the chapter. 
 
Referral numbers for Intervention and Control sites are plotted in Figures 6 
and 7 respectively. Data were available from most sites for most time 
points. The trends of both Intervention and Control sites appeared to be 
highly variable over time, although the variability of the Intervention group 
mean was less than the Control group mean. Many sites deviated from the 
group means, particularly Site 18 for Intervention sites and Site 17 for the 
Control sites. When examining the data from the earliest to the latest 
available time points, two Intervention sites (1 and 13) and two Control 
sites (5 and 12) showed increases in Referral numbers, while seven 
Intervention sites (4, 6, 7, 8, 11, 16 and 18) and five Control sites (2, 3, 9, 
17 and 20) showed decreases in Referral numbers.  
 
Wait >3m for Intervention and Control sites are plotted in Figures 6 and 7 
respectively. Data were limited, especially from Control sites, although most 
time points were available. The trends of both Intervention and Control sites 
appeared to be fairly constant over time, with the exception of Sites 4 and 
18 for the Intervention sites and Site 14 for the Control sites, which 
dramatically deviated from the Control group mean after T2, causing the 
group mean to rise unexpectedly. When examining the data from the 
earliest to the latest available time points, one Intervention site (18) and 
one Control site (14) showed increases in Wait >3m over time, while four 
Intervention sites (4, 6, 7, 8 and 19) and three Control sites (2, 3 and 20) 
showed decreases. One Intervention site data remained unchanged (6).  
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Figure 6.   Total procedures Referral numbers for each Intervention 
site and the Intervention group mean. 
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Figure 7.   Total procedures Referral numbers for each Control site and 
the Control group mean. 
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Figure 8.   Total procedures Wait >3m for each Intervention site and 
the Intervention group mean. 
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Figure 9.   Total procedures Wait >3m for each Control site and the 
Control group mean 
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Snapshot for Intervention and Control sites are plotted in Figures 10 and 11 
respectively. Data were extremely limited from both Site types, although 
most time points were available. The trends of both Intervention sites were 
highly variable while Control sites appeared to be fairly constant over time. 
The Intervention group mean was not representative of any of the individual 
sites, although none seemed to deviate from the mean for any extent, while 
the Control group mean showed a similar trend to many of the constituent 
sites. Site 9 showed extensive deviation from the Control group mean after 
T1 as it was double the mean value. When examining the data from the 
earliest to the latest available time points, one Intervention site (18) and 
four Control sites (9, 10, 11 and 12) showed increases in Snapshot over 
time, while three Intervention sites (1, 8 and 19) and one Control site (2) 
showed decreases. 
 
Lost slots for Intervention and Control sites are plotted in Figures 12 and 13 
respectively. Data were limited from both Site types, although most time 
points were available. The trends of both Intervention and Control sites 
appeared to be fairly constant over time, as reflected in the corresponding 
group means. Site 18 was generally double that of the Intervention group 
mean and the same trend was seen for Site 9 compared to the Control 
group mean from T2 onwards. When examining the data from the earliest to 
the latest available time points, no Intervention sites showed increases in 
Lost slots while two Control sites did (2 and 5). All five Intervention sites (1, 
6, 11, 13 and 18) showed decreases in their Lost slots over time compared 
with only two Control sites (3 and 9).  
 
Activity for Intervention and Control sites are plotted in Figures 14 and 15 
respectively. Data were available from most sites and for most time points. 
The trends of both Intervention and Control sites appeared to be fairly 
constant over time, as reflected in the corresponding group means. Site 18 
deviated from the Intervention group mean, while Site 17 appeared to 
deviate from the Control group mean although the degree of difference for 
both compared to the group means was actually quite small in terms of 
actual numbers. When examining the data from the earliest to the latest 
available time points, two Intervention sites (16 and 19) and four Control 
sites (2, 12, 17 and 20) showed increases in Activity, while seven 
Intervention sites (1, 4, 6, 8, 11, 13 and 18) and four Control sites (3, 5, 9 
and 10) showed decreases. 
 
As well as a graphical illustration of the data trends in each site over time, 
the actual changes in data were calculated using total procedures data for 
each individual study site to determine whether it had increased, decreased 
or remained relatively constant from the earliest time point to the latest 
time point with data submitted by that site. The calculation was done using 
data from individual time points and data aggregated according to year to 
cover the difference in the corresponding months (T0 to T7) and the mean 
values for the corresponding years (2003 to 2005/06), to ensure there was 
no obvious difference in the two time scales. The findings of this analysis 
are summarised in Table 32 with the actual difference in the data illustrated 
numerically, along with signs to illustrate whether the direction of the 
differences as increases (+) or decreases (-). 
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Figure 10. Total procedures Snapshot for each Intervention site and 
the Intervention group mean. 
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Figure 11. Total procedures Snapshot for each Control site and the 
Control group mean. 
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Figure 12. Total procedures Lost slots for each Intervention site and 
the Intervention group mean. 
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Figure 13. Total procedures Lost slots for each Control site and the 
Control group mean.  
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Figure 14. Total procedures Activity for each Intervention site and 
the Intervention group mean. 
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Figure 15. Total procedures Activity for each Control site and the 
Control group mean. 
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Table 32.   Summary of the trend of data for Referral numbers, Wait >3m, Snapshot, Lost slots and Activity over time. 
Data illustrates the difference in counts for each outcome measure from (i) T0 to T7 (or the closest time point with 
data) and (ii) 2003 to 2005/06. Key: + = increase in counts; - = decrease in counts. The number within the brackets 
signified the actual difference in counts. 
 
Site ID Site type Time Period Referral Nos Wait >3m Snapshot Lost slots Activity 
1 I 
T0 - T7 + (44) 
No data 
- (848) - (62) - (98) 
2003 - 2005/06 + (88) - (602) - (23) - (20) 
2 C 
T0 - T7 - (83) - (25) - (251) + (8) + (60) 
2003 - 2005/06 + (36) - (27) - (242) + (12) + (42) 
3 C 
T0 - T7 - (6) - (196) 
No data 
- (13) - (107) 
2003 - 2005/06 - (51) - (90) - (5) - (36) 
4 I 
T0 - T7 - (128) - (154) 
No data No data 
- (66) 
2003 - 2005/06 - (97) - (154) - (42) 
5 C 
T0 - T7 + (30) 
No data No data 
+ (60) - (57) 
2003 - 2005/06 No 2003 data No 2003 data No 2003 data 
6 I 
T0 - T7 - (83) No change 
No data 
- (4) - (97) 
2003 - 2005/06 - (88) + (4) + (6) + (26) 
7 I 
T0 - T7 - (8) - (82) 
No data No data No data 
2003 - 2005/06 + (37) No 2003 data 
8 I 
T0 - T7 - (438) - (36) - (68) 
No data 
- (393) 
2003 - 2005/06 - (191) + (14) - (28) - (176) 
9 C 
T0 - T7 - (73) 
No data 
+ (1653) - (78) - (93) 
2003 - 2005/06 No 2005/06 data + (882) - (10) - (61) 
10 C 
T0 - T7 
No data No data 
+ (500) 
No data 
- (21) 
2003 - 2005/06 No 2003 data - (15) 
 
(Cont’d…)
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(…Cont’d) 
 
Site ID Site type Time Period Referral Nos Wait >3m Snapshot Lost slots Activity 
11 
I 
T0 - T7 - (49) No data No data - (25) - (65) 
2003 - 2005/06 - (31) - (9) - (15) 
12 
C 
T0 - T7 + (77) No data + (212) No data + (73) 
2003 - 2005/06 + (41) + (90) + (50) 
13 
I 
T0 - T7 + (373) No data No data - (24) - (112) 
2003 - 2005/06 + (249) - (12) - (106) 
14 
c 
T0 - T7 No data + (737) + (826) No data No data 
2003 - 2005/06 + (823) + (930) 
15 
C 
T0 - T7 No data No data No data No data No data 
2003 - 2005/06 
16 
I 
T0 - T7 - (58) No data No data No data + (320) 
2003 - 2005/06 - (72) No 2005/06 data 
17 
C 
T0 - T7 - (125) No data No data No data + (42) 
2003 - 2005/06 - (41) + (119) 
18 
I 
T0 - T7 - (492) + (269) + (293) - (79) - (258) 
2003 - 2005/06 - (254) + (86) + (147) + (5) - (35) 
19 
I 
T0 - T7 No data - (53) - (61) No data + (5) 
2003 - 2005/06 - (34) - (35) + (11) 
20 
c 
T0 - T7 - (181) - (45) No data No data + (240) 
2003 - 2005/06 No 2003 data No 2003 data + (208) 
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5.4.10   Description of Intervention and Control group data 
 
The data from each Intervention site and each Control site were merged to 
become Intervention and Control group datasets. The mean values of each 
outcome measure at each individual time point and for data aggregated by 
year were tabulated for Intervention and Control groups using total 
procedures data (see Table 33) and split procedures data (see Table 34 for 
Intervention site data and Table 35 for Control site data). Trends for each 
mean data variable were discussed according to total procedures data and 
then split procedures data, according to the timescale used (individual time 
points or data aggregated by year).  
 
In addition to this, the group mean for each outcome measure was plotted 
graphically according to Site type and timescale used, using error bars 
marking the 95% CI for the mean total procedures data and stacked bar 
graphs for the mean split procedures data using UGEs, FS and colonoscopy 
data.  
Referral numbers 
 
The mean total procedures Referral number trend for the Intervention group 
fell from 483 to 387 between T0 and T7 while the Control group mean 
increased from 358 at T0 to 438 at T7. The Control group mean showed 
more variability over time than the Intervention group mean. When the data 
was aggregated according to year, the Intervention group mean showed a 
decrease from 462 at 2003 to 423 at 2005/06. The Control group mean 
showed a minor dip in Referral numbers for 2004 but overall, there was a 
slight increase from 467 at 2003 to 476 at 2005/06. 
 
When the data was split by procedure type, the Intervention group means 
for each procedure appeared to be relatively constant from T0 to T7 (see 
Figure 16) and 2003 to 2005/06 (see Figure 17). The only variation was for 
UGEs (OGD in the graph), which appeared to decrease over time. Data for 
all three procedures for the Control group were more variable over time for 
T0 to T7 and 2003 to 2005/06, with increasing numbers of LGEs (FS and 
colonoscopy on the graph) matching decreasing numbers of UGEs. 
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Table 33.   Mean values with standard deviations of each outcome measure for total procedures data at individual time 
points and according to year for the Intervention and the Control group.  
 
Site type Time Time Outcome measure 
Referral Nos (n) Wait >3m (n) Snapshot (n) Lost slots (n) Activity (n) 
Intervention   Individual 
time points 
T0 483 ± 238 (8) 135 ± 123 (5) 818 ± 289 (4) 94 ± 86 (5) 454 ± 170 (9) 
T1 458 ± 207 (8) 136 ± 180 (5) 673 ± 350 (4) 115 ± 112 (5) 494 ± 181 (9) 
T2 446 ± 187 (9) 131 ± 189 (5) 565 ± 133 (4) 137 ± 109 (5) 460 ± 166 (9) 
T3 460 ± 172 (9) 118 ± 140 (6) 602 ± 133 (4) 145 ± 79 (5) 463 ± 162 (9) 
T4 434 ± 157 (9) 115 ± 105 (6) 576 ± 145 (4) 110 ± 91 (5) 505 ± 162 (9) 
T5 457 ± 177 (9) 119 ± 128 (6) 548 ± 126 (4) 113 ± 114 (5) 474 ± 173 (8) 
T6 417 ± 133 (8) 91 ± 91 (5) 472 ± 106 (4) 159 ± 147 (5) 495 ± 187 (7) 
T7 387 ± 129 (7) 174 ± 235 (4) 767 ± 660 (2) 56 ± 60 (5) 349 ± 80 (7) 
Data by year 2003 462 ± 202 (25) 134 ± 154 (15) 685 ± 270 (12) 116 ± 97 (15) 469 ± 167 (27) 
2004 447 ± 160 (18) 116 ± 118 (12) 589 ± 130 (8) 127 ± 82 (10) 484 ± 159 (18) 
2005/06 423 ± 147 (24) 124 ± 145 (15) 561 ± 266 (10) 109 ± 113 (15) 441 ± 161 (22) 
Control  Individual 
time points 
T0 358 ± 100 (2) 278 ± 107 (2) 840 ± 219 (2) 143 ± 104 (2) 333 ± 133 (5) 
T1 460 ± 5 (2) 253 ± 233 (2) 1379 ± 913 (2) 103 ± 50 (2) 357 ± 124 (5) 
T2 514 ± 178 (5) 37 ± 37 (2) 1007 ± 653 (4) 57 ± 47 (3) 363 ± 140 (7) 
T3 396 ± 170 (6) 153 ± 164 (3) 1026 ± 584 (5) 62 ± 54 (4) 360 ± 117 (8) 
T4 502 ± 198 (7) 230 ± 385 (4) 1073 ± 659 (5) 70 ± 48 (4) 419 ± 166 (8) 
T5 450 ± 147 (6) 297 ± 530 (4) 1237 ± 623 (5) 74 ± 54 (4) 412 ± 150 (8) 
T6 527 ± 247 (6) 6 ± 7 (3) 1501 ± 1105 (3) 80 ± 50 (4) 419 ± 155 (6) 
T7 438 ± 170 (4) 19 ± 29 (3) 1608 ± 1472 (2) 72 ± 60 (3) 362 ± 140 (5) 
Data by year 2003 467 ± 147 (9) 167 ± 163 (7) 1058 ± 594 (8) 94 ± 67 (7) 352 ± 126 (17) 
2004 453 ± 186 (13) 197 ± 291 (7) 1049 ± 588 (10) 66 ± 48 (8) 390 ± 142 (16) 
2005/06 476 ± 187 (16) 127 ± 340 (10) 1390 ± 844 (10) 75 ± 49 (11) 401 ± 143 (19) 
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Table 34.   Mean values with standard deviations of each outcome measure for FS, Colonoscopy and UGE procedures at 
each at individual time points and according to year for the Intervention group.  
 
Procedure type Time Time Outcome measure 
Referral Nos (n) Wait >3m (n) Snapshot (n) Activity (n) 
Flexible sigmoidoscopy  Individual time points T0 79 ± 59 (8) 22 ± 29 (5) 150 ± 107 (4) 77 ± 56 (9) 
T1 72 ± 41 (8) 16 ± 25 (5) 136 ± 92 (4) 82 ± 61 (9) 
T2 72 ± 57 (9) 20 ± 25 (5) 129 ± 112 (4) 68 ± 63 (9) 
T3 76 ± 45 (9) 17 ± 13 (6) 124 ± 110 (4) 76 ± 67 (9) 
T4 74 ± 53 (9) 14 ± 14 (6) 139 ± 155 (4) 73 ± 55 (9) 
T5 79 ± 54 (9) 11 ± 11 (6) 101 ± 92 (4) 80 ± 53 (8) 
T6 86 ± 57 (8) 9 ± 10 (5) 104 ± 105 (4) 77 ± 53 (7) 
T7 79 ± 61 (7) 12 ± 10 (4) 20 ± 13 (7) 66 ± 45 (7) 
Data by year 2003 75 ± 51 (25) 19 ± 25 (15) 138 ± 95 (12) 75 ± 58 (27) 
2004 75 ± 47 (18) 15 ± 13 (12) 131 ± 124 (8) 74 ± 60 (18) 
2005/06 81 ± 55 (24) 11 ± 10 (15) 86 ± 88 (10) 75 ± 48 (22) 
Colonoscopy  Individual time points T0 121 ± 93 (8) 69 ± 93 (5) 255 ± 192 (4) 117 ± 77 (9) 
T1 144 ± 150 (8) 74 ± 91 (5) 220 ± 173 (4) 153 ± 118 (9) 
T2 121 ± 83 (9) 53 ± 66 (5) 184 ± 118 (4) 143 ± 129 (9) 
T3 129 ± 102 (9) 47 ± 55 (6) 220 ± 129 (4) 146 ± 125 (9) 
T4 139 ± 92 (9) 57 ± 60 (6) 162 ± 56 (4) 163 ± 108 (9) 
T5 145 ± 97 (9) 61 ± 70 (6) 161 ± 79 (4) 140 ± 121 (8) 
T6 119 ± 60 (8) 51 ± 53 (5) 149 ± 52 (4) 150 ± 154 (7) 
T7 105 ± 36 (7) 69 ± 86 (4) 246 ± 160 (2) 102 ± 64 (7) 
Data by year 2003 128 ± 107 (25) 65 ± 79 (15) 219 ± 152 (12) 138 ± 107 (27) 
2004 134 ± 94 (18) 52 ± 55 (12) 191 ± 97 (8) 155 ± 114 (18) 
2005/06 125 ± 70 (24) 60 ± 65 (15) 173 ± 86 (10) 131 ± 155 (22) 
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UGEs Individual time points T0 283 ± 130 (8) 44 ± 61 (5) 413 ± 175 (4) 259 ± 105 (9) 
T1 242 ± 82 (8) 46 ± 86 (5) 318 ± 229 (4) 259 ± 101 (9) 
T2 253 ± 115 (9) 59 ± 108 (5) 252 ± 47 (4) 249 ± 82 (9) 
T3 254 ± 102 (9) 55 ± 84 (6) 258 ± 86 (4) 241 ± 106 (9) 
T4 220 ± 94 (9) 44 ± 45 (6) 275 ± 74 (4) 269 ± 87 (9) 
T5 234 ± 113 (9) 47 ± 70 (6) 286 ± 85 (4) 254 ± 73 (8) 
T6 213 ± 98 (8) 31 ± 40 (5) 220 ± 55 (4) 268 ± 68 (7) 
T7 203 ± 67 (7) 93 ± 153 (4) 502 ± 514 (2) 180 ± 37 (7) 
Data by year 2003 259 ± 107 (25) 50 ± 81 (15) 328 ± 167 (12) 256 ± 93 (27) 
2004 237 ± 97 (18) 49 ± 65 (12) 266 ± 75 (8) 255 ± 95 (18) 
2005/06 218 ± 93 (24) 54 ± 89 (15) 303 ± 212 (10) 235 ± 71 (22) 
 
Table 35.   Mean values with standard deviations of each outcome measure for FS, Colonoscopy and UGE procedures at 
each at individual time points and according to year for the Control group. 
 
Procedure type Time Time Outcome measure 
Referral Nos (n) Wait >3m (n) Snapshot (n) Activity (n) 
Flexible sigmoidoscopy  Individual time points T0 9 ± 4 (2) 17 ± 2 (2) 15 ± 16 (2) 28 ± 22 (5) 
T1 24 ± 28 (2) 9 ± 6 (2) 17 ± 4 (2) 33 ± 24 (5) 
T2 56 ± 56 (5) 1 ± 2 (3) 61 ± 62 (4) 48 ± 36 (7) 
T3 73 ± 63 (6) 5 ± 5 (3) 225 ± 342 (5) 59 ± 41 (8) 
T4 98 ± 71 (7) 9 ± 14 (4) 75 ± 34 (5) 69 ± 58 (8) 
T5 97 ± 65 (6) 19 ± 23 (4) 89 ± 44 (5) 65 ± 53 (8) 
T6 100 ± 53 (6) 2 ± 3 (3) 118 ± 41 (3) 77 ± 60 (6) 
T7 81 ± 69 (4) 5 ± 9 (3) 72 ± 3 (2) 76 ± 70 (5) 
Data by year 2003 38 ± 46 (9) 8 ± 8 (7) 38 ± 48 (8) 38 ± 29 (17) 
2004 86 ± 66 (13) 7 ± 11 (7) 150 ± 243 (10) 64 ± 49 (16) 
2005/06 94 ± 58 (16) 10 ± 16 (10) 94 ± 39 (10) 72 ± 57 (19) 
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Colonoscopy  Individual time points T0 91 ± 9 (2) 199 ± 116 (2) 549 ± 135 (2) 66 ± 25 (5) 
T1 146 ± 5 (2) 211 ± 204 (2) 794 ± 361 (2) 76 ± 19 (5) 
T2 148 ± 39 (5) 24 ± 20 (3) 474 ± 404 (4) 87 ± 38 (7) 
T3 109 ± 39 (5) 95 ± 92 (3) 250 ± 178 (5) 80 ± 32 (8) 
T4 133 ± 53 (7) 139 ± 233 (4) 527 ± 451 (5) 101 ± 53 (8) 
T5 120 ± 58 (6) 179 ± 334 (4) 573 ± 424 (5) 121 ± 80 (8) 
T6 155 ± 98 (6) 4 ± 5 (3) 654 ± 516 (3) 112 ± 67 (6) 
T7 116 ± 54 (4) 12 ± 18 (3) 740 ± 722 (2) 89 ± 48 (5) 
Data by year 2003 135 ± 37 (9) 127 ± 137 (7) 573 ± 333 (8) 78 ± 30 (17) 
2004 122 ± 47 (13) 120 ± 175 (7) 388 ± 355 (10) 90 ± 44 (16) 
2005/06 132 ± 73 (16) 76 ± 213 (10) 631 ± 449 (10) 110 ± 66 (19) 
UGEs Individual time points T0 259 ± 96 (2) 62 ± 7 (2) 277 ± 100 (2) 240 ± 110 (5) 
T1 291 ± 18 (2) 33 ± 24 (2) 568 ± 556 (2) 248 ± 122 (5) 
T2 310 ± 121 (5) 12 ± 16 (3) 472 ± 270 (4) 228 ± 113 (7) 
T3 214 ± 100 (6) 53 ± 71 (3) 551 ± 344 (5) 221 ± 94 (8) 
T4 270 ± 113 (7) 83 ± 139 (4) 471 ± 244 (5) 250 ± 98 (8) 
T5 233 ± 86 (6) 99 ± 192 (4) 575 ± 238 (5) 226 ± 94 (8) 
T6 272 ± 140 (6) 1 ± 2 (3) 729 ± 593 (3) 230 ± 59 (6) 
T7 242 ± 86 (4) 2 ± 2 (3) 796 ± 747 (2) 197 ± 33 (5) 
Data by year 2003 294 ± 95 (9) 32 ± 26 (7) 447 ± 299 (8) 237 ± 107 (17) 
2004 244 ± 107 (3) 70 ± 107 (7) 511 ± 284 (10) 236 ± 94 (16) 
2005/06 250 ± 104 (16) 41 ± 122 (10) 665 ± 418 (10) 220 ± 70 (19) 
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Figure 16.   Mean split procedures Referral numbers for the 
Intervention and Control group datasets for individual time points 
(T0 to T7). 
Figure 17.   Mean split procedures Referral numbers for the 
Intervention and Control group datasets for data, aggregated by 
year (2003, 2004 and 2005/06). 
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Wait >3m  
 
The mean total procedures Wait >3m data showed an overall increase from 
135 at T0 to 174 at T7 due to a similar sharp increase in Hospital 18 data. 
The Control group mean showed an overall decrease from 278 at T0 to 19 at 
T7, with the rise at T5 greatly influenced by Site 14 data. When the data 
was aggregated according to year, the Intervention group mean showed a 
slight decrease from 134 at 2003 to 124 at 2005/06. The Control group 
mean showed a peak for 2004 but overall, there was a slight decrease from 
167 at 2003 to 127 at 2005/06.  
 
When the data were split by procedure type, the Intervention group mean 
for each procedure showed consistent trends until T7, when there was a 
large increase in UGEs (see Figure 18). This increase was not seen in the 
2005/06 dataset (see Figure 19). Data for all three procedures for the 
Control group was highly variable over time for T0 to T7, and to a lesser 
extent for 2003 to 2005/06, due to inconsistent changes in the colonoscopy 
figures and low sample numbers for T6 and T7. 
Snapshot  
 
The mean total procedures Snapshot data for the Intervention group fell 
from 818 at T0 to 767 at T7 to 387, while the Control group mean increased 
from 840 at T0 to 1608 at T7. Both the Intervention and the Control group 
mean showed remarkably constant trends over time that were also highly 
comparable. The aggregated data for the Intervention group mean 
decreased from 685 at 2003 to 561 at 2005/06 and the Control group mean 
increased from 1058 at 2003 to 1390 at 2005/06.  
 
When the data was split by procedure type, the Intervention group means 
for each procedure appeared to be relatively constant from T0 to T7 (see 
Figure 20) and 2003 to 2005/06 (see Figure 21). The only variation was for 
UGEs, which appeared to decrease over time, as was the case for Wait >3m 
data. Data for all three procedures for the Control group were more variable 
over time for T0 to T7 and 2003 to 2005/06, with varying numbers of LGEs 
and increasing numbers of UGEs. 
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Figure 18.   Mean split procedures Wait >3m for the Intervention and 
Control group datasets for individual time points (T0 to T7).  
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Figure 19.   Mean split procedures Wait >3m for the Intervention and 
Control group datasets for data, aggregated by year (2003, 2004 
and 2005/06). 
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Figure 20.   Mean split procedures Snapshot for the Intervention and 
Control group datasets for individual time points (T0 to T7). 
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Figure 21.   Mean split procedures Snapshot for the Intervention and 
Control group datasets for data, aggregated according to year 
(2003, 2004 and 2005/06). 
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Lost slots  
 
The mean total procedures Lost slots trend for the Intervention group fell 
from 94 at T0 to 56 at T7, while the Control group mean showed an overall 
decrease from 143 at T0 to 72 at T7. Both the Intervention and the Control 
group mean showed remarkably constant trends over time that were also 
highly comparable. When aggregated according to year, the Intervention 
group mean showed a slight decrease from 116 at 2003 to 109 at 2005/06 
and the Control group mean showed a decrease from 94 at 2003 to 75 at 
2005/06. Lost slots data was not split by procedure type so no further 
analysis was possible. 
Activity 
 
The mean total procedures Activity trend for the Intervention group fell from 
454 at T0 to 349 at T7, while the Control group mean increased from 333 at 
T0 to 362 at T7. Both the Intervention and the Control group mean showed 
small variations in data over time. When aggregated according to year, the 
Intervention group mean showed a decrease from 469 at 2003 to 441 at 
2005/06 and the Control group mean showed an increase from 352 at 2003 
to 401 at 2005/06.  
 
When the data was split by procedure type, both the Intervention group and 
Control group means for each procedure appeared to be relatively constant 
from T0 to T7 (see Figure 22) and 2003 to 2005/06 (see Figure 23), 
although the Control group means did show a slight increase in 
colonoscopies over time for both time scales. 
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Figure 22. Mean split procedures Activity for the Intervention and 
Control group datasets for individual time points (T0 to T7). 
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Figure 23.   Mean split procedures Activity for the Intervention and 
Control group datasets for data, aggregated according to time 
(2003, 2004 and 2005/06). 
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5.4.11   Correlation 
 
Significant relationships between combinations of each process measure 
were identified using Spearman’s correlation (rho). Only significant results 
were discussed in detail (p ≤ 0.05). Correlation values between 0.5 and 1 
were considered to be strong relationships, while those between 0.3 and 
0.49 were medium and those between 0.1 and 0.29 were low. Positive 
correlation results indicated that an increase in one variable corresponded 
with an increase in the other variable, although the result would not indicate 
which variable was the causative one (if either – a third confounding 
variable may have a causative effect on both variables being correlated), 
while negative correlation indicated that as one variable increased, the other 
decreased.  
 
For the Intervention group, there was strong positive correlation between 
Referral numbers and Activity for 2003 (p = 0.006), 2004 (p = 0.02) and 
2005/06 (p < 0.001) that grew in strength over time, indicating a successful 
and sustained response to any increased demand by increasing Activity (see 
Table 35). Lost slots and Activity also showed strong positive correlation for 
2003 (p = 0.006), 2004 (p = 0.03) and 2005/06 (p = 0.009), although the 
strength of the relationship decreased slightly over time, indicating that 
either the sites increased their Activity in response to an increasing Lost 
slots rate, or an increase in Activity may have increased the incidence of 
Lost slots proportionally. There were no other significant linear relationships 
identified for the other combinations of outcome measures. 
 
For the Control group, Referral numbers and Lost slots data for 2004 
showed strong negative correlation, with increasing Referral numbers being 
significantly associated with low numbers of Lost slots (p = 0.021). This 
indicated that for that point in time, these sites appeared to have 
successfully reduced their Lost slots while also coping with increasing 
Referral numbers (see Table 36). However, this result was obtained from 
relatively low sample numbers (n = 8) and may not be a true representation 
of the service in Control sites for this time period. Data for 2003 and 
2005/06 were not significant (p = 0.589 and 0.16 respectively), indicating 
that this change in services was not originally in place but was also not 
successfully maintained. There was a strong positive correlation between 
Referral numbers and Activity for 2004 (p = 0.027) and 2005/06 (p = 
0.002), but not 2003 (p = 0.17), indicating that after a slow start the 
Control group were also able to match Referral numbers with Activity.  
 
Lost slots and Activity showed a strong negative correlation for 2004 (p = 
0.004), whereby increased Lost slots were significantly associated with 
decreased Activity. This was not the case for 2003 or 2005/06 (p = 0.148 
and 0.066 respectively). This may be explained by the fact that Activity is 
counted as the number of completed procedures and as the number of Lost 
slots increases, the number of procedures completed decreases 
proportionally. Again, low sample numbers (n = 8) may have affected the 
results in Control sites for this time period. There were no other significant 
linear relationships identified for the other combinations of outcome 
measures. 
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Table 36.   Table of all significant (p ≤ 0.05) relationships between 
total procedures data aggregated according to year for Referral 
numbers, Lost slots and Activity from Intervention and Control 
group datasets using Spearman’s correlation coefficient (rho). Sig. 
= Significance. 
 
Site type Variable 1 Variable 2 
Sample 
No. 
Year 
Correlation  
Coefficient 
Sig. 
(2-tailed) 
Intervention Referral Nos Activity 22 2003 0.569 0.006 
Lost slots Activity 15 2003 0.675 0.006 
Referral Nos Activity 16 2004 0.574 0.02 
Lost slots Activity 10 2004 0.681 0.03 
Referral Nos Activity 21 2005/06 0.725 <0.001 
Lost slots Activity 15 2005/06 0.649 0.009 
Control  Referral Nos Lost slots 8 2004 -0.786 0.021 
Referral Nos Activity 13 2004 0.61 0.027 
Lost slots Activity 8 2004 -0.881 0.004 
Referral Nos Activity 12 2005/06 0.799 0.002 
5.4.12   Two-way analysis of variance 
 
When using a two-way ANOVA to analyse the total procedures data, there 
was no significant between-groups or within-groups effects for Referral 
numbers, Wait >3m, Snapshot, Lost slots or Activity. The only significant 
interaction effect reported was for the Activity dataset (F (2, 26) = 3.594, p 
= 0.042), indicating that there was a significant difference in the changes in 
the Activity data over time between the Intervention and Control groups 
(see Table 37). Closer examination of the total procedures data indicated 
that the significant interaction effect was attributable to a decrease in 
Intervention group Activity over time corresponding with an increase in 
Control group Activity over time (see Figure 24).  
 
When the data was split by procedure type, there were no significant 
between-groups effects for any of the five outcome measures (see Table 
36). The only significant within-group results were for UGEs over time for 
Referral numbers (F (1, 11) = 5.15, p = 0.03) and for Activity (F (1, 13) = 
5.25, p = 0.012), indicating that the data changed significantly over the 
three time periods analysed within the Intervention and Control groups.  
 
There were also significant differences in the UGE Activity data for the 
Intervention group (p = 0.03) but not for the Control group (p = 0.368). On 
closer examination of the raw data, it appeared that the mean Referral 
numbers data from the four sites constituting the Control group significantly 
decreased from 310.7 in 2003 to 260.1 in 2005/06 and that the mean 
Activity data from the eight sites constituting the Intervention group 
significantly decreased from 274.2 in 2003 to 232.4 in 2005/06. 
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Table 37.   Results of the two-way ANOVA for each of the five outcome measures using total procedures and split 
procedures data. All significant values are highlighted in bold. Proc. Type: 1 = FS; 2 = Colonoscopy; 3 = UGEs; 4 = 
Total procedures. 
 
Outcome 
measure 
Proc. 
type 
Intervention group 
means for 2003, 2004 
and 2005/06 
Control group means for 
2003, 2004 and 2005/06 
Within-subject 
effects  
(F ratio, sig.) 
Between-
subject effects  
(F ratio, sig.) 
Interaction 
effects  
(F ratio, sig.) 
Referral 
numbers 
1 72.9, 75.2, 79.5 (n = 9) 67.8, 89.9, 92.8 (n = 4) 2.12, 0.169 0.059, 0.813 0.94, 0.365 
2 127.3, 134.4, 126 (n = 9) 141.2, 143.3, 163.1 (n = 4) 0.347, 0.58 0.201, 0.663 0.733, 0.417 
3 254.1, 236.9, 209 (n = 9) 310.7, 271.8, 260.1 (n = 4) 5.151, 0.03 0.646, 0.439 0.284, 0.67 
4 454.3, 446.6, 414.5 (n = 9) 519.7, 505, 516 (n = 4) 0.28, 0.64 0.586, 0.46 0.317, 0.617 
Wait >3m 1 19.3, 15.7, 9.7 (n = 5) 6.7, 8.7, 15.8 (n = 3) 0.016, 0.984 0.246, 0.638 2.296, 0.143 
2 65.2, 58.5, 55.6 (n = 5) 108.9, 138.5, 236 (n = 3) 0.965, 0.367 1.004, 0.355 1.247, 0.308 
3 49.6, 48.1, 51.9 (n = 5) 31.8, 75.2, 131 (n = 3) 0.992, 0.362 0.226, 0.651 0.896, 0.385 
4 134.1, 122.3, 117.2 (n = 5) 147.3, 222.3, 382.8 (n = 3) 0.994, 0.36 0.594, 0.47 1.29, 0.3 
Snapshot 1 138.2, 131.4, 101 (n = 4) 61.5, 65.1, 82.3 (n = 4) 0.313, 0.737 0.826, 0.399 4.428, 0.036 
2 219.4, 191.3, 161.1 (n = 4) 490.4, 594.4, 692.2 (n = 4) 0.931, 0.421 4.351, 0.082 3.06, 0.084 
3 327.6, 266.3, 293.6 (n = 4) 455.8, 515.1, 647.4 (n = 4) 0.812, 0.467 3.23, 0.122 1.235, 0.325 
4 685.2, 588.9, 555.6 (n = 4) 1007.7, 1174.5, 1422.5 (n = 4) 0.733, 0.435 3.757, 0.101 2.461, 0.163 
Lost slots 4 115.5, 127.3, 109 (n = 5) 76.3, 70.7, 75.3 (n = 3) 0.313, 0.737 0.469, 0.519 0.965, 0.409 
Activity 1 84.3, 73.2, 74.9 (n = 8) 46.1, 58.1, 57.5 (n = 7) 0.019, 0.981 0.899, 0.36 3.14, 0.06 
2 119.1, 129.6, 125.6 (n = 8) 88.1, 94.8, 129.6 (n = 7) 2.928, 0.103 0.255, 0.622 2.259, 0.151 
3 274.2, 274.2, 232.4 (n = 8) 228.4, 232.6, 219.4 (n = 7) 5.249, 0.012 0.586, 0.458 1.789, 0.187 
4 477.6, 476.9, 433 (n = 8) 360.1, 384.8, 403.8 (n = 7) 0.348, 0.71 1.106, 0.312 3.594, 0.042 
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Figure 24.   Estimated Marginal Means of Activity using total 
procedures data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The only significant interaction effect was associated with FS Snapshot data 
(F (1, 6) = 4.43, p = 0.036), indicating that there was a significant 
difference in the changes in the FS Snapshot data over time between the 
Intervention and Control groups. The data corresponding to the significant 
interaction effect between Intervention and Control groups for FS Snapshot 
data, highlighted by mean plots whereby the lines are not significantly 
parallel, are illustrated in Figure 25.  
5.5   Discussion 
5.5.1   The availability of routinely collected process data 
 
Only four of the nine Intervention sites approached submitted any routinely 
collected, process data, and one of those was only for one time period in 
2003. This lack of data availability was surprising, since the MES 
programme based its redesign theories on the collection and analysis of 
accurate, measurable process data prior to the implementation of targeted 
innovations to improve services from a patient-centred perspective to 
address waiting list targets published by the NHS Cancer Plan(Department 
of Health 2000(a)). It also advocated the routine collection of this data by 
the endoscopy units themselves using data collection software, in preference 
to liaising with Trust departments.  
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Figure 25.   Estimated marginal means of Snapshot for FS 
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The study expected, at the very least, to obtain data for all three time 
periods in 2003 if nothing else, but even this was beyond the scope of the 
Intervention sites.  
 
It is clear that the key issue of the need for high quality data collection and 
analysis advocated by the MES programme was not taken on board with 
many Intervention sites. This may be explained by the fact that the data 
were routinely uploaded to the MESPT on a monthly basis and the staff were 
not properly trained in how best to analyse and understand the data at the 
ground level and so, they may not have realised its true potential for 
implementing effective, targeted changes or for measuring the impact of 
any modernisation strategies.  
 
Informal discussions with some Intervention site contacts during the data 
collection phase highlighted the difficulties they experienced in using and 
extracting any meaningful datasets from the ToolkitTM for their own use. 
Since the data collection process for the ToolkitTM was so labour-intensive, 
sites may have found it impossible to maintain the ToolkitTM in accordance 
with the strict deadlines imposed by the MESPT while also inputting the data 
into a second, more meaningful dataset for their own use and so, the 
ToolkitTM took priority. Many sites also expressed their frustrations at having 
to collect such detailed datasets when in their minds, they were able to 
analyse their services equally well with less complex, easier to collect data. 
This problem was further exacerbated with the change from the Excel-based 
version to the web-based version. They commented that they were less able 
to manipulate the data than before and viewed the Webtool as 
disadvantageous when compared to the Excel-based ToolkitTM. 
 
It is also possible that the rigorous nature of the data collection required by 
the ToolkitTM put them off continuing such a labour-intensive task, especially 
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since many sites commented on the fact that they had used some of the 
MES programme funding to pay for a data entry clerk to input data and 
when the funding ended, so did the data collection.  
 
They were however quite happy to agree that some form of data collection 
was necessary and acknowledged the ToolkitTM as being the instigator for 
their own in-house data collection processes, although this study suggests 
that routine data collection processes never really flourished in the same 
way they were spoken about.  
 
Another surprising aspect of this study was that half the Control sites had 
initiated their own, in-house data collection protocols, although these were 
instigated during the latter part of 2003 or early 2004. The Control sites 
were all aware of the MES programme because they had originally applied to 
take part but had been rejected. They were however offered the opportunity 
to be trained in the use of the ToolkitTM, if they so desired. Only one Control 
site took advantage of this opportunity and used the Excel-based version of 
the ToolkitTM to collect in-house data on a monthly basis. As a result, they 
were able to provide data for the majority of the time periods requested by 
this study.  
 
It is possible that the messages of accurate data collection advocated by the 
MES programme were disseminated to these sites and they began their own 
data collection processes, albeit later in the study. The raw datasets 
provided by the Control sites covered more of the outcome measures 
requested than those of the Intervention sites. It is feasible that having 
access to the ToolkitTM, they took on board the idea of data collection but did 
so in a rudimentary manner with basic counts of the relevant aspects of the 
service collected in Excel software. This backs up the theory that the 
ToolkitTM, the strict timetables and the high quality data collection processes 
associated with the MES programme may have deterred Intervention sites 
from ongoing data collection while the Control sites felt no pressure to 
collect specific datasets in conjunction with a strict timetable and as a 
result, were more motivated to capture data. 
 
During the course of the study, we were concerned to hear from some Trust 
personnel about the degree of potential coding ambiguities in their own 
endoscopy datasets, although there was no published evidence retrieved in 
the field of endoscopy to support this. For the sites that relied on Trust-held, 
it is questionable whether they were being given accurate process data. 
However, it was not part of the remit of this study to investigate how aware 
the endoscopy staff were of the quality of their data, but it was evident that 
the data were used by the units in the absence of anything else, irrespective 
of its origins and potential inaccuracies. 
 
The need for good quality routinely collected data in the NHS has been 
widely acknowledged based on independent assessment of current data 
collection practices (Audit Commission 2002; Audit Commission 2004; 
Benneyan, Lloyd and Plsek 2003; Thorne, Hutchings and Elwyn 2008). 
However, there is currently no national impetus to collect routine data in 
NHS endoscopy services, even in light of the MES programme which 
reported significant improvements in the services of Intervention sites 
based, in part, on high quality data collection and analysis (NHS 
Modernisation Agency 2004). With increasing demands on NHS endoscopy 
services from TWR referrals and the National Bowel Cancer Screening 
Programme (NBCSP), it is difficult to understand how NHS endoscopy 
services hope to become more efficient if they do not understand how they 
work and where underlying problems may exist in order to target any 
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redesign plans effectively. This may explain why the service is only able to 
achieve TWR targets at the expense of the routine waiting list (Thorne, 
Hutchings and Elwyn 2006). Even the most basic understanding of the 
demand and Activity within the endoscopy unit can identify seasonal effects, 
underused resources and potential problems for further investigation, as 
well as providing a baseline measurement with which to measure the impact 
of any change(s) to the service. It can also provide an invaluable source of 
evidence when submitting bids for funding, all of which make the effort of 
establishing even a basic data collection regime worthwhile.  
 
Perhaps the lack of experience in data analysis in some NHS managers can 
go some way towards explaining the ineffective working practices of many 
NHS services, not just endoscopy, as many NHS managers are not properly 
trained in redesign concepts that advocate data collection and analysis as 
the basis for improving a process. Even though the NHSMA was established 
to bridge the gap between redesign theory and its practical implementation 
in the NHS, the message of continuous data collection and analysis did not 
appear to be properly accepted by the Intervention sites used in this study. 
The Audit Commission have recently published a report aimed at public 
services to improve the quality of their data (Audit Commission 2007). If 
this could be used as a framework for the NHS to initiate an improved data 
collection strategy, the quality of NHS services may improve in line with its 
datasets. 
5.5.2   The validation of the process data 
 
When the data were first plotted as part of an Exploratory Data Analysis 
(EDA) exercise, there were many issues that gave cause for concern. The 
line graphs showed a high degree of variability over time for many sites, 
both Intervention and Control. As a result, it was deemed necessary to test 
the accuracy of the datasets received by comparing them with a nationally-
held dataset from HES.  
 
HES has been used in many health services research studies in NHS Trusts 
in England associated with GI disorders (Al-Sarira, David, Willmott, Slavin, 
Deakin and Corless 2007; Kang, Hoare, Tinto, Subramanian, Ellis, Majeed et 
al. 2003; Pollock and Vickers 1998), with reported cases of its use in 
investigating NHS endoscopy services (Williams 1999; Williams and Mann 
2002). Given its wide application for the measurement of NHS management 
patterns, HES data was considered to be a good standard against which to 
validate the study data submitted by each site.  
 
There was no significant difference between the HES and the study datasets 
from the eight endoscopy units.  The similarity of the data (following the 
exclusion of the two anomalous datasets) was to be expected, given that 
half of the data sources used in the study dataset originated from the Trust 
(Sites 2, 3 and 9) and of these three, all were Control sites. The other three 
data sources were from the endoscopy units, with two submitting routinely 
collected data (12 and 19) while the other site’s data came from the 
ENIGMA data collection forms (6). 
 
In most analyses, the mean study data were lower than that of the mean 
HES data. This may be because the HES data was more rigorous in its data 
requests and the routinely collected datasets from the endoscopy units may 
not have included as many counts. It is also possible that the restriction in 
the OPCS codes given to the TIS contacts for the study data request may 
have missed a particular aspect of Activity that was captured in the HES 
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data request by HIRU. Alternatively, the HIRU request may not have been 
refined enough to block the procedures not included in the study data. 
 
It is clear from these findings that the accuracy of the datasets used in this 
study has been validated by the use of a comparative analysis using the 
equivalent HES dataset. For this reason, we felt that it was reasonable to 
advocate the use of the study datasets presented in this study in the 
evaluation of the MES programme. 
 
However, it also brings into perspective the need to be vigilant when using 
HES data for evaluating endoscopic procedures in NHS Trusts, since some 
Trusts did not record them as day cases but rather as outpatient 
procedures. Researchers need to clarify with Trusts how they report their 
endoscopy Activity to HES to ensure the HES dataset provides an accurate 
count. This, along with the more rigorous guidelines for Trusts concerning 
the completion of their data returns to HES means that this problem should 
not arise as often using current datasets but caution should be used when 
using older datasets, as was the case in this study. 
5.5.3   The analysis of the data 
 
The problem with the availability, consistency and validity of the data so far 
discussed mean that any analysis has to be interpreted with caution. With 
this caveat the study has shown that there was a high degree of variability 
in the services of the 20 endoscopy units participating in this study over 
time for all five outcome measures, especially from the Control sites. 
However, both the Intervention and Control group means were relatively 
more stable over time.  
 
Referral numbers appeared to decrease over time in the Intervention group, 
but were more variable in the Control group. This may be explained by the 
Intervention sites taking a more proactive approach to managing the 
demand on their services, as advised by the MESPT. Examples of this 
management advice included validation of referrals, introducing new referral 
pathways and most importantly, the introduction of partial and full booking 
– a target stipulated by the MESPT. The implementation of partial and full 
booking for patients gave them the choice of appointment dates and may 
have affected the demand for Intervention sites more so than the Control 
sites. Another major contributor to changing the demand on NHS endoscopy 
services in both Intervention and Control sites has been the implementation 
of guidelines to allow health professionals to correctly refer their patients. 
This has reduced the number of inappropriate referrals, thereby reducing 
the demand on endoscopy services. Interestingly, the number of UGE 
referrals being made decreased in both Site types over time, possibly as a 
result of improved guidance regarding the referral of dyspepsia patients by 
NICE (National Institute for Clinical Excellence 2004).  
 
The Wait >3m measure remained relatively stable over time in Intervention 
sites, but was slightly higher and more variable in Control sites. However, 
both Site types showed decreases in Wait >3m over time. This was probably 
due to the fact that it was a nationwide target set by the Government in the 
NHS Plan (Department of Health 2000(b)). There were differences in the 
proportion of patients waiting for a colonoscopy between the Intervention 
and Control group, although this decreased over time as the Control sites 
reduced the number of patients waiting for this procedure by more than 
three months. 
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The Snapshot variable differed between the MES and Control group. While 
the Intervention group Snapshot decreased slightly over time, the Snapshot 
of the Control group increased dramatically to become more than double of 
that seen in the Intervention group. The Intervention sites may have 
successfully introduced a number of initiatives advocated by the MESPT, 
including waiting list validation and pooling. The Control sites may not have 
sought this advice and implemented innovations that did not improve their 
waiting lists. The need to meet the three month Government target may 
have been another confounding factor for the Control sites as, in a bid to 
meet Government targets, they were forced to reclassify and then 
reorganise their patients onto a routine waiting list so that only “eligible” 
patients were given priority to be seen within three months. This theory is 
borne out when looking at the number of patients waiting for a colonoscopy 
over time. The Wait >3m data in the Control sites showed a marked 
decrease over time. When we look at the colonoscopy Snapshot data over 
time we see that it has increased. It is highly likely that many colonoscopy 
patients were moved onto another waiting list not affected by the three 
month Government target, as evidenced by the Snapshot data presented 
here. 
 
Lost slots were lower in the Control group than in the Intervention group 
and both showed differing trends: the Intervention group data showed a 
peak whereas the Control group data showed a trough, indicating that the 
Control sites may have been better at reducing their Lost slots over time. 
This brings into doubt the validity of the findings of the MES report which 
stated that 71% of their 26 sites reduced their DNAs to less than 5%. The 
findings also show that any improvements in their DNA rates were 
subsequently not sustained over time. The reasons for this are unknown. 
What is more interesting is the fact that the Control group managed to 
reduce their DNAs over time without any MES programme support. Perhaps 
with less financial backing to implement changes, they sought to get the 
most out of their initiatives and if DNAs and cancellations were a huge 
problem for these sites, they may have focused in on them more in the hope 
that improving them would indirectly benefit their waiting lists as less 
people would be rebooked. However, this side effect was not evident in this 
analysis, although the numbers saved would not have stood out in the 
Snapshot dataset, given the large numbers contained within. 
 
The Activity in the Intervention group decreased over time while the Control 
group Activity increased, although the Intervention group Activity was far 
higher than that of the Control group to begin with. The MESPT provided 
endless advice and support to allow Intervention sites to increase their 
throughput by analysing their services and introducing targeted innovations. 
The introduction of Nurse Endoscopists (NE) into NHS endoscopy units 
would have increased Activity in both Site types to a degree, depending 
upon when they were employed and the extent of their skills. It is feasible 
that the decrease seen in the Intervention sites may have been attributable 
to the introduction of nurse-led clinics as outpatient consultations which will 
not have been recorded in this dataset, although there is no reason why this 
new way of working would not have been introduced in the Control sites too. 
When looking at the split procedures Activity data, it paints a clearer 
picture. The Activity in the Intervention sites for all three procedure types 
remains relatively constant, with only a minor drop in UGEs for 2005/06 
while the Control sites show an increase in colonoscopies that approaches 
that seen in the Intervention sites.  
 
There was a significant, strong, positive correlation between Referral 
numbers and Activity over time in both the Intervention and the Control 
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group, indicating a successful and sustained response to any increases in 
referrals in both Site types by increasing Activity. Lost slots and Activity in 
the Intervention group also showed a significant, strong, positive correlation 
over time, indicating that either these sites increased their Activity in 
response to an increasing Lost slots rate, or an increase in Activity may have 
increased the incidence of Lost slots proportionally. Lost slots and Activity in 
the Control group showed a significant, strong, negative correlation at only 
one time point. This may be explained by the fact that Activity is counted as 
the number of completed procedures and as the number of Lost slots 
increases, the number of procedures completed decreases proportionally. 
Low sample numbers (n = 8) may have affected the results in Control sites 
for this time period.  
 
A two-way ANOVA using total procedures data showed that there were no 
significant differences in the data for any of the five outcome measures over 
time within both Site types. There was also no significant difference 
between the Intervention and Control group data for any of the five outcome 
measures. The only significant interaction effect was for Activity, indicating 
that there was a significant difference in the changes in the Activity data 
over time between Site types. This was illustrated graphically with 
decreases in Intervention group Activity mirrored by increases in Control 
group Activity over time. This result highlights an interesting finding that 
was contrary to the original hypothesis that the Intervention sites would 
increase their Activity levels. The proposed explanation discussed earlier 
regarding the possibility of outpatient procedures accounting for Activity 
that was not recorded in this study, could partly explain this significant 
difference. Another contributory reason could be the fact that the Control 
sites had obviously made a degree of improvement in their services that, 
when compared to the Intervention sites, resulted in the significant 
difference found. 
 
When the data was split according to procedure types, more significant 
differences were found. For UGEs, there was a significant within-groups 
effect for Referral numbers and Activity, indicating that the data differed 
significantly over time within the Intervention and Control groups for these 
two outcome measures. There was one significant interaction effect whereby 
the changes in FS Snapshot data were significantly different over time 
between the Intervention and Control groups. When the data was illustrated 
graphically, there was an obvious downwards trend in Intervention group 
data over time that was significantly different to the trend in data seen from 
the Control group data over time. 
 
Whilst the Bonferroni test was used in this analysis, it is plausible that such 
a conservative test would affect the results of the two-way ANOVA, making 
results less significant. P-values of 0.5 or less indicate a 5% chance of a 
significant result occurring by chance. When adding together the number of 
tests included in this type of multivariate analysis, there were approximately 
51 individual tests being done (repeated measures and between site 
measures for five outcome measures according to total procedures and split 
procedures – see Table 36). Of these, four were statistically significant, 
approximately 7.8% of the tests. Since this is a just a little over the 5% 
figure we would expect to see given the number of tests being done, we can 
plausibly conclude that there were in fact no significant two-way ANOVA 
results and that those found by the analyses were probably due to chance 
alone due to the p-value being set at ≤ 0.05. 
 
The measurement and evaluation of NHS services is essential to ensure that 
a process is running optimally and to guarantee that there is no alternative 
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way of doing things that would be even more efficient. The most effective 
way to evaluate NHS services is to look at different aspects of demand, 
capacity and Activity and determine how well matched they are. This was 
one of the main principles of the ToolkitTM, using these measures in order to 
assess the performance of endoscopy services within Intervention sites 
during the MES programme. The evaluation method used in this study was 
based on the Toolkit’s own evaluation of Intervention sites by measuring 
changes within each study site and each Site type in Referral numbers, Wait 
>3m, Snapshot, Lost slots and Activity over time.  
 
It should be noted that all discussions in this section are based on the data 
analysed and are open to criticism based on the low sample numbers for 
some of the outcome measures at certain time points. This may account for 
some of the variability seen in the data, although it was hoped that by 
aggregating the data, there was less likelihood of using anomalous data. It 
was also feasible that the group means may have been affected by one or 
two rogue sites who did not perform in the same way as the majority of the 
sites in that group. Unfortunately, with such low sample numbers there was 
no way to control for it. Since the Intervention sites and Control sites were 
all geographically widespread, the data trends seen in this study were not 
likely to have been due to regional effects.  
5.6   Implications 
 
Unfortunately, the NHSMA disbanded in March 2005, making this evaluation 
of the MES programme less applicable to today’s NHS endoscopy services. 
However, there are still numerous important messages that have been 
derived from this evaluation in terms of NHS modernisation strategies and 
the importance of sustaining improvements in endoscopy units. It found that 
the MES programme did not significantly improve service delivery in 
Intervention sites when compared to the Control sites. This would have had 
a major impact on the NHSMA, had they still been in operation today. They 
would have been forced to re-evaluate their modernisation programmes in 
light of the evidence presented by this study, in particular the message of 
high quality data collection, since this study was able to identify major 
shortcomings in the data collection practices of Intervention sites both 
during and after the MES programme. 
 
Expanding on the issue of poor data collection, this study found that none of 
the Intervention sites continued to use the ToolkitTM following the close of 
the MES programme. The data collection aspect was a significant portion of 
the redesign message advocated by the MESPT that allowed sites to 
evaluate their services pre- and post-redesign, but that message did not 
have the intended impact on Intervention sites. There appears to be a clear 
message here for all externally-led modernisation agendas – no matter how 
good the concept, there is no guarantee that it will remain in use once it 
becomes voluntary. This means that future modernisation programmes will 
need to consider not only how they encourage NHS services to redesign and 
improve their services, but how they will sustain the importance of the key 
messages and the prolonged use of any ideas or tools after the projects 
close. In the case of the MES ToolkitTM, its complexity and rigorousness 
actually added to the workload of the endoscopy staff and so, was never 
likely to be sustained long term for that reason. New modernisation 
concepts need to be time- or resource-savers, adapted for more practical 
use and easily embeddable into everyday use in the service so that it takes 
more effort to withdraw it from use than to keep it in use. Without the 
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promise of sustainability, every modernisation agenda is set to fail before it 
has begun. 
 
This study provides an invaluable resource for NHS endoscopy staff wishing 
to modernise their services as it gives clear messages on the necessity for 
routine data collection practices to be instigated and maintained if services 
are to be measured, monitored and evaluated over time. It also provides a 
comprehensive list of innovations implemented by other sites to use for 
ideas on how to change a process, many of which were cost-neutral and 
only involved a change of working practices.  
 
The lack of routinely collected, service-related data from this selection of 20 
NHS endoscopy units highlighted the inadequacies of the service to 
proactively evaluate and manage services from within those departments. 
This is because much of the NHS is not rigorously managed by data. There 
are numerous audits and improvement projects that occur within NHS 
endoscopy units but they are sporadic and isolated. The service needs to 
adopt an ethos of data collection and analysis if it hopes to make and 
sustain any improvements in its delivery of care to patients. Endoscopy staff 
should be trained in the importance of data collection and analysis in its 
application to improve service delivery and patient satisfaction, to motivate 
them to accept a data collection regime as part of their daily tasks. This 
issue cannot be overstated as it is one of the keys to initiating change in the 
service. This would take time, investment, training and better IT provision 
but the end result should be a vastly improved service which would probably 
cost less to run in the longer term.  
 
Perhaps the government should consider taking a business-like approach to 
improving NHS services and place greater importance on the findings of 
data analyses when introducing new policies and targets. They need to 
realise that setting NHS targets does not facilitate data collection - instead 
they only serve to encourage the manipulation of data to best serve the 
needs of the department.  
 
It is feasible that the compulsory collection and analysis of rudimentary 
service-related data such as demand, activity and capacity would lead to an 
improvement in NHS endoscopy services, and maybe NHS services as a 
whole, as they are forced to collate the data and use it to measure their 
services themselves instead of waiting for a third party to highlight 
bottlenecks and problematic areas. This would allow NHS services to be 
proactive in process monitoring and would provide a good evidence base for 
building business plans for funding improvements. It is clear from this study 
that even the most basic datasets are of high enough quality to perform 
rudimentary data analysis – staff only need to be taught how to perform and 
interpret it effectively to examine their services. 
 
Finally, this study provides two warnings for external researchers intending 
to use routinely collected, service-related endoscopy data to analyse NHS 
endoscopy services. The first relates to the availability of this type of data, 
since not all endoscopy units collect service-related data routinely and even 
when they do, it is not necessarily easy to compare them as different 
definitions may be used nationwide. Prospective data collection may be 
more advisable to improve availability and accuracy but prevents any 
historical analyses. Alternatively, the clinical information system could be 
interrogated by endoscopy staff, probably at a cost.  
 
The second warning relates to the reliability of older HES Activity datasets, 
which was shown here to be flawed in two sites due to the terminology 
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applied to their endoscopies by the Trust, with both classifying them as 
outpatient procedures which were not recorded in their returns to HES for 
the time periods used in this study. 
 
The findings of this study highlighted the importance of independent 
evaluations to provide clear, unbiased conclusions using a high quality study 
design and sound research experience. It placed the impact of the MES 
programme in a more realistic light by describing the services of the 
Intervention sites in vivo using unbiased data that was analysed using the 
appropriate statistical tests. This study fully illustrated different aspects of 
service delivery relating to all 10 Intervention sites where available for any 
interested parties to examine the data trends over time to make their own 
decisions about whether these sites were truly successful in clinical terms, 
as well as in statistical terms.  
 
This study also brought into the research setting a group of sites that had 
not participated in the MES programme to evaluate their attempts at service 
redesign over the same time period and in doing so, provided a more 
realistic picture of what was achieved by the MES programme and what was 
achieved independently. In doing this, it was able to give a clear message 
that even though some endoscopy units were not part of the MES 
programme they still made clear improvements to their services over time, 
a message that may serve to sufficiently motivate endoscopy staff to 
improve their services.  
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6 Health Economics 
6.1   Executive summary  
6.1.1   Introduction 
 
This study is evaluating an intervention which involved extra financial and 
non-financial support by the NHSMA to selected hospital sites to assist them 
in modernising their endoscopy services. Given the underlying climate of 
modernisation which prevailed during the period of the study, the economics 
of ENIGMA can be seen more generally as being concerned with the costs 
and effects of modernising endoscopy services and the extent to which the 
intervention acted as a catalyst toward modernisation. 
6.1.2   Objectives 
 
The objectives of the economics component of the study were to address the 
following 5 questions; 
 
1.  What has been the cost of modernisation in each of the  ENIGMA sites?    
 
2.  Did modernisation costs differ between Intervention and Control sites? 
 
3.  Was there a difference in other NHS resource use between Intervention 
site patients and Control site patients? 
 
4.  Was there a difference in time off work by patients in Intervention versus 
Control sites? 
 
5.  Was there a difference in health outcomes (as measured by Euroqol 5D 
(EQ-5D) and GSRQ)) between Intervention and Control site patients? 
 
6.  If results are non-dominant, what are the extra costs (+ or -) per Quality 
Adjusted Life Year (QALY) and per unit of Gastrointestinal Symptom Rating 
Questionnaire (GSRQ) of Intervention versus Control site patients? 
6.1.3   Methods 
Cost of modernisation 
 
Two semi-structured interviews held one year apart were undertaken with 
key personnel at each study site to identify the resources which had been 
deployed to facilitate modernisation of the endoscopy service. Identified 
incremental resources were classified as investments which produce a flow 
of benefits over time (e.g. staff training), one off activities (e.g. sending 
patients to a private provider to clear a backlog) and recurring revenue 
costs (e.g. new posts). These were valued using standard methods. 
Other NHS costs 
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NHS resource use data were obtained from patients via the baseline 
questionnaire (BQ), post procedure questionnaire (PPQ) and 12 month post 
procedure questionnaire (12m PPQ). These data were multiplied by unit 
costs to assess primary care, secondary care, drug and total NHS costs. 
Costs were adjusted to account for baseline effects, group effects, and 
variations in length of time between baseline and subsequent 
questionnaires. Patients reported time off work was also examined.  
Incremental cost per Quality Adjusted Life Year and per unit GSRQ 
 
The intention was to plot differences in changes in EQ-5D scores 
(Intervention versus Control) across the five waves of the study and assess 
the QALY gain attributable to the intervention on the basis of the area under 
the curve. As the results showed no significant differences in EQ-5D scores 
(or GSRQ scores) this analysis was not undertaken.  
Lost productivity  
 
Data on patients’ time off work were reported on the BQ, PPQ and 12m PPQ. 
Time off work was valued using average male and female earnings. 
6.1.4   Results 
Cost of modernisation 
 
The extra financial support provided by the Modernisation Agency to 
Intervention sites was relatively small compared to the amount of funding 
most sites were able to secure from other sources. Total investments in 
modernisation were greater in Control sites although differences were not 
statistically significant.  
 
The mean total cost for one year of the intervention period was £131,446 
(sd = £81,890) in Intervention sites and £133,973 (sd = £100,928) in 
Control sites but the difference (£2,527) was not significant (p = .95, 95% 
CI = -£94,369 to £89,315). 
 
The mean total cost for subsequent years in Intervention sites was £79,557 
(sd = £72,282) and for Control sites was £93,209 (sd = 95,295). These 
differences (£13,652) were also not significant (p = .736, 95% CI =   = -
£98,171 to £70,867). 
 
There were no significant differences in the marginal cost per patient 
between Intervention and Control sites either in the first or in subsequent 
years. The mean difference in first year marginal costs was £7.26 (p = .47, 
95% CI = -£28.06 to £13.55) and the difference in marginal costs for 
subsequent years was £3.48 (p = .68, 95% CI = -£21.24 to £14.27). A 
sensitivity analysis, which assumed a 10 year life for training and equipment 
did not change the relative costs of Intervention and Control sites and 
differences were not statistically significant. 
Other NHS Costs 
 
The unadjusted analysis showed that in virtually all cases, primary and 
secondary costs were lower for patients in the Intervention group but the 
differences only rarely reached statistical significance. There were significant 
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differences in favour of the Intervention group (lower costs) in drug costs at 
12 month post procedure in Waves 1 - 4 but this was not seen Wave 5. 
Total NHS costs were significantly lower for patients in the Intervention 
group at 12 month post procedure in Wave 3 but not in the other waves. 
 
Application of multilevel modelling on a selection of resource variables did 
not show any important site-level effects on the resources used. As site-
level variations were statistically insignificant in all cases no further 
multilevel analyses were attempted. 
 
Adjusting for baseline effects, group effects and length of time between 
questionnaires showed broadly similar results with again almost all 
differences being in favour (lower costs) of the Intervention group but with 
few differences reaching statistical significance. Adjusted mean differences 
(Intervention minus Control) in primary care costs were statistically 
significant only on the PPQ in Wave 3 (adjusted mean difference = -£21.60, 
p<.01, 95% CI = -£32.50 to -£10.80)) but this was not seen at the 12M 
PPQ (adjusted mean difference = -£8.88, p = 0.34, 95% CI = -£27.10 to 
£9.31). 
 
There were no statistically significant differences in secondary care costs 
across in any wave.  
 
Adjusted mean difference in drug costs were statistically significantly lower 
only on the 12M PPQ in Wave 4 (adjusted mean difference = £10.80, p=.04, 
95%CI = -£21.10 to -£0.50). 
 
No statistically significant differences in total NHS costs were seen apart 
from on the PPQ at Wave 3 (adjusted mean difference = -£86.90, p=0.04, 
95% CI = -£169.80 to -£4.10). Again this significance was not maintained 
on the 12M PPQ (adjusted mean difference = -£80.10, p = 0.06, 95% CI = -
£162.50 to £2.30). 
 
Adjusted mean differences in time off work – again in favour of the 
Intervention group - achieved statistical significance only on the PPQ in 
Wave 4 (adjusted mean difference (days off) = -1.78, p = 0.04, 95% CI = -
£3.47 to -0.09). 
Lost productivity 
 
The adjusted mean difference in the value of lost productive output (-
£27.00) was not statistically significant (p = 0.07, 95% CI = -£56.7 to 
£2.60).  
Patient Outcomes  
 
Results of analyses of patient outcomes are reported in Chapter 4. As with 
costs, differences rarely reached statistical significance. The overall 
conclusion is that patient outcomes were not affected by the intervention.   
6.1.5   Discussion 
 
The intervention appears to have had little effect on NHS costs either in 
terms of direct investments in modernisation by study sites, or in terms of 
indirect effects on primary care, secondary care, drugs or total NHS costs. In 
the few instances where statistically significant results in adjusted mean 
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differences were shown, these tended not to be sustained either at the 
subsequent questionnaire or in subsequent waves. In virtually all cases, 
however, results tended to favour the Intervention sites (lower total 
modernisation costs) and the patients treated at Intervention sites (lower 
NHS resource use). 
 
From a cost effectiveness perspective, the lack of evidence for differences in 
either costs or outcomes makes is unnecessary to calculate an incremental 
cost effectiveness ratio. 
 
6.2   Introduction 
 
This study is evaluating an intervention which involved extra financial and 
non-financial support by the NHSMA to selected hospital sites to assist them 
in modernising their endoscopy services. It is evident, however, that in 
some sense ‘modernisation’ of health services is a natural process that is 
always going on and during the period of the ENIGMA study, all parts of the 
NHS were operating in a climate where modernisation was an explicit 
overarching philosophy of the Department of Health (DoH).  
 
The additional support provided by the NHSMA to ENIGMA Intervention sites 
has, therefore, to be seen in the context of a general trend toward 
modernisation which has to varying degrees influenced all NHS facilities. 
Moreover, the financial support provided by the NHSMA to the Intervention 
sites was not the only source of finance available for purposes of 
modernisation and many sites, both Intervention and Control, were able to 
secure funding from other sources to support their modernisation plans. In 
many cases these sums were considerably larger than those provided by the 
NHSMA.  
 
For these reasons the cost of modernisation is here regarded as all 
investments in modernisation regardless of how they were funded. While the 
intervention involved extra support by the NHSMA to selected sites, the 
economics of ENIGMA can also be seen more generally as being concerned 
with the costs and effects of modernising endoscopy services and the extent 
to which the intervention acted as a catalyst toward modernisation.  
 
For present purposes the term modernisation refers only to changes in the 
ways that endoscopy services are provided (delivery and/or administration). 
This excludes many improvements which, from a different perspective, could 
also be regarded as ‘modernisation’. For example, expanding a service 
without changing any of its processes, while clearly representing an 
improvement, essentially means doing more of the same. To be perceived 
here as a modernisation activity required changes in the ways that things 
are done, for example changing methods (e.g. new IT systems to manage 
waiting lists), altering staff skill mix (e.g. substituting nurse for consultant 
Endoscopists), introducing new types of sessions (e.g. emergency early 
morning slots to deal with overnight bleeds), purchasing different types of 
equipment (e.g. ultrasonography), setting up new processes to monitor 
progress (e.g. staff modernisation meetings) and so on.  
 
Investments in new facilities were considered as modernisation only if they 
were explicitly part of the unit’s modernisation plan. For example, altering 
the waiting area to improve the patient journey was considered to be 
modernisation but a recent move of the whole department to a new build 
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Treatment Centre was not. While the latter also improved the service – 
often dramatically – the decision to move to the new facility would have 
been made long before the MES programme and therefore could not be 
regarded as a direct response to the modernisation initiative.  
 
New equipment which was purchased as part of the unit’s rolling 
replacement programme was excluded for similar reasons. While old 
equipment will inevitably be replaced with newer models, ongoing 
replacement was not regarded as being a response to the modernisation 
initiative.  
6.3   Objectives 
  
The economics of ENIGMA set out to address the following economic 
questions: 
    
1.  What has been the cost of modernisation in each of the 18 ENIGMA 
sites?  (NB: As economics concerns the relationship between costs and 
effects – in this case between investments in modernisation and patient 
outcomes – only the 18 sites for whom patient level data were available 
have been included here) 
 
2.  Did modernisation costs differ between Intervention and Control sites? 
 
3.  Was there a difference in NHS resource use (apart from the costs of 
endoscopy) between Intervention site patients and Control site patients? 
 
4.  Was there a difference in health outcomes (as measured by EQ-5D and 
GSRQ) between Intervention and Control site patients? 
 
5.  In the case of non-dominance, what are the extra costs (+ or -) per 
Quality Adjusted Life Year and per unit of GSRQ of Intervention versus 
Control site patients? 
6.4   Methods 
6.4.1   Cost of modernisation: 
 
Economics is based on the principle that resources are scarce relative to the 
demands made on them. This means that every resource commitment 
involves an opportunity cost (benefit forgone from alternative uses of these 
resources). The cost of modernisation is thus equal to the value of all 
resources devoted to modernisation regardless of whether or not they were 
separately funded. Thus, for example, the time devoted by existing staff to 
modernisation activities is a cost of modernisation. 
 
In order to identify the resources devoted to modernisation, two semi-
structured interviews with key personnel at each study site were held one 
year apart; the first during December 2005 and January 2006 and the 
second during December 2006 and January 2007.  
 
Prior to the first visit each site was asked to provide any relevant 
documentary sources describing their modernisation efforts and related 
resource consequences e.g. bids to the NHSMA and internal reports to Trusts 
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related to modernisation plans. These were reviewed prior to the first 
interview which began with an explanation of principles to ensure that 
respondents had a clear understanding of what was to be considered a cost 
of modernisation. Respondents were asked to identify only the incremental 
resources deployed to facilitate modernisation of the services.  
 
Summaries of the resources identified were subsequently circulated to each 
respondent for validation. In addition, data were triangulated with another 
ENIGMA data collection tool (the Innovations Form – see Chapter 3) to 
check concurrence and ensure that that no key resource consequences of 
sites’ modernisation efforts were omitted. The second set of interviews 
provided the opportunity to address queries from the first interview, discuss 
any discrepancies with responses on the Innovations Form and identify any 
developments since the first visit.  
 
Thereafter, a basic cost analysis was undertaken using standard methods 
(Drummond, Sculpher, Torrance, O'Brien and Stoddart 2005). Identified 
resources were measured in relevant natural/physical units and valued 
using local data, where available, or national sources. A list of assumptions 
made and unit costs is provided in Appendix 12.  
 
Modernisation costs were regarded as being of three types; investments 
which produce a flow of benefits over time (these included equipment and 
training), one off activities such as demand and capacity studies which did 
not continue beyond the period of study, and recurring revenue costs such 
as those associated with newly created staff posts which are devoted to 
modernisation activities.  
 
All costs have been adjusted to 2006 prices using the Health Service Cost 
Index (Curtis and Netten 2006). Overall investment and the annual 
marginal cost of the modernised services are reported in Table 37 and 38. 
For the latter, capital and training costs are expressed in equivalent annual 
costs terms (Drummond, Sculpher, Torrance, O'Brien and Stoddart 2005) 
assuming in all cases a five year life for the investment and using a discount 
rate of 3.5% as currently recommended by HM Treasury. A sensitivity 
analysis was undertaken to show the effect of assuming a 10 year life on 
training and equipment.  
 
Results report separately the annual costs incurred during the modernisation 
period (reported as “first year costs”) and those incurred after the one off 
activities were completed (subsequent year cost). These were added to the 
marginal annual recurring revenue cost of the modernised service. In order 
to relate the costs of modernisation with patient level outcomes, the above 
costs for each site have been divided by the total number of procedures 
undertaken by each site in 2005.  
 
Mean total costs between Intervention and Control sites and mean per 
patient marginal costs in year one and subsequent years were compared 
using t tests.  
6.4.2   Other Health Service Costs 
 
Modernising an endoscopy service can also have indirect resource 
consequences across other parts of the NHS. For example a modernisation 
activity which leads to reduced waiting times could reduce the demands on 
primary care made by patients between referral and the time the procedure 
is undertaken.  
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NHS resource use data were obtained from patients via the BQ, PPQ and 
12M PPQ. Questions referred to visits to a GP surgery, home visits, hospital 
admissions and day cases, outpatient clinic visits and drugs taken in the 
three months prior to completing each questionnaire. Patient recall has been 
shown to be a valid means of obtaining data on resource use for at least 
three months (Brown and Adams 1992). As modernisation could potentially 
affect patients’ time off work a question on days lost due to illness or in 
order to see a health professional was also included.  
 
Unit costs of each resource are shown in Appendix 12. The period between 
the 2nd and 3rd questionnaires was one year and the period between the 
1st and 2nd was normally relatively short i.e. weeks or months. Accordingly, 
resource costs were not discounted.  
6.4.3   Quality of Life 
 
Quality of life was assessed in the ENIGMA project using three measures, 
Short Form 36 (SF-36), GSRQ and the EuroQol instrument EQ-5D. The latter 
was included for the economic analysis. EQ-5D measures patients’ health 
state across five dimensions (mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression) with three possible responses for 
each (no problems / moderate problems / severe problems). This locates 
each patient into one of 245 mutually exclusive states. Valuations of each 
state are provided by the EuroQol Group (2008) (EuroQol Group). The 
version preferred by the National Institute for Health and Clinical Excellence 
(version UK 1) was used here. This is based on a survey of 3395 members 
of the UK public (Dolan 1997). Values are on a scale from 1 (perfect health) 
to zero (equivalent to dead) with negative values for states considered to be 
worse than dead. Details of methods and results of the EQ-5D analysis are 
given in chapter 4.  
 
EQ-5D produces a single index number which can be converted to QALY for 
use in cost utility studies. In most evaluative studies, the object of interest 
is a patient level treatment with the focus on responses to treatment 
between Intervention and Control patients. QALYs are derived by plotting 
EQ-5D scores at various time points and then calculating the area 
Intervention and Control patients time profile curves. In the case of 
ENIGMA, however, the issue of concern is an organisational intervention. If 
effective, the QALY gain difference between patients in Intervention and 
Control sites should be greater at Wave 5 (post modernisation) than in 
Wave 1 (early stage of modernisation).  
6.5   Results  
6.5.1   Modernisation costs 
  
The costs of modernisation are shown in Tables 38 and 39 below. Column 3 
of Table 38 shows investments in medical and non-medical equipment. As 
anticipated there was wide variation in equipment costs – from between 
zero and £260,000.  
 
The magnitude of investment in new equipment, however, cannot be taken 
as an indication of post modernisation service quality since it was inevitably 
related to the situation at the start of the modernisation period. For 
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example, Site 7 reported no investment in new equipment apart from 
regular rolling replacements which are not included here. The lack of 
investment in equipment, however, was due to the fact that this endoscopy 
service had recently been re-provisioned in a new-build unit at a cost of 
some £2.5 million. However, since its modern equipment was in place 
before the NHSMA modernisation initiative it was clearly not a cost of that 
initiative. At the other extreme, Site 15 also made no investments in 
modernisation equipment, but the reason here was that the unit had been 
experiencing serious budget problems over the previous several years which 
meant that the climate was not one which was conducive to making new 
investments. (To quote the interviewee “we were not in a modernisation 
mood”). 
 
Training costs (Table 38 Column 4) also varied widely, from between £450 
and £32,000 and included a range of activities from a two hour session to 
train nurses to perform cannulations to full training courses to become 
Endoscopists. Again these costs were influenced by the training needs at the 
start of the modernisation period.  
  
Training and equipment have a common feature in that they are both one 
off costs which lead to a flow of benefits over time. Accordingly, Column 4 of 
Table 38 expresses them in term of their equivalent annual costs (EAC). 
Variations here are directly related to variations in equipment and training 
costs.  
 
Column 6 of Table 38 shows the value of ‘one off’ costs. These include a 
heterogeneous range of activities which were of finite duration and which 
were wound up when a given modernisation task was completed. Examples 
include running extra sessions on Saturday mornings to deal with backlogs, 
verifying waiting lists, undertaking demand and capacity studies, setting up 
project groups to oversee modernisation and so on. These are reported as 
“first year modernisation costs” although they did not necessarily occur 
within a 12 month period. Unsurprisingly, there was large variation in these 
costs due largely to the variation on the activities undertaken. One site, for 
example, produced a modernisation initiative endoscopy list and cleared it 
by sending patients to the local private hospital (£68,000). 
 
Column 7 of Table 38 shows recurring costs such as new permanent posts 
associated with modernisation. Many sites created new consultant and 
nursing posts solely for the purpose of increasing capacity but with no 
element of change to methods or processes. For reasons explained earlier 
these have not been included here. Only posts which changed the ways of 
working have been included. Where members of staff were re-graded 
following training it was assumed that the newly graded post included a 
modernisation role and the extra cost of the higher grade has been included 
here. Also included are a variety of ongoing activities such as permanent 
modernisation committees. 
   
Column 3 of Table 39 shows first year total modernisation costs made up of 
the one off costs described above, the EAC of equipment and training costs 
and the annual recurring costs. Marginal costs per patient based on 2004 
Activity figures are shown in Column 5 of Table 39. Columns 7 and 9 of 
Table 39 show total and marginal costs per patient for subsequent years.  
 
The mean total cost for first year in Intervention sites was £131,446 (sd = 
£81,890) and for Control sites was £133,973 (sd = £100,928). Difference in 
year one costs (£2,527) were clearly not significant (p = .95, 95% CI = -
£94,369 to £89,315). 
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The mean total cost for subsequent years in Intervention sites was £79,557 
(sd = £72,282) and for Control sites was £93,209 (sd = 95,295). 
Differences in subsequent year costs (£13,652) were also clearly not 
significant (p = .74, 95% CI =   = -£98,171 to £70,867). 
 
There were also no differences in marginal costs between Intervention and 
Control sites either in the first or in subsequent years. The mean difference 
in first year marginal costs (£7.26) was not significant (p = .47, 95% CI = -
£28.06 to £13.55) and the difference in marginal costs for subsequent years 
(£3.48) was similarly not significant (p = .68, 95% CI = -£21.24 to 
£14.27). 
 
The sensitivity analysis, which assumed a 10 year life for training and 
equipment did not change the relative costs of Intervention and Control 
sites. First year marginal costs for Intervention sites fell from £26.62 to 
£24.29 and for Control sites from £33.88 to £30.33. Subsequent year 
marginal costs in Intervention sites fell from £17.43 to £15.08 and Control 
sites from £20.91 to £19.47. Differences were not statistically significant.  
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Table 38.   Site Investments Totals 
 
SITE 
ID I/C Equipment Training EAC One Off Costs Recurring 
1 I  £              -     £   9,804.00   £    2,171.43   £      23,399.00   £    221,373.00  
2 C  £ 200,000.00   £      444.00   £   44,395.13   £      77,081.00   £    233,353.00  
3 C  £              -     £      700.00   £       155.04   £           127.00   £      28,508.00  
4 I  £    2,400.00   £ 16,439.00   £    4,172.54   £      22,520.00   £    103,039.00  
5 C  £ 142,054.00   £   8,091.00   £   33,254.71   £                 -     £      23,382.00  
6 I  £   10,000.00   £   8,891.00   £    4,184.05   £      12,574.00   £      96,633.00  
7 I  £              -     £ 13,747.00   £    3,044.74   £        7,852.00   £      17,720.00  
8 I  £    7,500.00   £   1,417.00   £    1,974.97   £      49,403.00   £        7,723.00  
9 C  £   15,000.00   £   3,254.00   £    4,042.97   £      72,610.00   £      29,047.00  
11 I  £   25,120.00   £   1,055.00   £    5,797.34   £    245,168.00   £      18,500.00  
12 C  £ 260,000.00   £   2,379.00   £   58,112.74   £      10,468.00   £    107,667.00  
13 I  £   48,915.00   £   2,072.00   £   11,292.80   £      42,873.00   £      51,495.00  
14 C  £    8,062.00   £ 31,085.00   £    8,670.43   £      87,159.00   £      26,132.00  
15 C  £              -     £   1,393.00   £       308.53   £      31,229.00   £      21,969.00  
16 I  £       957.00   £   4,193.00   £    1,140.64   £      51,157.00   £      18,486.00  
17 C  £   16,000.00   £   2,670.00   £    4,135.11   £      78,105.00   £      18,609.00  
19 I  £ 206,000.00   £ 11,927.00   £   48,267.33   £      12,046.00   £      94,576.00  
20 C  £   10,000.00   £   5,297.00   £    3,388.04   £      10,091.00   £    193,756.00  
Total Int  £ 300,892.00   £ 69,545.00   £   82,045.85   £    466,992.00   £    629,545.00  
Total Con  £ 651,116.00   £ 55,313.00   £ 156,462.68   £    366,870.00   £    682,423.00  
Total  £ 952,008.00   £124,858.00   £ 238,508.53   £    833,862.00   £  1,311,968.00  
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Table 39.   Site investments: year 1 and subsequent year total cost and marginal cost per patient 
 
SITE 
ID I/C 1st yr cost 
2004 
Activity 
1st yr 
MC/PT 2nd yr cost 
2005 
Activity 
Subsequent yr 
MC/PT 
1 I  £246,943.43  5,124  £48.19   £ 223,544.43  4908  £45.55  
2 C  £354,829.13  6,072  £58.44   £277,748.13  6132  £45.29  
3 C  £28,790.04  4,950  £5.82   £28,663.04  4788  £ 5.99  
4 I  £129,731.54  3,192  £40.64   £107,211.54  3600  £29.78  
5 C  £56,636.71  5,022  £11.28   £56,636.71  4920  £11.51  
6 I  £113,391.05  3,228  £35.13   £100,817.05  4104  £24.57  
7 I  £28,616.74  5,220  £5.48   £20,764.74  5280  £3.93  
8 I  £59,100.97  7,026  £8.41   £9,697.97  6792  £1.43  
9 C  £105,699.97  3,804  £27.79   £33,089.97  4008  £8.26  
11 I  £269,465.34  6,198  £43.48   £24,297.34  5604  £4.34  
12 C  £176,247.74  3,660  £48.16   £165,779.74  3600  £46.05  
13 I  £105,660.80  7,404  £14.27   £62,787.80  6300  £9.97  
14 C  £121,961.43  2,364  £51.59   £34,802.43  1884  £18.47  
15 C  £53,506.53  3,300  £16.21   £22,277.53  4764  £4.68  
16 I  £70,783.64  6,444  £10.98   £19,626.64  6444  £3.05  
17 C  £100,849.11  7,728  £13.05   £22,744.11  8640  £2.63  
19 I  £154,889.33  4,692  £33.01   £142,843.33  4164  £34.30  
20 C  £207,235.04  2,856  £72.56   £197,144.04  4344  £45.38  
Avg MC  I   £26.62   £17.43 
Avg MC C   £33.88   £20.91 
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6.6   An illustration of the costs of modernisation: 
Site 19 
 
Site 19 was an Intervention site. The site had requested £30,000 from the 
MA to be spent as follows: training of colorectal Nurse Endoscopist (NE) 
(£3,000), video conferencing equipment to support training and supervision 
(£7,000), a feasibility study for the physical integration of endoscopy 
services (£6,000) and redesigning the facility following the feasibility study 
(£14,000). 
 
The ‘sign off report’ form to the NHSMA does not ask for details of how the 
funding was actually spent. The report from Site 19 still spoke of the lack of 
physical integration as being a problem and referred to the feasibility study 
in the future tense. It was evident that by the time the interviews were 
undertaken, however, that both the feasibility study and the redesign of the 
facility had gone ahead. There was no mention of the purchase of video 
conferencing equipment. 
 
As stated earlier, the cost of modernisation is equal to the value of all the 
resources devoted to modernisation regardless of whether they were paid 
from NHSMA funding, other external funding or by using existing resources. 
On this basis, the total cost of modernisation at Site 19 was as follows. 
 
The one off activities included the feasibility study on unit re-design 
(£6,000), audits (£1,638), review of referral pathways (£580), patient 
evaluation (£362), revising patient information leaflets (£2,714) and 
pooling/validating lists (£752). Total one off costs, which were assumed to 
all occur in one year of modernisation, were £12,046. 
 
The unit was re-designed at a cost of £14,000 with an additional £5,000 for 
easy chairs. New medical equipment included a GI scribe system (£30,000), 
an ultrasound system (£94,000), pH manometry (£28,000), and capsule 
endoscopy kit with data recorder (£35,000). Total cost of the above was 
£206,000. 
 
Training costs included sending a nurse on an advanced ERCP course 
(£3,000), training one nurse in manometry (£1,000), consultant training on 
capsule endoscopy (£2,190), pH manometry training (£2,737) and sending 
a NE abroad specifically to learn about modernisation (£3,000). Total cost of 
above was £11,927. 
 
Equipment and training are both regarded as investments which produce a 
flow of benefit over time. The equivalent annual costs for the above 
(assuming five year life and 3.5% discount rate) is £48,267. 
 
Recurring modernisation costs include bi monthly modernisation meetings 
(£238), additional sessions from a nutrition nurse (£4,174), the cost of re-
grading nurses after training (£3,248), unit manager post for modernisation 
(£26,447), part time booking clerk manager (£10,823) and full time booking 
clerk (£15,446), input by a performance analyst (£668), nurse consultant 
clinical lead (£2,087) and a ward clerk (£13,445) plus the annual running 
cost of the ultrasound (£6,000) and endoscopy capsule kit (£12,000). Total 
cost of the above is £94,577. 
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The first year of the modernised service includes the one off costs, the 
equivalent annual cost for training and equipment and the recurring costs. 
This amounted to £154,889 for the first year and £142,843 thereafter. 
Based on Activity figures for 2004 (4692) and 2005 (4146) the marginal 
costs per patient were £33.01 in year one and £34.30 thereafter. The lower 
total costs in subsequent years produced higher marginal costs due to the 
higher Activity figures in the first year.  
6.7   NHS Resource Use 
 
Data on patient level resource use were obtained from six questions on the 
BQ, PPQ and 12M PPQ. 
 
The full dataset was subject to a general data entry accuracy check by 
checking one in every ten questionnaires. However, given the potential 
effects of outliers on costs, the recorded data on all resource use outliers 
was also checked against the questionnaires.  
6.8   Missing data imputations 
6.8.1   Imputation using last case carried forward method 
 
A total of 3818 BQs, 2940 PPQs and 2588 12M PPQs were available for 
complete case analyses. Imputation of missing data using the last case 
carry forward method (see chapter 4) increased the number of analysable 
PPQs to 3055 and 12M PPQs to 3039.  
 
To assess the effect of the imputation, separate analyses on resource use 
were undertaken using complete case (Table 40) and carry forward 
imputation (Table 41) analyses. Comparison of mean differences between 
patients in Intervention and Control sites showed little differences in results 
between methods. All differences that were statistically significant (p<.05) 
in the complete case analysis remained significant with imputation and no 
non-significant items became significant. Thus although the imputation 
increased the sample size, it had little effect on results. It was therefore 
decided that this imputation method would not be used for the base case 
comparisons. Results using the last case carry forward imputations can be 
regarded as a sensitivity analysis.  
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Table 40.   Mean differences in NHS resource use: Complete case analysis 
 
Item (Section D) Baseline n = 3818 Post Procedure n = 2940 End of follow up n = 2588 
 Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value 
(D1) How often have you consulted at the GP’s surgery with 
Doctor 2.53 
(2.46) 
2.7 
(2.67) 
.041 2.13 
(2.24) 
2.43 
(2.32) 
0.001 1.63 
(2.06) 
1.74 
(2.1) 
0.184 
Nurse 0.75 
(1.69) 
1.00 
(3.40) 
.010 0.66 
(1.26) 
0.89 
(2.31) 
0.003 0.64 
(1.34) 
0.84 
(2.14) 
0.010 
Other 0.10 
(0.93) 
0.08 
(0.64) 
0.54 0.11 
(0.85) 
0.07 
(0.53) 
0.22 0.08 
(0.63) 
0.13 
(0.43) 
0.37 
(D2) How often have you consulted at home with 
Doctor 0.20 
(0.98) 
0.20 
(0.98) 
0.99 0.13 
(0.66) 
0.14 
(0.64) 
0.87 0.11 
(0.60) 
0.20 
(1.9) 
0.09 
Nurse 0.11 
(0.91) 
0.17 
(2.9) 
0.36 0.10 
(0.73) 
0.13 
(1.13) 
0.38 0.11 
(0.70) 
0.17 
(1.20) 
0.16 
Other 0.01 
(0.14) 
0.03 
(0.27) 
0.14 0.01 
(0.10) 
0.03 
(0.45) 
0.16 0.02 
(0.23) 
0.02 
(0.19) 
0.79 
(D3) How often have you been 
admitted for any reason to a hospital 
as an  emergency  
0.13 
(0.53) 
0.16 
(0.59) 
0.21 0.12 
(0.56) 
0.14 
(0.79) 
0.33 0.09 
(0.53) 
0.08 
(0.50) 
0.53 
(D4) How often have you been 
admitted for any reason to a hospital 
as an non-emergency  
0.16 
(0.63) 
0.19 
(0.77) 
0.17 0.26 
(0.75) 
25 
(0.75) 
0.86 0.14 
(0.66) 
0.16 
(0.71) 
0.39 
(D5) How often have you been seen at a hospital outpatient clinic with  
Doctor 0.97 
(1.28) 
1.07 
(1.57) 
0.033 1.11 
(1.28) 
1.28 
(1.89) 
0.006 0.58 
(1.13) 
0.82 
(2.50) 
0.003 
Nurse 0.20 
(0.77) 
0.30 
(1.98) 
0.09 0.30 
(0.79) 
0.32 
(1.42) 
0.70 0.19 
(1.29) 
 
0.29 
(1.31) 
0.07 
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Other 0.05 
(0.45) 
0.06 
(0.45) 
0.31 0.06 
(0.44) 
0.08 
(0.58) 
0.41 0.06 
(0.60) 
0.08 
(0.59) 
0.29 
(D6) How many time have been admitted as a day case for 
Upper endoscopy 0.09 
(0.50) 
0.08 
(37) 
0.70 0.64 
(0.62) 
0.63 
(0.58) 
0.66 0.06 
(0.44) 
0.06 
(0.45) 
0.86 
Lower endoscopy 0.12 
(0.50) 
0.13 
(56) 
0.74 
 
0.59 
(0.68) 
0.57 
(0.58) 
0.34 0.05 
(0.32) 
0.07 
(0.42) 
0.21 
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Table 41.   Mean differences in NHS resource use: Missing data imputed using last case carry forward method 
 
Item (Section D)  Baseline n = 3818 Post Procedure n = 3055 End of follow up n = 3039 
 Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value 
(D1) How often have you consulted at the GP’s surgery with  
Doctor 2.53 
(2.46) 
2.7 
(2.67) 
0.041 2.15 
(2.25) 
2.46 
(2.39) 
0.00 1.71 
(2.05) 
1.83 
(2.11) 
0.11 
Nurse 0.75 
(1.69) 
1.00 
(3.40) 
0.010 0.66 
(1.24) 
0.89 
(0.25) 
0.00 0.67 
(1.26) 
0.57 
(2.31) 
0.00 
Other 0.10 
(0.93) 
0.08 
(0.64) 
0.54 0.11 
(0.86) 
0.09 
(0.64) 
0.53 0.08 
(0.63) 
0.13 
(1.43) 
0.38 
(D2) How often have you consulted at home with 
 
Doctor 0.20 
(0.98) 
0.20 
(0.98) 
0.99 0.14 
(0.65) 
0.13 
(0.59) 
0.69 0.13 
(0.69) 
0.19 
(1.78) 
0.17 
Nurse 0.11 
(0.91) 
0.17 
(2.9) 
0.36 0.09 
(0.70) 
0.13 
(1.09) 
0.27 0.11 
(0.70) 
0.18 
(1.3) 
0.070 
Other 0.01 
(0.14) 
.03 
(00.27) 
0.14 0.02 
(0.27) 
0.03 
(0.42) 
0.45 0.02 
(0.21) 
0.02 
(0.17) 
0.91 
(D3) How often have you 
been admitted for any reason 
to a hospital as an  
emergency 
0.13 
(0.53) 
0.16 
(0.59) 
0.21 0.13 
(0.53) 
0.16 
(0.59) 
0.20 0.10 
(0.54) 
0.10 
(0.54) 
0.72 
(D4) How often have you 
been admitted for any reason 
to a hospital as an non-
emergency 
0.16 
(0.63) 
0.19 
(0.77) 
0.17 0.25 
(0.75) 
0.26 
(0.76) 
0.84 0.16 
(0.64) 
0.18 
(0.73) 
0.27 
(D5) How often have you been seen at a hospital outpatient clinic with 
Doctor 0.97 
(1.28) 
1.07 
(1.57) 
0.033 1.12 
(2.06) 
1.27 
(1.87) 
0.04 0.71 
(1.26) 
0.91 
(2.55) 
0.01 
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Nurse 0.20 
(0.77) 
0.30 
(1.98) 
0.09 0.27 
(0.76) 
0.30 
(1.35) 
0.57 0.21 
(1.23) 
0.28 
(1.22) 
0.13 
Other 0.05 
(0.45) 
0.06 
(0.45) 
0.31 0.05 
(0.41) 
0.07 
(0.54) 
0.49 0.06 
(0.56) 
0.08 
(0.54) 
0.40 
(D6) How many time have been admitted as a day case for 
Upper endoscopy 0.09 
(0.50) 
0.08 
(37) 
0.70 0.56 
(0.61) 
0.54 
(0.58) 
0.46 0.15 
(0.50) 
0.13 
(0.49) 
0.47 
Lower endoscopy 0.12 
(0.50) 
0.13 
(56) 
0.74 
 
0.49 
(0.65) 
0.48 
(0.59) 
0.54 0.14 
(0.42) 
0.15 
(0.53) 
0.60 
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6.8.2   Imputation of missing items as zero 
  
Total resource use is assessed by valuing each resource item and summing 
over primary care, secondary care and drug use. A potentially major 
problem with attempting to use a complete case analysis of total costs is 
that a questionnaire would have to be rejected from the analysis if even a 
single item were recorded as missing across any of the three cost elements 
(primary care, secondary care or drugs).  
 
In the case of drug use, respondents were provided with a list of the 29 
most commonly used drugs for gastrointestinal complaints and asked to 
record the dose and number of tablets taken per day. A non-response 
against any drug item could thus be taken as a true zero. However, in the 
case of other NHS resources, the questionnaire asked patients to report the 
number of times they had consumed each listed item in the previous three 
months and to record a zero against any item that they did not use. This 
instruction was repeated for each question. Each non response was thus 
recorded as missing data.  
 
Examination of the dataset, however, suggested that while patients were 
reporting the number of times they had used any resource they appeared to 
be often ignoring those they had not – rather than reporting a zero as 
instructed. The high levels of missing data shown in Table 42 below – 
particularly for each of the “other” variables – reinforces the idea that some 
of these missing data were likely to have been true zero’s.  
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Table 42.   Percentage of missing data by item. 
 
Question Baseline 
 (n= 3818) 
Post Procedure  
(n=2940) 
12 Month Post 
Procedure 
(n = 2588) 
(D1) How often have you consulted at the GP’s surgery with                   
                   Doctor                                          
                                                        Nurse 
                                                        Other 
 
5.7 5.5 6.5 
15.8 16.4 14.3 
27.4 31.4 24.6 
(D2) How often have you consulted at home with                                    
                   Doctor 
                                                        Nurse 
                                                 Other 
 
4.8 4.3 4.6 
12.2 12 10.4 
18.7 21.9 17.5 
(D3) How often have you been admitted for any reason to a hospital as an  
emergency 
 
2.4 3.2 2.0 
(D4) How often have you been admitted for any reason to a hospital as an non –
emergency 
 
3.2 3.7 2.6 
(D5) How often have you been seen at a hospital outpatient clinic with       
                   Doctor 
                                                           Nurse 
                                                           Other 
 
6.4 7.8 7.3 
18.5 23.0 16.5 
20.6 25.9 18.7 
(D6) Times admitted as day case for  
                                            Upper endoscopy 
                                             Lower endoscopy 
 
6.5 16.0 4.2 
7.5 21.5 6.0 
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As can be seen in Table 42 the highest cost resource items, in particular 
hospital admissions as emergency or non-emergency, had very low rates of 
missing data varying from between 2.0% and 3.2% for emergency 
admissions and between 2.6% and 3.7% for non-emergency. Nevertheless 
in a complete case analysis, data on such high cost resource items would be 
disregarded if the patient failed to record a zero against, for example, the 
number of times they had seen someone other than a doctor or nurse at a 
GP surgery.  
 
Rejection of all questionnaires which had at least one missing item had the 
effect of reducing the number of analysable BQs by 44% (from 3818 to 
2123), PPQs by 55% (from 2940 to 1310) and 12M PPQs by 39% (from 
2588 to 1573). Given that many of these missing items were likely to have 
been zeros a separate analysis which treated missing data as zero was also 
undertaken. This had a major impact on the number of analysable 
questionnaires increasing BQ to 3802, PPQ to 2907, and 12M PPQ to 2575.  
 
Table 43 shows mean differences in resource use between patients in 
Intervention and Control sites when treating missing data as zeros. 
Comparison of Table 43 with Table 40 shows that the use of zeros for 
missing values had little effect on the overall results. As with the carry 
forward imputation, in virtually all cases, significant differences remain 
significant and nothing which was non-significant becomes significant.  
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Table 43.   Mean difference in NHS resource use: missing data imputed as zeros 
 
Item (Section D) Baseline (n= 3818) Post Procedure (n= 2940) End of follow up (n= 2588) 
 Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value Int 
Mean 
(SD) 
Cont. 
Mean 
(SD) 
p.value 
(D1) How often have you consulted at the GP’s surgery with 
Doctor 2.39 
(2.46) 
2.54 
(2.67) 
0.07 2.02 
(2.23) 
2.29 
(2.32) 
0.00 
 
1.53 
(2.03) 
1.62 
(2.08) 
0.27 
Nurse 0.63 
(1.57) 
0.84 
(3.14) 
0.01 0.55 
(1.17) 
0.75 
(2.15) 
0.00 0.55 
(1.27) 
0.71 
(2.00) 
0.02 
Other 0.07 
(0.80) 
0.06 
(0.54) 
0.51 0.07 
(7.11) 
0.05 
(0.44) 
0.20 0.06 
(0.55) 
0.09 
(1.24) 
0.40 
(D2) How often have you consulted at home with 
Doctor 0.19 
(0.96) 
0.19 
(0.95) 
0.96 0.13 
(0.64) 
0.13 
(0.63) 
0.86 0.10 
(0.60) 
0.19 
(1.87) 
0.10 
Nurse 0.09 
(0.85) 
0.15 
(2.71) 
0.37 0.09 
(0.68) 
0.12 
(1.07) 
0.34 0.10 
(0.67) 
0.15 
(1.14) 
0.16 
Other 0.01 
(0.13) 
0.02 
(0.24) 
0.16 0.01 
(0.09) 
0.02 
(0.40) 
0.15 0.02 
(0.20) 
0.02 
(0.18) 
0.77 
(D3) How often have you been 
admitted for any reason to a hospital 
as an emergency 
0.13 
(0.53) 
0.15 
(0.59) 
0.21 
 
 
 
 
0.11 
(0.55) 
0.14 
(0.78) 
0.32 0.09 
(0.52) 
0.08 
(0.49) 
0.54 
(D4) How often have you been 
admitted for any reason to a hospital 
as a non emergency 
0.15 
(0.61) 
0.18 
(0.75) 
0.18 0.25 
(0.74) 
0.24 
(0.74) 
0.89 0.14 
(0.65) 
0.16 
(0.70) 
0.40 
(D5) How often have you been seen at a hospital outpatient clinic with 
Doctor 0.91 
(1.26) 
1.00 
(1.54) 
0.04 1.02 
(1.26) 
1.18 
(1.84) 
0.00 0.54 
(1.1) 
0.76 
(2.41) 
0.00 
Nurse 0.17 
(0.70) 
0.24 
(1.79) 
0.10 0.23 
(0.71) 
0.24 
(1.25) 
0.74 0.16 
(1.19) 
0.24 
(1.20) 
0.09 
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Dietician 0.04 
(0.41) 
0.05 
(0.40) 
0.36 0.04 
(0.38) 
0.06 
(0.50) 
0.41 0.5 
(0.54) 
0.07 
(0.53) 
0.32 
(D6) How many time have been admitted as a day case for… 
Upper endoscopy 0.08 
(0.48) 
0.08 
(0.36) 
0.65 0.53 
(0.61) 
0.53 
(0.58) 
0.80 0.06 
(0.43) 
0.06 
0.44) 
0.86 
Lower endoscopy    0.12 
(0.48) 
0.12 
(0.54) 
0.79 0.46 
(0.64) 
0.45 
(0.56) 
0.77 0.05 
(0.31) 
0.07 
(0.41) 
0.20 
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Differences between the two approaches are summarised in Table 44 below. 
The difference in total costs between Intervention and Control patients 
shown in the 12M PPQ is significant in both the complete case and the zero 
imputation analyses. 
 
Table 44.   Comparison of complete cases on total costs 
 
 n Mean 
(£) 
SD 
(£) 
Mean 
Difference 
(£) 
P 
value 
95% CI (£) 
Complete Case  
Baseline  
        Int 
        Con 
 
1069 
1054 
 
342.31 
353.48 
 
474.79 
468.83 
 
-11.70 
 
 
.59 
 
-51.29  to 28.95 
PPQ 
        Int 
        Con 
 
654 
656 
 
774.39 
781.30 
 
525.65 
466.62 
 
-6.91 
 
.80 
 
-60.78  to 46.96 
12 Month PPQ 
        Int 
        Con 
 
790 
783 
 
193.07 
255.42 
 
360.37 
599.45 
 
-62.35 
 
.01 
 
-111.23 to -13.48 
Imputed Zero 
 Baseline  
        Int 
        Con 
  
1877 
1925 
  
347.70 
383.29 
  
506.58 
585.43 
 
-35.59 
 
.05 
 
-70.43  to -74.45 
 PPQ 
        Int 
        Con 
  
1450 
1457 
  
741.31 
765.73 
  
531.58 
568.92 
 
-24.42 
 
 
.23 
 
-64.47 to 15.62 
12 Month PPQ 
        Int 
        Con  
 
1253 
1322 
 
230.00 
283.37 
 
437.67 
664.29 
 
-53.36 
 
.02 
 
-97.08  to -9.64 
 
 
Given the far greater amount of usable information and the fact that the 
results do not show major changes, imputation of missing data with zeros 
was used as the base case for analyses by wave shown below. The complete 
case analysis (Table 40) can be regarded as a sensitivity analysis.  
6.9 NHS Resource use and costs by wave 
 
Results comparing primary care resource use by Intervention and Control 
patients by Wave are shown in Table 45, for secondary care resource use in 
Table 46. Cost of drugs and costs of primary care, secondary care and total 
NHS costs are shown in Tables 47-51. In all cases the zero imputation 
method was used. These results have not been adjusted for any covariants 
or for skewness. Explanation of the adjustments made and the results of the 
post adjustment analyses are given in the next section.  
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Table 45.   NHS Resource Use Primary Care by wave: Intervention versus Control. 
 
Item 
(Sectio
n D) 
Baseline (n= 3818) Post Procedure (n= 2940) 12 months PPQ (n= 2588) 
 Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value 
(D1) How often have you consulted at the GP’s surgery with 
Doctor 
Wave 1 2.41 
(2.65) 
2.53 
(3.17) 
0.55 2.11 
(2.25) 
2.14 
(2.26) 
0.89 1.60 
(2.22) 
1.65 
(2.13) 
0.78 
Wave 2 2.51 
(2.51) 
2.61 
(2.70) 
0.58 2.25 
(2.8) 
2.4 
(2.23) 
0.48 1.74 
(2.61) 
1.76 
(2.31) 
0.94 
Wave 3 2.39 
(2.66) 
2.45 
(2.23) 
0.74 1.91 
(2.02) 
2.46 
(2.67) 
0.01 1.41 
(1.73) 
1.52 
(2.11) 
0.52 
Wave 4 2.26 
(2.12) 
2.58 
(2.74) 
0.07 1.87 
(1.89) 
2.24 
(2.2) 
0.03 1.59 
(1.82) 
1.65 
(1.88) 
0.72 
Wave 5 2.39 
(2.36) 
2.53 
(2.34) 
0.44 1.95 
(2.09) 
2.21 
(2.16) 
0.16 1.27 
(1.53) 
1.5 
(1.89) 
0.15 
Nurse 
Wave 1 0.68 
(2.00) 
0.74 
(1.34) 
0.58 0.51 
(1.27) 
0.65 
(1.28) 
0.18 0.51 
(1.22) 
0.71 
(1.53) 
0.08 
Wave 2 0.60 
(1.18) 
0.75 
(1.32) 
0.09 0.59 
(1.28) 
0.64 
(1.32) 
0.65 0.68 
(1.41) 
0.49 
(1.05) 
0.09 
Wave 3 0.61 
(1.88) 
0.81 
(1.89) 
0.15 0.55 
(1.14) 
1.10 
(3.96) 
0.02 0.51 
(1.39) 
0.73 
(1.55) 
0.09 
Wave 4 0.65 
(1.33) 
1.12 
(6.28) 
0.144 0.5 
(0.99) 
0.71 
(1.21) 
0.03 0.52 
(1.12) 
0.8 
(1.86) 
0.03 
Wave 5 0.63 
(1.27) 
0.8 
(1.93) 
0.16 0.61 
(1.18) 
0.64 
(1.28) 
0.77 0.56 
(1.17) 
0.86 
(3.49) 
0.22 
Other 
Wave 1 
 
0.02 
(0.22) 
0.06 
(0.56) 
0.24 0.11 
(1.0) 
0.04 
(0.35) 
0.29 0.03 
(0.18) 
0.07 
(0.45) 
0.16 
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Wave 2 
 
0.15 
(1.44) 
0.07 
(0.49) 
0.27 0.15 
(1.12) 
0.05 
(0.35) 
0.11 0.06 
(0.66) 
0.03 
(0.18) 
0.47 
Wave 3 
 
0.02 
(0.19) 
0.08 
(0.71) 
0.16 0.03 
(0.21) 
0.2 
(0.19) 
0.61 0.07 
(0.60) 
0.17 
(2.4) 
0.5 
Wave 4 
 
0.10 
(0.81) 
0.06 
(0.57) 
0.33 0.04 
(0.29) 
0.10 
(0.82) 
0.24 0.11 
(0.76) 
0.08 
(0.66) 
0.58 
Wave 5 
 
0.05 
(0.65) 
0.02 
(0.19) 
0.38 0.04 
(0.32) 
0.03 
(0.24) 
0.59 0.05 
(0.36) 
0.13 
(1.03) 
0.25 
(D2) How often have you consulted at home with  
Doctor 
Wave 1 
 
0.18 
(0.67) 
0.19 
(0.91) 
0.74 0.17 
(0.67) 
0.12 
(0.57) 
0.31 0.10 
(0.57) 
0.13 
(0.72) 
0.58 
Wave 2 
 
0.26 
(1.41) 
0.18 
(0.62) 
0.32 0.21 
(1.04) 
0.18 
(0.72) 
0.64 0.14 
(0.74) 
0.20 
(0.86) 
0.43 
Wave 3 
 
0.24 
(0.99) 
0.11 
(0.49) 
0.01 0.08 
(0.42) 
0.14 
(0.69) 
0.22 0.12 
(0.7) 
0.12 
(0.56) 
0.88 
Wave 4 
 
0.11 
(0.64) 
0.23 
(1.16) 
0.07 0.09 
(0.45) 
0.11 
(0.70) 
0.71 0.10 
(0.56) 
0.13 
(0.91) 
0.63 
Wave 5 
 
0.19 
(0.92) 
0.26 
(1.38) 
0.42 0.07 
(0.39) 
0.1 
(0.43) 
0.39 0.04 
(0.21) 
0.42 
(4.23) 
0.17 
Nurse 
Wave 1 
 
0.07 
(0.66) 
0.05 
(0.41) 
0.56 0.09 
(0.57) 
0.08 
(0.62) 
0.87 0.15 
(0.99) 
0.08 
(0.67) 
0.34 
Wave 2 
 
0.08 
(0.62) 
0.12 
(1.15) 
0.61 0.10 
(0.67) 
0.11 
(1.23) 
0.86 0.14 
(0.72) 
0.23 
(1.39) 
0.32 
Wave 3 
 
0.16 
(1.45) 
0.10 
(1.23) 
0.47 0.05 
(0.43) 
0.17 
(1.46) 
0.19 0.04 
(0.37) 
0.14 
(0.92) 
0.13 
Wave 4 
 
0.08 
(0.67) 
0.44 
(5.85) 
0.23 0.15 
(1.12) 
0.13 
(1.07) 
0.81 0.11 
(0.57) 
0.17 
(1.58) 
0.57 
Wave 5 
 
0.07 
(0.54) 
0.06 
(0.55) 
0.92 0.03 
(0.24) 
0.09 
(0.75) 
0.19 0.04 
(0.43) 
0.14 
(0.97) 
0.17 
Other 
Wave 1 0.02 0.03 0.29 0.00 0.06 0.20 0.00 0.02 0.07 
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 (0.19) (0.27) (0.00) (0.77) (0.00) (0.15) 
Wave 2 
 
0.01 
(0.10) 
0.00 
(0.05) 
0.17 0.01 
(0.10) 
0.02 
(0.19) 
0.61 0.02 
(0.14) 
0.03 
(0.18) 
0.67 
Wave 3 
 
0.01 
(0.07) 
0.03 
(0.25) 
0.08 0.00 
(0.06) 
0.01 
(0.1) 
0.36 0.00 
(0) 
0 
(0) 
0 
Wave 4 
 
0.02 
(0.13) 
0.03 
(0.37) 
0.58 0.02 
(0.13) 
0.02 
(0.25) 
0.94 0.02 
(0.23) 
0.04 
(0.26) 
0.55 
Wave 5 
 
0.01 
(0.12) 
0.01 
(0.11) 
0.78 0.01 
(0.09) 
0.01 
(0.14) 
0.67 0.04 
(0.39) 
0.02 
(0.19) 
0.35 
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Table 46.   Resource Use Secondary Care by wave: Intervention versus Control 
Item 
(Section D) 
Baseline (n= 3818) Post Procedure (n= 2940) End of follow up (n= 2588) 
 Int Mean (SD) Cont. Mean 
(SD) 
p.value Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value 
(D3) How often have you been admitted for any reason to a hospital as an  emergency 
Wave 1 
 
0.09 
(0.45) 
0.14 
(0.47) 
0.12 0.12 
(0.53) 
0.15 
(1.24) 
0.66 0.13 
(0.57) 
0.05 
(0.31) 
0.04 
Wave 2 
 
0.16 
(0.55) 
0.16 
(0.65) 
0.93 0.15 
(0.64) 
0.12 
(0.48) 
0.61 0.10 
(0.58) 
0.09 
(0.49) 
0.76 
Wave 3 
 
0.14 
(0.52) 
0.17 
(0.63) 
0.42 0.12 
(0.70) 
0.16 
(0.68) 
0.57 0.06 
(0.48) 
0.09 
(0.65) 
0.47 
Wave 4 
 
0.10 
(0.45) 
0.16 
(0.70) 
0.16 0.08 
(0.45) 
0.12 
(0.57) 
0.32 0.08 
(0.47) 
0.09 
(0.57) 
0.88 
Wave 5 
 
0.18 
(0.64) 
0.14 
(0.42) 
0.35 0.10 
(0.32) 
0.13 
(0.53) 
0.41 0.09 
(0.49) 
0.08 
(0.33) 
0.9 
(D4) How often have you been admitted for any reason to a hospital as an non emergency 
Wave 1 
 
0.10 
(0.52) 
0.14 
(0.51) 
0.25 0.23 
(0.59) 
0.29 
(0.96) 
0.30 0.16 
(0.75) 
0.10 
(0.39) 
0.22 
Wave 2 
 
0.19 
(0.76) 
0.26 
(1.28) 
0.41 0.21 
(0.51) 
0.24 
(0.70) 
0.56 0.18 
(0.75) 
0.18 
(0.78) 
0.96 
Wave 3 
 
0.16 
(0.68) 
0.14 
(0.52) 
0.63 0.26 
(0.74) 
0.22 
(0.69) 
0.50 0.11 
(0.53) 
0.16 
(0.62) 
0.38 
Wave 4 
 
0.16 
(0.57) 
0.19 
(0.58) 
0.41 0.27 
(1.03) 
0.26 
(0.64) 
0.88 0.12 
(0.52) 
0.19 
(0.97) 
0.27 
Wave 5 
 
0.15 
(0.53) 
0.19 
(0.63) 
0.37 0.26 
(0.7) 
0.19 
(0.56) 
0.17 0.11 
(0.64) 
0.18 
(0.67) 
0.29 
(D5) How often have you been seen at a hospital outpatient clinic with 
Doctor 
Wave 1 
 
0.82 
(1.24) 
0.93 
(1.23) 
0.22 0.92 
(1.09) 
1.17 
(1.41) 
0.01 0.53 
(1.16) 
0.73 
(1.46) 
0.07 
Wave 2 
 
1.03 
(1.38) 
0.98 
(1.47) 
0.61 1.12 
(1.35) 
1.12 
(1.77) 
0.99 0.6 
(1.06) 
0.87 
(2.54) 
0.14 
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Wave 3 
 
0.92 
(1.29) 
1 
(1.50) 
0.45 0.94 
(1.18) 
1.27 
(1.60) 
0.01 0.47 
(0.98) 
0.57 
(1.22) 
0.28 
Wave 4 
 
0.89 
(1.17) 
1.21 
(2.06) 
0.01 1.12 
(1.42) 
1.36 
(2.9) 
0.2 0.54 
(1.05) 
1 
(4.27) 
0.09 
Wave 5 
 
0.89 
(1.19) 
0.91 
(1.33) 
0.82 1.03 
(1.25) 
0.97 
(1.17) 
0.62 0.57 
(1.24) 
0.65 
(1.16) 
0.46 
Nurse 
Wave 1 
 
0.16 
(0.71) 
0.18 
(0.70) 
0.58 0.28 
(0.84) 
0.16 
(0.47) 
0.03 0.26 
(2.22) 
0.19 
(1.00) 
0.62 
Wave 2 
 
0.16 
(0.8) 
0.34 
(3.18) 
0.3 0.19 
(0.64) 
0.15 
(0.48) 
0.42 0.16 
(0.64) 
0.24 
(1.15) 
0.36 
Wave 3 
 
0.13 
(0.51) 
0.36 
(2.14) 
0.05 0.21 
(0.58) 
0.39 
(2.25) 
0.21 0.10 
(0.56) 
0.19 
(1.22) 
0.32 
Wave 4 
 
0.20 
(0.81) 
0.16 
(0.63) 
0.53 0.23 
(0.63) 
0.29 
(1.26) 
0.45 0.11 
(0.44) 
0.35 
(1.23) 
0.00 
Wave 5 
 
0.19 
(0.62) 
0.14 
(0.63) 
0.33 0.24 
(0.80) 
0.24 
(0.78) 
0.95 0.14 
(0.85) 
0.23 
(1.41) 
0.43 
Other 
Wave 1 
 
0.05 
(0.62) 
0.06 
(0.38) 
0.77 0.07 
(0.53) 
0.07 
(0.43) 
0.94 0.12 
(1.01) 
0.08 
(0.56) 
0.55 
Wave 2 
 
0.03 
(0.24) 
0.05 
(0.40) 
0.29 0.04 
(0.31) 
0.02 
(0.13) 
0.27 0.04 
(0.40) 
0.04 
(0.39) 
0.97 
Wave 3 
 
0.02 
(0.17) 
0.03 
(0.2) 
0.70 0.02 
(0.14) 
0.08 
(0.70) 
0.16 0.04 
(0.39) 
0.07 
(0.45) 
0.29 
Wave 4 
 
0.02 
(0.18) 
0.07 
(0.56) 
0.13 0.05 
(0.40) 
0.06 
(0.63) 
0.81 0.02 
(0.12) 
0.12 
(0.83) 
0.04 
Wave 5 
 
0.07 
(0.57) 
0.04 
(0.36) 
0.44 0.03 
(0.38) 
0.05 
(0.42) 
0.55 0.01 
(0.15) 
0.01 
(0.12) 
0.99 
(D6) How many time have been admitted as a day case for 
Upper endoscopy 
Wave 1 
 
0.14 
(0.71) 
0.12 
(0.49) 
0.59 0.57 
(0.55) 
0.54 
(0.59) 
0.49 0.09 
(0.68) 
0.06 
(0.39) 
0.45 
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Wave 2 
 
0.09 
(0.51) 
0.09 
(0.41) 
0.87 0.61 
(0.74) 
0.6 
(0.59) 
0.77 0.03 
(0.17) 
0.08 
(0.60) 
0.23 
Wave 3 
 
0.05 
(0.22) 
0.06 
(0.29) 
0.79 0.47 
(0.54) 
0.49 
(0.62) 
0.70 0.07 
(0.44) 
0.06 
(0.46) 
0.77 
Wave 4 
 
0.05 
(0.22) 
0.06 
(0.26) 
0.58 0.56 
(0.67) 
0.48 
(0.54) 
0.12 0.04 
(0.2) 
0.06 
(0.33) 
0.47 
Wave 5 
 
0.09 
(0.54) 
0.06 
(0.25) 
0.31 0.45 
(0.52) 
0.53 
(0.52) 
0.06 0.06 
(0.44) 
0.06 
(0.34) 
0.99 
Lower endoscopy 
Wave 1 
 
0.11 
(0.36) 
0.15 
(0.64) 
0.22 0.47 
(0.76) 
0.47 
(0.55) 
0.92 0.05 
(0.23) 
0.04 
(0.20) 
0.81 
Wave 2 
 
0.09 
(0.32) 
0.11 
(0.53) 
0.56 0.47 
(0.77) 
0.44 
(0.63) 
0.65 0.05 
(0.23) 
0.08 
(0.57) 
0.32 
Wave 3 
 
0.12 
(0.62) 
0.13 
(0.59) 
0.9 0.42 
(0.54) 
0.49 
(0.55) 
0.13 0.03 
(0.18) 
0.10 
(0.57) 
0.06 
Wave 4 
 
0.13 
(0.48) 
0.09 
(0.33) 
0.2 0.44 
(0.54) 
0.47 
(0.52) 
0.45 0.08 
(0.55) 
0.05 
(0.26) 
0.35 
Wave 5 
 
0.13 
(0.56) 
0.12 
(0.51) 
0.72 0.50 
(0.56) 
0.38 
(0.55) 
0.02 0.03 
(0.18) 
0.06 
(0.30) 
0.26 
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Table 47.   Drug costs by wave: Intervention versus Control 
 
Item 
(Section E) 
Baseline (n= 3818) Post Procedure (n= 2940) End of follow up (n= 2588) 
 Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value Int Mean 
(SD) 
Cont. Mean 
(SD) 
p.value 
Indigestion medication 
Wave 1 
 
£27.24 
(58.59) 
£23.52 
(44.56) 
0.31 £26.05 
(47.07) 
£27.54 
(47.55) 
0.69 £22.73 
(43.70) 
£27.81 
(53.14) 
0.21 
Wave 2 
 
£20.13 
(38.56) 
£33.07 
(50.31) 
0.00 £22.44 
(41.56) 
£32.77 
(49.64) 
0.01 £21.76 
(37.34) 
£32.41 
(48.52) 
0.01 
Wave 3 
 
£27.42 
(55.47) 
£28.93 
(48.25) 
0.69 £28.10 
(47.87) 
£30.96 
(53.40) 
0.5 £26.50 
(45.01) 
£31.11 
(63.75) 
0.34 
Wave 4 
 
£28.40 
(60.69) 
£30.31 
(55.01) 
0.65 £28.96 
(52.39) 
£32.75 
(63.34) 
0.43 £26.40 
(45.81) 
£37.47 
(63.15) 
0.02 
Wave 5 
 
£25.88 
(51.05) 
£37.08 
(57.98) 
0.01 £24.64 
(47.62) 
£38.89 
(57.55) 
0.00 £21.50 
(47.81) 
£40.72 
(80.31) 
0.00 
Irritable bowel medication 
Wave 1 
 
£2.22 
(11.40) 
£1.64 
(7.65) 
0.38 £1.98 
(8.81) 
£2.12 
(8.57) 
0.84 £1.91 
(8.93) 
£2.13 
(9.53) 
0.78 
Wave 2 
 
£1.52 
(9.55) 
£2.05 
(9.90) 
0.47 £1.41 
(6.00) 
£1.69 
(7.08) 
0.61 £0.91 
(4.99) 
£1.68 
(7.16) 
0.17 
Wave 3 
 
£2.42 
(10.31) 
£2.46 
(11.51) 
0.96 £1.88 
(8.14) 
£2.21 
(8.09) 
0.62 £1.69 
(8.77) 
£1.72 
(7.34) 
0.97 
Wave 4 
 
£2.93 
(15.00) 
£1.47 
(6.49) 
0.08 £2.23 
(12.54) 
£1.39 
(7.41) 
0.34 £2.14 
(12.06) 
£1.01 
(6.08) 
0.18 
Wave 5 
 
£2.03 
(8.85) 
£1.98 
(10.87) 
0.95 £1.63 
(8.19) 
£0.84 
(3.97) 
0.16 £1.61 
(12.35) 
£0.71 
(3.50) 
0.3 
Anti-diarrhoeal medication 
Wave 1 
 
£0.85 
(4.95) 
£1.22 
(6.71) 
0.36 £1.10 
(5.76) 
£1.38 
(7.55) 
0.61 £1.29 
(11.53) 
£1.07 
(6.55) 
0.77 
Wave 2 
 
£0.82 
(6.00) 
£1.28 
(6.72) 
0.33 £0.56 
(4.54) 
£0.93 
(5.25) 
0.36 £0.15 
(1.43) 
£2.09 
(11.06) 
0.01 
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Wave 3 
 
£0.69 
(4.49) 
£1.52 
(17.70) 
0.38 £0.37 
(3.04) 
£1.01 
(6.08) 
0.12 £0.39 
(2.49) 
£1.33 
(6.25) 
0.03 
Wave 4 
 
£1.61 
(7.59) 
£1.25 
(6.61) 
0.48 £0.93 
(6.08) 
£1.02 
(6.47) 
0.87 £1.31 
(8.67) 
£1.61 
(8.29) 
0.69 
Wave 5 
 
£0.55 
(4.17) 
£0.88 
(5.48) 
0.36 £0.64 
(4.42) 
£0.33 
(2.45) 
0.31 £0.71 
(5.68) 
£1.08 
(6.12) 
0.51 
Colitis medication 
Wave 1 
 
£3.05 
(19.45) 
£9.43 
(64.79) 
0.06 £4.15 
(22.40) 
£13.76 
(80.42) 
0.04 £5.18 
(30.58) 
£12.04 
(62.53) 
0.1 
Wave 2 
 
£4.55 
(28.67) 
£7.42 
(60.06) 
0.41 £4.66 
(29.52) 
£4.60 
(25.53) 
0.98 £8.06 
(36.43) 
£6.01 
(30.74) 
0.49 
Wave 3 
 
£2.78 
(23.98) 
£7.26 
(36.37) 
0.05 £3.25 
(20.05) 
£8.75 
(38.43) 
0.03 £4.44 
(32.81) 
£11.72 
(53.81) 
0.06 
Wave 4 
 
£3.48 
(24.53) 
£5.37 
(29.14) 
0.33 £4.11 
(27.73) 
£6.89 
(33.40) 
0.28 £6.40 
(35.60) 
£8.28 
(42.89) 
0.59 
Wave 5 
 
£11.63 
(55.27) 
£2.37 
(17.43) 
0.00 £13.71 
(57.31) 
£1.59 
(10.85) 
0.00 £15.47 
(61.50) 
£4.13 
(24.93) 
0.01 
 
Table 48.     Total primary care costs by wave: Intervention versus Control 
  Total primary care cost (£) 
Wave 1 £68.59 
(84.87) 
£75.37 
(103.99) 
0.31 £61.81 
(84.28) 
£60.51 
(70.48) 
0.83 £45.51 
(65.10) 
£52.03 
(70.71) 
0.25 
Wave 2 £79.71 
(127.47) 
£74.32 
(79.68) 
0.49 £70.70 
(97.47) 
£68.61 
(75.42) 
0.77 £56.18 
(88.80) 
£57.00 
(90.75) 
0.92 
Wave 3 £72.48 
(95.57) 
£69.25 
(75.36) 
0.6 £50.41 
(61.39) 
£72.41 
(90.09) 
0.00 £43.07 
(75.21) 
£52.43 
(129.32) 
0.32 
Wave 4 £65.02 
(75.77) 
£84.13 
(170.03) 
0.04 £52.30 
(56.88) 
£63.67 
(85.08) 
0.06 £49.87 
(73.36) 
£52.84 
(86.91) 
0.67 
Wave 5 £69.95 
(87.38) 
£77.19 
(114.13) 
0.34 £53.15 
(61.64) 
£59.53 
(61.37) 
0.23 £37.15 
(47.20) 
£71.46 
(266.60) 
0.06 
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Table 49.   Total Secondary care costs by wave: Intervention versus Control 
 
Total secondary care cost (£) 
Wave 1 £262.78 
(479.79) 
£311.05 
(520.23) 
0.17 £691.44 
(483.62) 
£714.36 
(583.19) 
0.59 £227.74 
(506.29) 
£181.84 
(373.85) 
0.21 
Wave 2 £292.48 
(495.63) 
£336.44 
(663.29) 
0.31 £718.58 
(575.50) 
£694.83 
(575.39) 
0.62 £187.67 
(382.17) 
£257.31 
(714.12) 
0.18 
Wave 3 £263.71 
(467.24) 
£300.95 
(634.14) 
0.36 £626.22 
(552.18) 
£717.11 
(536.60) 
0.04 £151.09 
(350.28) 
£222.11 
(522.42) 
0.07 
Wave 4 £257.34 
(413.61) 
£301.73 
(474.52) 
0.17 £681.62 
(517.07) 
£698.94 
(561.33) 
0.70 £174.83 
(440.70) 
£265.52 
(905.08) 
0.15 
Wave 5 £302.09 
(525.71) 
£275.88 
(441.83) 
0.48 £653.91 
(415.63) 
£625.13 
(419.56) 
0.43 £162.94 
(357.18) 
£207.48 
(454.22) 
0.25 
 
Table 50.   Total drug costs by wave: Intervention versus Control 
 
Total cost of medication (£) 
Wave 1 £33.36 
(62.07) 
£35.81 
(79.01) 
0.62 £33.29 
(53.05) 
£44.80 
(92.41) 
0.05 £31.12 
(55.52) 
£43.05 
(84.44) 
0.05 
Wave 2 £27.03 
(48.84) 
£43.82 
(77.78) 
0.00 £29.07 
(50.87) 
£40.00 
(56.04) 
0.02 £30.89 
(50.71) 
£42.18 
(57.67) 
0.02 
Wave 3 £33.32 
(60.75) 
£40.17 
(60.85) 
0.12 £33.60 
(51.00) 
£42.92 
(66.40) 
0.06 £33.02 
(56.15) 
£45.87 
(83.86) 
0.04 
Wave 4 £36.36 
(68.34) 
£38.40 
(60.92) 
0.66 £36.23 
(62.05) 
£42.05 
(70.49) 
0.29 £36.25 
(62.01) 
£48.37 
(75.02) 
0.05 
Wave 5 £40.09 
(72.09) 
£42.32 
(63.42) 
0.66 £40.62 
(70.57) 
£41.66 
(59.47) 
0.86 £39.29 
(85.55) 
£46.65 
(85.02) 
0.36 
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Table 51.   Total NHS Costs by wave: Intervention versus Control   
 
Total NHS cost 
Wave 1 £364.72 
(505.62) 
£422.24 
(570.86) 
0.13 £786.55 
(516.74) 
£819.66 
(630.31) 
0.46 £304.37 
(524.90) 
£276.92 
(421.02) 
0.48 
Wave 2 
 
£399.22 
(542.58) 
£454.58 
(686.78) 
0.22 £818.35 
(605.46) 
£806.05 
(604.22) 
0.81 £274.74 
(407.41) 
£356.49 
(773.49) 
0.14 
Wave 3 
 
£369.52 
(511.96) 
£410.38 
(656.77) 
0.34 £715.01 
(581.21) 
£835.02 
(582.23) 
0.01 £227.17 
(381.01) 
£320.42 
(577.54) 
0.03 
Wave 4 
 
£358.72 
(442.99) 
£424.26 
(537.86) 
0.07 £770.15 
(535.83) 
£807.54 
(591.32) 
0.43 £260.95 
(492.58) 
£366.72 
(929.23) 
0.10 
Wave 5 
 
£412.12 
(556.98) 
£395.39 
(490.63) 
0.67 £747.68 
(441.51) 
£726.31 
(448.35) 
0.58 £239.38 
(391.91) 
£325.59 
(603.66) 
0.07 
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6.10   Adjustments 
 
These results show that there were differences between groups even at 
baseline.  Despite the large sample size, clustering effects are expected 
when randomisation is by site rather than by patient.  Also, and as is 
common with cost data, a high degree of skewness in costs was shown. 
  
The study also had another complicating factor in that the length of time 
between questionnaires varied between patients. While all patients 
completed questionnaires on entry to the study (baseline) and just after 
receiving their procedure (PPQ) the time between these two events could 
vary considerably. This, of course, meant that the time between BQ and 
12M PPQs showed the same variation. These issues are discussed in turn. 
6.10.1   Clustering 
 
The study provides a hierarchical structure of costs, resource use and 
patient outcomes, which may vary across sites. This variability can be 
assessed using appropriate analytical methods. Studies in this area 
commonly use ordinary least square (OLS) models which assume that 
observations across patients are independent and have a common variance. 
This assumption is unlikely to hold when using data from different sites, as 
patients’ resource use or costs within a particular site may be more similar 
than that in different sites. Multilevel models (MLMs) are able to incorporate 
the hierarchical structure of the data (that is, of patients within sites), and 
provide more appropriate estimates of patient and site-level effects. Use of 
a MLM in health economics has been recommended by Rice and Jones (Rice 
and Jones 1997). In this study we applied an MLM approach to explore site-
level variation in resource use (costs) either at post-procedure or 12 month 
post procedure. An OLS regression model takes the form 
 
 yi = β0 + β1xi + ei ,  ei ~ Normal (0, σe2) 
  
where yi is the outcome variable for the ith patient, xi is an explanatory 
variable with  associated slope β1 and intercept β0. The error term, ei  
represents explained variability between patients and is assumed to be 
normally distributed with mean zero. The OLS model assumes that the 
variance of the error term is the same for all patients. The most basic MLM, 
the random intercept models, includes an additional form which represents 
the unexplained variation that exists between sites. Using subscripts i and j 
for the ith patient in the jth site, the model can be written as  
 
   yij = β0 + β1xij + uj + eij ,  eij ~ Normal (0, σe2);  uj ~ Normal (0, σu2)   
 
where β0 is a fixed quantity applying to all patients, uj is a random variable 
with zero mean and constant variance (σu2) which applies to site j and eij is 
random error term which represents unexplained variation for patients 
within a site. Uj indicates the random effect of site on the outcome variable 
over and above that explained by the explanatory variables. The intercept 
for the jth site is now given as a fixed component β0 plus a random 
component uj. The regression coefficient, β1 can also be allowed to vary 
between sites which makes the model a ‘random slope’ model (i.e. site type 
(Intervention or Control) can be considered as a random factor in the 
model). 
The ENIGMA study 
©NCCSDO 2008 Page 170 
 
The degree of dependency between observations can be measured by the 
Intraclass Correlation Coefficient (ICC) defined as 
 
  ICC = 
2
u /(
2
u +
2
e ) 
 
which further reflects the strengths of ‘nesting’ within the data hierarchy. 
 
As a test case, we applied the simple MLM approach to data only on a few 
selected resource items at the PPQ and the 12M PPQ periods. Results from 
the estimated models at BQ and 12M PPQ period are presented in Tables 52 
and 53 below. 
 
These tables do not show any important effects of site on the resources 
used.  This can be verified by the fact that the estimates of σu2, which show 
site-level variation, are statistically insignificant in all cases except for 
primary care costs.  The standard error of σu2 appears large in comparison 
with its estimated coefficients.  An estimate of ICC in an MLM also reflects 
the degree to which data are clustered at higher level, which is in this study 
is site-level.  For example, the ICC of 0.032 in Table 53 shows that only 
3.2% of the total variations in primary care costs are attributed to site-level 
variation, which is small but statistically significant.  Similar findings were 
observed from all multilevel models developed in this section in order to see 
whether there are any important site-level variations in resource use data.  
It was therefore concluded that these analyses do not show any important 
site level effects for the observed patient-borne resource use data.  
Accordingly no further MLM analyses were attempted.  
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Table 52.   Multilevel models for five resource use dependent variables at post-procedure: D1a (consultations with GP at 
surgery), D1b (consultations with nurse at GP surgery), primary care costs, secondary care costs and total NHS costs 
 
 D1a D1b primary care costs secondary care costs total NHS costs 
Constant 1.417 (0.07) 0.47 (0.05) 39.5 (2.4) 615.9 (17.2) 670.6 (18.6) 
Fixed parameters 
    BQ score 
     
    Site-type 
          Control 
          Intervention 
   Length of      
   waiting 
 
0.43  (0.02) 
 
 
Reference 
-0.23 (0.07) 
 
-0.003(.001) 
 
0.42 (0.02) 
 
 
Reference 
-0.14 (0.06) 
 
-.001 (.000) 
 
0.39 (0.01) 
 
 
Reference 
-5.6 (2.7) 
 
-0.05 (0.02) 
 
0.38 (0.02) 
 
 
Reference 
-10.5 (19.5) 
 
-0.49 (0.14) 
 
0.41 (0.02) 
 
 
Reference 
-20.5 (20.3) 
 
-0.56 (0.15) 
Random effects 
  σu2(between site) 
  σe2 (within site) 
     
 
0.002 (0.02) 
3.96 (0.11) 
 
0.00 (0.00) 
2.53 (0.07) 
 
20.4 (23.7) 
4490.9 (119.2) 
 
1086.4 (1272.9) 
241331.3 (6408.3) 
 
1143.6 (1384.3) 
264075.2 (7012.4) 
ICC 0.001  0.004 0.004 0.004 
-2 log-likelihood 12319.7 11011.2 32900.6 44550.1 44812.9 
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Table 53.   Multilevel models for five resource use dependent variables at 12M PPQ: D1a (consultations with GP at 
surgery), D1b (consultations with nurse at GP surgery), primary care costs, secondary care costs and total NHS costs 
 
 D1a D1b primary care costs secondary care costs total NHS costs 
Constant 0.93 (0.28) 0.76 (0.23) 50.7 (15.8) 111.7 (73.2) 174.4 (78.9) 
Fixed parameters 
    BQ score 
     
    Site-type 
          Control 
          Intervention 
   Length of      
   waiting 
 
0.25 (0.02) 
 
 
Reference 
-0.05 (0.08) 
 
0.00 (0.001) 
 
0.18 (0.02) 
 
 
Reference 
-0.13 (0.06) 
 
0.00 (0.001) 
 
0.20 (0.03) 
 
 
Reference 
-9.1 (4.78) 
 
-0.02 (0.04) 
 
0.26 (0.02) 
 
 
Reference 
-39.3 (21.2) 
 
0.09 (0.17) 
 
0.30 (0.02) 
 
 
Reference 
-55.4 (21.5) 
 
0.08 (0.18) 
Random effects 
  σu2(between site) 
  σe2 (within site) 
     
 
0.00 
3.86  (0.11) 
 
0.02 (0.02) 
2.80 (0.08) 
 
408.9 (187.2) 
12282.4 (347.5) 
 
2323.2 (2382.6) 
264922.0 (7500.1) 
 
2511.3 (2734.0) 
308691.9 (8739.1) 
ICC 0.00 0.00 0.032 0.008 0.008 
-2 log-likelihood 10817.3 9933.4 31623.3 39551.3 39942.7 
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6.10.2   Differences in timing of questionnaires 
 
As PPQs and 12M PPQs varied in length of time from baseline, a regression 
based adjustment was carried out on data from these two questionnaires to 
account for baseline effects across all resource use items as well as for 
costs. The following adjustment was made; 
follow up effect i  = constant + a *  Baseline effect i + b *  Group i (C/I) + 
c* length of time between questionnaires 
 
where i is a patient identifier (i = 1, 2, …., N), a and b are estimated 
coefficients and group is a binary variable coded ‘1’ for Intervention and ‘0’ 
for Control. The coefficient b is here the effect of interest – the estimated 
difference between the two patient-groups after adjusting for BQ 
differences. This method adjusts each patient’s follow up effect for his/her 
baseline effect, but has the advantage of being unaffected by BQ 
differences. The results for PPQ and 12M PPQs shown in Tables 54 and 55 
below include this adjustment. 
6.10.3   Skewness 
 
Table 54 shows adjusted mean differences in individual resource use items. 
P values and 95% confidence intervals were calculated using a t-statistic. 
However, as is common with costs, the data here showed a high degree of 
skewness. Accordingly a non-parametric bootstrap method was used for 
analysis of the cost items. Table 55 reports the bootstrapped mean 
differences, p-values and 95% confidence intervals based on 10,000 
bootstrapped samples. 
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6.11   Results of adjusted analyses  
Table 54.   Comparison of resource use by Wave: Intervention versus Control. 
 
Item   Baseline (n= 3818) Post Procedure (n= 2940) End of follow up (n= 2588) 
 Mean 
Difference  
(I – C) 
p 95% CI Adjusted 
mean 
difference 
 (I – C) 
p 95% CI Adjusted 
mean 
difference 
 (I – C) 
p 95% CI 
(D1) How often have you consulted at the GP’s surgery with 
Doctor 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.12 
-0.11 
-0.06 
-0.32 
-0.14 
 
0.55 
0.58 
0.74 
0.07 
0.44 
 
-0.52 – 0.28 
-0.48 – 0.27 
-0.40 – 0.29 
-0.67 – 0.02 
-0.48 – 0.21 
 
  0.01 
-0.15 
-0.48 
-0.37 
-0.08 
 
0.94 
0.43 
0.00 
0.02 
0.62 
 
-0.29 – 0.32 
-0.53 – 0.23 
-0.80 - -0.17 
-0.66 - -0.07 
-0.39 – 0.23 
 
-0.07 
0.01 
-0.01 
0.02 
-0.20 
 
0.70 
0.96 
0.95 
0.89 
0.22 
 
-0.41 – 0.27 
-0.42 – 0.44 
-0.31 – 0.29 
-0.28 – 0.32 
-0.51 – 0.12 
Nurse 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.07 
-0.15 
-0.20 
-0.48 
-0.17 
 
0.58 
0.09 
0.15 
0.14 
0.16 
 
-0.30 – 0.17 
-0.33 – 0.02 
-0.46 – 0.07 
-1.11 – 0.16 
-0.41 – 0.07 
 
-0.03 
-0.04 
-0.48 
-0.16 
0.01 
 
0.73 
0.67 
0.03 
0.07 
0.93 
 
-0.20 – 0.14 
-0.24 – 0.15 
-0.92 - -0.04 
-0.33 – 0.01 
-0.18 – 0.19 
 
-0.16 
0.202 
-0.21 
-0.242 
-0.26 
 
0.16 
0.07 
0.10 
0.07 
0.28 
 
-0.38 – 0.06 
-0.02 – 0.42 
-0.47 – 0.04 
-0.49 – 0.02 
-0.74 – 0.22 
Other 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.04 
0.09 
-0.05 
0.05 
0.03 
 
0.24 
0.27 
0.16 
0.33 
0.38 
 
-0.09 – 0.02 
-0.07 – 0.04 
-0.13 – 0.02 
-0.05 – 0.15 
-0.04 – 0.10 
 
0.07 
0.09 
0.01 
-0.06 
0.01 
 
0.24 
0.17 
0.61 
0.22 
0.58 
 
-0.04 – 0.18 
-0.04 – 0.23 
-0.02 – 0.04 
-0.16 – 0.04 
-0.03 – 0.05 
 
-0.04 
0.02 
-0.12 
0.05 
-0.11 
 
0.20 
0.66 
0.43 
0.39 
0.27 
 
-0.09 – 0.02 
-0.06 – 0.10 
-0.43 – 0.19 
-0.07 – 0.18 
-1.4 – 0.38 
(D2) How often have you consulted at home with  
Doctor 
                 W1 
                 W2 
 
-0.02 
0.08 
 
0.74 
0.32 
 
-0.13 – 0.09 
-0.08 – 0.24 
 
0.06 
-0.02 
 
0.15 
0.75 
 
-0.04 – 0.10 
-0.13 – 0.10 
 
-0.03 
-0.06 
 
0.60 
0.37 
 
-0.14 – 0.09 
-0.20 – 0.08 
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                 W3 
                 W4 
                 W5 
0.14 
-0.12 
-0.07 
0.01 
0.07 
0.42 
0.03 – 0.24 
-0.26 – 0.01 
-0.24 – 0.10 
-0.07 
-0.01 
-0.02 
0.12 
0.90 
0.54 
-0.16 – 0.02 
-0.10 – 0.09 
-0.09 – 0.05 
-0.01 
0.01 
-0.40 
0.83 
0.85 
0.17 
-0.12 – 0.10 
-0.11 – 0.14 
-0.96 – 0.17 
Nurse 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
0.02 
-0.04 
0.07 
-0.36 
0.00 
 
0.56 
0.61 
0.47 
0.23 
0.92 
 
-0.05 – 0.09 
-0.17 – 0.10 
-0.12 – 0.26 
-0.94 – 0.22 
-0.08 – 0.08 
 
0.01 
0.02 
-0.13 
0.06 
-0.06 
 
0.79 
0.73 
0.16 
0.52 
0.22 
 
-0.08 – 0.09 
-0.07 – 0.10 
-0.30 – 0.05 
-0.12 – 0.23 
-0.16 – 0.04 
 
0.07 
-0.10 
-0.10 
-0.07 
-0.09 
 
0.29 
0.31 
0.11 
0.52 
0.20 
 
-0.12 – 0.83 
-0.30 – 0.09 
-0.23 – 0.02 
-0.27 – 0.14 
-0.23 – 0.05 
Other 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.02 
0.01 
-0.02 
-0.01 
0.00 
 
0.29 
0.17 
0.08 
0.58 
0.78 
 
-0.05 – 0.02 
-0.00 – 0.02 
-0.05 – 0.00 
-0.05 – 0.03 
-0.01 – 0.02 
 
-0.05 
-0.01 
-0.01 
0.00 
-0.00 
 
0.22 
0.68 
0.46 
0.99 
0.69 
 
-0.14 – 0.03 
-0.03 – 0.02 
-0.02 – 0.01 
-0.03 – 0.03 
-0.02 – 0.02 
 
-0.02 
-0.01 
 
-0.01 
0.02 
 
0.07 
0.49 
 
0.58 
0.50 
 
-0.04 – 0.00 
-0.04 – 0.02 
 
-0.05 – 0.03 
-0.04 – 0.08 
(D3) How often have you been admitted for any reason to a hospital as an emergency                         
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
-0.05 
-0.00 
-0.03 
-0.06 
0.04 
0.12 
0.93 
0.42 
0.16 
0.35 
-0.11 – 0.01 
-0.09 – 0.08 
-0.11 – 0.04 
-0.14 – 0.02 
-0.04 – 0.11 
0.03 
0.03 
-0.02 
-0.05 
-0.03 
0.68 
0.53 
0.73 
0.23 
0.35 
-0.11 – 0.16 
-0.06 – 0.11 
-0.13 – 0.08 
-0.13 – 0.03 
-0.10 – 0.04 
0.08 
0.02 
-0.04 
-0.01 
0.00 
0.02 
0.74 
0.49 
0.86 
0.99 
0.02 – 0.15 
-0.08 – 0.11 
-0.14 – 0.06 
-0.10 – 0.08 
-0.08 – 0.08 
(D4) How often have you been admitted for any reason to a hospital as an non  emergency 
                     
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.04 
-0.06 
0.02 
-0.04 
-0.04 
 
0.25 
0.41 
0.63 
0.40 
0.37 
 
-0.11 – 0.03 
-0.22 – 0.09 
-0.06 – 0.10 
-0.12 – 0.05 
-0.13 – 0.05 
 
-0.06 
-0.02 
0.03 
0.02 
0.08 
 
0.33 
0.65 
0.57 
0.73 
0.15 
 
-0.19 – 0.06 
-0.12 – 0.08 
-0.08 – 0.14 
-0.12 – 0.17 
-0.03 – 0.18 
 
0.06 
-0.00 
-0.04 
-0.05 
-0.05  
 
0.24 
0.95 
0.38 
0.42 
0.42 
 
-0.04 – 0.15 
-0.14 – 0.13 
-0.15 – 0.06 
-0.19 – 0.08 
-0.18 – 0.07 
(D5) How often have you been seen at a hospital outpatient clinic with 
Doctor 
                 W1 
                 W2 
                 W3 
                 W4 
 
-0.11 
0.05 
-0.08 
-0.32 
 
0.22 
0.61 
0.45 
0.01 
 
-0.28 – 0.06 
-0.15 – 0.26 
-0.27 – 0.12 
-0.56 - -0.09 
 
-0.18 
-0.08 
-0.31 
-0.03 
 
0.03 
0.45 
0.00 
0.83 
 
-0.35 - -0.01 
-0.29 – 0.13 
-0.52 - -0.10 
-0.33 – 0.26 
 
0.21 
-0.28 
-0.08 
-0.29 
 
0.03 
0.06 
0.38 
0.28 
 
-0.40 - -0.02 
-0.57 – 0.01 
-0.27 – 0.10 
-0.83 – 0.24 
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                 W5 -0.02 0.82 -0.21 – 0.16 0.07 0.46 -0.12 – 0.26 -0.08 0.48 -0.29 – 0.14 
Nurse 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.03 
-0.18 
-0.22 
0.03 
0.05 
 
0.58 
0.29 
0.05 
0.53 
0.33 
 
-0.12 – 0.07 
-0.52 – 0.16 
-0.45 - -0.00 
-0.07 – 0.13 
-0.05 – 0.14 
 
0.12 
0.03 
0.04 
-0.08 
-0.01 
 
0.02 
0.52 
0.64 
0.34 
0.88 
 
0.02 – 0.22 
-0.06 – 0.12 
-0.13 – 0.21 
-0.24 – 0.08 
-0.13 – 0.11 
 
0.07 
-0.08 
-0.08 
-0.25 
-0.08 
 
0.62 
0.32 
0.36 
0.00 
0.49 
 
-0.21 – 0.35 
-0.25 – 0.08 
-0.24 – 0.09 
-0.41 - -0.09 
-0.29 – 0.14 
Other 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.01 
-0.03 
-0.01 
-0.05 
0.03 
 
0.77 
0.29 
0.70 
0.12 
0.44 
 
-0.08 – 0.06 
-0.07 – 0.02 
-0.03 – 0.02 
-0.10 – 0.01 
-0.04 – 0.10 
 
0.00 
0.03 
-0.04 
-0.01 
-0.02 
 
0.91 
0.10 
0.31 
0.76 
0.55 
 
-0.07 – 0.07 
-0.01 – 0.06 
-0.12 – 0.04 
-0.10 – 0.07 
-0.09 – 0.05 
 
0.04 
-0.00 
-0.04 
-0.10 
0.001 
 
0.53 
0.93 
0.33 
0.06 
0.92 
 
-0.07 – 0.14 
-0.07 – 0.07 
-0.11 – 0.04 
-0.20 – 0.00 
-0.02 – 0.03 
(D6) How many time have been admitted as a day case for 
Upper endoscopy                                       
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
0.02 
-0.01 
-0.01 
-0.01 
0.03 
0.59 
0.87 
0.79 
0.58 
0.31 
 
-0.06 – 0.11 
-0.07 – 0.06 
-0.04 – 0.03 
-0.04 – 0.02 
-0.03 – 0.09 
 
0.03 
0.01 
-0.02 
0.07 
-0.07 
 
0.46 
0.82 
0.68 
0.18 
0.10 
 
-0.05 – 0.12 
-0.09 – 0.12 
-0.11 – 0.07 
-0.03 – 0.17 
-0.17 – 0.01 
 
0.03 
-0.05 
0.01 
-0.01 
-0.01 
 
0.48 
0.22 
0.86 
0.62 
0.78 
 
-0.06 – 0.12 
-0.13 – 0.03 
-0.07 – 0.08 
-0.06 – 0.04 
-0.08 – 0.06 
Lower endoscopy                                    
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
-0.04 
-0.02 
-0.01 
0.04 
0.02 
0.22 
0.56 
0.89 
0.20 
0.72 
 
-0.12 – 0.03 
-0.08 – 0.04 
-0.09 – 0.08 
-0.02 – 0.09 
-0.06 – 0.09 
 
0.01 
0.03 
-0.06 
-0.04 
0.12 
 
 
0.86 
0.56 
0.17 
0.35 
0.01 
 
-0.09 – 0.11 
-0.08 – 0.15 
-0.15 – 0.03 
-0.13 – 0.04 
0.02 – 0.21 
 
0.004 
-0.04 
-0.07 
0.04 
- 0.03 
 
0.80 
0.30 
0.06 
0.32 
0.17 
 
-0.01 – 0.23 
-0.12 – 0.04 
-0.14 – 0.00 
-0.04 – 0.11 
-0.08 – 0.01 
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Table 55.   Comparison of costs by Wave: Intervention v Control. Bootstrapped data. 
 
Item   Baseline (n= 3818) Post Procedure (n= 2940) End of follow up (n= 2588) 
 M.D.  
(I – C) 
(bs) 
p 
(bs) 
95% CI 
(bootstrap) 
Adj. M.D. 
 (I – C) 
p 95% CI Adj. M.D. 
 (I – C) 
P 95% CI 
primary care cost (£) 
W1 
W2 
W3 
W4 
W5 
-£6.74 
£5.35 
£3.34 
-£19.3 
-£7.28 
0.15 
0.75 
0.71 
0.02 
0.17 
-19.8 – 6.0 
-7.19 – 24.4 
-7.9 – 16.11 
-43.8 - -4.22 
-25.2 – 5.9 
£5.15 
-£2.47 
-£21.6 
-£9.16 
-£1.42 
0.33 
0.69 
0.00 
0.11 
0.76 
-5.28 – 15.58 
-15.92 – 9.99 
-32.5 - -10.8 
-20.23 – 1.92 
-10.65 – 7.82 
-£5.97 
-£1.28 
-£8.88 
£0.87 
-£35.6 
0.28 
0.87 
0.34 
0.90 
0.06 
-16.72 – 4.79 
-16.8 – 14.2 
-27.1 – 9.31 
-12.5 – 14.3 
-71.9 – 0.08 
secondary care cost (£) 
W1 
W2 
W3 
W4 
W5 
-£48.3 
-£43.4 
-£37.6 
-£44.3 
£26.2 
0.08 
0.16 
0.17 
0.08 
0.76 
-111.3 – 23.8 
-122.5 – 48.4 
-116.8 – 37.4 
-107.1 – 17.6 
-45.8 – 98.7 
-£12.5 
£23.0 
-£66.6 
-£7.98 
£32.7 
0.76 
0.62 
0.10 
0.85 
0.34 
-91.7 – 66.6 
-66.7 – 112.7 
-146.2 – 12.9 
-89.1 – 73.2 
-34.9 – 100.4 
£37.6 
-£62.6 
-£62.9 
-£58.6 
-£48.6 
0.29 
0.19 
0.10 
0.33 
0.22 
-33.4 – 108.6 
-156.2 – 30.9 
-138.6 – 12.6 
-176.0 – 58.9 
-125.9 – 28.6 
drug care cost (£) 
W1 
W2 
W3 
W4 
W5 
-£2.46 
-£16.9 
-£6.9 
-£2.05 
-£2.23 
0.31 
0.00 
0.06 
0.33 
0.33 
-12.3 – 6.9 
-26.5 - -8.2 
-15.4 – 1.4 
-10.5 – 7.6 
-11.8 – 8.1 
-£9.99 
-£3.9 
-£6.1 
-£5.0 
-£2.5 
0.08 
0.32 
0.13 
0.24 
0.54 
-21.1 – 1.1 
-11.7 – 3.8 
-14.1 – 1.8 
-13.4 – 3.3 
-10.5 – 5.5 
-£10.6 
-£5.9 
-£8.5 
-£10.8 
-£6.4 
0.06 
0.20 
0.15 
0.04 
0.40 
-21.8 – 0.54 
15.0 – 3.1 
-19.9 – 2.9 
-21.1 - -0.5 
-21.4 – 8.5 
Total NHS cost (£) 
W1 
W2 
W3 
W4 
W5 
-£57.5 
-£54.9 
-£41.1 
-£65.6 
£16.7 
0.06 
0.12 
0.16 
0.03 
0.66 
-128.2 – 19.8 
-137.3 – 45.9 
-123.9 – 37.9 
-135.8 – 3.1 
-62.1 – 93.7 
-£17.2 
£15.5 
-£86.9 
-£21.2 
£27.2 
0.69 
0.74 
0.04 
0.62 
0.45 
-101.6 – 67.3 
-77.0 – 108.0 
-169.8 – - 4.1 
-105.6 – 63.3 
-43.8 – 98.0 
£20.6 
-£66.0 
-£80.1 
-£64.0 
-£91.4 
0.59 
0.19 
0.06 
0.30 
0.06 
-54.7 – 95.8 
-166.6 – 34.6 
-162.5 -2.3 
-186.3 – 58.3 
-187.3 – 4.5 
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6.12   Lost Productivity  
 
Table 56 below shows the reported mean number of days off work and value 
of lost productivity by Intervention and Control patients. In terms of time off 
alone, there was a statistically significant difference in favour of the 
Intervention group (adjusted mean difference = -1.78 days, p = 0.04, 95% 
CI = -£3.47 to -0.09) at Wave 4 but not at any other wave. When valued 
using the relevant average earnings (male or female), however, the 
adjusted mean difference (-£27.00) was not statistically significant (p = 
0.07, 95% CI = -£56.7 to £2.60). This result replicates those of NHS 
resource use i.e. that there is a consistent tendency for patients in the 
Intervention sites to have less time off work but no firm conclusions can be 
reached due to the lack of statistical significance show.  
 
6.13   Discussion 
 
The Quasi-experimental approach used here is comparing sites which 
received additional support from the NHSMA (Intervention) with those that 
did not (Control). However, any effects of the intervention need to be seen 
in the context of a general climate of modernisation being pursued by the 
DoH and the fact that all participating sites had registered their intentions to 
modernise. The effects of the intervention as a catalyst to modernisation 
were thus inevitably going to be relatively small.  
 
In the event, most sites managed to secure funding from other sources 
either instead of, or in addition to, the financial support provided by the 
NHSMA to Intervention sites. More importantly, the costs of modernisation 
are not restricted to financial expenditures. For example, the time devoted 
by existing staff to modernisation activities is a cost of modernisation 
regardless of the fact that it does not incur a change in the wages bill.  
 
Analysis of the costs incurred by ENIGMA sites shows major investments in 
equipment, training, one off activities and in recurring costs. The extent to 
which these increased the per patient cost of the endoscopy services was, 
however, slightly lower in the Intervention sites (£26.62 v £33.88 first year 
and £17.43 v £20.91 subsequent years) although the differences were not 
statistically significant. 
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Table 56.   Time off work and value of lost productivity by Wave: Intervention v Control 
 
Item (Section D) Baseline (n= 3818) Post Procedure (n= 2940) 12 month post procedure (n= 2588) 
 M.D.  
(I – C) 
p 95% CI Adj. 
M.D. 
 (I - C) 
p 95% CI Adj. M.D. 
 (I - C) 
p 95% CI 
(D7) Time off from work  
                 W1 
                 W2 
                 W3 
                 W4 
                 W5  
Cost of Time off from work 
                 W1 
                 W2 
                 W3 
                 W4 
                 W5 
 
-0.03 
-1.20 
0.55 
1.59 
-0.82 
 
£0.86 
-£18.6 
£12.3 
£32.0 
-£17.3 
 
0.97 
0.22 
0.37 
0.07 
0.28 
 
0.95 
0.28 
0.29 
0.05 
0.22 
 
-1.55 – 1.49 
-3.11 – 0.71 
-0.64 – 1.74 
-0.13 – 3.32 
-2.33 – 0.68 
 
-27.5 -29.2 
-52.6 - 15.3 
-10.7- 35.3 
-0.30 – 64.3 
-44.9 – 10.2 
 
0.27 
0.49 
-0.55 
-0.04 
-1.04 
 
£5.47 
£14.05 
-£10.7 
£1.60 
-£20.7 
 
0.61 
0.56 
0.22 
0.95 
0.31 
 
0.59 
0.37 
0.15 
0.88 
0.29 
 
-0.75 – 1.28 
-1.16 – 2.13 
-1.41 – 0.32 
-1.26 – 1.18 
-3.04 – 0.97 
 
-14.4 – 25.3 
-16.9 – 45.0 
-25.4 – 3.9 
-20.6 – 23.9 
-59.7 – 18.3 
 
-0.48 
0.11 
-0.05 
-1.78 
-0.16 
 
-£9.8 
£2.40 
-£1.45 
-£27.0 
-£6.2 
 
0.57 
0.80 
0.89 
0.04 
0.82 
 
0.57 
0.73 
0.83 
0.07 
0.65 
 
-2.12 – 1.16 
-0.70 – 0.91 
-0.85 – 0.75 
-3.47 - -0.09 
-1.58 – 1.26 
 
-43.4 – 23.9 
-11.6 – 16.5 
-14.8 – 11.9 
-56.7 – 2.6 
-33.2 – 20.7 
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Similarly the intervention seemed to have slightly reduced the subsequent 
NHS costs incurred by patients in terms of primary care, secondary care and 
drugs although again the differences were rarely statistically significant.  It 
should be noted that in the adjusted analyses of resource use/cost, 170 
tests of significance were performed on post procedure and 12 month post 
procedure data.  Of these only 13 showed statistically significant mean 
differences in resource use items or in costs; 9 at post procedure and 4 at 
12 months post procedure.  Thus despite the consistent tendency for costs 
to be lower in patients at intervention sites, no firm conclusion can be drawn 
regarding whether or not the intervention is cost saving.    
 
At the same time, the results of the patient outcome analyses suggest that 
the intervention did not impact on patients’ health. Although there was a 
statistically significant difference in the adjusted mean difference in EQ-5D 
scores in favour of the Control group at Wave 2 (p = .04), there was also a 
statistically significant difference favouring the Intervention group at Wave 5 
(p = .04). The differences in the other 8 analyses were insignificant with 4 
favouring the Intervention group and three favouring the Control (mean EQ-
5D scores were identical the remaining two tests).  
 
Taken together these results suggest that the intervention is likely to fall in 
the South West quadrant of the cost effectiveness plane (see for example 
Drummond, 2005 (Drummond, Sculpher, Torrance, O'Brien and Stoddart 
2005)) as it is equally costly or possibly less costly and at least equally 
effective as compared with the controls – a dominant result.  
 
A number of caveats need to be applied to these conclusions. Many of these 
can be related back to the ‘philosophy’ section (2.1) which explained and 
justified the decision to evaluate the MES programme as an area wide 
complex intervention. For example, the sampling of sites had to be within a 
sampling frame determined by the NHSMA and where all sites had 
undergone some degree of pre-intervention preparation.  
 
Perhaps a greater caveat, though, has to be applied to the lack of a clear 
definition by the NHSMA regarding what was to be considered as 
‘modernisation’ – and in particular how (if at all) modernisation was seen as 
being different from improvement. This ambiguity led to difficulties in 
teasing out the ‘costs of modernisation’ from those interviewed at the site 
visits. Although every effort was made to explain how the term was being 
used for present purposes – in particular to ensure that all interviewees 
were responding to the same question – it is possible that some 
interviewees regarded investments to improve the endoscopy service as 
being modernisation even when they did not fit the chosen definition.  
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7   Patient Views 
7.1   Executive summary 
 
As part of the evaluation and to understand more about Intervention and 
Control sites in terms of patients’ perceptions, telephone interviews were 
undertaken with patients referred either as urgent or non-urgent, to the 
nine Intervention and nine Control sites, to elicit responses on their 
experience of the referral process. In keeping with the overall aims of the 
study this enabled an understanding of patients’ views of the accessibility 
and acceptability of service provision   The interviews took place after the 
second and fifth waves (hereafter referred to as first round and second 
round interviews) of patient recruitment. Patients were randomly selected 
from lists of Intervention/Control and urgent/non-urgent patients who had 
agreed to take part in the study. The interviews, conducted by two 
researchers, lasted five to 10 minutes, were recorded and transcribed. The 
interviews were analysed using content analysis. 
 
Five key themes emerged from the data: waiting for an endoscopy, 
information provision, staff, differences in experience of endoscopy services 
over time and suggestions for improvement. As this study was evaluating 
the MES programme, the research team looked for differences between 
Intervention and Control sites. However, there were no detectable 
differences between the responses from patients attending Intervention or 
Control sites. There were also no discernable differences in the opinions of 
patients over time. 
7.1.1   Waiting for an endoscopy  
First round interviews 
 
Patients referred as urgent were satisfied with the time they had to wait. 
The majority of non-urgent patients anticipated and accepted waiting some 
time for their test. However, suggestions for improvement were often 
connected with speeding up the time from referral to procedure. 
Second round interviews 
 
The majority of urgent and non-urgent patients were satisfied with the time 
they had to wait and many were surprised at the speed of their 
appointments, while fewer patients than in the first round said they would 
like to have had the procedure sooner. 
7.1.2   Information provision  
First round interviews 
 
Most patients felt that the information given to them before the procedure 
was sufficient and were satisfied with being given an appointment date and 
time with the option to change it. 
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Second round interviews 
 
The majority of patients were satisfied with the amount of information. 
Patients appreciated being able to book appointments themselves but there 
was criticism of the amount of paperwork sometimes involved in the 
appointment system. 
7.1.3   Staff  
First round interviews 
 
The majority of patients felt the treatment and care received was good. 
There were very few negative comments about staff or treatment but, when 
expressed, concerns were about the insensitivity of staff to personal feelings 
and the physical surroundings. 
Second round interviews 
 
The majority of patients felt the care and treatment was good. There were 
no negative comments about staff and patients were empathetic towards 
the stresses and strains of health professionals’ working lives. 
7.1.4   Differences in experience of endoscopy services over a 
period of time                                 
First round interviews 
 
Of 14 patients who had had an endoscopy in the past, five (two from 
Intervention, three from Control sites) felt that their recent experience was 
better and one patient felt this might have been because the procedure was 
performed by a Nurse Endoscopist (NE). 
Second round interviews 
 
Of 26 patients who had had an endoscopy in the past, 11 (six 
Intervention/five Control) felt that their recent experience was better for a 
variety of reasons such as quicker appointments, more modern units and 
better appointment making systems. 
7.1.5   Suggestions for improvement  
First round interviews 
 
One third of patients found it difficult to think of suggestions for 
improvement in the referral process and spoke about their satisfaction with 
the service and with staff attention. However, two-thirds made suggestions 
for change and improvement most often related to a reduction in the waiting 
time for their procedure and the desire for more information in advance 
about the procedure. 
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Second round interviews 
 
Many patients found it difficult to think of suggestions for improvement to 
the referral process and two-thirds made no suggestions. The approximate 
third of interviewees who made suggestions most often related to a reduced 
waiting time, improvement in communication before and after the procedure 
and a desire to have another person present when being told results having 
had sedation. 
7.1.6   Summary - Differences between Intervention and 
Control sites  
 
The first and second round patient interviews show no detectable differences 
between Intervention and Control sites in terms of service delivery and 
organisation and demonstrate that, from a patient perspective, the MES 
programme appeared to have no detectable impact. However, across all 
sites, at the time of the second interviews (autumn 2006), patients were 
getting their procedures more quickly and had fewer suggestions for 
improving the service than at the time of the first interviews (summer 
2005). This suggests that in spite of no detectable differences resulting from 
the MES programme, the changes that both groups are making to their 
services are impacting positively on patient views. However, this could be 
related to demographic differences rather than an improvement in services, 
as there was a significant difference in patients’ ages between first and 
second round patient interviews. 
7.1.7   Major issues arising  
 
 
First round interviews 
 
 
Second round interviews 
Waiting for an endoscopy 
 Patients referred as ‘urgent’ were 
satisfied with the waiting time for 
endoscopy 
 Patients referred as ‘non-urgent’ 
accepted having to wait but would 
prefer a quicker investigation 
 
Waiting for an endoscopy 
 Patients referred as ‘urgent’ were 
satisfied with the waiting time for 
endoscopy 
 Majority of ‘non-urgent’ patients 
thought the waiting time was better 
than expected 
 More patients expressed surprise at 
speed of getting procedure 
 Less patients saying they would 
have liked the procedure sooner 
Information provision 
 Information provided in advance of 
endoscopy was satisfactory 
 Patients appreciate the ability to 
alter an appointment 
 
Information provision 
 Information provided in advance of 
endoscopy was satisfactory 
 Patients appreciate the ability to 
book an appointment themselves 
 Criticism of paperwork involved in 
some appointment systems 
Staff 
 Patients were satisfied with 
treatment and care received 
 
Staff 
 Patients were satisfied with 
treatment and care received 
 Patients had empathy for working 
lives of staff 
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Differences in experience of endoscopy 
services over time 
 General perception that there had 
been no change in experience since 
a previous endoscopy 
 
Differences in experience of endoscopy 
services over time 
 General perception that there had 
been no change in experience since 
a previous endoscopy 
 However, where better reasons – 
quicker appointments, more modern 
units, better appointment making 
systems 
Suggestions for improvement 
 Two-thirds made suggestions for 
improvement including more 
information in advance of procedure 
and the need for shorter waiting 
times 
 
Suggestions for improvement 
 One third made suggestions for 
improvements to services including 
need for shorter waiting times, 
improved communication and 
another person  present when being 
told results after sedation 
7.2   Aims 
The main aim of the interviews was to clarify how patients perceived the 
accessibility and acceptability of the innovations in service delivery and 
organisation in endoscopy units that were being evaluated in this study. 
7.3   Objectives 
 
a) To understand patients’ experiences of innovations in terms of their 
satisfaction with endoscopy services, in particular their experience of 
the referral process; 
b)  To describe differences between Intervention and Control sites; 
c)  To capture patient experience over time, at two stages during the   
  study, as innovations impacted on service delivery; 
d)  To clarify whether patients’ views of current endoscopy services tell us 
  more about the successes and failures of innovations. 
7.4   Method 
 
Telephone interviews were undertaken with patients from the second wave 
of patient recruitment which started in November 2004 and with patients 
from the fifth wave of recruitment which started in April 2006 (hereafter 
referred to as first and second round interviews). Patients were given the 
opportunity to indicate whether or not they wished to be interviewed by 
ticking a box in the Baseline Questionnaire (BQ) completed when consenting 
to take part in the study, and had the opportunity to amend this whilst 
completing a Post Procedure Questionnaire (PPQ) soon after their 
endoscopy. Issues concerning ethics, consent and selection of study sites, 
are detailed in chapter 2.  
 
It was decided that for the first round interviews two patients would be 
interviewed per site, from the 18 sites recruiting patients. More patient 
views on the differences in experience of endoscopy over time were required 
from second round interview patients, so interviews specifically sought out 
these patients (see Figures 26 and 27). 
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The aim of this aspect of the study was to interview patients as soon as 
possible after their endoscopy to encourage an easier recall. To ensure the 
views of recruited patients could be ascertained, whose waiting time for an 
endoscopy varied from less than two weeks to many months, one patient 
referred as an ‘urgent’ case and one referred as a ‘non-urgent’ case, from 
each site, were interviewed (see Figures 26 and 27).  
7.4.1   Telephone interviews 
 
Telephone interviews were selected as the most appropriate method of data 
collection. It is recognised that telephone interviews have advantages and 
disadvantages. Advantages include reduced interviewer effects, better 
uniformity in delivery, greater standardisation of questions, researcher 
safety, greater cost-efficiency and fast results (Shuy 2002). Limitations to 
telephone interviews include difficulties in contacting people as a result of 
call screening, answer phones and ex-directory numbers. To some extent 
this can be overcome by the use of a computer randomly selecting 
telephone numbers (Bryman 2004) but is not appropriate when targeting a 
specific sample. To overcome this, a letter can be sent to potential 
interviewees asking them to make the initial contact. However, this was not 
an issue in this study as the researchers had access to the majority of 
patient telephone numbers. There are also the difficulties of respondents 
with hearing impairment, and evidence that telephone interviews may be 
shorter and less effective when asking about sensitive issues (Bryman 
2004). However, as the sample of patients to be interviewed was 
geographically dispersed, telephone interviews were seen as the method of 
choice. They could take place at a time convenient to the patient and did not 
involve the patient in additional travel. They also saved researcher travel 
time and ensured a wide population view (Platt 2002). 
7.4.2   Interview schedule 
 
At a Project Steering Group (PSG) meeting prior to the interviews, it was 
agreed that as interviews were to take place over the telephone they should 
be brief and focused. Each interview should consist of between four and six 
questions and should last approximately 20 minutes and no longer than 30 
minutes. 
 
The interview schedule was semi-structured in design (Bryman 2004). It 
was understood that as the ENIGMA study was recruiting patients newly 
referred for endoscopy, many patients would be unaware of issues such as 
‘new models, innovations, novel systems or nurse substitution’. It was 
therefore agreed that the questions had to be simple and an interview 
schedule was produced to elicit responses from patients on their experience 
of the referral process (see Appendix 13 for detail). 
7.4.3   Pilot study 
 
A pilot study (Janesick 1998) was conducted using the patients recruited 
from the pilot study described in chapter 2. Three patients recruited into the 
pilot study were randomly selected and interviewed. The transcripts were 
circulated to the PSG. Following feedback and discussion it was agreed that 
the interview schedule was providing data in keeping with the project aims 
and objectives. It was decided that no changes to the interview schedule 
were necessary although it was acknowledged that patients would have a 
limited knowledge of changes that might be taking place. 
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7.4.4   Sampling strategy and recruitment 
 
Once all 100 patient recruitment packs for wave 2 (round one interview 
cohort) had been sent out by a hospital and the reminder process had been 
completed, two lists were created for patients returning the BQ, for each 
hospital – one list of urgent referrals, one of non-urgent referrals, using the 
degree of urgency (DOU) designated on the study register. The two lists 
would capture the views of patients who were seen within a matter of weeks 
of their referral (urgent) and those who might have waited for many months 
to have their endoscopy (non-urgent). 
 
Exclusion criteria were applied to the list:  
 
-  all patients not wishing to be interviewed according to the BQ or 
PPQ  
-  patients with no retrievable telephone number. 
 
The same strategy was followed for patients from wave 5 (round two 
interview cohort).  
 
The lists were exported into the SPSS V13 (Lead Technologies, USA) 
computerised statistics package. For wave 2, five random numbers were 
selected from each urgent and each non-urgent list, per hospital. For wave 5 
no random selection took place but the lists were reordered randomly. The 
researchers contacted patients in the order in which they presented on the 
list. 
 
Once the patient’s procedure date had passed, the researchers attempted to 
contact the first patient on the list by telephone to arrange a date and time 
to interview. If no contact was made, the researchers made two more 
telephone attempts on different days, at different times. Voice messages 
were left where possible. If there was no response to the voice message by 
the next day, the researchers tried ringing again. 
 
If no contact was made, a letter was posted to the patient asking whether 
they would like to take part in the interview and asking them for a 
convenient day and time for a phone call. At the bottom of the letter was a 
return slip for them to complete and return in a FREEPOST envelope. The 
researcher’s phone number was also printed on the letter to answer any 
queries. 
 
If no contact was received within a week of sending the letter, the 
researchers moved on to the next patient on the list. 
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Figure 26.   First round interview patient sampling strategy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Second round patient sampling strategy 
 
   
 
  
  
Hospital 
List of non-urgent referrals during 
recruitment period agreeing to 
interview 
Random sample of five from list 
First on list contacted by 
telephone then letter - if no 
response, moved to next patient 
on list 
First on list contacted by 
telephone then letter - if no 
response, moved to next patient 
on list 
Random sample of five from list 
List of urgent referrals during 
recruitment period agreeing to 
interview 
Hospital 
List of non-urgent referrals during 
recruitment period agreeing to 
interview 
List reordered randomly 
First on list contacted by 
telephone then letter - if no 
response, moved to next patient 
on list. Stopped when patient 
interviewed who had previous 
endoscopy 
First on list contacted by 
telephone then letter - if no 
response, moved to next patient 
on list. Stopped when patient 
interviewed who had previous 
endoscopy 
 
List reordered randomly 
List of urgent referrals during 
recruitment period agreeing to 
interview 
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7.5   Data collection and analysis 
First round interviews 
 
Thirty six first round interviews were planned with patients (one urgent 
referral and one non-urgent referral from each site) from the 18 sites 
recruiting patients. At two hospitals, no patients who had been referred as 
‘urgent’ had indicated on their BQ that they would take part in an interview. 
At one hospital the only patient referred as ‘non-urgent’ who had indicated 
that they would take part in an interview could not be contacted and did not 
respond to a letter inviting them to take part. There were no other patients 
referred as ‘non-urgent’ who had indicated they would take part in an 
interview. During two interviews it was discovered that the patients were 
having repeat surveillance colonoscopies so they were not included in the 
analysis. It was possible to replace only one of these as there were no other 
appropriate referrals. A total of 32 interviews were conducted that were 
suitable for analysis (see Table 57). 
 
Table 57.   Number of second wave interviews 
 
36 Interviews planned 
-2 no urgent referrals agreeing to take part 
-1 discovered to be repeat surveillance so excluded 
-2 discovered to be repeat surveillance so excluded 
+1 Only possible to replace one surveillance-no other appropriate referrals 
=32 interviews for analysis 
Second round interviews 
 
In the first round interviews 50% of patients were found to have had a 
previous endoscopy. As a result the second round interviews sought the 
views of patients who had had a previous endoscopy to clarify the 
differences in experience over time. In order to do this, interviews were 
conducted until one patient who was an urgent referral and one who was a 
non-urgent referral from each site were interviewed and if any of these 
patients had had previous endoscopies no further interviews with patients 
from these sites were pursued. At sites where the first patient interviewed 
had not had a previous endoscopy, further interviews were conducted until a 
patient was interviewed who fell into this category. Consequently, a total of 
103 interviews were conducted. In keeping with the first round interviews, 
the first interview from each site, urgent and non-urgent, was included in 
the analysis. Where a first interview patient had not had a previous 
endoscopy, the first interview conducted with a patient who had had a 
previous endoscopy was included in the analysis. Table 58 shows that 11 of 
the first interviews (numbers in italics/red) included patients who had had a 
previous endoscopy. A blank indicated that either where no patients in that 
category agreed to take part in an interview or where patients could not be 
contacted or replaced by another patient. To make sure we conducted a 
thorough analysis of telephone interviews with patients, we analysed over 
half of the total interviews conducted (n=61), in qualitative terms a large 
body of data for analysis purposes, to ensure that we would be able to 
account for all the major themes arising. Of the 61 interviews, 26 were with 
patients who had had a previous endoscopy. 
 
The interviews were conducted by the same two researchers as for the first 
round. All interviews were conducted by telephone and recorded by the 
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researchers on an interview template. Patients were asked for their 
permission to record the interviews before they began; no patients refused. 
The interviews were transcribed by the Project Secretary soon after 
completion and the transcripts were reviewed independently by the two 
researchers. 
 
Data were analysed using content analysis. This method enables the 
reduction of qualitative data to manageable portions of text that can be 
analysed by searching for patterns and themes in the data as well as 
incongruities between different participants’ views (Patton 2002). The 
researchers read the transcripts and developed a coding system. The 
transcripts were then read again to ensure complete coding of the data. The 
coding system was also used to count the number of instances that 
reportage adhered to each category (Silverman 2001). This process 
established the following emergent themes: waiting for an endoscopy, 
information provision, staff, differences in experience of endoscopy services 
over time and suggestions for improvement. 
 
While conducting the interviews and undertaking the analysis, it was clear 
that very similar themes were emerging. It was therefore decided to write 
up the findings from the first and second rounds of interviews as one piece. 
   
Table 58.   Patients (ID numbers) included in analysis of second round 
interviews 
 
 1st interview  Previous endoscopy 
Site Urgent Non-urgent  Urgent Non-urgent 
1 1402 1446  - 1413 
2 2411 2455  2426 2455 
3 3421 3474  3402 3405 
4 4478 4481  - 4481 
5 5414 5411  5478 - 
6 6407 6421  - 6433 
7 7480 7462  7480 7492 
8 8457 8404  - 8429 
9 - 9414  - - 
10 Withdrawn from patient recruitment 
11 11459 11470  11428 11477 
12 12429 12444  12459 - 
13 13455 13448  13455 13448 
14 14492 14489  14492 14486 
15 15468 15452  15468 15452 
16 16446 16466  16446 16403 
17 17465 17479  17420 17430 
18 Withdrawn from study 
19 19432 19404  - 19404 
20 20410 20435  20410 - 
7.6   Findings first and second round interviews 
 
Results will be presented under the following five headings in keeping with 
the five themes that emerged from the data: 
 
1. Waiting for an endoscopy 
2. Information provision 
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3. Staff 
4. Differences in experience of endoscopy services over time 
5. Suggestions for improvement 
 
A detailed examination of the themes follows a description of differences 
between Intervention and Control sites. 
7.7   Differences between Intervention and Control 
sites 
First round interviews 
 
To ensure that the patient sample in both groups (Intervention and Control) 
was not significantly different, descriptive statistics were performed which 
showed no significant difference in age, gender, DOU or procedure type. 
 
In spite of the patient sample being defined according to urgent and non-
urgent cases, differences between these two groups were not apparent in 
these data in terms of responses to the questions, except in relation to 
waiting times. 
 
At the time of the interviews the researchers did not know what the sites 
were doing with regard to modernising their referral processes. 
 
Patients were unaware whether they fell into an Intervention or Control site 
group and there were no detectable differences in the responses of patients 
between Intervention and Control sites. 
 
Analysis of the data from the patient interviews shows no differences 
between Intervention and Control sites and this demonstrates that, from a 
patient perspective, the MES programme appeared to be having no 
detectable impact. 
Second round interviews 
 
To ensure that the patient sample in both groups (Intervention and Control) 
was not significantly different, descriptive statistics were performed which 
showed no significant difference in age, gender, DOU or procedure type. 
 
To check for differences between the groups of patients interviewed in round 
one and round two, descriptive statistics were performed. There was no 
significant difference in gender, DOU or procedure type. However, second 
round interview patients were significantly older than first round interview 
patients (first round = 53y, second round = 64y, p=0.03).  
 
As in the first round, patients were unaware whether they fell into an 
Intervention or Control site group and there were no detectable differences 
in the responses of patients between Intervention and Control sites. 
 
In spite of the patient sample being defined according to urgent and non-
urgent cases, differences between these two groups were not apparent in 
these data in terms of responses to the questions.  
 
In the second round there were fewer patients expressing a desire for 
quicker waiting times and more expressing surprise at the speed with which 
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they had their endoscopy. There were also less suggestions for 
improvements from patients. However, whilst second round patients are less 
likely to have wanted their procedure done sooner, this could be related to 
demographic differences between the two rounds of interviews rather than 
an improvement in services between the two study time points. 
Summary 
 
Analysis of the data from the second round patient interviews (April 2006) 
shows no detectable differences between Intervention and Control sites in 
terms of, for example, information provision, satisfaction with treatment, 
service provision, and this demonstrates that, from a patient perspective, 
the MES programme appeared to be having no detectable impact. However, 
across Intervention and Control sites patients appear to be getting their 
procedures more quickly than when the first round of interviews were 
reported (summer 2005) and it could be said that, because fewer patients 
are making suggestions for improvement, the delivery and organisation of 
endoscopy services is improving. This suggests that while there are no 
detectable differences between the Intervention and Control sites as a result 
of the MES programme, the fact that sites are modernising their services 
does seem to be having some positive impact on patient views. However, 
this could be related to demographic differences rather than an 
improvement in services, as there was a significant difference in patients’ 
ages between first and second round patient interviews. 
7.8   Examination of findings in detail 
7.8.1   Theme 1 – Waiting for an endoscopy 
 
The patients being interviewed were drawn from two types of referral – 
urgent and non-urgent. Urgent referrals are seen within a matter of weeks 
whereas the non-urgent referrals can be on a waiting list for many months 
before their procedure. 
First round interviews 
 
The patients interviewed from Intervention and Control sites who fell within 
the urgent referral group, thought the speed at which they were seen was 
better than expected: 
  
I was impressed, I was expecting something like 6 months, 
something like that, and then all of a sudden the letter came through 
and it was about 3-4 weeks from seeing her to the actual 
appointment so that was quite, I was impressed. (1166) 
 
The remaining patients were referred as non-urgent cases and many of 
them anticipated having to wait some time for their endoscopy because they 
were being referred to hospital and a wait was expected: 
 
Obviously having to wait 3 months, something like that, when you’ve 
got an indigestion problem is a little bit frustrating but you just 
accept that as part of the thing , you know. (3150) 
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Yes obviously everybody’s going to say any wait is too long but you, 
you know, on the other hand you appreciate that there is going to be 
a wait and 3 months is far better than 6 months or 9 months. (3150) 
 
However, two-thirds of the non-urgent group (split evenly between 
Intervention and Control sites), actually felt that the speed of access to their 
endoscopy appointment was good - in one case eight months was 
considered a speedy referral: 
 
Patient -Good points – quick, thorough. 
Researcher – when you say quick – you have waited a total of 8 
months and you think that’s OK? 
Patient – For around here, that’s quick. (2132) 
 
In spite of having to wait for an endoscopy, a couple of patients were simply 
relieved that their symptoms were being investigated: 
 
I felt better knowing that I had been referred because then you think 
well if things don’t get better, I know…. (7111) 
 
Just four (two Intervention/two Control site) of the 32 interviewees felt they 
had waited too long (one of these had their appointment expedited by their 
General Practitioner (GP)). A couple of patients expressed surprise at 
getting an appointment sooner than expected, one being offered a 
cancellation while phoning to find out where he was on the waiting list. 
While patients accepted having to wait, a quarter of patients did express the 
view that a shorter wait would have been preferable: 
 
Well we all want it a bit shorter don’t we?  It’s not possible … tend to 
want it the next day don’t you which is not possible, not unless you 
are paying. (5103) 
 
A few commented on the fact that they understood there were other 
patients with symptoms that should take priority: 
 
“…it was a long wait but because I was OK, more or less, and I know 
that there are an awful lot of people who need endoscopies for 
serious problems”. (4153) 
 
Four patients felt that their GPs had not referred them quickly enough in the 
first place, but once referred, were satisfied with the length of time they had 
to wait for their endoscopy.  
Second round interviews 
 
The majority of the 23 patients from Intervention and Control sites who fell 
within the urgent referral group, were satisfied at the speed with which they 
were seen: 
 
I didn’t have to wait very long at all. Well you know you hear of such 
long waits in some areas and I mean I’m 81 years old, I didn’t expect 
such treatment quite so soon. (17465) 
 
Of the patients referred as non-urgent cases, two-thirds were satisfied at 
the length of time they had to wait and were quite understanding: the NHS, 
they are having problems I know so I’m afraid there are waits for everything 
(7462).  
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Of the nine patients (six Intervention/three Control site) who felt they had 
waited too long, just one fell into the urgent referral group. The main issue 
for these patients was that while waiting for an appointment they were 
experiencing pain: 
 
I had been in a lot of discomfort for a long, long time and I’d waited a 
long time to get the appointment to see the doctor and then sort of 
having to wait again it just seemed to last forever really – quite 
annoyed, a bit upset, because as I say I was in so much discomfort 
that I just wanted it over and done with. (4481) 
 
Many patients (both urgent and non-urgent) expressed surprise at getting 
their appointment sooner than expected: 
 
I’d been told I’d be waiting about three months but I certainly didn’t 
have to wait three months. I was quite impressed. (20435) 
 
I was quite surprised how quick it was …well because most people 
seem to wait ages for their appointment. (12459) 
 
Summary – Waiting for an endoscopy 
 
First round interviews 
 
The patients were drawn from two lists – urgent and non-urgent referrals to 
capture the views of patients who are seen within weeks of their referral for 
endoscopy and those who wait for many months for their procedure. The 
patients referred as urgent were satisfied with the time they had to wait for 
their procedure. The majority of patients, referred as non-urgent, 
anticipated having to wait some time for their test but accepted this and 
some were pleasantly surprised when the wait was less than expected. 
While many patients accepted waiting for their procedure, the suggestions 
for improvement were often connected with speeding up the time from 
referral to procedure. 
Second round interviews 
 
The majority of patients referred as urgent and non-urgent cases thought 
the waiting time for the procedure was better than expected and many 
patients were surprised at how quickly they were seen. While talking about 
the length of wait, few patients said they would have liked to have been 
seen sooner. 
7.8.2   Theme 2 – Information provision 
First round interviews 
 
Fourteen (six Intervention and eight Control site) of the 32 interviewees felt 
they had enough information given to them prior to their endoscopy and ten 
patients thought the information was of a high quality standard: 
 
A really good self-explanatory leaflet. (16129) 
 
I had very good information from the hospital. Their letter part was 
very good. It did explain quite a bit of it actually. (7119) 
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I was given all the information I wanted and then I was told to ask 
questions before they did it if I didn’t understand anything. (6129) 
 
Just one patient said they had received no information, while two felt the 
information provided was not sufficient: 
 
I wasn’t given any information about what was going to happen to 
me at that particular referral. They just sort of said to me I’m going 
to refer you to have a camera put down and have a look and see 
what is going on and see if they can find anything from that. That 
was all I knew, I didn’t know anything about how it was done or 
anything, that was all I sort of knew. (1166) 
 
No not really [enough information] (9103) 
 
I can’t remember. I remember I received a few packages, like one 
must have been quite close at the time because it contained the 
details about an enema. … We didn’t seem to have enough details 
about where to actually go which was a bit of a problem, so there 
weren’t any specific directions either to the hospital or specifically 
what part of the hospital we had to go to apart from on the address it 
said … (20116) 
 
Seven patients said they would have liked more information. Of these, five 
(two Intervention and three Control site) would have liked more information 
before the procedure, with two specifically mentioning they would have liked 
more information about sedation options and one suggesting it would have 
been helpful to have been given links to websites about the procedure. One 
patient would have liked more condition-specific information having been 
given a diagnosis and another would have liked the opportunity to see the 
doctor who performed the procedure after it was done: 
 
After the endoscopy I would have liked more information but the 
doctor doing the endoscopy doesn’t have time to see patients 
afterwards does he. I would have liked to have known, I ‘d have liked 
him to say to me what the staff nurse said. I’d like him to have said 
to me personally I’ve seen something there so I’m going to take a 
biopsy just to make sure everything’s OK. I didn’t see anyone else 
who’d had it done asking for information. (4153) 
 
The majority of patients had been contacted by letter with three contacted 
by telephone. When asked if they were offered a choice of appointment, just 
five said yes and 24 said no. However, half went on to say that if the 
appointment was not convenient they had instructions to contact the unit to 
arrange an alternative: 
 
No, just that date and if you can’t make it please telephone them and 
make another appointment. (7119) 
 
Three patients linked appointments to employment issues. One self-
employed patient commented on how it was easy to attend any appointment 
he was given, whereas another said being given a choice of appointments 
was important. The third patient commented on the problems caused in her 
workplace when the hospital altered the appointment: 
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My only difficulty is that I work in a job where it is very difficult to 
take time off … so if a date was changed it made it slightly tricky for 
me in terms of arranging time off work. (17172) 
Second round interviews 
 
Thirty-nine (19 Intervention/20 Control site) of the 50 interviewees felt they 
had enough information given to them before the endoscopy with the 
majority considering that the information was of a good standard: 
 
I think it was acceptable. You were given as much information as you 
need. (7462) 
 
You couldn’t ask for anything more, plus you’ve got phone numbers 
so if you’ve got any queries you just phone up. (2455) 
 
That was excellent, I knew exactly what to expect. (17479) 
 
Just two patients (one Intervention/one Control) said they had received no 
information, while three (two Intervention/one Control) would have 
preferred more information: 
 
I would have liked a bit more information I think, you know a bit 
more detail …  I could have been told more, I feel myself, you know 
rather than … you know all that I was told was that they would put a 
camera down and that was it sort of thing, you know. (1413) 
  
Two patients pointed out that the information did not indicate the possibility 
of a long wait on the day of the endoscopy although one of these 
understood that this was because the unit had to see inpatients: 
 
Because they do inpatients from within the hospital as well as the 
outpatients and of course when you haven’t had anything to eat or 
drink all that time and I mean it’s not the patients fault and it’s not 
the hospital’s fault…  (14489) 
 
Just over half of the patient interviewee group had been contacted by letter 
to make an appointment, 13 had been contacted by telephone and three 
had made appointments directly from clinic. The latter system was 
appreciated for its efficiency and a patient able to make an appointment by 
telephone praised the facility: 
 
The new thing is where you have to phone up and make your own 
appointments so that you keep them. It fitted in for when I wanted it 
– with four children it’s a lot easier you see. (16466) 
 
There was some criticism from one patient who had previous experience of 
endoscopy who felt “it’s a bit long winded now. It’s a bit messy to what it 
was before” (8429) because of the amount of letters sent from the hospital 
about just one appointment. 
 
When asked if they were offered a choice of appointment 25 said yes and 10 
indicated no; for the remainder it had not been an issue as they were able 
to keep the first appointment offered. 
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Summary – Information provision  
 
First round interviews 
 
The fact that most patients felt that the information given to them before 
the procedure was sufficient, is highlighted by less than a quarter of 
patients expressing a desire to have had more information before the 
procedure. 
 
Patients were satisfied with being given an appointment date and time as 
long as there was the opportunity to change it if it was not convenient. 
Second round interviews 
 
Once again, the majority of patients felt the information provided before the 
procedure was sufficient, with only three patients stating that they would 
have preferred more information. However, it was suggested that the 
information should indicate the possibility of a long wait once in the 
endoscopy unit. The ability to book an appointment directly with the unit 
was appreciated, as was the flexibility of changing appointments. However, 
the booking system that results in several letters going to and fro, was 
criticised. 
7.8.3   Theme 3 – Staff 
First round interviews 
 
Many patients from both Intervention and Control sites spoke about the 
care, sensitivity and efficiency with which they had been treated: 
 
I can’t fault the hospital, the staff the treatment, anything really. It’s 
all, as far as I’m concerned, they’ve really dealt with me brilliantly. 
(17136) 
 
It was all done very efficiently and the staff were very kind and 
considerate. I was amazed really. (6190) 
 
Very few patients had negative comments about the staff or units, however, 
one patient said she felt staff were rude and she was made to feel like a 
hypochondriac because comments about ‘getting a hernia or bad back’ were 
made by staff about handling her very large set of notes: 
 
The nurse there said ‘oh what a lot of notes, I’ll do my back in lifting 
these’, just jokingly and I didn’t say nothing but I do feel as if they 
are insensitive sometimes about a patient’s notes. I can’t help having 
that amount of notes, I can’t help being born with a birth defect. 
(5156) 
 
Another (from the same Control site as the patient above) found the 
hospital staff unprofessional and did not know who people were or what role 
they played: 
 
I didn’t really understand the situation or who these people were 
because I’ve never seen them before. They were either dressed in 
black or navy blue, I’m not sure what. What role they played there, I 
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have no idea at all. They seemed very unprofessional to me, both in 
their behaviour and their speech. I don’t know why they were or why 
there were there. … very unprofessional sounding interview – I was 
steadily losing confidence… until by the end of it I was full of 
indecision as to whether I should proceed or not. (5103) 
 
From all my dealings with consultants, I don’t think they are very 
good at talking to patients and that’s a general thing. (16121) 
 
Unsatisfactory circumstances on the day of the procedure were described by 
one patient: 
 
There was a hell of a lot of waiting and there weren’t enough chairs 
for everybody so there were a lot of people who were quite stressed 
about it all and we were all sort of hanging about in the corridor. 
(12101) 
 
One patient (16129) spoke about her feelings at being seen on a Saturday. 
She had queried the appointment with the hospital but had been told that 
she had to be seen within 11 weeks and as 11 weeks had almost passed, it 
had to be on a Saturday. She had excellent treatment but felt dreadful, as 
she was the only one there with a doctor and two nurses. 
Second round interviews 
 
As in the first round interviews, patients spoke about compassion and care 
from staff and the efficiency with which they were treated: 
 
Apart from there was a wait I was treated exceptionally well, I 
couldn’t fault any of them at all. I couldn’t have had better treatment 
had I been the Queen of England. (7462) 
 
It was nice having somebody on my left hand, someone was telling 
me what was going on and all the rest of it. (3421) 
 
Apart from a couple of comments relating to how the actual procedure had 
been undertaken and about there being too many administrators, there 
were no direct criticisms of staff. Even when there were criticisms about 
waiting times or the fact that a hospital appeared dirty, these were quickly 
followed up by how good the nurses and doctors were: 
 
I was disappointed in the condition of the hospital and particularly 
the ward where I was situated. I thought it was antiquated. I actually 
thought it was quite dirty. Apart from that I thought the staff were 
very good and I can’t complain, I mean everything went well. (3474) 
 
Indeed there was a degree of sympathy for the staff working in difficult 
times: 
 
In the circumstances and the fraught existence they have and the cut 
down of staff, I think they are marvellous. I do care about the nurses 
and doctors and I think they have a very hard time. (13448) 
 
Summary – Staff 
 
First round interviews 
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The majority of patients felt that the treatment and care they received was 
good with very few negative comments about staff or treatment. Where 
there were concerns, they were about the insensitivity of staff to personal 
feelings and the physical surroundings and one patient was concerned at 
being seen at a weekend. 
Second round interviews 
 
As in the first round, many patients spoke about the good care and 
treatment they received. There were no negative comments about staff, 
rather empathy for them working in what were considered difficult times in 
the National Health Service (NHS). 
7.8.4   Theme 4 – Differences in experience of endoscopy 
services over time 
First round interviews 
 
Just under half of the patients (seven from Intervention sites, seven from 
Control sites) had had previous endoscopies but some were many years ago 
and could not be recalled. However, six patients (five of these from 
Intervention sites) felt there was no difference in their experience since 
previous endoscopies, while five (three of these from Control sites) felt the 
most recent procedure was better. One suggested this was because, having 
gone through the experience before, they were less stressed: 
 
Well I think it was better this time but I really don’t know if that’s 
because I’d done it before and I sort of knew what was going to 
happen. (9115) 
 
The other patient (from a Control site) wondered if it was because 
the person performing the endoscopy, a Nurse Endoscopist, was 
better than the doctor who performed the previous one (9103): 
 
I don’t know if things have come on or if it was that the woman that 
did it was better than the doctor or person who did it in …  I had a 
Nurse Endoscopist who did it … and actually it was the nurse who was 
better than the doctor. (9103) 
Second round interviews 
 
When the first round interviews were conducted it was found that half of the 
patients interviewed had had previous endoscopies. It was therefore decided 
to interview second round patients until one urgent and one non-urgent 
referral from each site who had had a previous endoscopy were found, 
where possible. This resulted in a total of 26 patients interviewed who had 
experience of a previous endoscopy. Some patients found it difficult to 
accurately recall details, which might reflect the brevity of an endoscopy 
procedure in terms of a patient’s overall care pathway. However, half of the 
group (split evenly between Intervention and Control sites) felt there was no 
difference in their experience since previous endoscopies, while just under a 
half (split evenly between Intervention and Control sites) felt the most 
recent procedure was better for a variety of reasons. These included being 
seen quicker than previously, more modern units, improvements in making 
appointments, more information given about what was going to happen on 
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the day and the time spent in the unit on the day was thought to be 
quicker: 
 
The process probably was a lot quicker this time because I was 
surprised to have got an appointment so quickly so I’m guessing that 
from past experiences I thought ‘oh that’s a lot quicker’ so the 
process must have got a lot quicker. (11428) 
 
Tremendous changes because when I went the first time they were 
actually reconstructing the whole of the area so they now have a very 
nice suite. (2426) 
 
It’s been a lot quicker than when I first had it done a few years ago, 
you know a sort of quicker procedure rather than having to wait in 
the waiting rooms for sort of an hour on the day. (1413) 
 
I do think that hospitals are different now, I do think they tell you 
more and discuss things more. I don’t think that everything in 
hospitals is better but I think the information that you are given 
when you go for this sort of thing is better. They tell you more. As I 
say, I don’t always want to know so sometimes I’d rather not, but 
you do have access to exactly what they are going to do and what 
the results will be and all that sort of thing at the time. (12459) 
 
However, two patients (one Intervention/one Control) felt that their most 
recent experience was worse than their previous one, with one commenting 
on having to wait longer and the other disliking the appointment system 
where the hospital send letters at different stages: 
 
I mean it was just easy before. You went to see your doctor and they 
arranged an appointment to see the specialist and you went to the 
specialist. There was no letter flowing backwards and forwards. 
(8429) 
 
Summary – Differences in experience of endoscopy services over time 
 
First round interviews 
 
Of the 14 patients who had had an endoscopy in the past and could recall 
the experience, six felt there was no difference in their experience while five 
felt that their recent experience was better but, interestingly, one of these, 
from a Control site, commented on the possible reason for this being that 
the procedure was performed by a NE. The mix of patients from Intervention 
and Control sites responding in this way, highlights the lack of detectable 
difference in patient responses. 
Second round interviews 
 
Of the 26 patients who had had an endoscopy in the past and could recall 
their experience, half felt there was no difference in their experience while 
just under half felt that their recent experience was better for a variety of 
reasons such as quicker appointments, more modern units and better 
appointment making systems. As in the first round, the mix of patients from 
Intervention and Control sites highlights the lack of detectable difference in 
patient responses. 
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7.8.5   Theme 5 – Suggestions for improvement 
First round interviews 
 
When asked for suggestions for improving the referral process, many 
patients found it difficult to think of any and 11 of the 32 patients, from 
both Intervention and Control sites, were satisfied and had no suggestions. 
However, two-thirds of patients made the following suggestions (number in 
brackets indicates the number of patients making the suggestion): 
 
 waiting time should be less (6) 
 more information before procedure (5) 
 more information after procedure (2) 
 GP should refer sooner (2) 
 hospital should contact patient soon after referral (1) 
 there should be a choice of dates (1) 
 opportunity to discuss with specialist first (2) 
 cut out outpatient appointment to reduce waiting times (1) 
 more hospital staff (1) 
 hospital should try not to alter dates (1) 
 should be referred to hospital with shortest waiting list (1)  
 follow up appointment with consultant too long (1) 
Second round interviews 
 
As in the first round, many patients found it difficult to think of any 
suggestions for improvement and 35 of the 50 patients had no suggestions. 
However, just under a third of patients made the following suggestions 
(number in brackets indicates the number of patients making the 
suggestion): 
 
 waiting time should be less (5) 
 communication, before and on the day, could be improved (2) 
 another person should be present when being told results after 
sedation (2) 
 should be given realistic view of waiting time to procedure (1) 
 appointment by telephone better than too many letters to and fro 
(1) 
 honesty about what found (1) 
 would like results on day (1) 
 clearer instructions on who to contact about problems after the 
procedure and when (1) 
 administration of follow up inefficient (1) 
 
Summary – Suggestions for improvement 
 
First round interviews 
 
When asked for suggestions for improving the referral process, many 
patients found it difficult to think of any and a third of patients spoke about 
their satisfaction and had no suggestions. Two-thirds of patients made 
suggestions which most often related to a reduced waiting time and desire 
for more information in advance of a procedure. 
Second round interviews 
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Many patients found it difficult to think of suggestions and interestingly only 
just over a third of patients made suggestions the majority of which related 
to a shorter waiting time, improved communication before and after the 
procedure and a desire to have another person present when being told 
results having had sedation. 
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8 Professional views at study sites 
8.1   Executive summary 
 
As part of the evaluation, interviews were undertaken with clinicians and 
key people, based in the 10 Intervention sites and 10 Control sites that had 
played a role in modernising units. Two rounds of interviews took place. The 
first between May and October 2004, concentrated on the two years since 
2002, to cover the period of the MES programme. The second follow up 
interviews took place two years later. To enable an understanding of the 
impact of the MES programme the interviews aimed to capture the views of 
clinicians and key people on innovations in service organisation and 
provision, clarifying their perceptions of the accessibility and acceptability of 
the innovations, and exploring how each unit functioned to consider what 
innovations had been made or were planned.  
 
Interviews were recorded and lasted between half an hour and one and a 
half hours, most being approximately one hour. A total of 39 first round 
interviews (one site withdrew before the Key Person could be interviewed) 
and 38 second round interviews were conducted and analysed using 
thematic content analysis (Bowling 2002; Robson 2002; van Manen 1990). 
 
Three key themes emerged:  Drivers for change, the human dimension 
of endoscopy units and financial resources. 
 
As this study was evaluating the MES programme, the research team looked 
for differences between Intervention and Control sites. It was found that the 
majority of all sites were actively modernising their units and that while 
Intervention sites achieved this more quickly, Control sites had also, or were 
shortly to, modernise. The MES programme appears to have been a catalyst 
for change rather than an arbiter of change and for those actively taking 
part, it resulted in timelier implementation of modernisation. 
8.1.1   Theme 1 – Drivers for change 
First round interviews 
 
The NHSMA was seen as a catalyst for change and units had benefited from 
involvement in the MES programme but there was overwhelming criticism of 
the ToolkitTM training and the ToolkitTM itself, reflected by the fact that no 
Intervention sites continued with its use after the year of obligatory data 
collection. However, units had benefited from data collection in assessing 
and understanding their service and data had supported business cases and 
many Intervention and Control sites were continuing with some form of data 
collection.  
Second round interviews 
 
The Global Rating Scale (GRS) and NHS Bowel Cancer Screening Programme 
(NBCSP) have taken over from the NHSMA/MES programme in terms of the 
way people think about modernisation in their units. These initiatives have 
The ENIGMA study 
©NCCSDO 2008 Page 203 
been welcomed because they have raised the profile of endoscopy services 
with Trusts and made their work more visible. Interviewees focused on 
quality aspects of endoscopy, however, it was difficult to say if the focus 
resulted from awareness of the needs of patients or from politically and 
managerially driven targets that had to be met and, as a consequence, that 
led to patient benefits almost by default. 
8.1.2   Theme 2 – The human dimension of endoscopy units 
First round interviews 
 
The majority of interviewees responded positively to the plans for 
modernising endoscopy units but recognised that they faced particular 
challenges regarded the sharing of services and equipment across different 
specialties. Change to the autonomy of doctors was described as one of the 
major hurdles to overcome in influencing their views on the NHSMA. 
Interviewees noted the importance of leadership in the unit and a lack of 
clear leadership roles affected all unit staff. They also discussed the 
complexities of: working relationships, morale, teamwork, communication, 
resistance to change, training, staffing levels and skill mix, all of which were 
perceived as both facilitators and barriers to modernisation. Where barriers 
existed, such as low morale and lack of training for staff, efforts were being 
made to overcome them. 
Second round interviews 
 
In the first round of interviews working relationships and staff morale were 
clearly problematic and an important issue, discussed at great length. This 
was clearly different in round two, where participants moved on to other 
topics but spoke about the benefits of staff working in new ways. There were 
ongoing tensions raised between physicians and surgeons across a range of 
issues: scoping each other’s patients, personal autonomy, the significance of 
endoscopy, attendance at meetings and pressures of new referral systems, 
however, it was acknowledged that working relationships were improving. 
More appropriate skill-mix had been achieved as a result of more staff 
training and greater flexibility in staff roles. However, the issue of low 
staffing levels and the need for increased training and skilling was 
mentioned alongside the need for an appropriate number of staff to fulfil the 
demands of units. The process of modernisation has brought resolution to 
some of the issues raised in the first round. People are less averse to the 
notion of change and have adopted a mindset of modernisation as a result 
of their involvement in the MES programme, its impact on all sites, both 
Intervention and Control, and are, therefore, less resistant to change. 
8.1.3   Theme 3 – Financial resources 
First round interviews 
 
Some modernisation was considered to be cost-neutral whereas other 
changes to services were not pursued as a result of insufficient funding. 
Units are creative and inventive in their search for funding but Trusts (many 
in financial deficit) are criticised for crisis management and short term 
funding. As a consequence, there is an ‘ad hoc’ approach to modernisation 
among endoscopy staff and Trusts. However, many endoscopy units have 
been successful in obtaining funding, albeit short term, and found that data 
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collected in endoscopy units supported business cases, which made a 
significant difference to obtaining funding. 
Second round interviews 
 
As in the first round, financial resources are seen as an ongoing concern and 
the situation is said to have deteriorated in the previous two years. There is 
recognition that a certain amount can be achieved through motivated staff 
and innovative ideas but frustration arises over the limitations to further 
development because of financial constraints and there are concerns about 
the way endoscopy will be funded in the future. There is a recognition that 
some money has been spent on, for example, equipment and more 
appropriately skilled staff, however continuing lack of appropriate staffing 
levels impacts on appropriate use of these new resources. GRS and NBCSP 
are said to provide useful leverage in gaining additional resources. 
 
The extensive data sets, accessibility to views and range of views from 
senior consultants and key people across units in both rounds of interviews 
suggests that the study achieved a valid cohort, providing reliable data, 
representative of the views of people working in the endoscopy units.  
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8.1.4   Major issues arising from the interviews 
 
Table 59.   Major issues arising from first and second round interviews 
ROUND ONE ROUND TWO 
Theme 1 – Drivers for Change 
 
NHSMA/NHSMA Funding 
 The NHSMA was a catalyst for change but the changes 
introduced could not have been predicted at the outset; 
 MES programme funding was a short term solution, but by its 
very nature, lacked continuity; 
 MES programme staff lacked practical endoscopy experience 
and therefore credibility; 
 
Training 
 The MES programme training was offered too early by ill 
prepared teachers; 
 
ToolkitTM 
 The MES programme ToolkitTM was strongly disliked but had led 
to changes as a result of the opportunities it initiated in 
developing understanding of unit need; 
 No Intervention sites continued using ToolkitTM after year of 
obligatory data collection; 
 Data collection was acknowledged as necessary to understand 
services and was an important aspect in support of business 
cases and other unit initiatives; 
 In-house data collection was ongoing in many Intervention and 
Control sites. 
Theme 1 – Drivers for Change 
 
Progression from NHSMA/MES programme to GRS and Bowel 
Cancer Screening 
 The Endoscopy GRS (GRS) has superseded the NHSMA/MES 
programme; 
 Prior experience of modernisation (both Intervention and 
Control sites) enabled units to undertake the GRS more easily; 
 In spite of the additional workload of GRS and the fact that it 
was not compulsory, all sites were participating; 
 With its link to Bowel Cancer Screening Centres (something 
units and Trusts both aspire to), the GRS is seen as more 
successful then the MES programme in raising the profile of 
endoscopy; 
 GRS is considered a good tool, providing evidence of 
improvements and of quality of performance and the website 
was considered useful for sharing good practice; 
 Difficulty in assessing if patients are at the centre of the 
‘quality agenda’ or if they benefit anyway as units strive to 
achieve high GRS scores. 
 
The impact of Government initiatives 
 Eighteen week referral to treatment target has put the spotlight 
on diagnostics e.g. endoscopy 
 Two week wait target has impacted negatively on other 
patients who are waiting longer; 
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ROUND ONE ROUND TWO 
Theme 2 – Human Dimension of Endoscopy Units 
Staff 
Working relationships & staff morale 
  Tensions between different specialties sharing endoscopy units, 
led to poor working relationships; 
  Isolated cases of poor working relationships within endoscopy 
units; 
 Poor morale due to lack of communication, lack of ownership of 
changes, lack of involvement in running of units and staff under 
pressure feeling undervalued; 
 
Resistance to change 
  Consultants, in particular surgeons, were considered the group 
most likely to resist change in working practices; 
 
 
 
Overcoming poor working relationships, poor morale and 
resistance 
  Good communication with all staff and growing sense of 
staff ownership was achieved through redesign days, time out 
sessions and meetings, helping overcome poor working 
relationships, poor morale and resistance; 
  Ongoing resistance to change was further challenged 
through persuasion, patience and training; 
  Leadership of change was significant in overcoming problems; 
  Greater clarity is evident over control and leadership of units; 
  Key people responsible for leading change benefited from clinical 
lead support; 
 
 
 
Theme 2 – Human Dimension of Endoscopy Units 
Staff 
Working relationships & staff morale 
 Tensions between different specialties, whilst still in evidence, 
have decreased with improvements in working relationships 
between physicians and surgeons  
 Staff respond positively to changes in service provision, are 
supportive and co-operative and welcome the challenge of new 
ways of working; 
 
 
Resistance to change 
 less resistance from surgeons; 
 Isolated reports of physicians becoming resistant to pooled 
lists resulting from concerns over quality of scoping and the 
impact of ‘2 week wait targets’ for their patients; 
 
Overcoming poor working relationships, poor morale and 
resistance 
 Improvements in units that previously reported poor working 
relationships and morale 
 Strong leadership, staff involvement, teamwork and good 
communication are important when introducing change; 
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Training 
  Training helped update staff and ensured appropriate skill mix 
to improve efficiency and flexibility of units (Nurse Endoscopists 
(NE) and nurse specialists); 
 
 
Skill mix/staffing levels 
 Training aids appropriate skill mix; 
  Insufficient staffing, particularly shortages of endoscopy 
nurses and clerical staff, hindered change. 
  Good clerical support for endoscopy units was vitally important; 
 
 
Patients 
 The aim of modernisation was to improve access to, and 
experience of endoscopy services for patients; 
 
Training 
 High quality training is a recognised goal for units but lack of 
staff and time and sparse financial resources impede this; 
 Increase in training of  non-medically qualified staff; 
 Staff helping other units to modernise; 
 
Skill mix/staffing levels 
 Achieving an appropriate skill mix is a recognised goal but 
lack of staff and time and sparse financial resources impede 
this; 
 Staffing levels are acceptable but increased levels would 
enable further improvements; 
 
Patients 
 Greater commitment to patient satisfaction and involvement; 
 Access to, and acceptability of, endoscopy services have 
improved with shorter waiting times, greater throughput, more 
patient information, more responsiveness to patient views and 
better communication between reception staff and patients. 
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ROUND ONE ROUND TWO 
Theme 3 - Financial Resources 
An issue of concern 
 
 Insufficient financial resources for sustained change; 
 
 
 
 
 
 
 Trusts were criticised for adhering to crisis management tactics 
and short term funding instead of investing in future; 
 The units’ search for funding highlighted the ‘ad-hoc’ nature 
with which modernisation was taking place with no clear 
development plan. 
 
 
 Some processes were recognised as cost neutral whilst others 
required substantial funding; 
 
Theme 3 - Financial Resources 
An issue of concern 
 
 Frustration of striving to improve within financial constraints; 
 Lack of resources impacts on staffing, equipment, information 
technology and facilities; 
 Financial situation has deteriorated in last two years, relating 
to the financial crisis of Trusts; 
 
 
 Forward planning has been difficult because of concerns over 
payment by results and the impact of endoscopy being performed 
in primary care or the independent sector. 
 
 
 
 
 Some success in getting funding, with the GRS and NBCSP useful 
leverage tools in achieving additional resources; 
 
 
 
Type in bold italics indicates links within the theme between the issues in the two rounds. 
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8.2   Aims 
The main aim of the interviews was to clarify how professionals perceived 
the accessibility and acceptability of innovations in service delivery and 
organisation in endoscopy units that were being evaluated in this study. 
8.3   Objectives 
a) To describe differences between Intervention and Control sites 
b) To clarify how the endoscopy units functioned prior to modernisation 
c) To describe new models of service delivery and organisation and their 
impact 
d) To describe professionals’ experience of introducing the new models 
8.4   Method 
Between May 2004 and October 2004, 39 semi-structured interviews were 
conducted with ‘clinicians’ and ‘key people’ in endoscopy units taking part in 
the ENIGMA study. The ENIGMA study team were aware that the units were 
at different stages of modernisation and the interviews were held early in 
the study to clarify how each unit functioned and what innovations had been 
made or were planned and from this to develop an understanding of the 
impact of the MES programme. The interviews concentrated on events over 
the previous two years, i.e. since 2002, to cover the period of the MES 
programme. The interviews also aimed to capture the views of clinicians and 
key people on innovation in service organisation and provision. A second 
round of interviews was conducted two years later, between July and 
November 2006, with the same clinicians and key people (where possible) 
to clarify what had taken place in the intervening two years and capture 
changes in the perceptions of participants. 
8.4.1   Interview schedule first round interviews 
 
The interview schedule was semi-structured in design (Bryman 2004) 
comprising key questions that were asked of the clinicians and key people at 
both Intervention and Control sites (see Appendices 14-15 for detail). 
 
The key questions were developed in line with the study aims, and were 
fine-tuned following preliminary visits to endoscopy units, meetings among 
team members and the PSG. In addition, the interview schedule was 
clarified through a pilot study (see below) and areas covered included the: 
 
 endoscopy unit prior to modernisation; 
 innovation/change introduced or planned; 
 problems implementing innovation/change; 
 source of funding for innovation/change; 
 staff response to innovation/change. 
8.4.2   Pilot study 
 
A pilot study (Janesick 1998) was conducted in April 2004. One consultant 
and one Key Person at two hospitals not taking part in the study were 
interviewed as well as a Key Person from a Control site who was unavailable 
for the main study. The transcripts from these three interviews were 
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circulated among PSG members. Following feedback and discussion it was 
agreed that the interview schedule was providing data in keeping with the 
project aims and objectives. However, certain aspects of the schedule were 
refined and two questions were added – one an opening question to 
establish the role of the interviewee and another, which examined the 
impact of the Modernisation Agency and the ToolkitTM on Units. 
Consequently, the final interview schedule for the first round of interviews 
(found in Appendix 14) covered the following areas: 
 
 the role of the interviewee in modernisation; 
 the endoscopy unit prior to modernisation; 
 innovation introduced or planned; 
 problems implementing innovation; 
 the funding required for innovation; 
 staff response to innovation; 
 the impact of the Modernisation Agency and the ToolkitTM. 
8.4.3   Interview schedule second round interviews 
 
The interview schedule for the second round of interviews (found in 
Appendix 15) generally followed the same schedule as for round one. 
However, participants were not asked again about the endoscopy unit prior 
to modernisation and they were not asked a direct question about the 
NHSMA/MES programme. In round two, they were asked what changes had 
taken place in the intervening two years. Their views were sought on the 
accessibility and acceptability to patients of the endoscopy service as a 
result of any changes that had been made. 
8.4.4   Sampling strategy 
 
Purposive sampling which allows the selection of information-rich cases to 
enable the in-depth study of the topic of interest (Patton 2002; Robson 
2002), was used to select the clinicians and key people to be interviewed at 
the ten Intervention and ten Control sites. The sampling strategy used to 
select the ten Intervention and ten Control sites, together with issues of 
ethics and consent, are detailed in chapter 2. The clinicians at the 
Intervention and Control sites were those who had been involved in the 
application for the MES programme, so were easily identifiable. ‘Key people’ 
were less easily identifiable. In Intervention sites they were those people 
who had been in contact with the NHSMA, but since then some had changed 
posts and where unavailable, the advice of the clinician was sought for the 
most appropriate person. In certain Control sites no single person was 
clearly identified and, again, the clinician’s advice was sought for the most 
appropriate person to interview. It was decided by PSG members that, if 
necessary, a third person could be interviewed in order to collect as much 
rich, in-depth data as possible. The second round of interviews were to be 
conducted by the same researcher as first round interviews with the same 
clinicians and key people. 
8.5   Data collection and analysis 
 
The first round interviews were conducted by two researchers between May 
and October 2004 - eight in May, 13 in June, 13 in July, four in August and 
one in October. Interviews were recorded and transcribed by the Project 
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Secretary soon after completion and transcripts were reviewed by two 
researchers and the qualitative lead. 
 
Four interviews were selected at random (two clinicians and two key people, 
one each from Intervention and Control site) to be read independently by 
four people (a Professor, a qualitative specialist and the two researchers) 
and, using thematic content analysis (Patton 2002), these data were 
considered in terms of ‘first level’ emergent themes (May 1998). Group 
discussion led to broad agreement that emergent categories concerned: 
people, the organisation within which innovation was taking place, the 
political climate, funding, NHSMA, ToolkitTM and outputs (sustainability, 
continuity, vision). Themes were considered during the process of data 
collection and analysis in terms of their ability to throw light on the issues 
hindering or supporting innovation. Two researchers revisited the four 
interviews and an additional six interviews were analysed and themes were 
refined to include: people, NHSMA/MES programme and financial resources. 
The two researchers coded a total of ten interviews each and following 
consensus, one coded the remaining interviews. The qualitative lead 
confirmed data saturation when no new themes or categories were emerging 
and group agreement over interview data suggested validity and reliability 
had been achieved in the analysis process. In addition, data regarding 
endoscopy unit function prior to modernisation and innovation taking place 
were used to triangulate health economics data (see chapter 6). 
 
The second round interviews were conducted by one researcher between 
July and October 2006 (four in July, twenty-six in August, two in 
September, four in October, two in November). Interviews were recorded 
and transcribed by the Project Secretary soon after completion and 
transcripts were reviewed by the researcher and the qualitative lead. 
Analysis was conducted using thematic content analysis, as outlined above. 
 
The findings section (below) includes verbatim quotations, anonymised and 
presented in terms of an identifier number and line number. Thus, it is 
possible to identify quotes from ‘clinicians’ as .1, for example, 17.1/20, and 
quotes from ‘key people’ as .2, for example, 17.2/30. 
8.6   Findings: First round of interviews 
 
Three major themes emerged from the data: ‘Drivers for Change’, ‘The 
Human Dimension of Endoscopy Units’ and ‘Financial Resources’:   
 
 Drivers for Change 
-  NHSMA Funding 
-  Training 
-  ToolkitTM 
 The Human Dimension of Endoscopy Units 
–  Staff 
 Working relationships and staff morale 
 Resistance to change 
 Overcoming poor working relationships, poor morale and 
resistance 
 Training 
 Skill mix/staffing levels 
    –  Patients 
 Financial Resources 
   - An issue of concern 
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A detailed examination of themes and categories from the first round of 
interviews follows a description of differences between Intervention and 
Control sites and their responses to modernisation which enables an 
understanding of the impact of the MES programme. A detailed examination 
of themes and categories from the second round of interviews starts on 
page 238. 
8.6.1   Differences between Intervention and Control sites 
and their responses to modernisation 
 
As mentioned above, the study team were aware that, at the time of the 
first interviews, the units were at different stages of modernisation and this 
became obvious in the interviews. 
 
Six Intervention sites indicated that modernisation had commenced in their 
units before the MES programme, while modernisation in the remaining four 
seemed more in line with the timing of the MES programme (see Table 59). 
Of these ten sites it was perceived that all had made good progress in 
modernising their units but that two had some outstanding issues such as 
one unit experiencing ongoing problems with working relationships between 
consultants and their lack of involvement in the endoscopy unit, while the 
other had reached a point where further modernisation was restricted 
because of a lack of space. 
 
The Control sites were at more varied points within the modernisation 
process; two sites indicated that modernisation had commenced before the 
MES programme, three sites had made a lot of changes over the previous 
two years and one had made some changes (see Table 60). This latter site 
was limited by space but was due to move to a new unit. The remaining four 
Control sites were still considered to be at the start of the modernisation 
process but three of these were moving to new units and of these, two 
described detailed plans for new ways of working. Of the ten Control sites, 
five were perceived as having made good progress and one Control site that 
was very limited by resources (financial and structural), with no new unit 
planned, was perceived by interviewees to be a long way behind in the 
modernisation process. 
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Table 60.   Stage in the modernisation process at time of first interview 
 
 Stage in modernisation process at time of 
interview 
Overall progress at time of 
interview 
 Sites started 
modern-
isation before 
MES 
programme 
Sites 
modern-
ised in 
previous 
2 years 
Sites 
with 
some 
modern
-isation 
Sites at 
start of 
modern-
isation 
Good 
progress 
Issues to 
be 
resolved 
Modern
-isation 
yet to 
start 
I
n
te
r
v
e
n
ti
o
n
 4 
7 
8 
11 
13 
18 
1 
6 
16 
19 
  1 
4 
6 
7 
8 
13 
16 
19 
11 
18 
 
C
o
n
tr
o
l 3 
9 
12 
17 
20 
5 
 
2 
10 
14 
15 
3 
9 
12 
17 
20 
5 2 
10 
14 
15 
 Number = site identification number 
 
 
The fact that all of the Intervention sites had made a lot of changes in 
comparison to half of the Control sites, could be interpreted as being a 
direct result of the MES programme. However, there should be caution with 
this interpretation as many of the Intervention sites had already started 
modernising prior to the MES programme, while just two Control sites were 
in this position. This raises issues about the selection of sites by the NHSMA 
and the impact of this on the ENIGMA sampling strategy. It is possible that 
the NHSMA were biased in their selection, preferring sites that had already 
shown the ability to modernise. The criteria to take part in the MES 
programme included the ability to complete three months’ data collection 
and to submit an appropriate action plan. However, the sites that had 
already started modernisation may have been more likely to fulfil these 
criteria and more likely, as a result, to be accepted by the NHSMA 
programme, rather than the NHSMA itself being biased in their selection. 
The NHSMA stated that they ‘went for those teams that we felt would 
benefit from the funding and improve their service’. It is difficult to judge 
from this whether they selected sites that, while able to meet the criteria, 
had poor services and therefore could improve, or sites that met the criteria 
and had a reasonable service, but could benefit further; this detail was not 
known by the ENIGMA study team. ENIGMA sampled the ten Intervention 
sites from the twenty-six selected by the NHSMA to take part in the MES 
programme and was therefore subject to the effects of the NHSMA selection 
and it is possible that strong sites were over-represented. As a result of 
these issues, it is difficult to be absolutely clear whether the fact that 
Intervention sites have made a lot of changes in comparison to the Control 
sites, is directly due to the MES programme or whether the Intervention 
sites were always going to be stronger. 
 
The research team perception is that the majority of Control sites were 
pursuing modernisation but were lagging behind the Intervention sites for 
the following possible reasons: 
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 Control sites had no obligation to adhere to the tight deadlines 
of the MES programme; 
 Control sites did not necessarily have the benefit of a specific 
person appointed to oversee the modernisation process; 
 the lack of financial support, albeit a relatively small amount, 
from the NHSMA, meant Control sites were less likely to employ 
additional staff to help with data collection. (Data collection will 
be shown below to be important in understanding the way a 
unit works and identifying problems); 
 Control site data collection was less efficient in the early stages 
of   modernisation so identification of the way a unit works and 
its problems  may have taken longer; 
 financial resources acquired by Control sites were earmarked 
for specific use, in comparison to the MES programme funding 
which could be used  flexibly; 
 the absence of backing from an NHSMA project could result in a 
lower profile of modernisation efforts at more senior levels 
within the unit and the Trust resulting in less support in terms 
of resources and encouragement from senior staff; 
 Control sites moving to new units had modernisation plans in 
place to implement after the move; 
 most Control sites started modernising at a later date, so to 
some extent were always ‘catching up’. 
 
All the sites in this study had applied to take part in the MES programme 
indicating that from the outset they had an interest in modernising their 
units and it was found that the majority of all sites were actively 
modernising their units and that while Intervention sites achieved this more 
quickly, Control sites had also, or were shortly to, modernise. The MES 
programme appears to have been a catalyst for change but for those taking 
part, it resulted in timelier implementation of modernisation. 
 
Apart from the differences in the stages of modernisation in the units, there 
were no other detectable differences between Intervention and Control sites 
as the same issues arose when participants spoke about the modernisation 
of their units. 
8.7   Findings in detail – First round of interviews 
8.7.1   Theme 1 – Drivers for change 
Introduction 
 
A major theme to emerge from the data concerned Drivers for Change. The 
issues that emerged in relation to this theme are examined below. 
 
Ten of the endoscopy units were part of the MES programme (Intervention 
sites) and had to use a “ToolkitTM” for data collection and analysis so the 
majority of comments were from clinicians and key people in those sites. 
The ToolkitTM was a computer-based management tool to record demand, 
capacity, Activity and waiting list data, produce tables and graphical reports 
from this information and help analyse capacity and demand information. 
The tool collated and manipulated information at the request of the user. 
The remaining ten sites (Control sites) had access to the ToolkitTM and 
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training and also expressed views about it. The issues that emerged about 
the MES programme centred on funding, training, the ToolkitTM and the 
project in general. 
NHSMA 
 
There were mixed views about the NHSMA in general, with some people 
questioning if the motivation behind the NHSMA was political. However, the 
majority of interviewees felt that the concept was sound and as there was 
an acknowledgement that changes were necessary within the NHS, 
suggested the NHSMA had acted as a catalyst for change providing 
necessary tools, techniques and organisational skills: 
 
I think it was a good concept and I think it has certainly enabled the 
NHS to look at change in a different light and through involvement in 
projects. (16.2/290) (16=site ID, .2=Key Person, 290=line number) 
 
If it hadn’t been for the MA and the spread of some of the tools and  
techniques such as capacity and demand study and process mapping, 
it’s because of those things that we’ve been able to better 
understand our service … I think it has been a very positive influence 
on the way in which the NHS works. (12.2/425) 
 
There were, however, criticisms levelled at the scale of change – that it was 
just not large enough to make a significant difference – and there were 
criticisms about the credibility of the NHSMA and it was felt that staff lacked 
practical experience of endoscopy units: 
 
To staff on the whole, talking across the board here, it’s the suit 
category, if you know what I mean, people talking about change 
who’ve not actually done the job. The fact that they live in, seen as 
living in their ivory towers, without actually listening the other way 
round. (13.2/207) 
NHSMA Funding 
 
The funding provided by the NHSMA appears to have played an important 
role in the modernisation in four Intervention sites who highlighted that the 
MES programme and funding had identified the areas for modernisation, 
without which, they would not have proceeded. However, six units would 
have pursued modernisation irrespective of the MES programme but would 
have had to source funding from elsewhere for changes that carried cost 
implications: 
 
“…lot of them were natural progression anyway. … most of the things 
were in our plans anyway to do. We’ve always been quite forward 
thinking really”. (4.2/181) 
 
No, because we wouldn’t have had the information to be able to help 
us pinpoint the problems and help us make decisions about where 
the problem was or identify the problem. (16.2/244) 
 
The sites that were unsuccessful in their bid to be part of the MES 
programme were disappointed not to receive funding from the NHSMA 
having demonstrated a willingness to change. However, this was combined 
with a determination to push ahead with modernisation: 
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Oh well, we’ll just get on and do it anyway (9.2/593) 
 
There is no point in crying about it. Part of me belligerently would 
take the attitude of s** you, we’ll do it without you. (10.1/518) 
 
The NHSMA funding enabled Intervention sites to employ staff, including a 
project manager, Information Technology and clerical staff, to help with the 
additional workload, particularly the ToolkitTM data collection and 
maintenance. In addition, funding had been used to employ receptionists, 
nursing auxiliaries and staff to wash scopes. In most instances, Trusts 
agreed to fund these posts for a further year once the NHSMA funding 
ceased. However, there was frustration over the lack of continuity when the 
project manager post was discontinued, as there was no one to follow up on 
what had been started. In some units the funding was used to run additional 
lists to decrease waiting lists, to validate waiting lists and reduce Did Not 
Attend (DNA) and cancellation rates. Some equipment was purchased and 
the funding was also used for minor refurbishments, often to reception or 
office space, areas that do not attract funding easily. The funding had also 
been used to cover travel and subsistence for attending NHSMA events. 
 
Some of the changes that had been introduced were considered to be cost-
neutral as they had been achieved through the modernisation of processes 
within existing resources, for example, pooling of lists, validation of waiting 
lists: 
 
“… a lot of it didn’t need to be funded it was just a different way of 
working. … it is changing the way that you work really in some 
respects rather than more staff.” (6.2/824) 
 
However, there were three clinicians who felt that ‘change’ always carried 
cost implications. 
Training 
 
As part of the MES programme, the NHSMA ran training events focussing on 
the ToolkitTM and on practical methods to improve services. This training 
was open to staff from Intervention and Control sites and while some key 
people from the latter attended, it was, in the main, key people from 
Intervention sites. 
 
The training in the practical methods to improve services was considered 
satisfactory but highlighted the fact that sites were at different points in 
their modernisation. Some units found they were quite advanced in what 
they were doing and felt they had little to learn from the training sessions, 
the discovery of which gave them confidence: 
 
“… we were quite far advanced from a lot of other areas so we were 
going along and listening to sort of projects that were going on in 
other Trusts that we were already carrying out here. So it wasn’t 
really applicable to us” (8.2/565) 
 
However, the training in practical methods to improve services was 
satisfactory and, together with regional ‘buddy groups’, was seen as a 
networking opportunity to exchange ideas, leaflets and information. 
 
“…nice to see what other Trusts had done both with and without 
funding and where they are going. You can sort of benchmark a bit, 
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how you’ve gone and things like that and get lots of ideas from other 
Trusts as well. It’s nice to share information” (9.2/437) 
 
There was overwhelming criticism of the ToolkitTM training, with many 
interviewees feeling it was introduced too early and that the trainers were 
ill-prepared: 
 
The people delivering the training obviously hadn’t any chance to 
work the systems themselves because they were sort of showing us, 
there was no written guidance. (8.2/558) 
 
It was implemented very badly, it was implemented before it was 
ready, before it was technically ready, there was no training 
provided. I went to a training day and I walked out it was so bad. It 
was like a scene from The Office. (19.2/707) 
ToolkitTM 
 
All the Intervention sites had to use the MES programme ToolkitTM for data 
collection and analysis and while only two Control sites used it, several had 
considered it and expressed views about it. The data collection itself caused 
problems initially because of the additional work involved in manual data 
collection -  “the amount of work that went into it was horrendous 
(8.2/499)” - but sites had found ways of overcoming these difficulties. Some 
had designed forms to make the data collection easier and some had 
employed or freed up staff to help with data collection. 
 
Interviewees’ comments regarding the ToolkitTM were overwhelmingly 
negative, and this was reflected by the fact that at the end of the year of 
obligatory data collection for the NHSMA, none of the Intervention sites 
continued to use the ToolkitTM. Indeed, the ToolkitTM presented users with 
problems from the time it was transferred to a web-based system from the 
Excel computer software used in the pilot phase of the MES programme. 
 
The ToolkitTM was fine when it was Excel-based but the web-based 
was a nightmare and I don’t think it was actually reasonable to 
introduce something new part way through a project when it hasn’t 
been properly trialled, endless problems. (11.1/664) 
 
The ToolkitTM was not considered ‘user friendly’, used unhelpful technical 
language and management jargon and technical problems were 
experienced, resulting in several units requesting assistance from the 
NHSMA or Trust Information Technology (IT) staff to help them understand 
how to use it: 
 
“… major problems with the ToolkitTM. Major technical problems which 
I know have been a national problem. It was horrendous. But we got 
past that because we had this performance analyst who was brilliant 
and she worked with the IT people who run the ToolkitTM to get round 
some of the problems.”  (19.2/616) 
 
There were also concerns that the ToolkitTM did not accurately reflect the 
true level of work and the data did not meet the organisational needs of 
units, as it could not be manipulated locally: 
 
I felt it was negatively weighted such that you could never perform 
anywhere near your capacity which is misleading. (18.1/113) 
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Once the data was put in you could only get back a presentation in a 
manner that the ToolkitTM wished to give you it. You can’t get back to 
your raw data and re-manipulate it. So all of that work, once it’s 
gone centrally is essentially lost. (4.1/363) 
 
There were also issues about the reliability of the data: “You can look at one 
sheet and you put in two and the graph will be showing six” (16.2/336) and 
the fact that, on occasion, data were lost while being downloaded to the 
NHSMA: 
 
They would spend two days downloading all the information and then 
it would all get lost. It was heart rending, sometimes the staff were in 
tears so it wasn’t all easy going. (4.2/325) 
 
The pressures of the amount of work and time involved with data collection 
and maintenance of the ToolkitTM were compounded by the NHSMA 
deadlines: 
 
There was always pressure on, they were always ringing them up 
saying ‘we must have your report by this date’. (4.2/322) 
 
However, the deadlines proved useful for some, keeping them on schedule 
and acting as a reminder of what needed to be done: 
 
“…I would think I haven’t done anything about that, right OK, and we 
would do something about it. So it was quite a good prompt. It kind 
of put it back on the agenda. That was useful.”  (6.2/954) 
 
In contrast, being free from the strictures of the MES programme was 
appreciated within some of the Control sites: 
 
“… to be honest it has been better because we haven’t had to use the 
ToolkitTM and we haven’t had to report like the other sites have. In 
some way that is probably, from my perspective, I feel we have 
benefited lots not being a pilot site in some ways.”  (17.2/395) 
 
The collection of data was a central tenet of the MES programme and it is 
clear that this was seen as a way forward by Control sites as, while only two 
used the ToolkitTM, the majority developed their own system of data 
collection, selecting the most relevant data to collect. Several of the 
Intervention sites also developed their own data collection systems 
alongside the ToolkitTM: 
 
We had our own ToolkitTM, or our own capacity and demand data 
which was in line with our true capacity. (18.1/450) 
 
In spite of the difficulties associated with the data collection there was a 
very positive response by those implementing modernisation to the data 
that resulted from the ToolkitTM and the in-house data collected. Firstly, the 
data had allowed units to assess their service, see exactly how it was 
working, understand it better and introduce changes where necessary and 
had demonstrated differences resulting from the changes that had been 
made: 
 
“… had the information to be able to help us pinpoint the problems 
and help us make decisions about where the problem was or identify 
the problems.”  (16.2/244) 
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Secondly, the data proved helpful in making business cases as it was hard 
evidence to back up cases for both Intervention and Control sites and in the 
case of Intervention sites, it also carried the weight of the NHSMA: 
 
It is fair to say that without really good data it would have been 
much more difficult to make that case, so it has been a tool to back 
up the case for more staff, nursing time, Nurse Endoscopists and 
most important in the last year, a new consultant. (4.1/207) 
 
Having found the data useful, Intervention sites were likely to continue 
some form of data collection, but using an in-house system: 
 
We have abandoned the endoscopy ToolkitTM…  We developed our 
own Excel spreadsheet so we could look at patient journey time 
which the endoscopy ToolkitTM was never designed to collect and that 
is what we are maintaining. (16.2/318) 
 
Interestingly, one Control site planned to continue using the ToolkitTM as “it 
is part of the way of life really” (2.2/415) and another Control site, that had 
developed an in-house detailed data collection method, was continuing with 
high level data collection. Other Control sites planned to continue data 
collection as and when they felt it was required: 
 
 Reactive data collection rather than continuous. (20.1/556) 
 
While acknowledging the issues with training and the ToolkitTM, the general 
perception was that involvement with the MES programme had benefited 
units and raised their profile within their Trusts, in part, due to the fact that 
evidence could be provided to support business cases which in turn led 
Trusts to understand that if they required data from the units, it was readily 
available. Within the units it led to a better understanding of exactly how 
the unit worked and consequently had introduced more efficient ways of 
working. However, involvement in the project had a personal impact with 
people describing increased stress and pressure: 
 
Personally, it added a good 5 hours to my work, my dining room 
became my office, my other half knows more about the project than 
me. (13.2/137) 
 
Summary – Drivers for change 
 
While interviewees involved in the first round of qualitative interviews 
revealed mixed views about the success of the NHSMA’s MES programme 
there was the overall sense that the units had benefited from involvement in 
the MES programme. Not only had the Project raised their profile within 
Trusts, it had acted as a catalyst for change to service provision and 
delivery. Where the MES programme was less well received, however, 
criticisms were directed at the scale of change, which was considered 
insufficient for any significant difference to be experienced in terms of 
service provision, and the lack of credibility afforded to MES programme 
staff, who did not have necessary practical experience of endoscopy. 
 
The funding provided by the NHSMA was used to employ staff, to introduce 
new waiting list initiatives, to buy in new equipment and enable minor 
refurbishments to take place. This funding was also used for staff travel and 
subsistence to attend NHSMA events. Some of the staff employed collected 
data for the Project and while a number of these posts were funded by 
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Trusts for an additional year, the concern was raised that these roles would 
not be continued when funding ceased. 
  
There were mixed views about the training provided by the NHSMA, in part 
due to the fact that different sites had different needs. The training in 
practical methods to improve services was satisfactory. However, there was 
overwhelming criticism of the ToolkitTM training, with interviewees keen to 
stress that ill-prepared trainers offered training far too early. Indeed, the 
reaction to the use of the ToolkitTM was particularly negative, reflected in the 
fact that none of the Intervention sites had continued with its use after the 
first year of obligatory data collection. The ToolkitTM was described as time 
consuming, not at all ‘user friendly’, full of technical problems and leading to 
too tight deadlines. In addition, it employed obtuse technical language and 
management jargon and did not meet organisational needs because it could 
not be manipulated locally. Finally, there were doubts about the reliability of 
the data it produced. This resulted in several Intervention sites developing 
their own systems of data collection alongside the ToolkitTM. Interestingly, 
as a result of having used the ToolkitTM, units had moved forward in their 
assessment and understanding of the service. The process had enabled units 
to support business cases, which had the knock-on effect of introducing 
appropriate change. This was emphasised by the majority of Control sites 
developing their own data collection systems and many Intervention and 
Control sites continuing with some form of data collection, be it of their own 
design. 
8.7.2   Theme 2 – The human dimension of endoscopy units 
Introduction 
 
All staff involved in the endoscopy units – the consultants, nurses, 
administrators, managers and clerical staff, recognised the need to provide 
patients with high-quality care and support, with the expectation that 
modernisation would improve access to, and experience of, endoscopy 
services. 
 
The interviews highlighted, however, that the units were at very different 
stages in the process of modernisation, some very much still at the planning 
stage, while others were advanced in their thinking and implementation of 
change. Nevertheless, all interviewees recognised there was still some way 
to go before implementation was fulfilled and still more to be done. This 
resulted in some interviewees speaking in anticipation of what would 
happen, while others spoke from experience. In spite of this difference in 
perspective, interviewees covered similar topic areas - working relationships 
and staff morale, resistance to change, training, skill mix and staffing levels, 
recognising in each case the potential for these aspects of staffing to hinder 
or support change. 
Working relationships and staff morale 
 
Historically, some units have been managed under more than one 
directorate, for example, surgery and medicine or medicine and radiology, 
and this has led to a lack of clarity as to exactly who has responsibility for 
control and leadership of units: 
 
The ENIGMA study 
©NCCSDO 2008 Page 221 
There was no ownership either, there was no leadership within the 
department from the clinicians … no pulling it all together.”  
(6.2/103) 
 
There is no data stored in this trust for the way endoscopy has been 
practiced – I think it is just because it has never had a leader. 
(10.1/148) 
 
While, it was clear that all hospital departments face challenges when 
modernising their service delivery and organisation, endoscopy units faced 
additional challenges resulting from the facilities being used by a variety of 
specialties, often with different working practices and perspectives on 
change. Those responsible for implementing change have had to work with 
staff from a range of specialties and in a quarter of units, poor working 
relationships with these staff were highlighted: 
 
It’s not an endoscopy service, it is medical and surgical and so there 
is a big divide. (11.1/66) 
 
The big problem really was that I had to speak to 7 consultants. You 
can’t just go through the 2 lead people because as you know with 
personalities, not everybody gets on with everybody… (6.2/122) 
 
There were also a limited number of examples of poor working relationships 
within disciplines in units, for example: 
 
The nurses get assigned to a section, you know recovery or 
whichever room. If say a nurse was assigned to room 2 but they 
were stood by the telephone in recovery, they won’t pick up the 
phone because they are not assigned to that area (15.2/421) 
 
There were also examples of tensions between nursing and clerical staff:  
 
The nursing team feel that they don’t cross react with the clerical 
team and vice versa … nurse could be sitting there doing nothing and 
the clerical staff have got jobs that they could do even if it is only 
sticking labels on a pack … needs one person directly controlling both 
things and saying if one hasn’t got work-that isn’t happening. 
(11.1/332) 
 
Poor working relationships and a lack of leadership could contribute to the 
development of poor morale among unit staff and in less than a quarter of 
units, poor morale was highlighted as being an issue of particular note at 
the beginning of the modernisation process, when trying to introduce 
change in endoscopy units. This stemmed from management problems 
within units, a lack of communication, ownership and involvement in how 
units were run, staff feeling under pressure and undervalued and a failure to 
recognise and reward staff at all levels. In some units it also stemmed from 
a lack of training and a sense that endoscopy had a low priority within 
Trusts: 
 
We had a rather dysfunctional unit with poor performance in lots of 
ways and very unhappy staff … unhappiness with the management of 
the whole unit from the sister, lead clinician through to the manager. 
(16.1/12) 
 
The resource of the business that partial booking hit us … completely 
under resourced … hence a very high level now of time off, people 
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feeling that they are under serious pressure in their day to day work 
and vast numbers of telephone calls. (4.1/269) 
 
Poor morale was sometimes reflected by high absenteeism: 
 
It is too easy to take a day off for a headache or a cold which a lot of 
people won’t even, even though it impacts on their colleagues who 
are here. I think absenteeism like that is a sign of poor morale. 
(11.1/419) 
 
At other times poor morale was reflected by a high turnover of staff: 
 
For some reason a lot of units have high turnover and I guess a lot of 
that comes down to in a lot of places, overruns from lists, not getting 
away on time, family commitments, people work in endoscopy purely 
because of the 9-5 or whatever, they want to get away. (19.1/130) 
 
As mentioned above, poor working relationships and poor morale were 
issues raised by a quarter of the interviewees. However, half of the 
interviewees reported no problems of this nature. Indeed in these units, 
staff commented on the positive way in which change was accepted: 
 
We are quite lucky because we have a lot of motivated staff who do 
embrace change rather than running away from it. (9.2/452) 
 
In terms of the endoscopy teams themselves you know most of them 
have taken it in their stride really and indeed there are levels of 
enthusiasm for improving the service which is a priority for all of us 
really. (2.1/530) 
 Resistance to change 
 
Clinicians and key people demonstrated an awareness of staff’s resistance to 
change, even if they do not actually experience resistance themselves and 
they understood that poor working relationships and poor morale could 
contribute to resistance to change: 
 
“… change per se is not a good thing and the majority of folk don’t 
like it.”  (4.1/401) 
 
It was important to have all consultants ‘on board’ and this was seen as a 
big challenge as it was this group, and particularly surgeons, who were 
noted in approximately half of the interviews, to have demonstrated more 
resistance to change than nursing or clerical staff. They were resistant to 
changing their work practices, such as the way in which their patients and 
waiting lists were managed and resistant to changing list templates, as well 
as disliking work being monitored and their methods questioned: 
 
I think engaging clinicians was probably the biggest challenge, to 
change practice. (19.2/567) 
 
Surgeons are, I’m sure they won’t mind me saying, are recognised as 
an interesting group of people, they tend to have very strong 
opinions about things, like to do things the way they have always 
done them and changing surgical practice is difficult. (10.1/466) 
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Clinicians and key people also mentioned some resistance to change from 
the nursing staff, but this was not perceived as a major problem and often 
related to specific issues, such as nurse consent and inpatient link nurses. 
There were very few direct comments relating to resistance to change from 
clerical staff with just one Key Person noting strong resistance in this 
direction. 
 Overcoming poor working relationships, poor morale and resistance 
 
Identifying a named person to lead the change process was seen as 
significant in both achieving change and overcoming any problems that 
might arise. Clinicians leading change saw themselves as a “front man to 
talk to various people” (10.1/383), someone to lead “from the front showing 
what could be done” (16.1/50) and as achieving change through 
“perseverance and being a pain” (17.1/561). Where key people were 
responsible for leading change, they noted the importance of having a 
supportive clinical lead: 
 
He is willing to listen and is very supportive and I get on OK with him 
and we have an arrangement, if I need something doing, it’s all right, 
I have to do, it but he will support me if it goes wrong. (16.2/279) 
 
Ensuring good communication between all members of staff, staff 
involvement and staff ownership of the change process, were also seen as 
significant steps forward in overcoming poor working relationships, poor 
morale and resistance to change. Communication, both within endoscopy 
units and with other hospital departments, through redesign days, time out 
sessions and regular meetings, gave staff a sense of ownership and 
involvement over the changes taking place and ensured that everybody 
knew what was happening at all times: 
 
From the start they were involved and all of the training that we had, 
we did mixed training sessions, so that health record staff were there 
with nursing staff and staff from admin, the nursing officers, the 
consultants, they were all mixed sessions so they weren’t segregated 
and doing it on their own, they were mixed in with everybody else 
and then everybody knew what everybody else was going to be 
doing. (9.2/516) 
 
Meetings, such as Endoscopy User Groups’ meeting, gave credibility to the 
plans for change and in six cases were said to raise the low profile of 
endoscopy units: 
 
“I think the first obstacle was the low priority given to endoscopy … 
because there were no political targets attached to endoscopy … 
senior management level didn’t really take it seriously because the 
senior managers were really concentrating on the national targets. 
But we addressed that by developing the GI Steering Group which 
was high level support.”  (19.2/559)  
 
When met with ongoing resistance, clinicians and key people described how 
they managed to gain acceptance of change or at least to reach a 
compromise by persevering through ‘nagging’, ‘persuasion’, and a lot of 
‘patience’ and could illustrate problems by offering staff good quality 
information (such as evidence obtained through data collection): 
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One particular surgeon wanted to keep his own waiting list and that 
just took a lot of, I mean, it took a year to gradually wear him down. 
(20.1/354) 
 
Training was also a means of overcoming resistance to change as illustrated 
by the story of a booking clerk who was resistant to new methods but was 
eventually won over: 
 
I’ve retrained the booking clerk. She had old ideas and didn’t believe 
in the new changes. After lots of patience, she now realises what a 
major impact the changes have made. They’ve improved things 
tenfold. (7.2/79) 
 
The efforts made by clinicians and key people to overcome poor working 
relationships, poor morale and resistance to change by ensuring good 
communication and involvement in change was said to have had a number 
of positive outcomes. In just over a quarter of units’ relationships among 
staff and team working practices had improved within both the units 
themselves and other departments in the hospital: 
 
Whereas you previously tended to work a bit in isolation, there was a 
problem with retention and recruitment, now we have a very close 
integration with the ward, with exchanges and acquaints and that is 
going to increase because we have been successful in establishing a 
day case unit which is co-located with the ward, adjacent to the ward 
... staffed both from endoscopy and the ward. (17.1/381) 
 
Furthermore, this had led to better working relationships for managers with 
both clinicians and endoscopy staff. While two clinicians expressed negative 
views about managers, in a number of units, clinicians spoke about the 
benefits of the process in terms of gaining a better understanding of the role 
of managers: 
 
I feel it has brought me a lot closer to the management because I 
understand more of what goes on and I think when you begin to 
understand the whole funding management process you have a lot 
more sympathy for managers than you do if you don’t understand 
these things. (10.1/569) 
 
“…if I have somebody go sick tomorrow who has got a list they all 
rally round and help me and I think they share responsibility for the 
unit whereas before they’d have just thought let the manager get on 
with it, it’s her problem not ours.”  (6.2/664) 
 Training 
 
The majority of clinicians and key people recognised the training needs of 
staff in their units (doctors, nurses and clerical staff) and the importance of 
developing staff skills “training is good for the employee and employer – it’s 
investment in the future” (3.1/271), noting the lack of training prior to 
modernisation in some units which was attributed to lack of funding, lack of 
space and concerns over staffing levels: 
 
Many of the staff had worked there for many years and had never 
had development opportunities. (19.2/101)) 
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However, there were units with clear training pathways such as training that 
enabled nursing staff to rotate between the various areas within endoscopy, 
thus allowing for greater flexibility; 
 
We rotate nurses through different rooms so they become universally 
trained in all endoscopic procedures (18.1/385) 
 
Where appropriate, staff had been sent on external training courses, 
supplemented by in-house training. However, in-house training was 
mentioned as being potentially problematic when long patient waiting lists 
existed;  
 
All our lists are totally full even when they have got somebody who is 
training which they should be half – you should reduce the lists. 
(6.2/603) 
 
Training was noted as essential in keeping staff up-to-date with the latest 
techniques, developing staff skills and ensuring an appropriate skill mix (see 
below). With an ever-increasing demand for more Endoscopists and growing 
demand for governance of units and good quality control, some units had 
appointed or planned to appoint a clinical lead with a specific remit on 
training. Where there was evidence of an ongoing lack of training, it was 
suggested that this was due to a lack of a dedicated budget, insufficient 
staffing and the pressures of full lists. 
Skill mix and staffing levels 
 
Linked with training is the skill mix of staff in endoscopy units and as part of 
modernisation, many units had reviewed staff roles to get the right skill mix 
at all levels in order to increase efficiency and flexibility. Prior to 
modernisation, nurses were carrying out many non-nursing duties, such as 
setting up equipment, washing scopes and arranging appointments, which 
the majority of interviewees deemed inappropriate. In these cases, 
interviewees felt the priority for nurses should be to be with patients. To 
facilitate this, units had attempted to employ staff such as endoscopy 
technicians and health care assistants to remove clerical duties from nurses: 
 
“… nurses were doing a lot of non-nursing duties so one of the main 
issues was relieving nurses of these non-nursing problems. Through 
the project we have employed a person from HSDU to clean the 
scopes and we have employed a receptionist to help with the filing of 
notes before and after procedures, ring the wards confirming 
appointments, ring porters for the staff and all that sort of things, so 
that has been a big change.”  (1.2/47) 
 
Adapting the roles of nurses had clearly had an impact on working practices 
as evidenced by the fact that NEs were in post in all but two units. However, 
most NEs were trained to undertake upper GI procedures and, in 
preparation for the Government’s plans for colorectal cancer (CRC) 
screening and the anticipated increase in demand for colonoscopy, many 
were also involved in on-going training to perform colonoscopy and flexible 
sigmoidoscopy. NEs were seen as the best way forward, always in the unit, 
not on-call or required to attend meetings and consequently available to 
cover cancelled lists and utilise otherwise wasted capacity: 
 
One of the important aspects of the next stage of modernisation is to 
have our two Nurse Endoscopists working flexibly covering the lists 
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that are cancelled so that you increase our outputs without increasing 
the number of staffed lists that you are actually performing. 
(20.1/505) 
 
The implementation of nurse specialists was also seen to have contributed 
to the flexibility of endoscopy units. Nurse specialists often take a particular 
interest in a specific aspect of the work of the unit such as screening for 
CRC, irritable bowel syndrome, feeding access, dyspepsia and some use 
protocols to determine appropriate follow up for patients who have had a 
biopsy: 
 
Very successful in implementing specialist nurses within 
gastroenterology and they are a very key component to the smooth 
running both to the gastroenterology service overall but actually also 
impacting on organisation in matters endoscopic really. (2.1/252) 
 
Other examples of nurses taking on duties traditionally performed by 
doctors included: taking consent, performing cannulation, performing pH 
manometry and giving sedatives and antibiotics. 
 
While nurses were clearly an essential part of endoscopy unit workings, 
there was recognition from both clinicians and key people of the important 
role played by clerical staff in the efficient running of a complex unit, and 
the responsibility of that role: 
 
In terms of my opinion about what makes an effective endoscopy 
service, I think the clerical part of the service is as important as the 
clinical part. … one of my top ten tips would be – get your clerical 
service right. (12.2/175) 
 
However, it was felt that there was a lack of appreciation of just how much 
clerical support endoscopy units needed and that staff on low A&C grades 
were often performing jobs that were “significantly more complex than they 
appear to be on paper”  (4.1/324). 
 
The problem of insufficient staff could hinder a unit’s aims to achieve an 
appropriate skill mix and this was raised frequently by clinicians and key 
people, with a major concern being the inability to cover for cancelled lists, 
holidays or study leave because of a lack of Endoscopists: 
 
It is also important to make sure that when people go on holiday 
there is not a huge void in endoscopy because there isn’t anyone else 
to do it and that does rely both on nursing manpower, administrative 
manpower and medical or nurse specialist manpower as well and if 
we are going to improve the service it does cost money because it is 
salaries for experienced staff effectively. (14.1/522) 
 
In this respect, it was suggested that there were shortages in nursing and 
clerical staff rather than doctors and that while NEs were not always easy to 
recruit, the shortage of endoscopy nurses could impact on the work of units: 
 
There are a number of slots that cannot be used, potentially they are 
available. But that has been hampered by lack of nursing staff, just 
numbers not being there to run it. (1.1/72) 
 
While more staff had been recruited, from consultants to nurses and clerical 
staff, few units were fully staffed, with some running on minimum staff.  In 
some areas this was not solely due to lack of financial resources, but 
The ENIGMA study 
©NCCSDO 2008 Page 227 
resulted from local difficulties recruiting and retaining staff because of the 
high cost of living in the area and it was noted that as endoscopy units 
traditionally work a nine-to-five day, staff do not have the opportunity to 
boost their income by working ‘out of hours’ shifts.  Where lack of staff 
related to lack of financial resources, there was frustration about the fact 
that some ideas for change could not be taken forward: 
  
Funding is an issue, in particular health record staff. I think that 
unless you have sufficient administration staff to institute these 
changes to booking and the whole way that lists are administered, it 
is very hard to introduce change. (10.1/473) 
Patients 
 
The patient and their well being was recognised as an important aspect of 
positive change in endoscopy units and modernisation of endoscopy services 
was aimed at improving access to, and experience of, endoscopy for 
patients. Clinicians and key people acknowledged that waiting times were 
unacceptable for patients and needed to be reduced to provide more timely 
access to endoscopy and that the actual experience of patients before, 
during and after their endoscopy could be improved: 
 
Our sole focus is a better patient experience. We aim to reduce 
waiting times and improve quality. We need to speed up the 
management of the patient’s clinical condition. We need to be more 
patient friendly. (7.1/122) 
 
There were efforts to improve the experience of both outpatients and 
inpatients. Some units had redesigned their patient information leaflets with 
the help of patients. They found that sending this information in advance of 
their procedure together with admission forms and consent forms, meant 
that patients were better informed and could complete the forms in their 
own time and in the comfort of their own home. Reducing the time a patient 
spent in a unit by sending information in advance and by better scheduling 
of appointments was considered advantageous, as patients are “less anxious 
and irritable” (3.1/215) and, as this clinician pointed out: 
 
…it is important for the success of what we do, if the patients leave 
here feeling they have been well dealt with I think that is going to 
make a big difference to them and their other doctors in the future 
and looking after them, so I think that is very important. (3.1/235)  
 
Some units had wanted to improve the physical surroundings for patients 
and had made changes to reception areas, such as replacing carpets, which 
it was felt made a difference to patients when they arrived at a unit. 
However, there were concerns about the lack of privacy and dignity for 
patients “sitting in open waiting areas wearing nothing, the breeze flying 
between their legs!” (2.1/351) and the lack of a suitable place to speak to 
patients or take a patient history, acquire consent and explain results.  
 
There were many examples of staff responding positively to plans for 
modernisation of their endoscopy unit, recognising that ultimately the 
patients would benefit: 
 
Generally an excellent group of workers in the unit and they are well 
motivated and they are a very patient-centred group of nurses. They 
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all set off to do whatever they can to improve the patient experience. 
(6.1/493) 
 
Our sole focus is a better patient experience. (7.1/122) 
 
We want to make the patients more comfortable and relaxed and 
enjoy the process as much as possible and that is very important. 
(3.1/232) 
 
If there is something that comes on board which is exciting or will 
make life better especially for patients then we will look at it. 
(11.2/131) 
 
Even in a unit with ongoing issues over morale and poor working 
relationships, the basic sense of wanting a better service for patients came 
through: 
 
I think everyone who runs or is involved in an Endoscopy Unit want 
to provide a better quality of service. (15.1/27) 
 
Summary – The human dimension of endoscopy units 
 
The aim of modernisation is to provide a better quality service for patients, 
that is to say, more timely access to endoscopy and improved experience 
before, during and after endoscopy while in the unit. The majority of the 
staff interviewed in the first round of interviews responded positively to the 
plans for modernising endoscopy units, in the knowledge that patients 
would benefit from the changes. This, in spite of the fact that little was 
reported on the manner in which services, would now be more patient-
focused. 
 
In the past, some units had been managed under more than one 
directorate, leading to a lack of clarity over the responsibility for the control 
and leadership of units. As a result of restructuring, units are now often 
managed under a single directorate and the issue of control and leadership 
of units has become clearer. However, issues of clear lines of accountability 
and leadership-through-example remain, exacerbated by the need for unit 
staff to share space, and rifts between surgeons and physicians.  
 
As a result of shared facilities and spaces across specialties, a quarter of 
sites taking part in the study highlighted tensions between staff groups and 
poor working relationships. However, it should be stressed that working 
relationships within units are described in positive terms with only isolated 
cases of poor working relationships. 
 
The negative impact of across-group tension is low staff morale, resulting in 
lack of communication among staff, a sense of lack of personal ownership 
and involvement in the running of units, and additional pressure on staff, 
leaving them feeling undervalued. This was noted within a quarter of units, 
particularly at the beginning of the modernisation process, while other units 
reported no experience of these signs and described staff as responding 
positively to modernisation with good morale. The remainder did not talk 
about these issues.  
 
Poor working relationships, poor morale and resistance to change could be 
overcome through the development of better lines of communication 
between members of staff, staff involvement in the process of change and 
staff ownership of change. Enhancing lines of communication and group 
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involvement was supported by ‘redesign days’, time out sessions and 
regular meetings, which gave staff a greater sense of commitment by their 
units. In addition, these meetings gave credibility to the plans for change 
and raised the profile of endoscopy units.  
 
Consultants, and in particular surgeons, were seen as the staffing group 
most likely to resist change in terms of working practices, others managing 
their patients and waiting lists and others attempting to monitor or question 
their work and methods of practice. Nevertheless clinicians and key people 
were working together to overcome resistance to change, employing a range 
of measures including compromise and negotiation tactics such as 
persuading staff to change, displaying patience with them and offering them 
additional training. Training ensured that staff were kept up-to-date with 
the latest techniques and helped develop their skills, however it was limited 
in terms of the scope it offered to ensure change, exacerbated by a lack of 
funding and lack of space, as well as the pressures of full lists.  
 
Ensuring the right skill mix helped increase the efficiency and flexibility of 
units, achieved through the adaptation of the role of nurses with many units 
having NE and nurse specialists as well as ensuring that endoscopy nurses 
were free from any non-nursing duties. Of equal importance was the role 
played by clerical staff for the efficient running of what were seen to be 
complex units. However, achieving the right skill mix was often hindered by 
insufficient staff – most commonly endoscopy nurses and clerical staff rather 
than doctors or NEs – with few units fully staffed, which in turn led to the 
inability of units to cover cancelled lists, holidays or study leave.  
 
In spite of all these difficulties, efforts were being made to improve working 
relations, enhance staff morale and overcome resistance to change. Indeed, 
it was in the very process of working towards improved working relations 
where the most promising outcomes were recognised – stronger 
collaborations among staff were being engendered, both within and outside 
of endoscopy units. This was particularly successful where units identified a 
‘Key Person’ or clinician to lead the change process and in the case of the 
responsibility falling on a ‘Key Person’, that they then gained the support of 
the clinical lead. 
8.7.3   Theme 3 – Financial resources 
Introduction 
The issue of financial resources was raised throughout the interviews by 
clinicians and key people in both Intervention and Control sites with the 
majority facing the challenge of insufficient resources. As one clinician put 
it: 
 
Endoscopy is a black hole, you give us more money and we will 
spend it. (9.1/299) 
An issue of concern 
 
There was acknowledgement that some modernisation initiatives do not 
require funding as they are based on redesigning work processes: 
 
These changes have just been made with just tweaking the existing 
system. It is just looking at how we function and how we can 
improve it, cutting down duplication, cutting time down, wasting of 
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time. We have had efficiency gains within the existing provision 
rather than new capacity. (1.1/254) 
 
However, as one clinician said: “… one of the devils of the NHS is this 
nonsense that change has to be cost neutral, change is never cost neutral” 
(4.1/422) and there was frustration and disappointment that further 
modernisation plans could not be pursued due to the lack of financial 
resources, a situation that was unlikely to change in the foreseeable future: 
 
I think that is the thing that irritates us most of all, us clinicians, is 
that you join these things with good motivation, goodwill, and you 
start off accepting that there is no investment but we all hope that 
once we have shown that we have done A, B and C that there is 
some investment, some true investment at the end of it. (18.1/500) 
 
I think the sad thing is when you want to make a change and there is 
a financial implication and you just can’t move it forward because of 
that. (14.2/384) 
 
Areas where more could be achieved but where funding was problematic, 
related to the need for additional staff, from clerical to consultant, and 
effective IT which was not available in all units. IT was seen as essential for 
the smooth running of an efficient unit and, in addition, equipment was 
often lacking, with many units struggling with old equipment, needing 
rolling replacement programmes. The funding of NEs was raised frequently 
in terms of the difficulty some units had in obtaining funding for the post 
which also had to take into account the support required to run additional 
lists with nursing support, equipment and space: 
 
No funding of the modernisation changes seem to be straightforward 
… difficulty in funding has been on the clinical end where there has 
been an inability to understand the needs for more endoscopy staff 
and an inability to accept the justification for the Nurse Endoscopists 
that we were requesting. (20.1/374) 
 
The lack of financial resources led to an ongoing search for funding and an 
element of creativity and inventiveness was recognised: 
 
“… you do sort of get some yourself don’t you by being inventive and 
using what there is available.”  (9.2/571) 
 
We packaged it up, not saying we just needed more staff to do that, 
into a new package where we had nurse led surveillance. (17.1/184) 
 
In the search for funds it was an advantage to have a knowledge of the 
various sources of funding, such as charitable funds and cancer funds and 
the need to be able to cope with the frustrations of writing and submitting 
business cases and having to go out to tender for equipment. 
 
However, obtaining funding was never a certainty and rather than being 
able to follow a clear development plan, modernisation initiatives appeared 
to happen on an ‘ad hoc’ basis: 
 
We took the opportunity of having things on the shelf that you could 
put forward and just entire opportunism. (17.1/456) 
 
The fact that many Trusts are in financial deficit was seen to impact on 
funding for endoscopy units and Trusts were criticised for funding on a crisis 
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management basis, providing short term funding and not recognising the 
need to invest in the short term in order to gain in the long term: 
 
The Trust is in a big financial deficit so it is very difficult. At the 
moment we are having great difficulty getting anything from them. 
(5.1/266) 
 
“… in a way you have to fail before money can be allocated … there 
are many conflicting an differing demands on cash so it’s only when 
something becomes flagged up as an issue that could mean you loose 
one of your stars, that they suddenly allocate resources.”  (15.1/381) 
 
However, in spite of the ongoing problems with financial resources many 
Intervention and Control sites had been successful in obtaining funding, 
albeit short term, from various sources for additional staff including 
consultants, NEs, nurses, health technicians and administrative staff. There 
had also been some funding for equipment and to improve IT facilities 
although some units were still struggling with old systems. The data 
collected, either through the MES ToolkitTM or in-house versions in Control 
sites, had made a significant difference in getting funding approved as it 
had been used to support business cases by illustrating exactly what the 
issues were. 
 
Summary – Financial resources 
 
Trusts’ financial deficits had impacted on the majority of endoscopy units 
who faced the challenge of insufficient resources and did not anticipate the 
situation changing in the foreseeable future. Trusts were criticised for crisis 
management, for providing short term funding and for not investing in the 
future. 
 
Some modernisation was recognised as achievable at no additional cost, by 
redesigning work processes. Other aspects of modernisation such as 
extending the working day, expanding the NE service, having rolling 
replacement programmes for scopes, achieving effective IT systems and 
introducing one stop clinics, had not been pursued. This resulted from the 
funding implications of additional staff, effective information technology, 
new equipment and NEs. This led units to continue to search for funding 
from alternative sources such as charities and cancer funds, with an element 
of creativity and inventiveness necessary. As a consequence, rather than 
following a clearly developed plan this created an ‘ad hoc’ approach to 
modernisation. 
 
In spite of these issues, many endoscopy units had been successful in 
obtaining funding, albeit short term, for additional staff, equipment and IT 
and data collected in endoscopy units had been used to support business 
cases put forward to Trusts which had made a significant difference in 
obtaining funding. 
8.8   Findings: Second round of interviews 
 
This section reports on the findings from the second round of interviews. 
 
As described in the Method section on page 211 the aim was to conduct the 
second round of interviews with the same clinicians and key people as two 
years previous. One Intervention site had withdrawn form the study by the 
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time of the second interviews. Table 60 shows the breakdown of the roles of 
people interviewed and shows that all but one of the clinicians were the 
same. An SpR was nominated by a clinician to be interviewed because he 
himself was unavailable on the day of the interview. Of the key people, six 
were the same in each of the Intervention and Control sites. Two General 
Managers had moved on, one Sister was not available, one Nurse Manager 
had left, one administrator had left. The same procedure was followed as 
the first round of interviews in that, where an original interviewee was not 
available, the clinician was asked to nominate someone with a good 
knowledge of endoscopy. At one site a manager with a specific remit for 
endoscopy was nominated and a new manager was interviewed at the site 
used as a pilot. Two new key people interviewees (one Intervention, one 
Control) wanted to be accompanied by another member of staff from the 
endoscopy unit ‘in case they forgot something’. There was a real possibility 
that the interviews would not take place unless this was agreed to so the 
researcher went ahead with this and found that the other members of staff 
corroborated what the main interviewee was saying. 
 
Table 61.   Role of interviewees and changes between interviewees in 
first and second interviews 
 
 INTERVENTION CONTROL 
 Clinical 
representatives 
Key People 
representatives 
Clinical 
representatives  
Key People 
representatives 
 7 Consultants 3 Sister 10 Consultants 3 Sister 
 1 Nurse Research 
Manager 
1 Matron  1 NE 
 1 SpR 1 NE   Nurse Specialist 
  3 Manager (2 
General, 1 Nurse 
Manager) 
 5 Manager (3 
General, 2 Nurse 
Managers) 
  1 Administrative 
staff 
 1 Administrative 
staff 
TOTAL 9 9 10 10 
 Same except for 
SpR 
6 same 
2 Sisters & 1 
General Manager 
different 
Same 6 same 
1 Nurse Manager, 
1 Sister, 2 General 
Managers different 
 
Although seven different key people were interviewed it was reassuring to 
find that the same issues arose across the group. 
 
The interviewees in both rounds were recognised by the team as a valid 
cohort, providing reliable data that was representative of the views of 
people working in the endoscopy units. It could be considered that clinicians 
nominated key people they felt would give a positive account of endoscopy. 
However, the fact that interviewees included nurses, managers and 
administrative staff, who spoke about the same issues, emphasises a cross-
section of views and validates the representative nature of the sample. 
 
While conducting the interviews and undertaking the analysis, it was clear 
that similar themes were emerging but that clinicians and key people were 
responding to questions in the context of being two years further on in the 
change process and some of the questions would have been familiar to 
them. It was therefore decided to write up the findings from the second 
round of interviews as a follow up piece following the same themes and 
headings, where appropriate. 
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As in the first round, three themes emerged from the data. ‘Drivers for 
Change’, ‘The Human Dimension of Endoscopy Units’ and ‘Financial 
Resources’. However, the content of ‘Drivers for Change’ had changed as 
there was little mention of the NHSMA or the Modernising Endoscopy 
Services Project, and it became clear that other drivers for change had 
emerged in the intervening two years, in particular the Endoscopy GRS and 
other Government initiatives such as Bowel Cancer Screening and the 18 
week target. 
 
 Drivers for Change 
- Progression from NHSMA/MES programme to GRS and 
Bowel Cancer Screening 
    - The impact of Government initiatives 
 The Human Dimension of Endoscopy Units 
    - Staff 
 Working relationships and staff morale 
 Resistance to change 
 Overcoming poor working relationships, poor morale and 
resistance 
 Training 
 Skill mix/staffing levels 
    - Patients 
 Financial Resources 
   - An issue of concern 
 
A detailed examination of themes and categories follows a description of 
differences between Intervention and Control sites two years after the first 
interviews. 
8.8.1   Differences between Intervention and Control sites  
and their responses to modernisation 
 
The first round of interviews suggested that the MES programme was a 
catalyst for change and had resulted in timelier implementation of 
modernisation as Control sites appeared to be lagging behind Intervention 
sites. However, as illustrated in Table 62 Control sites had made progress in 
the intervening two years with no sites perceived as ‘modernisation yet to 
start’. Two Control sites while making progress, were considered by the 
researcher to be modernising their services but had specific ongoing 
problems that were limiting their progress, for example, expensive location 
causing staff difficulties. Thus Control sites appear to be ‘catching up’ in 
modernising the service delivery and organisation of their units. 
 
However, it is interesting to note that midway between the two rounds of 
interviews the Endoscopy GRS was introduced and although not compulsory, 
all the ENIGMA sites were taking part. In spite of the differences between 
Intervention and Control sites in terms of the funding they received from the 
NHSMA, the different levels of support they received in modernising their 
service and the different stages they may have been at, they all embraced 
the use of the GRS and seemed able to adapt to its use easily.  
 
There was no detectable difference between the responses of Intervention 
and Control sites to the GRS and their experience of modernising their units 
over the previous two years, whether with or without support from the 
NHSMA, facilitated their ability to use it. By the time the GRS was 
introduced, all of the units had adopted a mindset of modernising their units 
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and were used to collecting data and to many, the GRS seemed a natural 
progression, moving from the MES programme’s emphasis on the process 
side of endoscopy to the quality issues of endoscopy. 
 
As in the first round, there were no detectable differences between 
Intervention and Control sites and the same issues arose when participants 
spoke about the modernisation of their units. 
8.8.2   Recommendations from second round interviews 
 
When the data from the interviews are considered, a particular issue that 
stands out is the implementation of the GRS during the study period and the 
fact that the professionals interviewed perceived it as driving change in 
endoscopy units. Therefore, we recommend a sixth wave of patient 
recruitment, including further interviews with professionals, to enable a 
greater understanding of the impact of the GRS on endoscopy services.  
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Table 62.   Progress in the stage of modernisation between the first and second interviews 
 
 Stage in modernisation process at time of first 
interview 
Overall progress at time of first 
interview 
Overall progress at time of 
second interview 
 Sites started 
modern-
isation 
before MES 
programme 
Sites 
modern-
ised in 
previous 
2 years 
Sites 
with 
some 
modern-
isation 
Sites at 
start of 
modern-
isation 
Good 
progress 
Issues to 
be 
resolved 
Modern-
isation 
yet to 
start 
Good 
progress 
Issues to 
be 
resolved 
Modern-
isation yet 
to start 
I
n
te
r
v
e
n
ti
o
n
 
4 
7 
8 
11 
13 
18 
1 
6 
16 
19 
  1 
4 
6 
7 
8 
13 
16 
19 
11 
18 (since 
withdrawn) 
 1 
4 
6 
7 
8 
11 
13 
16 
19 
  
C
o
n
tr
o
l 
3 
9 
12 
17 
20 
5 
 
2 
10 
14 
15 
3 
9 
12 
17 
20 
5 2 
10 
14 
15 
2 
3 
5 
9 
10 
12 
17 
20 
14 
15  
 
 Number = site identification number 
This table shows where the researcher perceives the units to be in the process of modernisation in comparison to the time of the 
first interview. Sites 11 and 5 have moved from ‘Issues to be resolved’ to ‘Good progress’. 
Sites 2 and 10 have moved from ‘Modernisation yet to start’ to ‘Good progress’. 
Sites 14 and 15 are modernising their service but have ‘Issues to be resolved’. Site 14 has only 1 endoscopy room open because of 
funding issues and Site 15 is limited by the structure of the old hospital where it is situated and has staffing difficulties because of 
its expensive, city location. N.B. Site 18 withdrew from the study so there was no follow-up interview. 
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8.9   Findings in detail – second round of interviews 
8.9.1   Theme 1 – Drivers for change 
 Introduction 
 
This theme concentrates on drivers for change and specifically drivers that 
have emerged over the last two years - the Endoscopy GRS and Government 
targets for Bowel Cancer Screening, ‘two week wait’ referral and ‘18 week’ 
referral to treatment, all of which are explained below. 
 
The GRS is a tool that enables endoscopy units to assess how well they 
provide a patient-centred service across two dimensions – Clinical Quality 
and Quality of Patient Experience (Valori 2005). The primary purpose of the 
scale is to support quality improvement by helping endoscopy staff identify 
areas for improvement and provide ideas and information to help staff make 
changes. It was introduced in March 2005, almost midway between the two 
interviews. Completion was not compulsory but, in spite of its additional 
workload, it was widely accepted by endoscopy units, in part because the 
GRS became part of the accreditation process to become a Bowel Cancer 
Screening Centre, something many units aspired to. The NBCSP is being 
introduced as a screening procedure for CRC, and Screening Centres were 
presented as the local management point to provide endoscopy and nurse 
clinics for the follow up of individuals with positive faecal occult blood tests 
(a test that raises the suspicion of cancer) (Weller, Moss, Butler, Campbell 
and Coleman 2006). 
 
The other drivers for change that emerged in the interviews and are 
explored below are the Government targets of ‘two week wait’ referrals and 
the ‘18 week referral to treatment’ target. The ‘two week wait’ was 
introduced in the NHS Cancer Plan in 2000 with the aim that everyone with 
suspected cancer would be seen by a specialist within two weeks of their GP 
deciding they needed to be seen urgently and requesting an appointment 
(Department of Health 2000(a)). The ‘18 week’ target was introduced in the 
NHS Improvement Plan in 2004 with the aim that by the end of 2008 no one 
will have to wait longer than a maximum of 18 weeks from the point of 
referral up to the start of any treatment (Department of Health 2004). 
 
In the first round of interviews the NHSMA and the MES programme was a 
clear theme emerging from these data, but in the second round fewer 
people talked about these drivers for change. It was apparent that, to a 
great extent, the NHSMA and MES programme have been superseded in 
people’s minds by the GRS and the NBCSP. This theme will clarify the 
relationship between the NHSMA’s MES programme and the GRS and Bowel 
Cancer Screening drivers and will show how little was said about the drivers 
for change that came to light in the first round of interviews. The impact of 
the ‘two week wait’ and ’18 week’ target will also be explored. 
Progression from NHSMA/MES programme to GRS and Bowel Cancer 
Screening 
 
As mentioned above, in the first round of interviews the NHSMA and the 
MES programme emerged as the drivers for change but in the follow up 
interviews there was little mention of either the NHSMA or the MES 
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programme. However, as the overall aim of this study is to evaluate the 
impact of the NHSMA and the MES programme, it is relevant to report what 
was said and to indicate how the comments were often linked to the GRS. 
 
When people did talk about the NHSMA and the MES programme in the 
second round interviews they often related these issues to the GRS, with 
some people seeing the GRS as a natural progression from the MES 
programme and suggesting that the MA had been a catalyst for all that had 
happened since: 
  
I think it is excellent. I think it is a really good tool. … As a tool I 
think it is fantastic, a really, really good innovation and I think it’s 
done more for endoscopy than anything else really. … I think the MA 
brought about the mindset of modernisation … started the ball 
running. Without the MA Programme you wouldn’t have had Roland 
Valori, Liz Allen or Debbie Johnston who came up with the GRS so 
really in my view the GRS came from the MA programme and it’s just 
been a natural progression of the scheme. (19.2/615) 
 
It was acknowledged that the MES programme had dealt with the process of 
delivering an endoscopy service and the GRS then followed on from this by 
addressing the quality aspects of an endoscopy service: 
 
“.. the MA ToolkitTM for endoscopy focused on measuring and 
counting and looking mainly at the process of what happened … but 
there is so much more to running an endoscopy service than the bit 
about actually processing patients on a daily basis … the GRS is a 
more rounded tool.”  (12.2/179) 
 
The introduction of the GRS was viewed by the majority of interviewees as a 
good idea. The GRS assessment tool is a web-based tool that calculates the 
GRS scores providing units with a summary view of their service. The GRS 
was considered a useful tool, focused units on the quality of clinical care and 
patient experience and provided evidence of quality improvements in the 
form of higher GRS scores: 
 
“… you can improve your score very quickly by focussing on passing 
that particular part of the test … it’s sort of when you are doing an 
exam, it’s knowing how to answer the questions but that is no bad 
thing. … makes you focus on areas that otherwise, because they are 
not directly medical areas, a lot of them are quality areas that are to 
do with patient interaction and patient flow through the unit, but as a 
doctor, as an Endoscopist you are not directly involved with so they 
don’t come high priority. So I think it’s useful in that sense.” 
20.1/309 
 
“…they show the markers and competition I suppose. I think that 
always makes a difference doesn’t it. They don’t like to think that 
they are all Ds or something like that and it’s the way it’s been 
marketed I suppose really. It is a continuation and an improvement 
so I think how that was set up wouldn’t have happened maybe.”  
4.2/170 
 
Intervention sites felt that their experience of the MES programme and 
Control sites their experience of modernising their units, had been of benefit 
when undertaking the GRS, as it had prepared staff for the type of activity 
required for the GRS and in particular they were used to collecting data: 
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The advantage of having been part of the MA stuff is that the nurses 
are already doing it. It wasn’t a big shock to add on the extra bits for 
the GRS because we were all familiar with the needs of doing the 
data collection. It is all still happening but it’s now bigger. 19.1/149 
 
As explained above, the GRS assessed units on clinical quality and quality of 
patient experience and while interviewees were not asked specifically about 
‘quality’ it was spoken about by interviewees across Intervention and 
Control sites in a more patient focused manner than in the first round of 
interviews: 
 
I think actually there was a genuine desire to improve the efficiency 
of the service and to improve the quality of the service for the 
patients. (9.1/275) 
 
“… so often in the NHS you’re driven by targets and sort of 
quantitative issues. With the GRS it focused the mind on the quality 
issues.”  (12.2/156) 
 
This appears to stem from the ‘quality’ agenda which has come to the fore 
in endoscopy units as a result of the GRS with its assessment of clinical 
quality and quality of patient experience. Changes have been made in units 
as they try to achieve high GRS scores and this has given rise to 
interviewees talking a great deal about quality. However, as quality or high-
quality patient experience is never clearly defined, and how talk is directed 
at target-driven assessment it is difficult to ascertain whether the patient 
has actually become the focus of the drive to improve quality or whether the 
focus is achieving high GRS scores and almost by default, the patient has 
become the focus and benefited as a result:   
 
“… I’m a big fan of the GRS. It’s bringing quality into the service - 
most of us in medicine want to provide a good quality service. We are 
not so interested in quantity, we are more interested in quality and 
because you have to have quality in service to achieve the 
appropriate GRS and I suppose we all like to come first … if you have 
got a good quality unit the person who gets the greatest benefit is 
the patients, that is important.”  9.1/721) 
 
A specific quality issue that arose was the point that there was variation in 
the quality of the performance of endoscopy, in particular colonoscopy, 
between various practitioners, but that this was now being addressed 
through audits which meant that evidence was available to demonstrate 
performance. Those found to be poor at conducting high quality colonoscopy 
could either be given additional training or stopped from performing 
procedures: 
 
“… where there may be a discrepancy in quality between various 
practitioners, you know colonoscopy is a prime example, but we’ve 
found with those we proved that aren’t necessarily the best at the 
procedures, have decided not to be seen doing them any more, so 
the total pool has gone down but the quality as a result has gone up, 
which is the way it should be.”  (19.1/106) 
 
The importance to many units of improving their GRS scores was directly 
linked to the aspiration of becoming a Bowel Cancer Screening Centre 
(which generates income and equipment), as eligibility is, in part, 
determined by the GRS score: 
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“… because the carrot at the end of the whole thing is to get Bowel 
Cancer Screening going …”  (4.1/436) 
 
For this reason it was felt that the GRS had been more useful than the MES 
programme in raising the profile of endoscopy and driving change as Trusts 
were keen to acquire the status of being a Bowel Cancer Screening Centre: 
 
It’s a massive driver because everyone wants to do it … competitive 
across the area with five Trusts competing. That has been a massive 
driver which has brought endoscopy to the forefront, which we didn’t 
manage to do with the previous project. (11.1/75) 
 
Because of this, units were finding Trusts more supportive than in the past 
as there was a higher level of awareness of endoscopy and its requirements. 
This combined with the data from the GRS audits provided evidence to 
acquire funding specifically to target problem areas, for example, long 
waiting lists, in order to improve GRS scores: 
 
“… but we have waiting lists which need to be hit and things like the 
Bowel Cancer Screening are very effective levers in getting additional 
money.”  (10.1/565) 
 
While the majority of clinicians and key people felt the GRS was of benefit to 
service provision, there were aspects of the GRS that were criticised and 
these included the additional workload and increase in paperwork – “what I 
lack is manpower to do it” (11.1/274) and lack of time to undertake audits: 
 
“… always torn between providing an acceptable clinical service with 
waiting lists not too bad, yet doing all this other stuff like audit, 
which I fully endorse and think is important but probably in the past 
hasn’t played a major part in services, and having time to do that 
properly.”  (16.2/387) 
 
Some of the GRS targets were considered to be unrealistic in that some 
elements within the GRS are beyond the control of the endoscopy unit, such 
as ensuring that pathology reports are received within five working days and 
there was some frustration at how the ‘goalposts’ had changed in the early 
days of the GRS. A few interviewees felt that certain elements within the 
GRS were easy to achieve giving rise to comments about it being a tick box 
exercise, for example, patients should be able to make their views known 
and this is easily achieved by putting a suggestion box on the wall. The final 
criticism related to the fact that the GRS can be too specific and does not 
allow for variation in the set up of units which can result in a score being 
dragged down by just one element not being achieved: 
  
So like most sites we have no problem with 90% of our procedures 
but one procedure has a horrendous waiting list, i.e. colonoscopies, 
and that drops you down to a D where for colonoscopies it would be a 
D but for everything else we would be an A. (13.2/269) 
 
While the majority of interviewees spoke about the GRS there were a few 
Intervention and Control site interviewees who did not express an opinion 
about it while one clinician expressed a wholly negative view: 
 
“..most of it is a complete waste of time, it’s taken a lot of time from 
senior nursing staff who should have been looking after patients 
rather than filling in questionnaires and going to lots and lots of 
meetings.” (14.1/533) 
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The positive aim of the MES programme ToolkitTM to speed up productivity 
was acknowledged, however, it was also criticised once again with 
interviewees recalling how it was time consuming, not user friendly and that 
the web based ToolkitTM was a “nightmare” (11.1260). Nevertheless, an 
Intervention and a Control site reported that they were still using the 
ToolkitTM, albeit the old, version and one, who stated that “it’s not user 
friendly at all” (13.2/245), was only using parts of it simply because she has 
a Personal Assistant who was happy using it and it was preferable to 
maintaining various databases. 
 
In contrast there was no criticism of the arrangements for data collection for 
the GRS (apart form the additional workload) and the accessibility of the 
website associated with the GRS was praised for the way it encouraged the 
sharing of good practice: 
 
“… the GRS website and it makes you put in your information yourself 
so you do it yourself. You can then actually look at what other people 
have done and it’s a useful tool as well because if there is any, if you 
are looking for guidelines that you want to look at, maybe somebody 
else has done them and they are actually on the website now so you 
can go and see if there is anything or if there is not then go ahead 
and do it. So I suppose it has really, it’s been good.”  (3.2/66) 
 
In spite of a few aspects of the GRS being criticised, all of the Intervention 
and Control sites were undertaking the necessary data collection and audits 
required for the GRS and for the majority that was directly linked to Bowel 
Cancer Screening: 
 
You know if you had spoken to me nine months ago I would have 
been fairly down in the dumps because I didn’t think we were making 
much progress over all the things we had done but I think year on 
year we’ve made better and better progress. Getting Bowel Cancer 
Screening was a huge, huge thing. (10.1/429) 
 
Whatever was considered to be the driver behind the changes to services 
and care provision, the majority of participants considered that the changes 
that had been made had improved the endoscopy service: 
 
It’s hugely better than it was when I first came here which was six 
years ago. It’s come on leaps and bounds really. (6.1/109) 
 
However, interviewees felt there was still more to be done that could 
improve the service such as opening additional endoscopy rooms, better 
reporting systems, one stop clinics (where patients have an outpatient 
appointment and if needed an endoscopy the same day) and providing out 
of hours service. There were some concerns about the ability to cope with 
the additional demands of Bowel Cancer Screening (increased referrals) 
because units face limitations mainly relating to funding and space within 
the units: 
 
The facilities that we have got available to us are still under great 
pressure. We are trying to keep up with numbers. (7.1/14) 
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 The impact for Government initiatives 
 
In addition to the Government initiative for Bowel Cancer Screening, other 
targets have been introduced that have impacted on endoscopy units. The 
Government’s introduction of waiting time targets for the period from 
referral to treatment (18 weeks including the diagnostic element), was 
acknowledged as a further driver for change because for the first time, “the 
journey time being in the spotlight that has put diagnostics in the spotlight” 
(9.1/721). This has resulted in endoscopy becoming a higher priority for 
senior Trust management, who have focused on endoscopy, as a diagnostic 
service, needing to fall within the 18 week target. 
 
However, there was criticism from just under a third of participants about 
the ‘two week wait’ target for patients with symptoms that may suggest 
cancer. It was felt that some GPs and clinicians were referring patients 
inappropriately in order to get their patients seen quickly and this was 
impacting on the waiting times of patients with other serious 
gastrointestinal diseases and those referred as routine cases: 
 
Now if anybody is referred by the 2 week wait target, has to have all 
their investigations within a short period in order to meet the overall 
Government targets. From a patient perspective that is absolutely 
right. However, it would only be right if the GPs were only referring 
the patients who were suspected of having cancer as opposed to the 
fact that they were worrying for other reasons. The 2 week wait is 
widely abused. (17.1/84) 
 
Summary – Drivers for change 
 
It is clear that the GRS and NBCSP have been very strong drivers for change 
and that while the NHSMA and MES programme are acknowledged as having 
been helpful in preparing the way for the GRS, they have largely faded into 
the background. The 18 week referral to treatment target has been 
welcomed because for the first time a target includes the diagnostic element 
of a patient’s referral and as a consequence the profile of endoscopy within 
Trusts has been raised. In contrast, the two-week-wait referral, while being 
of benefit in speeding up referral times for patients with possible cancers, 
has had a negative impact on waiting times for other patients. 
 
The second round interviews focus more on the patient and the quality of 
their clinical care and experience. However, it is not clear from the data 
whether this is truly because interviewees and their units are more patient 
focused, or whether the real focus is the achievement of the highest possible 
GRS scores in the quest to become a Bowel Cancer Screening Centre. The 
GRS tool measures units’ clinical quality and quality of patient experience so 
it is almost by default that the patient has become more central to 
discussion. Whichever way it is viewed, interviewees perceived that the GRS 
is driving changes that are improving the service and so benefiting patients. 
 
While the drivers for change have altered over the two years since the first 
interviews and clinicians and key people felt changes had improved the 
service and ensured patient benefits there was no sense of complacency. 
Interviewees feel further improvements could and should be made, such as 
providing an out-of-hours service, one-stop-shop clinics and opening 
additional endoscopy rooms. They are also aware of the increased demands 
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that might be placed on their units with the advent of NBCSP and resultant 
increased referrals. 
8.9.2   Theme 2 – The human dimension of endoscopy units 
Introduction 
 
This theme concentrates on the human dimension of endoscopy units - staff 
and patients. The first round of interviews identified that units were at 
different stages in the process of modernisation and therefore interviewees’ 
experiences of change in their units varied but issues concerning working 
relationships, morale, resistance to change, staffing levels, training and skill 
mix and patients were raised. Two years later all the units had undergone 
modernisation to some extent and interviewees were able to talk about what 
had actually happened rather than, as some had done previously, in 
anticipation of what might happen. However, interviewees moved away from 
speaking quite so much about staffing issues and this second round of 
interviews will clarify how their perceptions have changed over the 
intervening two years and will explore whether the issues concerning 
staffing of the unit have changed and the way that the topic has progressed 
in two years. This theme will also explore the views of the interviewees 
about the need for staff to provide patients with quality care and support 
and their reflections on the experience of patients. 
Working relationships and staff morale 
 
In the first round of interviews issues of poor working relationships and poor 
morale were raised by a quarter of interviewees. However, in the second 
round there were only isolated reports of this and the overall perception was 
that working relationships and morale were good and that staff had 
responded positively to change, were supportive and co-operative and had 
welcomed the challenge of new ways of working: 
 
There is a lot of very positive nursing input and again from the 
administrative staff and the reception staff, it’s all very ‘please can 
we look at doing this’ … (8.1/590) 
 
I think our staff have been brilliant. … Of course, morale has been 
low at areas but mainly people are motivated. Nursing staff have 
been completely brilliant … clerical staff have been great and very 
obliging. (17.1/512) 
 
The issue of working relationships between the different specialties was 
highlighted again but by only four interviewees who commented on the 
ongoing tensions between physicians and surgeons. This takes the form of 
surgeons not attending meetings, inappropriately referring their patients as 
urgent and being unwilling to scope medical patients. As one clinician put it: 
 
It’s not run as an endoscopy unit, it’s run as a unit that has other 
hospital departments using it. (8.1/582) 
 
There was, however, some insight into the tensions between physicians and 
surgeons from a clinician who suggested that they “have very different ideas 
about what endoscopy is and how important it is to the grand scheme of 
things” (10.1/481) and a Key Person explaining that they work in different 
ways following different clinical pathways: 
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“…the surgeons are probably more likely to investigate a patient 
using a barium enema and flexible sigmoidoscopy rather than 
colonoscopy, where the physicians have a gold standard” (19.2/504) 
 
Interestingly in this round of interviews physicians were noted by two 
interviewees as becoming unwilling to scope surgical patients. This was a 
consequence of the ‘two week wait’ referral system resulting in more 
surgical patients being referred as a ‘two week wait’ meaning that in sites 
with pooled lists, physicians found they were scoping more surgical patients 
while their own patients were having to wait longer. It was also 
acknowledged that physicians have concerns about the quality of scoping by 
some surgeons. 
 
However, it was felt that working relationships between physicians and 
surgeons had improved and there had been a realisation among surgeons 
that change was necessary to utilise capacity: 
 
“… there has been a real cultural shift, particularly between the 
physicians and surgeons and it is going in the right direction” 
(19.2/427) 
 
The comments of one Control site clinician are particularly interesting in that 
he speaks of his embarrassment at not getting surgeons on board with 
modernisation during his five years as Clinical Lead and yet within six 
months of the role being taken over by someone else, there had been a 
complete turnaround. He explained that the new Clinical Lead ensured that 
meetings were held when surgeons could attend and this had made a 
difference in the level of attendance by surgeons and their subsequent 
involvement in changes. 
 
There were isolated incidences of clinicians feeling they lacked control of the 
endoscopy service, “just don’t control your unit” (17.1/411), in that they 
were unable to appoint or dismiss staff or open up endoscopy rooms across 
the Trust. It was suggested this was due to the Trust which “looks at money 
these days rather than service to patients” (14.1/298).  
 
A unit cited in the first round as having poor working relationships and 
morale within the unit reported great improvements within their 
reception/booking office following a change in personnel. This same site, 
however, was still experiencing problems with the morale of nursing staff 
resulting in issues with sick leave. The clinician felt this was due in part to 
the location of the hospital in an expensive area and the consequent 
inability to attract quality staff to work there. 
 
It was highlighted in the first round of interviews that several units were due 
to move to new units. Four units reported that they had moved but had 
experienced difficult and disruptive periods when moving which had caused 
anxiety and stress but the interviewees involved reported that staff had 
pulled together and this, combined with the benefits of working in new 
units, had resulted in improved morale: 
 
Having got a nice new unit that has certainly improved the morale of 
the staff. (14.1/507) 
 
There were two personal stories from key people (one Intervention, one 
Control) whose morale had suffered as a result of issues that arose when 
they took over the modernisation process in other units in the Trust while 
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continuing to manage their own unit. Initially both had found that staff at 
the other site felt they were being taken over: 
 
That would happen at any two sites wouldn’t it, it’s the bigger 
hospital and the smaller, they view it as a takeover, we see it as a 
merger. (13.2/409) 
 
Both had found it a huge challenge and one could not understand “why it 
gets so personal, but it does” (13.2/457) and the other spoke about 
“reaching rock bottom” (10.2/58). 
 
While low morale was not generally viewed as a problem in the sites a 
clinician suggested that the media coverage of the NHS – that it is failing, 
jobs are on the line, hospitals are under pressure – could lead to feelings of 
insecurity among staff and another commented on the lack of 
acknowledgement at a senior level of the excellent service that the 
endoscopy unit delivered under great pressure. 
Resistance to change 
 
Once again clinicians and key people demonstrated an awareness of 
people’s reaction to change: 
 
I think people find change difficult. Any sort of change management 
programme, people like their set ways and their ways of doing 
things. So it’s always difficult for people to take on and change new 
roles. (15.1/459) 
 
However, very little actual resistance was reported and in contrast to the 
first round of interviews just four interviewees spoke specifically about 
surgeons resisting change. It was suggested that the more recently trained 
clinicians were more accepting of change: 
 
We are a young unit so I think some of these things were easier to 
bring in. …the consultants are young here, almost across the board 
within GI. … I just think people get in a rut, they get used to doing 
things they have always done. (2.1/632) 
 
As noted above some physicians were becoming resistant to the pooling of 
waiting lists. There were two reasons given for this, firstly, physicians were 
concerned about the quality of scoping by their surgical colleagues and 
secondly, more surgical patients were being referred as a ‘two week wait’ 
referral and physicians were finding they were scoping a lot of surgical 
patients and their own patients were being pushed further down the waiting 
list: 
 
It is difficult to convince the medics that it should be pooled because 
there is such a huge disparity in the number of patients and that if 
we pooled lists all of us would be scoping surgical patients all the 
time and it’s become very obvious certainly with the 2 week wait that 
the medical patients are just being bumped from list to list to list in 
order to get the urgent patients in and the medical urgents are 
getting on to longer and longer waiting lists. (8.1/171) 
 
Two Unit Nurse Managers (one Intervention, one Control) reported that they 
had faced huge resistance when they were tasked with running and 
modernising another unit in their Trusts. They felt this was due to different 
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working cultures in the other units and the fact that rather than being 
viewed as a merger of units it was viewed as being a take over: 
 
That would happen at any two sites wouldn’t it, it’s the bigger 
hospital and the smaller, they view it as a takeover, we see it as a 
merger. (13.2/409) 
 
The Control site manager also experienced resistance from within its own 
unit as staff resented having to cover for sickness in the other unit. 
Overcoming poor working relationships, poor morale and resistance 
 
As interviewees had reported that working relationships and morale were 
generally good, there was little said about how to overcome problems in 
these areas. However, certain elements were, once again, spoken about as 
being important in achieving change such as leadership, involving staff, 
teamwork and communication: 
 
“…got to have a coherent team and you’ve got to listen but 
underlying it you’ve got to have a belief in what you are doing.”  
(17.1/512) 
 
As in the first round of interviews, the importance of someone leading the 
change process with vision and direction and the right approach was 
highlighted and in some units it was noted that a change in leadership could 
be effective: 
 
“..with fresh eyes and a real desire to crack the problems.” 
(20.2/212)   
 
One of the Intervention sites that reported surgeon resistance, “I’m not 
changing, I’ve always done it that way, I think it’s best” (11.1/736), 
explained that this was improving as this particular surgeon had become 
clinical lead and was becoming more involved but also because the Clinical 
Director has given assurances that he will be forced to change. 
 
The importance of involving staff in any change is still seen as significant, 
and regular meetings to discuss key issues and the direction of the service 
help with this and are an effective means of involving staff which is seen as 
important in managing change: 
 
If I put it [change] forward to them [staff] right from the beginning 
and say look you know we are looking at doing this, how you feel 
about doing so and so, I involved them right from the beginning. 
(7.2/389) 
 
Of the two Unit Managers who faced huge resistance when they were tasked 
with running and modernising another unit in their Trusts, one reported a 
huge improvement and suggested this was in part due to rotating staff 
between the units so they could experience different ways of working, get to 
know other staff and be more involved in different types of endoscopy, e.g. 
emergency bleeds. The other Manager is still facing resistance but is 
persevering and sees rotating staff as one way forward. 
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Training 
 
Once again training was recognised as important to ensure that staff have 
the appropriate education and expertise but lack of staff and time make it 
difficult to release staff for training because everyone is working to capacity 
and the endoscopy unit has to continue its work. There is the ongoing 
pressure, as reported in the first interviews, of accommodating training lists 
which should have less patients on: 
 
Training is an issue. We have 2 medical SpRs and occasional surgical 
SpRs that all need training in endoscopy and find fitting in the 
training requirements quite difficult even though we have the luxury 
of short waiting times and can cut down some of the lists a little bit, 
but it’s still quite a burden especially in the last 3 years we have also 
had to train the Nurse Endoscopists – 3 people training in one 
particular type of endoscopy, that is really hard, everybody’s list is a 
training list. (20.1/373) 
 
There is also the ongoing issue of training budgets highlighted by one 
interviewee who explained that in the absence of a training budget the unit 
now do fund raising events such as sponsored walks to raise money for 
training. Some units felt there was less money available for study leave and 
conference attendance and as a result most training was now done in-
house. 
Skill mix and staffing levels 
 
In spite of the limitations on training, it is clear that it still takes place as 
training staff to achieve an appropriate skill mix is still high on the agenda 
for the majority of sites. There is greater flexibility as more nurses are 
trained to undertake various additional roles such as admitting and 
discharging patients, taking consent, performing cannulation, triaging 
referrals, visiting inpatients to assess them before endoscopy, running pre-
assessment clinics and writing patient information: 
 
We’ve looked more at skill mix and we’ve upped the skills of our 
nursing assistants so they now discharge patients and take cannulas 
out and do much, more than they did a year ago. (6.2/423) 
 
In many units nurses rotate within the unit so that they fully understand the 
various aspects and can provide cover as and when necessary. Nurses are 
able to take on these additional roles because health care assistants are 
carrying out non-nursing duties such as setting up equipment and washing 
scopes, something that was also highlighted in the first round of interviews. 
However, three sites reported the further development of health care 
assistants in that one was training to do ERCP and another two as Training 
Associate Practitioners (TAPs). 
 
In the first round of interviews there were just two units that did not have 
NEs. Two years later all the endoscopy units have NEs and units reported 
that while many nurses were still training, particularly in colonoscopy, many 
were now fully competent and running their own lists which helps 
throughput, they are able to take on the routine work of consultants freeing 
them up for more complex procedures and are also flexible and being used 
to backfill adding to the efficiency of units. In one Control site a NE had 
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become the Clinical Lead for endoscopy, a role usually taken by someone at 
directorate level. 
 
A clinician pondered on the future of the role of the NE believing that with 
technological advances, the demand for diagnostic endoscopy and therefore 
routine flexible sigmoidoscopy and colonoscopy will fall in the future and 
there will be little work for NEs unless they become “super specialised as 
consultants” (14.1/166). 
 
There is a growing interest in training non-medical, non-nursing people to 
undertake roles that would traditionally have required a medical 
background, with three sites currently involved in training endoscopy 
technicians and one site training a member of staff who has run a 
physiology service for 10 years now training to run a dyspepsia clinic: 
 
“…I think it is the principle, that you can train someone who is not 
medically qualified to not only do the procedure but also use 
sedation.” (15.1/229) 
 
It is interesting to note that staff in several units reported becoming 
involved with other units within their Trust to help in the modernisation 
process and promote standardisation of practice across the Trust. Those that 
spoke about it felt it was important to standardise practice for various 
reasons such as patients receiving the same information wherever they were 
referred within a Trust and in order to streamline nursing practice: 
 
It is all streamlined from the nursing aspect, just the same 
documentation and we are all moving in the same direction, working 
together as one big team rather than four separate teams. 
(14.3/208) 
 
Moving to a new unit had given some units an opportunity to review their 
staffing and at one site the move had initiated changes in the work of some 
nurses because they had started undertaking day case procedures related to 
gastroenterology, e.g. blood transfusions, paracentesis and iron infusions 
which had impacted on bed stays in the hospital as patients would 
previously have been admitted to a ward. 
 
In the first interviews the importance of clerical staff was highlighted and 
this was reiterated: 
 
“… getting the booking co-ordinator really trained I think for the 
running of the unit you need, that is the first port of call and you 
need that to run efficiently.” (3.2/179) 
 
It was also apparent that in the last two years clerical roles had expanded 
with almost a quarter of interviewees explaining that clerical staff had taken 
on more responsibility: 
 
The two secretaries, one on each site, have become service co-
ordinators and they are going to link in with the doctors filling the 
sessions – their jobs have expanded. They are in close liaison with 
the consultants so hopefully they will be able to look at the templates 
and get them to swap about. (4.2/46) 
 
As in the first round of interviews it was reported that more staff had been 
recruited such as scope cleaners, data analysts, clerical support, endoscopy 
managers, nurses and consultants. However, when interviewees spoke 
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about staffing levels it was often set in the context of current difficulties 
arising from Trusts being in financial crisis and many reviewing jobs, 
restricting the use of bank staff and maintaining a freeze on recruitment 
resulting in half of the interviewees commenting on the need for additional 
staff at all levels including clerical: 
  
“… poor 7.21 is our booking clerk and her workload is humungous … 
could do with another admin person really.”  (7.2/537 & 553) 
 
Just two Intervention sites reported actually losing staff but had overcome 
this by planning with what staff were available and by changing shift 
patterns. 
 
Given the current climate, interviewees were reasonably satisfied with 
staffing levels but acknowledged that this impacted on their work, for 
example, restricting waiting list initiatives, lists being cut, an inability to 
backfill lists, restricting training: 
 
If you don’t have enough staff then you can’t do the job anyway, 
then you can run into training issues and you need so many staff to 
train and then you’ve got to encourage them to train and it’s just an 
ongoing cycle but it’s always down to numbers in the end I think. 
(2.2c/518) 
 Patients 
 
In the first round of interviews sites were at different stages of modernising 
their units and participants spoke about the way in which they hoped to 
modernise endoscopy services to improve access to, and experience of, 
endoscopy for patients. As all sites had made progress in modernising their 
units by the time the second round interviews took place, participants were 
able to reflect on the changes and their impact on patients. 
 
As in the first round, participants recognised the need to provide patients 
with high quality care and support but in the second round they spoke more 
about ‘quality’ and how this issue has moved up the agenda as a result of 
the GRS and its assessment of ‘clinical quality and quality of patient 
experience’. However, they did not define or elaborate on what they meant 
by quality or patient-centred, high quality care. As mentioned on page 240, 
because the conversation about quality relates closely to data about the 
GRS and Bowel Cancer Screening, it is difficult to assess whether the patient 
is really at the centre of this quality agenda or benefiting almost by default 
as units strive to achieve high GRS scores. Nevertheless, participants did 
talk about patients in ways that demonstrate that the aim of the 
modernisation process is to improve the service for patients and these are 
described below.  
 
In the first round of interviews it was clear that many of the changes were 
aimed at improving the service for patients and this was similar in the follow 
up interviews with many of the changes introduced over the last two years 
aimed at improving the service for patients:  
 
So there have been a lot of improvements, not directly necessarily 
relating to the endoscopy procedure itself but globally we are able to 
do a lot more with patients than we ever before have. (14.1/701) 
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However, in the second round of interviews there was evidence of a greater 
commitment to patient satisfaction with most interviewees referring to 
patient satisfaction and the fact that they take action on patients’ 
comments, for example, keeping patients informed when there is a delay 
caused by an emergency. Patients appear to be more involved in that they 
have been shadowed and in some units are invited to take part in patient 
forums “that has been great because it has given us a handle on what is 
going on” (9.1/31). However, it was pointed out that getting patients 
engaged in a forum can be difficult and it was suggested this might be 
because the time in endoscopy is only a short part of their overall pathway 
but for this very reason it was “really important for us to be seen as being 
professional” (5.2/566). 
 
Some of the general changes mentioned in the first round of interviews were 
mentioned again such as improved information leaflets, some now 
accessible on the internet, patients being given patient-friendly reports and 
translation facilities when required. An example of a change introduced in 
one unit in the last two years that directly impacts on the service for 
patients, is evening clinics which enable patients to attend without having to 
take time off work. 
 
It was noted that anxiety that can be caused to patients when guidelines are 
changed resulting in patients being removed from waiting lists or having 
less frequent surveillance procedures. It was felt that it was important to 
bring the patient up to a clinic to explain the reasons behind the decision: 
 
“… we don’t want to cause anxiety in patients’ minds so usually I will 
book them into a clinic to have a chat with them. We do that pretty 
quick because these people have been waiting for a long time, it’s not 
fair to leave them waiting again for clinic.”  (1.1/46) 
 
In addition to quality improvements, the majority of interviewees also 
believed that patients have better access to endoscopy because of shorter 
waiting times, greater throughput, more patient information, including, in 
some units, a copy of the endoscopy report, choice of date and booking from 
outpatient clinics so patients have an appointment before leaving hospital. 
They also felt units were more responsive to patients’ views and comments, 
and in some units that there was better communication between reception 
staff and patients: 
 
There is much more patient information provided, for example, a 
simple thing, they now get a copy of the endoscopy findings so I 
think patient information has improved. (7.1/371) 
 
I think patients are more aware of being able to phone in, talk about 
their procedures, get their appointments and talk to anybody that 
they need to talk to. (3.2/443) 
 
However, a minority of interviewees felt that accessibility had not improved 
because colonoscopy waiting lists remain too long, and guidelines have 
restricted access to endoscopy, although this was acknowledged as 
necessary to cope with demand: 
 
In the past it’s been a case of ‘they’ve got a bit of heartburn, scope 
them’, but now perhaps we’re not becoming so accessible with all the 
new guidelines. I think we’ve got to be choosy in who we do, haven’t 
we?  (1.2/487) 
 
The ENIGMA study 
©NCCSDO 2008 Page 250 
At a small number of sites accessibility was felt to be impeded because of 
difficulties getting through to booking centres and at one site, accessibility 
for patients in terms of contacting the unit had deteriorated as a result of 
the hospital’s automated telephone system and the fact that when patients 
got through to the unit they often reached an answerphone. 
 
The majority of clinicians and key people from all sites also felt that the 
service was more acceptable to patients with several citing the good results 
of patient satisfaction surveys and stating that units do respond when 
patients highlight problems: 
 
“…picking up on a few things that the patients have said with the 
satisfaction survey – noting the privacy bit, we are a bit short on 
space here but being aware of that sort of thing is good ... so we got 
rid of all the seats, made our sub-wait area bigger so we only had 
two seats in reception, so there is only one person there at a time, 
confidentiality was the impact there.”  (3.2/466) 
 
Specific reasons for the service being acceptable included:  shorter waiting 
times, nicer environment, more privacy, better patient information, choice 
of appointment, improved quality and patient focused staff. 
 
The aesthetics of it are better. It’s nicer, it’s a nicer place to be. The 
safety side of it is much better controlled. … décor is reassuring I 
think … somebody meets the patient, books them in, talks them 
through their procedure and that is somebody who has got time 
because they are the person who has been designated to do that and 
then they chat to them as they go along the corridor and accompany 
them to the rooms so it’s just better. I think it’s much more 
acceptable to patients. (12.1/489) 
 
While many of the changes were undertaken to benefit patients and the 
majority of interviewees felt that the service had improved, was more 
accessible and acceptable, there were some reservations about particular 
aspects of the service. A quarter of interviewees felt that there could be 
more privacy and dignity for patients and that changing the structure of 
units would help with this but this was not really feasible because the 
recovery area has to be set up in the way it is for patients to be cared for: 
 
“… obviously your dignity is preserved because you are in a different 
unit, a room to have the procedure done, but actually it’s the 
recovery area isn’t it … it’s not very private, I mean there are screens 
and things so your dignity is preserved but if I had to chose that 
would be the one thing I would change.”  (20.2/381) 
 
The idea was raised that patients, particularly patients with cancer, just 
want to be seen and treated quickly and that resources are not available to 
respond to everything that patients want: 
 
“… the NHS hasn’t got the resources to listen to every single person 
and that is why they are having a problem because every single thing 
you do has an audit on patient satisfaction and we are killing 
ourselves trying to provide an efficient service, increase capacity and 
make everyone happy and we can’t do that with the funding we have 
got.”   (16.2/287) 
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Summary – The human dimension of endoscopy units 
 
As in the first round of interviews, working relationships and morale was 
generally reported as high in the units under scrutiny, and staff were 
positive about, and supportive of change, as long as there was good 
communication among them and they all felt fully involved. However, some 
units had seen improvements in morale and this was evident in the four 
sites that had moved to new units. While this had proved to be a difficult 
and disruptive time, it was an experience that pulled staff together and 
combined in a positive way the benefits of working in new units. 
 
There are still tensions, albeit reduced, between those who use the facilities 
of the endoscopy units. Physicians and surgeons, for example, display 
ongoing tensions with regard to scoping each others’ patients. In addition 
the introduction of the two-week-wait referral has created tension as 
physicians’ patients are pushed down the waiting list. However, it appears 
that working relationships are improving and there was less emphasis in this 
round of interviews on infighting between physicians and surgeons. Indeed, 
there is a reported improvement in relations and it has emerged that better 
understanding is in evidence between the two groups, with specific 
examples of such as less resistance to change from surgeons. 
 
This reduction in the reporting of resistance is reflected in the interviews 
generally. In the first round of interviews some interviewees spoke about 
resistance, not from experience but in anticipation of what might happen. 
However, all the units had now gone through the process of modernisation 
and the fact that resistance was mentioned infrequently reflects the fact that 
it was less of an issue. 
 
Better working relationships and stronger staff morale are attributes that 
are important in supporting the achievement of an appropriate skill mix 
within units, something that is still high on the agenda. There has to be 
understanding and flexibility when staff are undergoing training and an 
acceptance of the development of training non-medical, non-nursing people 
to undertake roles that would traditionally have required a medical 
background. There is greater flexibility as the nurses who were reported as 
undertaking training in the first round of interviews, for example in 
colonoscopy, have completed their training. Nurses also continue to 
undertake various additional roles and in many units rotate so that they are 
trained in all aspects of the unit. There are also reports of the expansion of 
some clerical roles with staff taking on more responsibility. 
 
While achieving an appropriate skill mix is of importance to the efficient 
delivery and organisation of endoscopy services, it does make demands on 
staffing levels and while additional staff had been recruited over the last two 
years, it was clear that because of the pressure of work more are needed, in 
particular nurses and clerical staff. 
 
Patients are perceived to benefit from units where staff have good working 
relationships and high morale and where the modernisation process has 
resulted in improvements in the delivery and organisation of the service. 
While it is difficult to assess whether the quality agenda is driven by targets 
or patients, there is evidence that the aim of the modernisation process is to 
improve the service for patients and there is greater commitment to their 
satisfaction. The service is generally thought to be more accessible and 
acceptable to patients although it is acknowledged that there are areas 
where further improvements can be achieved. 
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Two years after the first interviews there are some ongoing issues with 
regard to staffing but it appears that going through the process of 
modernisation, with someone to lead the change, has built stronger 
collaborations among staff, particularly with those outside endoscopy units. 
With morale improving further there is also less resistance to change. It is 
difficult to ascertain whether the patient is really the focus of the 
modernisation process or whether the focus is the achievement of targets, 
and neither patient-centred, quality care nor quality services were clearly 
defined. Nevertheless, in achieving the targets patients are benefiting from 
improvements in the clinical quality and quality of experience when having 
an endoscopy. 
8.9.3   Theme 3 – Financial resources 
Introduction 
 
This theme picks up on the availability of financial resources and, as in the 
first round interviews, links many of the interviewees, who have similar 
concerns about the limitations of resource restrictions and how lack of 
finances impacts on: staffing, equipment, information technology and 
facilities. The theme also highlights those issues that arise when money is 
available and examines people’s successes or otherwise in getting funding. 
This theme will identify important changes that have raised the profile of 
endoscopy within Trusts and elaborates upon how interviewees perceive 
funding policy to have changed in the last two years. It explores the impact 
of these changes on their units, the concerns over ‘payment by results’, and 
the implications of endoscopy being done in primary care and the 
independent sector. 
 An issue of concern 
 
As in the first round of interviews it was acknowledged that some 
modernisation initiatives could be achieved within existing resources such as 
the more efficient use of lists, but there was frustration that for very little 
extra funding it was felt a lot could be achieved. However, some 
interviewees disagreed strongly with the idea that change is cost neutral, 
one blaming the Department of Health (DoH) and the other tabloids as the 
source of the idea: 
 
There is a management ethos which I think probably stems 
somewhere from the DoH that change has to be cost neutral which, 
of course, is rubbish. (4.1/479) 
 
The majority of clinicians and key people from all sites felt that the financial 
situation had deteriorated in the last two years and that “everything is cost 
orientated, much more than it used to be” (2.2/275). It was appreciated 
that the use of resources needed to be carefully controlled and almost all 
interviewees, while accepting their current financial situation agreed that 
they are facing greater financial constraints than two years ago because of 
tighter control of finances within the Trust often explained as a consequence 
of financial crisis within Trusts. Interviewees were frustrated over the 
demands of striving to improve the service but within tighter financial 
constraints and this was impacting on the ability of endoscopy units to 
recruit staff, run weekend lists, purchase equipment, update IT systems, 
train staff to achieve an appropriate skill mix, allow study leave, make 
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minor structural changes, open additional endoscopy rooms and develop the 
service. There appears to be a constant battle to win additional resources: 
  
Personally I think we are restricted by the lack of NHS funds and 
therefore re-equipping and the rolling replacement programme, I 
don’t think we’ve actually got enough endoscopes for the procedures 
that we are doing. We could be doing more. (12.1/282) 
 
 
This hospital has had a major financial crisis in the last two years and 
there has been a very strict review of expenditure. We can’t employ 
people on the bank any more … I’m sure that’s had an impact on the 
amount of work that is done here. (3.1/341) 
 
However, it is clear that similar to two years ago, various sources of funding 
are being sought and while the submission of business cases remains “…a 
tortuous process” (14.2/633) important changes in the form of the 
introduction of the GRS and Bowel Cancer Screening have occurred, raising 
the profile of endoscopy within Trusts and proving to be useful leverage 
tools when applying for funding. Some interviewees reported success in bids 
for equipment and staff but emphasised that in comparison to two years ago 
the GRS and Bowel Cancer Screening had made a difference when applying 
for funding: 
 
I mean it’s always been difficult to get hold of money but I think 
particularly in the last six months to get service improvement pushed 
ahead with additional monies is very difficult but we have waiting 
lists which need to be hit and things like the Bowel Cancer Screening 
are very effective levers in getting additional money. (10.1/565) 
 
The overall picture was that finding additional resources for equipment, 
additional staffing, training and modernisation initiatives was not easy and 
had to be fought hard for and just a few interviewees expressed some 
optimism for the future: 
 
I predict that it will be more favourable, we will have a fairer amount 
of funding from now on, partly linked to payment by results … partly 
linked to the fact that we have got the 18 week target in 2008 and 
we know that we have got to get our diagnostic waits down to six 
weeks to be successful. So I think that as long as we continue to 
demonstrate that we are using current resources efficiently ... then I 
think it is going to be easier to argue and get extra resources…. 
(12.2/568) 
 
However, there were concerns about ‘payment by results’ especially 
expressed in terms of the tariff that will be attached to procedures and 
whether the money will actually reach the endoscopy unit: 
 
Whether that money comes down to us is a different question. … 
They will spend it on other bits. If we are being efficient and we’re 
gaining lots of money they may have to … there are some services 
that are crucial but aren’t money spinners. I think we are sort of low 
hanging fruit really, easy picking to make money. (9.1/509 – 519) 
 
Linked to payment by results is anxiety that as the procedures have a fixed 
cost in secondary care, PCTs may find cheaper endoscopy in primary care or 
the independent sector. One clinician, while welcoming the transfer of some 
capacity to an independent treatment centre, felt the amount of money 
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being transferred was far in excess of what they are paid to do the 
procedures: 
 
Any strategic planning thrown into complete disarray by DoH decision 
to remove 20% of activity and to transfer what will amount to 50% 
of our funding to an independent sector who will build an endoscopy 
service. (17.1/159) 
 
The concerns over payment by result and the impact of endoscopy in 
primary care and the independent sector makes forward financial planning 
difficult for those trying to manage endoscopy units. 
 
Summary – Financial resources 
 
It is clear that financial resources are an ongoing concern in the majority of 
endoscopy units and there is tighter financial control than two years ago due 
to the financial crisis in the majority of Trusts. While there is an 
understanding of the need for careful control of finances (and once again 
recognition that some changes that can be made at no additional cost), 
there is clearly frustration that the lack of funding does place limitations on 
further development of the endoscopy service. Lack of funding restricts the 
appointment of additional staff, opening more endoscopy rooms, purchasing 
equipment and updating IT. The situation has also impacted on the ability of 
staff to attend study days and conferences. Nevertheless, staff continue to 
seek funding and go through the process of submitting business cases, 
some of which are successful. 
 
There is concern about the future of the units with regard to the impact of 
‘payment by results’ and the financial implications of endoscopy taking place 
in primary care or the independent sector, making planning for the future 
difficult. In spite of the concerns, however, it was felt that the GRS, NBCSP 
and the 18 week target have pushed endoscopy up the agenda in Trusts and 
have raised the profile of units. As a consequence, these services have been 
useful levers in acquiring funding. 
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9   Professional views at non-study sites 
9.1   Executive summary 
 
Four focus groups were conducted, the first (FG1) in England with non-
participant endoscopy specialists who had not been involved in the study. 
The other three (FG2, FG3 and FG4) were in Wales with gastroenterology 
professionals who had no connection with the ENIGMA study, but were 
aware of the NHSMAs work.  
9.1.1   Aim 
 
The aim of the focus groups was to capture people’s views on innovations in 
service delivery and organisation and to examine whether any of the issues 
raised by the group had resonance with other study data. In addition, the 
Welsh focus group data were considered in terms of overlapping themes and 
data resonance with the English focus group data and in addition, Welsh 
focus group participants’ responses to the NHSMA’s support for English 
endoscopy units and the impact change in England had had on Welsh units. 
9.1.2   Participant groupings 
 
FG1 comprised five gastroenterology professionals (four consultants one 
nurse researcher). FG2 comprised three participants, one endoscopy 
consultant and two endoscopy nurse specialists. FG3 comprised six 
participants (physicians and surgeons) and FG4 comprised six participants 
(physicians and surgeons).  
 
Participants who took part in the Welsh focus groups represented hospitals 
across Wales, between Carmarthen and Merthyr Tydfil. Four of these 
hospitals were teaching hospitals. Participants were accessed through the 
British Society of Gastroenterology’s (BSG) list of all registered 
gastroenterologists in the UK and were sent details of the study and the 
request to take part in a focus group. On the day of the focus group 
participants were reimbursed in recognition of their time. 
9.1.3   Method 
 
Each focus group followed a similar procedure, lasted approximately one 
hour and was tape recorded and transcribed. Focus groups were facilitated 
by the ENIGMA qualitative research lead (FR) or one of two senior research 
officers working on the study (AS, GJ). In each case an observer was 
present to take notes, manage the tape recording equipment and discuss 
their overall impression of the focus group with the facilitator at the end of 
the session. The focus groups were facilitated according to a pre-designed 
interview schedule. The same schedule was used for all focus groups with 
the Welsh groups having one additional question regarding the NHSMA’s 
support for English units and the impact of change in English units on Welsh 
units. The interview schedule was devised to respond to the other 
qualitative datasets in the study, such as the professional interviews, and 
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concentrated on issues connected with: staffing, changes in units, funding, 
and barriers and facilitators to change. The focus groups enabled all 
participants to have an equal say in discussions, whilst many questions were 
directed to each participant in turn.  
9.1.4   Analysis 
 
Analysis was undertaken to derive first summative paragraphs from group 
analysis sessions and then a final paragraph that defined the main aspects 
of each focus group. Using the ‘wholistic’ (sic) approach to data analysis and 
management (van Manen 1990) , all summative workings attempted to 
capture the essential significance of the text. This approach was supported 
by in-depth examination by seven data analysts working as part of the 
ENIGMA team. The whole process was managed by the lead qualitative 
researcher with support from the two researcher officers.  
9.1.5   Findings 
 
Major themes arising suggest similar issues are of concern to both English 
and Welsh focus group participants and there was little variation across 
themes. Two of the three Welsh focus groups, in particular, presented a 
disappointed group of individuals, with disparate opinions, seeing recent 
changes in gastroenterology as predominantly for the worse.  
 
The major points to arise concerned:  
 
1) The lack of senior management understanding and management 
systems in place to appropriately support the work of the units. The lack of 
support and support systems meant units were unable to make appropriate 
and long-lasting changes to service delivery and organisation, whilst 
decisions towards modernisation were made by ill-informed management 
with neither scientific, clinically experienced nor evidence-based approaches 
to change. This was exacerbated by a lack of funding for necessary changes, 
particularly in Wales, and a general sense across English and Welsh groups 
of extensive resource deficit.  
 
2) Resource deficits such as under staffing meant that those changes that 
had taken place, such as the investment in new equipment or the 
implementation of new procedures could not be best utilised. However, 
participants were keen to stress that in spite of lack of funding some 
positive changes had taken place such as pooling of lists that did not have 
resource implications, but most changes towards innovation and 
modernisation could not be undertaken without funding. This deficit de-
motivated participants, as they felt their needs were not being recognised or 
met, particularly nursing staff, where training would enable them to take 
more responsibility, meet tasks more appropriately and take a stronger 
leadership role.  
  
3) Staff – internal discord within units: There was also an awareness of 
discord between factional groups, both in England and Wales, and a sense of 
tribalism within units. Here different groups working in the same unit spaces 
were unhappy to accommodate each others’ needs as a result of a sense of 
territorialism over patients and lack of communication between groups. This 
was most evident amongst surgeons and physicians, but also amongst 
junior and senior staff and between staff and managers.  
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4) Erosion of professional self-identity: Lack of recognition by senior 
management for the work of the units, lack of steer (particularly discussed 
in Welsh groups) from the Government, lack of match between political, 
managerial and unit agendas, low profile for endoscopy in the Trust, lack of  
support systems in place and factional discord led to disillusionment 
particularly amongst senior clinicians. It also led to an erosion of individual 
autonomy, whereby notions of professionalism linked to the individual’s 
ability to make informed decisions that could impact on modernisation, was 
being undermined. This left a dispirited workforce, with low morale, 
perceived as employees rather than professionals. This could be countered, 
to some extent, by a few motivated individuals who tried to make a 
difference and were described by their colleagues as leaders in the field and 
by the excellent support of nursing staff and the good working relationships 
and team working within teams. Indeed, much progress had been made in 
terms of team working. However, particularly in Wales it would appear that 
sticking together was part of a ‘sinking ship’ mentality, where people cling 
to the same life raft, because all around is chaos, creates a sense of team 
commitment, integration and belongingness.  
 
5) Patient focus versus Government targets: Where facilitators to 
change and their outcomes were mentioned, reduction in waiting times was 
of particular note. Interestingly however, this was rarely discussed in terms 
of patient benefit or changes to patient care or increased patient 
satisfaction. Rather, patients were noticeably absent from the conversations, 
and it was the need to meet Government targets, such as a reduction in 
waiting times, that drove change. From participants’ narratives it became 
apparent that reduced waiting times, almost by default, are of primary 
benefit to patients.  
 
6) Political Visibility of Gastroenterology: Participants mentioned the 
Global Rating Scale (GRS) and NHS Bowel Cancer Screening Programmes 
(NBCSP) as helping to bring more visibility and credibility to the work of the 
units, and they saw these initiatives as predominantly positive. There was 
also the opportunity that these initiatives would bring further funding to 
units and ‘put units on the map’. Finally Welsh groups described Welsh units 
as lagging behind their English counterparts, though they were considered 
on a par when it came to services. To some, lagging behind was 
disadvantageous, whilst others spoke of the opportunity to learn from 
successes or mistakes following the changes that had been engendered in 
England through the work of the MA.  
9.2   PART 1 - Focus Group 1: Non-participant 
endoscopy specialists in England 
 
Part 1 describes a focus group that took place with a group of endoscopy 
specialists in England who did not participate in the ENIGMA study, neither 
as an Intervention or Control site. Part 2 describes a further three focus 
groups that took place with endoscopy specialists in Wales to put the 
English focus group data into perspective. Each of the four focus groups will 
be discussed in turn. In both English and Welsh cases, each Part begins with 
a background section, followed by methods and group conduct and analysis. 
Each focus group starts with a summary of results followed by the major 
themes arising. A presentation of individual research analysts’ summative 
analytic paragraphs can be found in Appendix 16. 
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9.2.1   Focus group 1: Background 
 
On March 21st 2006 a one-hour focus group was conducted with five 
Gastroenterology professionals (4 consultants and 1 nurse researcher) 
representing five units from five Trusts and who were members of five 
different Endoscopy Units not directly involved in the ENIGMA study. The 
aim of the focus group was to capture their views on innovations in service 
delivery and organisation and to examine whether any of the issues raised 
by the group had resonance with other study data. 
 
The study team felt it was important to talk to those not sponsored in any 
way by the NHSMA to gain an understanding of the barriers and 
achievements in units completely independent of the NHSMA. To facilitate 
this, details of the ENIGMA study were circulated to members of the BSG 
asking those who were committed to genuinely independent redesign of 
their gastroenterology services, to contribute to the study. Thirteen 
gastroenterologists responded and when contacted again, five of these were 
available to take part in the focus group. 
 
The focus group was held halfway through the ENIGMA study. As these sites 
were independent of the NHSMA, the ENIGMA study team had not contacted 
them in the intervening period, so the extent of redesign in the sites was 
unknown. It was hoped that by the time the focus group was convened, the 
sites would have had sufficient time to have some experience of redesigning 
their gastroenterology services. 
9.2.2   Method 
 
The focus group was supported by an interview schedule comprising five key 
questions. These were derived from the literature and developed in line with 
study aims and interview schedules from previous interviews with key 
people and consultants in Control and Intervention sites. This ensured 
consistency within the data collected and enabled the team to consider any 
emergent cross-comparator themes. Issues covered included: 
 
 Perceived facilitators and barriers to change; 
 Changes made in units; 
 The necessity for funding for innovation development; 
 Staff responses to the introduction of change within and across 
services; 
 The success of those changes that had been implemented. 
 
A qualitative methodologist with expertise in focus group work facilitated the 
focus group (FR). A researcher took notes, and observed and recorded the 
session (AS). The facilitator was responsible for questioning the group and 
prompting for detail, the observer, for observing the session and taking 
notes about group interaction, body language and agreement or 
disagreement across topics. Both facilitator and observer discussed what 
had taken place at the end of the focus group and further insights were 
noted. 
9.2.3   Analysis 
 
Analysis was undertaken in accordance with an adapted analysis framework 
developed by the Dutch pedagogue, Max van Manen (van Manen 1990). van 
Manen describes his ‘wholistic’ or ‘sententious’ approach as a means of 
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encouraging summative paragraphs of text that capture a text’s essential 
significance, before in-depth examination of data can take place. van Manen 
argues for the examination of meaning crystallised from the whole, rather 
than from small, workable portions of text. The sententious approach can be 
used with large or small data sets and concentrates how understanding can 
be drawn out into essential and non-essential themes, which are then 
codified. This approach involves both individual and group work. Individual 
researchers write a paragraph of text that is taken forward and reviewed by 
a group of research analysts. Researchers read each other’s paragraphs and 
use the group session(s) to explore comparative themes and features that 
might be described as outliers within the text. Group discussions encourage 
sharing of ideas and reflect on the main impact of data towards a 
concordance of views.  
 
Six researchers analysed the data individually and five were involved in one 
group analysis session discussing how text might be distilled into its 
essential properties. Thorough, in-depth examination of the data enabled 
the group to work towards individual and group summative paragraphs.  
9.2.4   FG1  
 
In line with the analysis process, results are presented in terms of the 
group’s summative paragraph followed by a detailed examination of the 
main, emergent themes. Individual summative paragraphs have been 
included in Appendix 16.  
9.2.5   FG1 Summary of results  
Discordance between groups 
 
There was some discordance identified between three groups of people: 
those supporting change or ‘change hungry’ innovators (such as a number 
of those people involved in the focus group interview), those colleagues with 
whom innovators came into contact who were resistant to change (such as 
surgeons), and managers.  
Lack of cohesion 
 
Differences were mentioned between the different groups of professionals, 
particularly doctors and nurses. Doctors were seen as more resistant to 
change, nurses as more compliant, though not universally so. Reasons for 
differences between these groups were related back to doctors’ medical 
arrogance, the sense that they were already overburdened with work and 
clinician autonomy. 
Positive changes 
 
Changes that had been introduced that had made a difference included the 
pooling of lists, guidelines for patient management and referral and the new 
Nurse Endoscopist (NE) role. 
Barriers to change 
 
Focus group participants discussed many more barriers than facilitators to 
change. In addition, barriers to change were mentioned first, and the 
The ENIGMA study 
©NCCSDO 2008 Page 260 
Government, senior management and lack of resources came in for 
particular criticism. 
Affecting real change 
 
Frustration was strongly felt alongside a sense of failure to affect 
improvement. Improvement had been achieved, but there was the notion of 
failure to affect real change. Frustration was also linked to lack of resources 
and poor working relationships with management. 
Lack of managerial support 
 
As the keepers of resources, managers were perceived as needing to work 
more closely with the individual units to support their needs. Good 
management could help facilitate change whilst bad management could 
clearly discourage change. 
Funding 
 
Funding was critical for achieving change, but it was recognised that there 
was still an identified lack of resources for the purpose of innovation. 
Furthermore, there was the need to re-deploy resources to affect change. 
Low staff morale 
 
Low staff morale, resulting from staff pressure and stress, was in evidence. 
This was described as being exacerbated by an increase in referrals, the 
burden of extensive workloads and the manner in which change was 
introduced, without clear implementation strategies in place. 
9.2.6   FG1 Results in detail: main themes arising 
Discordance and lack of cohesion between professional groups 
 
There was discordance between different groups of people in terms of their 
views of the need for change and innovation: change hungry innovators, 
those colleagues with whom innovators came into contact (such as 
consultants) and managers. This was exacerbated by a lack of cohesion 
between doctors and nurses. Doctors were considered the most awkward of 
the professional groups, ready to resist change within what was perceived 
as an environment dictated to by out-of-touch management. Doctors were 
particularly resistant to those changes relating to management agendas and 
unwilling to adapt to changes of which they did not approve. Doctors were 
more likely to respond to changes introduced by their peers with whom they 
came into regular contact and those changes that were part of a more 
gradual, accumulative process.  
 
If you can get one or two clinicians on board then others start 
responding, if it’s the right kind of environment and not dictated to 
by management (FG1.1). 
 
Doctors were described as overburdened by change, especially changes 
introduced ‘through the back door’.  
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We feel saturated so that any other change that is brought on is seen 
as another thing we need to do (FG1.5). 
 
They saw themselves as at the pinnacle of their career and consequently 
powerful, autonomous individuals, most likely to know the necessities of 
their job.  
 
We are trained to be autonomous individuals, we think quite highly of 
ourselves, or we did… through research and things we are 
encouraged to develop our own hypotheses and take things through. 
And all of that’s being challenged… so it can feel a little bit like a 
nuclear attack (FG1.1). 
 
Doctors are trained in a certain way to be independent thinkers and 
to make decisions and to hold a view (FG1.2). 
 
Nurses were also perceived as resistant to change in certain circumstances, 
and this resistance had led to bad relationships with management.  
 
There are limits up to where nurses will come on board as well 
(FG1.5). 
 
Poor management came in for criticism, seen to be discouraging change, 
even preventing it.  
 
The main barrier is the management team (FG1.5).  
 
Managers were described as resistant to changes introduced by endoscopy 
professionals, unable to develop close working relationships with endoscopy 
professionals, unsupportive of individuals and determined to push through 
unpopular initiatives. Nevertheless, in different ways participants recognised 
that good management had the potential to facilitate change. 
Facilitators and barriers to affecting real change 
 
Focus group participants, with possibly one exception, were keen to express 
their support for the modernisation of endoscopy units, the improvement of 
services through change and the innovation of service delivery. However 
there were a number of recognised impediments to long-lasting change. 
Firstly, when asked to discuss changes that had been implemented, there 
was an expression of general scepticism, with barriers to change highlighted 
over and above facilitators to change. Secondly, many more barriers than 
facilitators were mentioned, and the Government, senior management and 
resources all came in for particular criticism. 
 
Backlogs are getting even worse, being driven by Government 
directive rather than clinical need (FG1.3). 
 
Thirdly, there was little belief in those changes that had been introduced 
affecting any real change. Finally, there was discontentment at the speed 
with which changes were introduced and disappointment that those changes 
that had been introduced were time-limited.  
 
It’s not change that is the problem it’s the rate of change – trying to 
get a BMW into a mini. What have we done? (FG1.3). 
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Facilitators to change included: fast tracking of patients, more NEs, sensible 
targets, pooled lists, new guidelines for referral and management of 
endoscopies, prep nurses and more specialist staff. Longer waiting lists were 
also, paradoxically, seen as a facilitator for change, encouraging the 
generation of new resources and acting as impetus to the fulfilment of 
waiting list targets. 
 
Longer waiting lists generate pressure on managers to put resources 
in to get rid of them (FG1.2). 
 
Nevertheless, lack of resources was still in evidence, alongside: lack of 
involvement by managers, staff’s inability to overcome traditional working 
patterns and little agreement as to who should be leading on strategy in 
relation to innovation.  
Funding 
 
It would appear that much can be achieved within existing resources 
through greater efficiency, driven by targets, audit and guidelines, as well 
as changing roles, notwithstanding the feeling that funding is the main 
barrier to improvements. Indeed, the notion that not all change requires 
funding was defined in terms of professionals’ ability to cleverly re-deploy 
funds and manipulate the service to meet their own goals.  
 
You can out-manoeuvre a manager any day you like… I bet you’ve 
got yourself into trouble like we have because we’re too good 
(FG1.3). 
 
However, re-deployment and manipulation was countered by the sense that 
Government driven initiatives and associated funding opportunities as well 
as poor resource decisions were undermining the power of the professionals 
to move forward and influence local need.  
 
They have just completely redone the car park and employed two car 
park attendants to facilitate the patients arriving in the hospital… that 
is the sort of thing that gets intelligent little chaps like me a little bit 
flustered and wanting to give up (FG1.3). 
 
Funding was, nevertheless, seen as critical to achieving real change: “You 
have to invest a bit and that’s where funding comes in” (FG1.2), and 
examples of where funding was particularly necessary, included: the 
appointment of extra staff, the purchase of new health and information 
technology, the replacement of old equipment, the payment of incentives, 
and the refurbishment of buildings.  
Staff morale 
 
Staff morale was described as being low, especially amongst doctors, a 
downside to change.  
 
There is an attitude of suspicion (FG1.1). 
 
Nurse morale is really low and if they don’t do something, they’ll all 
be leaving (FG1.4). 
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However, there was general agreement that changes had been effective and 
had led to greater efficiency, with people working more quickly but perhaps 
achieving less.  
 
Our unit is more efficient than it used to be, bit more consistent 
(FG1.4). 
 
Maybe the numbers of referrals have gone up so much that we can’t 
seem to be making any inroads (FG1.5). 
 
Change may be a good thing: “I think they have worked well” (FG1.2), but 
this was often described as being at the expense of morale, which had 
worsened of late: “They were good changes but it doesn’t feel that way, I 
can’t explain why” (FG1.5). There was also the sense that participants, 
though not directly involved, perceived the NHSMA Programme as being 
neither run smoothly nor well received. They commented that in general, 
professionals had been left with: “all the responsibility and no authority” 
(FG1.5), failing to recognise improvements in their units and feeling that 
they were under attack. When Trusts functioned well and changes fitted in 
with the professionals’ ways of working, the results were more effective. The 
group concluded that there needed to be better retention of staff, greater 
nurse engagement, less staff pressure and stress and fewer challenges to 
doctors’ autonomy from management.  
 
We found that nurses that are leaving through natural wastage are 
not being replaced, it’s a deliberate act not to replace them (FG1.3). 
 
The sense of frustration and failure to affect improvement was strong and 
‘change fatigue’ was in evidence, though there was also the hint that strong 
leadership and the application of change management is vital to progress. 
9.2.7   Additional points of note 
 
1. Although no questions were directly addressed about patient experience, 
patients were on the periphery of the conversation. 
 
2.   Innovations have been a success in terms of outcomes (speed of 
referral, waiting list reduction, improvements to the process of patient 
throughput). This must be tempered by anecdotal evidence of weak 
management, missed opportunities, poor relationships between professional 
groups and perceptions of misuse of funding. 
 
3. Staff morale is low, but it is unclear whether this is as a result of failure 
to change or because of the impact of change. 
4. Although the outcomes, such as lower waiting lists, may have been 
achieved from innovations to service delivery, this may be at the expense of 
staff motivation and staff morale. 
 
5. The FG, supported by findings from first round interviews with patients 
and professionals, suggests that further detail needs to be elicited around 
the following issues: 
 
 Whether the lowering of waiting times, which is seen as 
successful, is a result of innovations to service delivery and 
organisation. 
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 Which aspects of innovation are having a detrimental effect on 
staff morale, which appears to have worsened since the 
introduction of innovations? 
 Why are innovations to service delivery and organisation not 
improving patient experiences, which appear to have remained 
unchanged since the introduction of innovations, with a generally 
positive outlook on endoscopy procedures and interventions? 
9.3   Part 2 - Three focus groups with endoscopy 
specialists in Wales 
9.3.1   Focus groups 2-4: Background 
 
In October 2007 three one-hour focus groups were conducted with a total of 
15 Gastroenterology professionals (13 consultants and two nurse 
practitioners) who were members of Welsh Endoscopy Units. As with the 
focus group we conducted with English Gastroenterology professionals, 
those representing Welsh units were not in any way involved in the ENIGMA 
study, which was evaluating the impact of the MES Project.  
 
The aim of these three focus groups was to capture health professionals’ 
views on innovations in service delivery and organisation in Wales, to gain 
an understanding of barriers to change and achievements in their units, and 
to examine whether issues raised by these participants reflected previous 
study data and to put the English focus group data into perspective. 
 
To facilitate this work, a brief study background was circulated to all Welsh 
members of the BSG asking those who were committed to introducing 
changes and innovations within their gastroenterology services, to 
contribute to the study. Eighteen gastroenterology consultants and nurse 
practitioners consented to participate; 15 of these were available to attend 
one of the three focus groups. 
 
Participants represented GI units in nine different hospitals in Wales. Across 
the total sample of 15, one unit was represented by four participants, a 
further three units were represented by two participants each, and the five 
remaining units were represented by one person each. Three professionals 
participated in the first focus group, six in the second and six in the third. 
Each of the focus groups was recorded with a digital voice recorder and a 
minidisk recorder for later transcription. The first and last of the focus 
groups was facilitated by the lead qualitative researcher (FR), with a 
research officer (GJ) present to observe and take notes; the second group 
was facilitated by a research officer (GJ) and an observer was present to 
take notes (AS). On all occasions, focus group participants were very open 
and willing to talk about their work and their units.  
9.3.2   Method 
 
To uphold consistency across study sites, the methods of data collection 
were similar and reflected our previous work in England. The same interview 
schedule was also adopted across all three groups, covering: 
 
 Perceived facilitators and barriers to change; 
 Changes made in units; 
 The necessity for funding for innovation and other developments; 
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 Staff responses to the introduction of change within and across 
services; 
 The success of those changes implemented. 
 
In a change to the focus group schedule used with the English group (see 
Appendix 17), in Wales we also explored: 
 
 Responses to the NHSMA’s support for English Endoscopy units; 
 The impact that changes to English units made on Welsh units.  
9.3.3   Analysis 
 
Analysis followed much the same approach as the English focus group. 
Groupwork, involving seven members of the ENIGMA team, lead to 
summative paragraphs of text from each analyst to capture the essential 
significance of the transcript. The group then met to read and discuss each 
other’s summative paragraphs, and to work towards a definitive 
understanding of the focus group content. Three one-hour discussion groups 
were held, one for each of the focus groups. At each session, the team’s 
individual work was considered and discussed. The analysis group was 
facilitated by the lead qualitative researcher (FR), whose job it was to direct 
and support the group. However, the team were fully involved in defining 
the final output and were in general accord with each other throughout the 
process. Where disagreements arose, the group worked towards a final 
consensus position.  
 
Prior to the analysis meetings the lead researcher conducted a basic 
synthesis exercise of all individual summative paragraphs. The synthesis 
was presented in bullet-point form at the beginning of each group analysis 
session. The synthesis identified major points of agreement across the group 
and points that only some of the seven individuals had raised. The sessions 
considered each point in turn and the relationship between each issue. 
 
The results of the analytic process will be presented in the order in which 
the focus groups were transcribed and analysed. In view of the English focus 
group (FG1), the three Welsh focus groups will be defined as FG2, FG3 and 
FG4. 
9.3.4   FG2 
 
This focus group comprised three participants, two NEs and an Endoscopy 
Specialist working in Gastroenterology. All were keen to participate fully and 
discussed issues raised in detail and with high levels of agreement across 
the group. 
9.3.5   FG2 Summary of results  
 
Participants in this focus group, two nurses and an endoscopy specialist 
were in agreement that the major changes that had been made to their 
units were process-orientated, most specifically a reduction in waiting lists. 
Money was of major concern to all three, particularly in light of the 
expenditure needed for the GRS and Bowel Cancer Screening Services, but 
some changes had been undertaken that were not dependent on resource 
availability and these were considered a great success. Participants were 
proud of the services they could offer and noted that in spite of problems 
between groups within the unit (particularly the territoriality of surgeons 
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and physicians), the units were working as a group in a more integrated 
way, with pooled lists supporting that approach. The participants would 
have liked more recognition from the Trusts in which they worked and from 
external sources, and would have liked to be recognised for the hard work 
undertaken in their units. However, they realised that endoscopy was not 
perceived as a priority area. Participants looked to their English 
counterparts, were aware of the innovative changes and modernisation that 
was going on across the border and had learned from the positive aspects of 
those changes. They were also wary of making the mistakes their English 
colleagues had made and wished to guard against following in their 
footsteps in that respect. 
9.3.6   FG2 Results in detail: Main themes arising 
Resources 
 
Participants recognised that limited resources were available for the 
modernisation process to be successful or sustainable. Changes had been 
made that were predominantly resource neutral, however the GRS, as a 
significant driver for change, would demand resources if it were to be 
sustainable: “I don’t think we can do GRS without any money” (FG2.1). All 
three participants suggested that lack of money was a major barrier to 
change and that the small amounts of money units had already received 
from their Trusts and other agencies had not gone far enough in supporting 
them in any substantial way: “with the bowel cancer screening and so on 
coming in we really need finances” (FG2.2). 
Improvements in units 
 
Despite the limited financial support, Welsh Gastroenterology units had 
been able to address a range of issues towards an improved service, 
including: long waiting lists, lack of communication between staff 
particularly surgeons and physicians and poor performance. Their ability to 
address these issues resulted from changes to the service through better-
managed and nurse-led approaches: “the prime movers here are the 
nurses” (FG2.3). Improved workflow, changing roles and validated waiting 
lists had led to pooling of lists, a drop in waiting times and less territoriality 
over patients: “doctors have become far less territorial over their patients” 
(FG2.1). Of all the changes mentioned, however, reduction in waiting times 
was seen as having the most impact. Interestingly, there was little mention 
of quality of care or patient benefit and the changes described were process 
oriented. In addition, they were predominantly of a reactive rather than a 
proactive nature, responding to external factors such as audits, the GRS and 
seeing late cancers.  
Barriers to change 
 
Improvements to service organisation and delivery were hindered by 
problems of poor skill mix, bad leadership and a lack of good team working 
as well as an opposition to change from across the different groups of 
professionals within the unit: “pulling all those people together and 
managing change is very difficult” (FG2.2). Furthermore, the absence of a 
National Service Framework for gastroenterology, the additional workload 
brought about by the GRS and Bowel Cancer Screening, poor quality 
information from GPs regarding the prioritisation of patients for referral, and 
a lack of interest at an executive level, did not engender a sense of worth. 
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The participants commented on the fact that gastroenterology was not seen 
as a high priority area and did not carry a high profile in terms of its cutting 
edge work. As a consequence, gastroenterology was nowhere near the top 
of the funding list within the Trusts. This sense of low priority was 
exacerbated by senior managerial inertia: “endoscopy as an area was never 
effectively managed” (FG2.1), lack of support from external sources such as 
the Welsh Assembly Government and discord within units.  
Facilitators for change 
 
Despite these obstacles, focus group participants were keen to emphasise 
the high level of camaraderie across Welsh units, the close links between 
units, the strongly supportive nursing teams and the positive steps some of 
the staff members were taking towards improved services: “I think the 
community in Wales is strong and we do work well together” (FG2.1). 
Although there was little discussion of the nature of patient benefits and 
what was meant by ‘improved quality care’, they noted the need to work 
towards a patient focused agenda to improve the patient experience. This 
was at odds with the weight of discussion concentrating on service re-
evaluation towards performance-related goals and targets (for example, one 
of the participants mentioned that they were proud of being able to keep 
their waiting times for patients down to below one month for two years): 
“waiting lists have gone from 18 months to three weeks” (FG2.1).  
Performance 
 
With the performance-related activities in mind, the three participants 
reported wide variation in performance for endoscopy across their units, 
reflecting not only variation in approach to modernisation, but slow 
movement towards change due, in part from fractured units, with 
enthusiasm from some professional groups and opposition from others: “its 
all happening slowly, taking small steps” (FG2.2). 
The Welsh perspective 
 
There was a strong sense that participants considered Welsh units lacked 
recognition amongst the wider healthcare community for the excellent work 
they were doing and the changes they had already made towards an 
improved service. They were sceptical that funding and other resources 
would be made available from external sources, and emphasised that they 
were lagging behind their English counterparts. The changes made in 
English units, as a result of the work of the NHSMA, were described in 
predominantly positive terms, whilst the Welsh units were happy to learn 
from their successes and avoid repeating their failures. “We have learnt 
good things and bad things especially the waiting list management, patient 
care, patient information, nursing care and so on and I think for us in Wales 
that helped us immensely” (FG2.2). Indeed, it was considered that being 
one step behind English Gastroenterology units meant that you could guard 
against making the same mistakes that they have made. 
9.3.7   FG3 
 
This Focus Group comprised a good mix of six specialists in 
gastroenterology, though all were doctors. Participants represented three 
units in three different Trusts in Wales.  
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9.3.8   FG3 Summary of results 
 
This was a group of doctors keen to highlight their discomfort with changes 
that had been brought about through a management-led agenda. They 
discussed a range of barriers to change and some facilitators, such as 
motivated colleagues. The group were generally negative about changes in 
their units, identifying rifts between groups of physicians and surgeons, lack 
of training for staff, particularly nurses, and understaffing, all of which 
created considerable pressure for staff. Some hoped the GRS would raise 
the profile of endoscopy within their Trusts, but neither the GRS nor the 
NBCSPs featured extensively in this focus group. Lack of funding was an 
ongoing problem. Some changes were in evidence without finances, brought 
about through the efforts of a few motivated individuals prepared to lead 
others and instil an ethos of modernisation in their units. However, without 
budgetary power and with resource deficits, there was always going to be 
limitations to what could be achieved. This, along with little understanding 
from senior management about the needs of endoscopy units and their staff 
had led to a deflated workforce, whose sense of professionalism and status 
was being eroded in favour of Government-driven targets instigated within a 
top-down, managerial environment. Wales was lagging behind England in 
many respects in terms of patient care, funding and facilities, but it could 
still hold its own in respect to clinical outcomes, and was learning not to 
make the mistakes of English counterparts leading change, as a result of the 
NHSMA’s agenda. 
9.3.9   FG3 Results in detail: Main themes arising 
Loss of autonomy and erosion of professionalism 
 
The transcript presented a coherent group who saw recent changes in 
gastroenterology as generally for the worse. The dominant theme emerging 
was about the distrust and dislike felt for management, resulting from NHS 
Trusts in Wales being target-driven organisations, failing to base decisions 
on clinical knowledge or experience. The adverse consequence of managerial 
decisions was loss of autonomy for the senior staff: “clinical autonomy has 
gone” (FG3.3). In addition, top-down decision-making was to the detriment 
of both endoscopy teams and the unit as a whole. Loss of autonomy was 
played out through people’s evolving roles, the erosion of professionalism 
and loss of conventional function. Loss of autonomy led to clinicians feeling 
disengaged and being less flexible, and nurses spending less time caring for 
patients due to increasing bureaucratic demands. Participants commented 
on professionals being seen as mere employees rather than health 
professionals; a change in professional identity that caused despair and 
great frustration:  
 
If you want my Damascus moment, when somebody came back from 
a meeting sitting alongside a hospital administrator who said that 
consultants as far as managers are concerned are really on the level 
of a store manager. (FG3.2) 
 
We are now, I think, seen as employees rather than professionals. 
(FG3.5) 
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Facilitators and barriers to change 
 
As with FG2, in this focus group participants concentrated on a reduction in 
waiting times as the main outcome of facilitators for change such as pooled 
lists and flexible staff working. “Our waiting list has dropped a lot” (FG3.4). 
However, this was not discussed in terms of better patient care or enhanced 
quality of care. Indeed, patient outcomes, greater patient satisfaction with 
services, patient-centred care or change for the good of the patient were 
predominantly absent from the conversation. Rather, reduced waiting times 
were discussed in terms of meeting Government targets for improved 
service provision and as something easily measured. However, reduction in 
waiting times was a double-edged sword, and the participants realised that 
the targets driving clinicians to treat ‘two week referral’ patients were at the 
expense of other patients on the waiting list. This created: “a depressed 
atmosphere” and “distressing times” (FG3.1) and led to healthcare services 
that: “lose the plot in basic patient care” (FG3.4). It was noted that the 
implementation of the new consultant contract led to a decrease in working 
hours and consequently the quality of patient care that could be offered. 
 
Other facilitators to change included: committed and motivated team 
members who worked towards new ways of organising, managing and 
delivering services such as pooled lists. The group were unsure whether the 
NBCSP or GRS was going to have a positive impact on the unit, and Trust 
mergers had unknown implications. The group agreed that the decisions 
about some mergers were badly informed. Nevertheless, the manner in 
which the merger had taken place, clearly politically aligned with little 
involvement of endoscopy staff, was a point of great contention. The group 
was also unhappy about other decisions that had been made by 
management without their input, such as how doctors’ training was going to 
take place. Without clinician involvement, management were less well 
placed to make such decisions: “…there have been quite a few things, not so 
much from the science but from the dictate of managers and politicians we 
have now suffered immensely with training issues” (FG3.1). The GRS did not 
play a large part in this focus group, and was neither discussed in terms of a 
facilitator or a barrier to change, however, on the occasions it was 
mentioned it was clearly giving units more visibility in Trusts.  
Funding 
 
Funding was not seen as a huge catalyst for change. Furthermore, there 
were changes that could be implemented and were effective with little cost 
implication attached, such as pooled lists. Nevertheless, lack of funding was 
a barrier to change along with Government and Trust-driven initiatives 
(politicians setting Trust targets). Lack of funding had led to badly informed 
decisions and financial problems: “Well I suppose funding has to be a major 
problem” (FG3.2). Badly informed decisions were twofold. Firstly there were 
the decisions at Trust level, such as the Trust mergers. Secondly there were 
decisions at the individual level, with questions raised as to whether 
patients had a better health status as a result of funding new services:  
 
I think we are losing the plot really certainly in the hospitals I go to 
seeing elderly patients left on trolleys alone in various departments 
without a nurse or attendant  we may have high powered CT 
scanners or MRI scans or endoscopy in our units but I think there is 
the danger we are loosing the plot of basic care of the patient. 
(FG3.4)  
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The group were quick to recognise individuals who had been proactive in 
acquiring funding, including some of those in the focus group, who, despite 
limited resources and the financial ambivalence of Trust managers could 
bring about change. Indeed, changes that came from within were 
considered to have more impact and more positive.  
 
The link to evidence-based decisions was made and it was asked why Trust 
management decisions affecting clinical processes are not based on 
evidence: 
 
In practical treatment the changes we want to bring have to be 
evidence based. I cannot suddenly go and do something to a patient 
which I think is right irrespective of what the data shows. But 
changes are applied to us through the political and management 
system and there is no evidence to do it… so changes from our point 
of view should be evidence based and we should expect the same 
from the managerial point. They tell us change – show us evidenced 
data saying that change is good for you. (FG3.1) 
 
It was the individuals who were enforcing positive change based on good-
science, driven by a desire to make a difference, that were the real 
facilitators for change. Individuals with a creative outlook could make things 
happen irrespective of funding, had the greatest chance of benefiting the 
unit: 
 
People are inventing and going forward. (FG3.1) 
 
Colleagues with their new ideas and sort of sharing knowledge, going 
to conferences and courses. (FG3.6) 
Staff relationships 
 
Difficult relationships existed within the units, not so much amongst nursing 
and administrative staff, but amongst different groups of staff working in 
the same space, such as physicians and surgeons. Difficult relationships also 
existed between junior staff and consultants, and between unit staff and 
Trust management. “Relations with junior staff and others are difficult… 
junior staff come to a radiology department often having no knowledge of a 
particular patient” (FG3.4).  
 
Trust management curtailed research, offered insufficient staff training, 
recruited the wrong sort of people, made uninformed decisions on behalf of 
the unit and dictated change. This led to factions and discord amongst 
groups: “recruiting the right sort of people has been a problem at the 
moment” (FG3.2).  
  
…we’re looking for a specialist nurse in gastroenterology for some 
time and we have not been able to do that…unless it is a political 
priority in the Trust, they wouldn’t buy that, while they will spend a 
lot of money on things you know is not going to bring enough 
benefit. (FG3.3)   
 
Better communication, raised morale, greater staff autonomy and better 
training were all opportunities for resolving some of these difficulties. 
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The Welsh perspective 
 
The Welsh units were said to be lagging behind their English counterparts in 
terms of strategic vision, resource availability, Government and Trust 
support (including financial support), good management, colorectal 
screening and technical development. In addition, change was at a slower 
pace in Wales.  
 
We are lagging behind – the waiting times in England are much 
better than in Wales. Colorectal cancer screening we are lagging 
probably two years behind, and some of the technological 
developments again we are lagging behind, but funding hasn’t been 
as much because that wasn’t the agenda of the modernising agency. 
(FG3.6)  
 
However, in spite of lagging behind England and changes taking effect at a 
slower pace, no major differences were mentioned regarding clinical 
outcomes, and Welsh units were possibly seen as better off from the 
medical perspective. Furthermore, Welsh units were at an advantage in 
being able to learn from the mistakes of the English units: “I think Welsh 
gastroenterology is quite robust” (FG3.1).  
9.3.10   FG4 
 
This focus group was held with six doctors representing five units across 
three Trusts in Wales. This was a difficult group to summarise, with 
outspoken individuals offering very diverse and predominantly negative 
views. Indeed, there was more diversity of opinion in this focus group than 
in the other three focus groups, whilst much of the discussion highlighted 
the difficulties units faced rather than discussing modernisation within the 
units. This diversity of opinion and careful choice of issues discussed may 
reflect the hierarchical structure of this particular focus group, with one 
participating Medical Director and a number of people professionally 
associated with this person.  
9.3.11   FG4 Summary of results 
 
The tone of this focus group, which comprised six doctors working across 
endoscopy units in Wales, was predominantly negative. Doctors spoke of 
disempowerment of staff, lack of staff cohesion and lack of the ability within 
units to bring about the changes necessary to modernise. In addition, it was 
noted that the geography and population in Wales poses difficulties for 
training in general and in relation to specialisation. Whilst endoscopy teams 
worked well together, factions were evident between surgeons and medical 
specialties and clinicians and managers. In addition, team members looked 
after one another but as part of a ‘sinking ship’ mentality. They were 
answerable to management they disliked and distrusted and working within 
managerial systems that were failing them. Management was seen as 
making inappropriate, ill-informed decisions that did not best serve the 
interests of the units and units lacked the visibility to make a difference. 
Consequently, few positive changes were mentioned other than the GRS and 
NBCSP, which it was hoped would bring future change and raise the profile 
of endoscopy. However, it was still unclear how these would impact in the 
long run to ensure positive change for patients. Necessary funding was 
lacking and when initiatives had been funded, spending on the 
infrastructure required to support them, was not forthcoming. This resulted 
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in units that lacked staff, or sufficiently skilled and well-trained staff to 
make autonomous decisions and take any sort of leadership role. 
9.3.12   Results in detail: Major themes arising 
 
Management and management systems: As with the other focus groups in 
Wales, this group commented on a range of conflicting interests, both 
between groups within units, such as surgical and medical specialties, and 
between clinicians and managers: “I think historically, if you look at the way 
endoscopy services sit in most Trusts they don’t sit very easily in one service 
group” (FG4.4). Conflicting interests between units and management was a 
particular barrier to change and both management and management 
systems came up for considerable criticism throughout. Trust management 
were seen as not in tune with the needs of units, reactionary and distrusted: 
“management have their own agenda in terms of fulfilling their local delivery 
plans to the LHBs [Local Health Boards]” (FG4.4). New, target-driven, 
political and managerial directives had the effect of engendering 
bureaucracy and legislation and creating large amounts of paperwork, 
particularly where nursing staff were concerned. In addition, there were 
difficulties convincing Trust management of the importance of endoscopy, 
problems of pulling together different specialties using the same spaces and 
getting through the many layers of managerial red tape.  
 
If management were supportive of change, then change was effected, but 
this was often in the context of crisis management: “This is a reactionary, 
entirety management when the crisis arises” (FG4.1). Management systems 
were described as an: “enormous and complex labyrinth” (FG4.2), with 
middle managers pressurised from senior management to reach targets and 
clinicians wanting to bring about change but in their own way, without 
targets attached. Distrust of management was exacerbated by lack of 
communication between clinicians and Trust managers leading to a 
heightened sense of frustration and futility. To pass through management 
structures and get changes approved and funded was complex, and often 
decisions were being made that were not based on clinical or medical 
expertise:  
 
We were left to the same hierarchy that’s there in terms of “go up to 
the unit management up to where the next management is”. It would 
never have gone forward at all but as it happens, because of having 
bypassed that to come from top down, it seems to have moved 
forward at least to a reasonable extent. (FG4.4) 
Barriers and facilitators to change 
 
Alongside the major barriers surrounding management and management 
structures, other myriad barriers to change suffused the focus group with 
the mention of facilitators to change, a rare occurrence. When facilitators 
were noted, they were mainly around the GRS and NBCSP, which it was 
hoped would raise the profile of the units. However it was felt that 
politicians had not acknowledged the extent to which change was required 
within gastroenterology, if Bowel Cancer Screening and the GRS were to be 
properly implemented.  
 
Barriers to change covered a wide range of areas, including: training in 
endoscopy, the problems of gastroenterology spanning medicine and 
surgery, the lack of a National Service Framework in gastroenterology, 
staffing deficits, staff deskilling, clinical workload, lack of secretarial support 
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and the need for gastroenterology to be: “politically visible” (FG4.6). Under-
staffed units and staff deskilling were of particular concern, both for nurses 
and consultants. Thus, whilst expansion had been helpful, units appeared to 
be running without their full complement of staff with no major drives to 
recruit additional staff. In addition, greater staff specialism suggests some 
erosion to the professional ‘all-rounder’ role, different specialties are 
working according to their own individual agendas and people are unsure 
who should be taking on which tasks: 
 
I would like to see a Welsh health strategy that decides what’s being 
done where so it actually happens to certain things and certain places 
with enough people to do it sufficiently specialised and not everybody 
trying to do everything everywhere. (FG4.2) 
 
Endoscopy staff 
 
Endoscopy staff were described as dedicated and supportive, working well 
as a team and, as a result of some of the more positive changes that had 
occurred such as the introduction of the GRS, recognising the value of team 
working. However there was still concern about low staff morale due to 
stress, indicated by high levels of staff absence and staff turnover, and 
although the team stuck together and supported each other – all in the 
same predicament – they were described as: “People clinging to a life raft. 
They stick together because there is only one life raft” (FG4.2). This sense of 
being part of a sinking ship was described as follows: 
 
They feel under the cosh, and I think it’s because they feel under the 
cosh that they pull together in slightly adverse circumstances to work 
as a team and they don’t want to let each other down because they 
are working in a closely-knit community (FG4.3) 
 
Doctors recognised the invaluable role dedicated nurses in the unit played, 
but at the same time talked of lack of nurse leadership, lack of authority 
amongst nursing staff and lack of role models for junior staff. Lack of 
authority bore a strong relationship to the many managerial problems 
mentioned above, with nursing staff neither given the power to be 
autonomous and make decisions for themselves nor provided with: “an 
environment in which they can flourish and develop” (FG4.2). 
Investment in endoscopy 
 
Focus group participants described endoscopy services as disadvantaged. 
Not only were they a low priority for investment, Trusts failed to consult 
widely to use their investments wisely. Although Trusts had invested in 
some new equipment and facilities, for example, these were not necessarily 
the most essential investments that units needed. The sense of 
inappropriate investment was heightened by a lack of investment services 
and people. Indeed, the group could only think of one change to services 
that did not need extra funding and this was ‘pooled lists’. New posts were 
clearly short of money and as a consequence Welsh units lagged behind 
their English counterparts: “I just feel that Wales has been lagging behind 
far too long and it does need a kick up its pants to change things” (FG4.1). 
As with other focus group participants, English units were described as one 
step ahead of Welsh units and without the necessary funding, Welsh units 
would not be able to provide the same services or achieve the appropriate 
number of jobs: “we have to acknowledge that there is just a difference in 
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the resourcing in the English hospitals” (FG4.3). In spite of this, good 
clinical practice was still in evidence in Wales. With funding shortages, 
facilities that had been invested in could not be properly utilised and without 
the necessary staff in place, management were supporting change to the 
detriment of people. It was mentioned that some changes could be made 
without funding and that some funding was obtained through external 
sources. Consultant funding, for example was ensured, whilst other staff 
funding was not always in place:  
 
We’ve had funding from the local health board for purchasing 
equipment but unfortunately  we haven’t got quite the staffing to 
open a second room full time at the moment so but it isn’t all 
sweetness and light but we’re getting there slowly. (FG4.6) 
9.4   Summary 
These four focus groups with non-participants in Intervention or Control 
groups presented very similar data to all the other elements of qualitative 
data capture for ENIGMA, namely interviews with professionals and patients 
in Intervention and Control groups. The one area where data differed was in 
terms of Welsh participants’ responses to the MA work in England and its 
impact on their English counterparts and their work procedures. It also 
highlighted Welsh participants’ views of the changes that had taken place in 
England in relation to Wales. In this respect, the focus group data opened 
up the picture across localities and countries, highlighting that Welsh units 
felt on a par with England in terms of the standard of services provided but 
lagged behind in terms of modernising units and were disadvantaged in 
terms of the resource provision for new staff and greater staff training. 
Resource deficits were perceived as having a negative impact on Welsh 
units’ ability to make the necessary changes to benefit staff and patients 
and to optimise service organisation and delivery.  
 
van Manen’s “wholistic” or “sententious” approach, which we adapted for the 
purpose of the analysis of focus groups, proved both timely and appropriate 
to group working practices across a large team of researchers and 
academics. It enabled the team to work both on an individual and group 
basis, to meet on a number of occasions through informal and formal group 
work, to clarify extensive, in-depth datasets and to reach consensus of 
opinion over the essentiality of the datasets. The approach is inclusive and 
with leadership and support can be used to encourage those with either a 
basic or advanced understanding of qualitative analytic frameworks to work 
together to achieve thorough codification, clarification and interpretative 
presentation. The approach is versatile, adaptive and easy to teach and 
comprehend. It can be applied as effectively to face-to-face interview data 
as it can to focus group data, indeed, to any textual qualitative data format. 
As a result, the analysis techniques we employed have far reaching 
possibilities for application to a range of large-scale mixed-method studies 
including trials. 
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10  GP views at study sites 
10.1   Executive summary 
10.1.1   Objectives 
 
To compare General Practitioner (GP) views of changes in endoscopy 
services between those who referred patients to the Intervention sites with 
those who referred to the Control sites. 
10.1.2   Methods 
 
Questionnaires were sent to GPs who had at least one patient in ENIGMA. 
Responding and non-responding GPs were compared by gender, practice 
types and the types of unit they referred patients. GPs were asked whether 
they perceived a change in endoscopy services, and whether those changes 
improved 10 specific aspects of and the service overall.   
10.1.3   Results 
 
682 of 1979 eligible GPs completed the questionnaire (35%). There was no 
significant difference between responding and non-responding GPs. No 
significant difference was found in GP awareness of service changes between 
intervention and control group. More GPs thought changes made by the 
control sites led to better services in nine of the 10 specific aspects of 
endoscopy services but these did not reach statistical significance. 
10.1.4   Implications 
 
There were indications that GPs thought units without MES funding were 
able to achieve a similar, if not higher level of service improvement. More 
research is needed because of the unexpected findings.  
10.2   Introduction 
 
The MES programme facilitated modernisation of twenty-six NHS endoscopy 
units in England. The study assessed impact of the MES programme by 
comparing 10 MES-funded sites (Intervention sites) with 10 Control sites 
who redesigned their endoscopy services independently. 
 
The ENIGMA brief included estimating: 
 
• the acceptability of service delivery to professionals in primary 
care and their perception of the value of the models 
• the outcomes as assessed by professionals in primary care. 
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This chapter described how the research team addressed these aspects of 
the ENIGMA brief and the findings about GP views of the impact of the MES 
programme.  
10.3   Objectives 
 
The current survey aimed to compare GP awareness and rating of changes 
in endoscopy services between those who referred patients to the 
Intervention sites with those who referred to the Control sites. The areas of 
enquiry included changes in: access to endoscopy services; waiting times; 
communication from secondary; demands on primary care and GP views of 
endoscopy services overall. 
10.4   Method 
10.4.1   Population 
 
The study group comprised of GPs with at least one ENIGMA patient who 
had given consent for their GPs to be contacted. GPs referring patients to 
Hospital 10 and 18 were included, although these sites had been excluded 
from other aspects of the ENIGMA study. 
10.4.2   Survey Design 
 
GP views were collected through postal survey by a semi-structured 
questionnaire with closed and open-ended questions. Only one 
questionnaire per GP was sent, irrespective of the number of patients they 
had in the ENIGMA study. Questionnaires were sent out between November 
2006 and February 2007. A reminder letter and questionnaire was sent if 
there was no response after three weeks. The deadline for completion was 
the end of April 2007.  
10.4.3   Development of the questionnaire 
 
The questionnaire was designed by the Project Steering Committee which 
consisted of gastroenterologists, experts in quantitative and qualitative 
methodologists, health economists and researchers. Six GPs based in the 
School of Medicine at Swansea University were interviewed with this 
questionnaire to test the layout, wording and GP understanding of the 
questions. Minor amendments were made to the questionnaire. 
 
The amended questionnaire was piloted with GPs within the Neath & Port 
Talbot Hospital catchment area to test its use as a postal questionnaire. Out 
of the seventy-seven pilot questionnaires sent, 29 were returned. There 
were some inconsistencies in the way GPs completed the questionnaire. 
Further amendments were made with the advice of two GPs based in the 
School of Medicine at Swansea University. 
 
The GP questionnaire asked respondents whether they had perceived any 
changes to 10 specific aspects of the endoscopy services delivered by the 
study hospitals. GPs were then asked to rate the changes as “Better”, 
“Neither better nor worse” or “Worse”. They were also invited to give free 
text comments to elaborate their answers (see Appendix 18).  
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10.5   Analysis 
10.5.1   Non-respondent analysis 
 
The proportion of GP Responders and GP Non-responders were compared to 
determine whether there were any significant differences in response rate 
for Site type (Intervention or Control), GP Gender and Size of practice 
(single-handed or Group). This was assessed by Pearson’s Chi-squared (χ2) 
tests. Possible interactive effects between Site type and GP gender or 
Practice size on response rate were assessed by hierarchical log linear 
analysis. If significant differences were found, the weighting of the answers 
from any under-represented group(s) would be adjusted to minimise 
possible bias. 
10.5.2   Quantitative analysis of questionnaire response 
 
Although information was collected from individual GPs, the purpose of the 
enquiry was to find out their perceptions of changes in endoscopy services 
delivered by the study hospitals. As the service changes were introduced by 
the hospital, all GPs making referrals to a study hospital were subjected to 
the same set of changes. There would be more than one GP making referrals 
to one study hospital, but the data collected from individual GPs were 
multiple observations of that hospital. Several techniques existed which 
explicitly took account of this multiplicity (Bland and Kerry 1997). A simple 
approach to analyse such data was to construct a summary statistic where 
GP observations of individual hospitals was weighted by the number of GPs 
making referrals to that hospital (Kerry and Bland 1998). As the hospitals 
were randomised to Intervention and Control groups, differences between 
the study groups would be assessed with a weighted two sample t test 
(Bland and Kerry 1998). This approach had the advantage of simplicity and 
the calculation of the weighted means, sums of squares and 95% 
Confidence Interval were published (Bland and Kerry 1998). 
10.5.3   Qualitative analysis of questionnaire response 
 
All questionnaires that included a written comment in the blank box at the 
end of the questionnaire were included in the qualitative analysis. Data were 
analysed using content analysis techniques. This method enables the 
reduction of qualitative data to manageable portions of text that can be 
analysed by searching for patterns and themes in the data. The researcher 
read the comments and developed a coding system. The remaining 
comments were then read to ensure complete coding of the full dataset. The 
coding system was also used to count the number of instances that 
reportage adhered to each category (Silverman 2001) and for differences 
and similarities between intervention and control sites. This process 
established the following emergent themes: accessing endoscopy, waiting 
times and communication relating to an endoscopic procedure. 
10.6   Results 
 
There were 1979 eligible GPs for inclusion in the study, 689 GPs completed 
and returned their questionnaires. However, there were seven GPs who 
returned duplicate questionnaires. After removing the duplicates, there were 
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682 questionnaires to be analysed (34.46%). Of these, 299 (72 with 
qualitative comments) were from GPs referring to Intervention sites and 383 
(118 with qualitative comments) were from GPs referring to Control sites 
(see Figure 28).  
 
Figure 28. Flowchart of GP recruitment for questionnaire analysis 
 
 
 
 
 
 
 
 
 
 
 
 
10.6.1   Findings from non-respondent analysis 
 
There was no significant difference between GP Responders and GP Non-
responders (Table 63) for Site type (χ2 = 0.836, p = 0.361), Gender (χ2 = 
0.488, p = 0.485) or Size of practice (χ2 = 3.334, p = 0.068).  
 
   
1979 questionnaires to GPs 
689 questionnaires returned 
1290 questionnaires not 
returned 
7 duplicated questionnaires 
682 questionnaires for analysis (190 with 
comments for qualitative analysis) 
299 from GPs referring to Intervention sites (72 
with comments for qualitative analysis) 
383 from GPs referring to Control sites (118 with 
comments for qualitative analysis) 
The ENIGMA study 
©NCCSDO 2008 Page 279 
Table 63.   Profile of Responding and Non-responding GPs 
 
 Responders 
% (n) 
Non-responders 
% (n) 
P value 
 
Site type   0.361 
Intervention 33.3 (299) 66.7 (598)  
Control 35.4 (383) 64.6 (699)  
    
Size of practice   0.068 
Single-handed 25.8 (23) 74.2 (66)  
Group 35.9 (644) ( 64.1 (1149)  
    
Gender   0.485 
Male 36.8 (434) 63.2 (746)  
Female 38.7 (213) 61.3 (338)  
   
Hierarchical loglinear analysis showed a small interactive effect between Site 
type and Size of practice on GP response rate (Likelihood Chi-square change 
if this effect is deleted from the saturated model = 3.904, p =0.0482). Table 
64 showed that the percentage of GPs from Single-handed practice making 
referrals to the Control sites returning the questionnaires was low (15.8%) 
as compared to GPs in the other categories. However, only about 3.7% of 
eligible GPs who used Control sites came from Single-handed practices (38 
out of 1027). Data was not weighted by practice size in subsequent 
analysis. 
 
Table 64.   Percentage of eligible GPs returning the questionnaire, 
classified by Practice size and Site-type 
 
 Intervention % 
(respondents / 
total) 
Control % 
(respondents / 
total) 
GPs from Single-handed 
practices 
(n=89) 
33.3% 
(17/51) 
15.8% 
(6/38) 
GPs from Group practices 
(n=1793) 
34.3% 
(276/804) 
37.2%  
(368/989) 
Total number of eligible GPs 855 1027 
 
*There were 97 GPs with no information on Practice size  
10.6.2   Findings from quantitative analysis of 
questionnaire response 
 
The 682 GP respondents made referrals to 20 study sites (Intervention: 10, 
Control: 10). Number of GPs making referrals to the same study site ranged 
from four to 54.  
 
Percentage of respondents who explicitly said in the questionnaire that they 
saw changes in various aspects of endoscopy services ranged from 23% 
(communication from secondary care concerning complications) to 55% 
(speed of referral). There were also some GPs who did not explicitly say 
they saw changes in endoscopy services but went on to give their views 
about whether the service had improved. These GPs were considered to be 
implicitly saying that they were aware of some changes. Including the 
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implicit responses, percentage of GPs who perceived a change in endoscopy 
services ranged from 47% (communication from secondary care concerning 
complications) to 73% (speed of referral) (Table 65). To ensure full use of 
the data, the implicit responses were included in subsequent analysis. 
 
Table 65.   Percentage of GPs perceiving a change in specific aspects of 
endoscopy services and types of response 
 
 
N=682 
Percentage of GPs who said they saw a 
change 
Explicitly % 
(n) 
Implicitly % 
(n) 
Total % (n) 
Way referrals made into unit 52.05 (355) 17.74 (121) 69.79 (476) 
Understanding of prioritisation 37.54 (256) 20.97 (143) 58.50 (399) 
Outcome of prioritisation 
process 
36.07 (246) 20.53(140) 56.60 (386) 
Speed of referral in terms of 
access 
54.69 (373) 18.77 (128) 73.46 (501) 
Information from 2º care 
following referral 
47.51 (324) 24.05 (164) 71.55 (488) 
% patients requesting further 
GP appointments 
34.02 (232) 21.41 (146) 55.43 (378) 
Communication from 2º care – 
outcome of endoscopy 
45.60 (311) 20.82. (142) 66.42 (453) 
Communication from 2º care – 
final diagnosis 
39.88 (272) 23.75 (162) 63.63 (434) 
Communication from 2º care – 
complications 
23.17 (158) 24.05 (164) 47.21 (322) 
Communication from 2º care – 
treatment initiated 
36.07 (246) 22.29 (152) 58.36 (398) 
 
Percentage of GPs perceiving a change in specific aspect of endoscopy 
service ranged from 48% to 73% for those who made referrals to 
intervention sites and ranged from 47% to 74% for those who made 
referrals to the control sites. No significant difference was found in GP 
awareness of service changes between intervention and control group after 
weighting for number of GPs who made referrals to the same hospital (Table 
66). 
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Table 66.   Differences in GP awareness of service changes between 
Intervention and Control groups (Weighted by number of GPs 
making referrals to various study sites) 
 
 
Perceiving a change 
in: 
Weighted mean percentage Diff in means 
(95% CI) 
P value 
Intervention 
Max n = 299 
Control 
Max n = 383 
Way referrals made into 
unit 
68.56 70.76 -2.19 
(-10.99, 6.59) 
0.61 
Understanding of 
prioritisation 
59.87 57.44 2.42 
(-5.43, 10.28) 
0.52 
Outcome of prioritisation 
process 
56.52 56.66 -0.14 
(-8.73, 8.46) 
0.97 
Speed of referral in 
terms of access 
72.24 74.41 -2.17 
(-10.98, 6.63) 
0.61 
Information from 2º care 
following referral 
72.91 70.50 2.41 
(-5.55, 10.38) 
0.53 
% patients requesting 
further GP appointments 
56.86 54.31 2.55 
(-5.45, 10.55) 
0.51 
Communication from 2º 
care – outcome of 
endoscopy 
65.22 67.36 -2.14 
(-12.49, 8.20) 
0.67 
Communication from 2º 
care – final diagnosis 
62.88 64.23 -1.35 
(-10.29, 7.58) 
0.75 
Communication from 2º 
care – complications 
48.16 46.48 1.69 
(-5.32, 8.69) 
0.62 
Communication from 2º 
care – treatment 
initiated 
60.20 56.92 3.28 
(11.74, 4.30) 
0.40 
 
 
Percentage of GPs perceiving better changes in specific aspects of 
endoscopy service ranged from 34% to 63% for those who made referrals to 
intervention sites and ranged from 40% to 69% for those who made 
referrals to the control sites. More GPs thought changes made by the control 
sites led to better services in nine of the 10 specific aspects of endoscopy 
service but these did not reach statistical significance (Table 67). 
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Table 67.   Differences in GP views of service changes between 
Intervention and Control groups (Weighted by number of GPs 
making referrals to various study sites) 
 
 
Perceiving better 
changes in: 
Weighted mean percentage Diff in means 
(95% CI) 
P 
value Intervention 
Max n = 218 
Control 
Max n = 285 
Way referrals made 
into unit 
47.32 54.98 -7.66 
(-29.16, 13.83) 
0.46 
Understanding of 
prioritisation 
42.46 48.18 -5.72 
(-23.90, 12.46) 
0.52 
Outcome of 
prioritisation process 
42.60 47.47 -4.86 
(-25.24, 15.52) 
0.62 
Speed of referral in 
terms of access 
55.09 60.35 -5.26 
(-25.51, 14.99) 
0.59 
Information from 2º 
care following referral 
55.05 59.26 -4.21 
(-19.79, 11.36) 
0.58 
% patients requesting 
further GP 
appointments 
34.12 40.38 -6.27 
(-29.21, 16.68) 
0.57 
Communication from 
2º care – outcome of 
endoscopy 
62.56 68.60 -6.04 
(-15.08, 3.00) 
0.18 
Communication from 
2º care – final 
diagnosis 
57.45 54.88 2.57 
(-10.53, 15.66) 
0.69 
Communication from 
2º care – 
complications 
35.42 40.45 -5.03 
(--17.13, 7.06) 
0.39 
Communication from 
2º care – treatment 
initiated 
46.67 52.75 -6.09 
(-20.62, 8.44) 
0.39 
10.6.3   Findings from qualitative analysis of questionnaire 
response 
 
Out of the 682 GPs returning the questionnaire, 190 GPs (28%) made free 
text comments on endoscopy services in the questionnaire. Seventy-two of 
the 299 GP respondents (24%) who made referrals to Intervention sites and 
118 of the 383 GP respondents (31%) who made referrals to Control sites 
commented on the endoscopy services. 
 
When the comments were considered as a whole, 62 made only positive 
comments and 81 only negative comments, whilst 47 GPs expressed mixed 
views. This is shown in Table 68, split between Intervention and Control. 
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Table 68.   Comments made by GPs referring to Intervention and 
Control sites 
 
 Intervention Control Total 
Positive 
comments 
26 36 62 (32.6%) 
Negative 
comments 
31 50 81 (42.6%) 
Mixed 
comments 
15 32 47 (24.7%) 
 
Results are described below according to the main themes: Access, Waiting 
times, Communication and the demand on primary care.  
10.6.4   Accessing endoscopy services 
 
Seventeen GPs (five referring to Intervention sites, 12 to Control sites) felt 
the referral process had improved in part due to Rapid Access clinics but 
also because of improved referral guidelines and criteria: 
 
Proforma and referral guidance has improved referral process. (203) 
 
However, there were many more GPs (twenty-three referring to Intervention 
sites, twenty-seven referring to Control sites) who were critical of changes 
in the referral process.  
 
The “Choose and Book” initiative was blamed for a deterioration in the 
process of booking an endoscopy by four GPs, split evenly between those 
referring to Intervention and Control sites.  
 
Centralised appointment systems were also criticised (six GPs referring to 
Intervention sites, three referring to Control sites). They were seen as being 
impersonal, an obstacle and slowing the referral process down: 
 
Now have to refer to ‘CAS’ – a clearing house. I feel it is a technical 
rather than a wisdom-led service. (408)  
 
Other GPs also commented on the impersonal service highlighting the 
difficulty in referring a patient back to the same consultant, referring to a 
named consultant and finding it difficult to access consultant advice about 
patients who do not meet formal referral criteria. 
10.6.5   Waiting times 
 
The majority of GP comments related to the time patients were waiting to 
have an endoscopy. Forty-seven GPs (14 referring to endoscopy units at 
Intervention sites, 33 to Control sites) felt that the waiting time for 
procedures had improved and in particular commented on the effectiveness 
of the two week referral for patients with symptoms suspicious of cancer. 
However, 68 GPs (22 referring to Intervention sites, 46 referring to Control 
sites) were critical of the continuing long waits for patients who did not fulfil 
the two week referral criteria - the routine referrals, and in particular for 
referrals for colonoscopy: 
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The two week rule works well but others the WL is too long especially 
for bowel endoscopy. (947) 
 
Two GPs criticised one hospital (a Control site) which had ‘rationalised’ its 
waiting list feeling that it was “frankly disgraceful … simply removing 
patients from the waiting list unless they (the patient) states that they “still 
want” the procedure (1480)”. 
10.6.6   Communication 
 
Fifteen GPs referring to Intervention sites and 20 GPs referring to Control 
sites were satisfied with the communication from the hospital following the 
endoscopy. Whilst, some commented that a report had always been 
received promptly, many felt that this aspect of the service had improved: 
 
Results are clearer and generally quicker. (747) 
 
In particular it is a great improvement that serious endoscopy 
findings are faxed to us the same day. (483) 
 
There were also a number of GPs (12 referring to Intervention sites, 26 to 
Control sites) who were unsatisfied with the level of communication and four 
GPs referring to Intervention sites and nine referring to Control sites, made 
specific mention that biopsy results were not always forwarded to the GP 
“Often have to chase HP/biopsy results (1751)”.  
 
This can result in wasted GP appointments when patients have been told to 
return to their GP for the results: 
 
Patients often come back for confirmation before it has been received 
especially final diagnosis/follow-up – a waste of appointment. (191) 
 
To avoid this situation some GPs suggested that whilst at the endoscopy 
unit patients should be advised to check with their surgery before making an 
appointment. Some also felt it would be useful to know what information a 
patient had been given about the endoscopy findings as some are unable to 
take in the information or forget: 
 
Only thing I’d like is report to say what patient was told at the time 
as they forget!”  (192) 
 
There were also concerns from four GPs referring to Intervention sites and 
four referring to Control sites, about follow-up arrangements which they felt 
were not always as clear as they should be with “little comment or action on 
further follow-up” (1284). 
10.6.7   GP views of endoscopy service overall 
 
Twenty-nine GPs (16 referring to Intervention sites, 13 to Control sites) 
praised the overall service that was being provided “Vastly improved 
service” (518) with seven Intervention and four Control site GPs highlighting 
the fact that the service has always been good “We seem to have an already 
good service for patients that has got even better” (1095).  
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10.7   Discussion 
10.7.1   Summary of findings 
 
This survey found no significant difference in the perception of possible 
changes to the endoscopy service of Intervention and Control sites indicated 
by GPs. The number of GPs from Intervention and Control sites who 
identified, either explicitly or implicitly, that a change had occurred to a 
particular aspect of the endoscopy service was remarkably similar in most 
cases. 
 
When GPs were asked to rate the effect of the changes in the endoscopy 
services, more GPs thought changes made by the control sites led to better 
services in nine of the 10 specific aspects of endoscopy service. The 
difference ranged from 4% to 8% but these did not reach statistical 
significance. 
 
As shown above, the views of GPs are mixed on accessing endoscopy, 
waiting times, and communication and it should be remembered that just 
under a third of GPs wrote any comment on the questionnaire. However, it 
is interesting to note that in relation to each theme, more GPs referring to 
Control sites made comments, both positive and negative, than GPs 
referring to Intervention sites.  
 
Accessing endoscopy is clearly viewed by GPs as more problematic than four 
years ago, i.e. before changes were introduced. A similar number of GPs 
referring to Intervention and Control sites expressed views reflecting their 
perception of the negative impact of ‘Choose and Book’, the guidelines and 
referral criteria, the centralised booking systems and the impersonal nature 
of the process. Of note, is the fact that just over double the number of GPs 
referring to Control sites made positive comments relating to Rapid Access 
clinics and improved guidelines and referral criteria, in comparison to GPs 
referring to Intervention sites. However, the negative comments are 
distributed fairly evenly between Intervention and Control sites and 
outweigh the positive comments suggesting that it is difficult to determine a 
difference between the two types of site. 
 
In relation to waiting times, the number of GPs referring to Control sites 
that felt there had been improvements was double that of GPs referring to 
Intervention sites. However, the number of GPs referring to Control sites 
who felt that waiting lists were still too long was also double that of GPs 
referring to Intervention sites. Overall, there were more comments about 
waiting times being too long (68) which reflects the frustration at the long 
waits for colonoscopy in comparison to the satisfaction with the two week 
referral (47) in both Intervention and Control sites. It is difficult to 
determine any difference between Intervention and Control sites because 
whilst Control sites appear to be doing better than Intervention sites they 
also have more negative comments than Intervention sites. 
 
There was little difference in the overall number of positive (35) and 
negative (38) comments about the communication with and from endoscopy 
units. However, of GPs referring to intervention sites, over double were 
satisfied with the level of communication. In comparison GPs referring to 
control sites, were almost equal in their comments on their level of 
satisfaction with communication. This suggests that changes in the 
intervention sites had been more successful than those in control sites. 
The ENIGMA study 
©NCCSDO 2008 Page 286 
 
Whilst there are aspects of the endoscopy service that GPs feel have 
deteriorated, there are other aspects where they see improvement but they 
do feel that further improvements are necessary. Having considered the 
results of the qualitative data analysis it has not been possible to detect any 
particular difference in GPs perception of the changes between Intervention 
and Control sites. 
10.7.2   Internal validity 
 
 Our overall response rate was low though no different between 
Intervention and Control sites. 
 GPs from single-handed practices making referrals to Control sites 
were less likely to return a questionnaire. However, as the number of 
this GP group was small we did not adjust the analysis because the 
impact of the adjustment would not have affected the findings. 
10.7.3   External validity 
 
 The response rate is not high but this is acceptable because it is a 
postal questionnaire to GPs with no incentive to complete it. 
10.7.4   Implications 
 
 There was a trend indicating that GPs using the Control sites are 
more positive about the changes that those sites introduced. This is 
an unexpected finding and further study will be needed. 
 
There were systematic differences between GPs who gave their views about 
service improvements without explicitly saying they saw changes in the 
services were significantly less likely to perceive better changes than those 
who explicitly said they saw service changes (Table 69). Excluding the 
implicit responses from the analysis would overestimate GP acceptance of 
the service changes, so all the implicit responses were included in all 
subsequent analysis. 
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Table 69.   Comparison of un-weighted percentage of GPs who 
perceived better changes between those explicitly and those 
implicitly said they saw changes in endoscopy services 
 
 
Perceiving better changes in:  
% (n) 
Type of  Response to questions about seeing 
changes in endoscopy services 
Explicit Implicit P value 
Way referrals made into unit 60.1% 
(208/346) 
31.4% 
(38/121) 
< 0.001 
Understanding of prioritisation 58.6% 
(146/249) 
25.2% 
(36/143) 
< 0.001 
Outcome of prioritisation 
process 
57.2% 
(139/243) 
25.7% 
(36/140) 
< 0.001 
Speed of referral in terms of 
access 
68.1% 
(250/367) 
32% 
(41/128) 
< 0.001 
Information from 2º care 
following referral 
74.2% 
(239/322) 
25.0% 
(41/164) 
< 0.001 
% patients requesting further 
GP appointments 
49.8% 
(114/229) 
19.2% 
(28/146) 
< 0.001 
Communication from 2º care – 
outcome of endoscopy 
82.4% 
(252/306) 
33.1% 
(47/142) 
< 0.001 
Communication from 2º care – 
final diagnosis 
73.4% 
(204/278) 
25.8% 
(39/151) 
< 0.001 
Communication from 2º care – 
complications 
63.0% 
(97/154) 
15.9% 
(26/164) 
< 0.001 
Communication from 2º care – 
treatment initiated 
69.0% 
(169/245) 
20.3% 
(30/148) 
< 0.001 
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11   Discussion 
11.1   Summary of findings 
 
In this study we have found that, although the MES programme may have 
reduced the number of patients on waiting lists, there is no evidence that it 
significantly affected waiting times, investment in modernisation, service 
innovation, the collection of service activity and process data, patient 
outcomes, their use of other NHS services or their time off work.  The 
average time patients waited for an endoscopy was significantly shorter at 
those hospitals that received financial support from the MES programme 
than at those that did not.  However there are three cogent reasons why we 
cannot attribute this to the MES programme: first in the absence of rigorous 
data on waiting times before the MES programme there is no evidence that 
this was not merely due to differing characteristics of Intervention and 
Control hospitals; secondly this effect was reversed in the final wave of data 
collection two years after the end of the MES programme; and thirdly the 
average time Intervention and Control patients waited for an endoscopy did 
not decrease over the duration of the study. 
    
All participating sites made major investments in modernisation during the 
study period. Investments were in physical facilities, clinical and 
administration equipment, staff training, new posts, staff substitutions and 
new modernisation activities.  Our assessment of the number and type of 
innovations introduced showed that there was no real difference between 
the Intervention and Control sites.  Innovations included changed roles and 
responsibilities and many new working practices to manage demand and 
increase capacity. The costs of modernisation, and consequent NHS costs in 
both primary and secondary care, were lower in the Intervention sites.  The 
cost of lost productivity by patients due to time off work was also slightly 
lower in Intervention sites.  However none of these cost differences were 
statistically significant.  So there was no strong case for calculating cost-
effectiveness or cost-utility ratios. 
 
Activity data showed no significant difference between Intervention and 
Control sites in the number of referrals, patients waiting more than three 
months, lost procedure slots or procedures performed. The total number of 
patients waiting decreased over time in the Intervention sites, and increased 
in the Control sites, a significant difference that grew over time.  This 
finding, from data supplied by sites themselves, is concordant with the 
finding from patient questionnaires that average waiting times increased in 
the control sites until reversed in the final wave of data collection, while 
waiting times in the Intervention sites showed little change. 
 
Although patient quality of life scores improved after endoscopy we found no 
difference in patient outcomes between Intervention and Control sites or 
over time. Suggestions made by patients for improvement focused on the 
need to decrease waiting times and communication before and after the 
procedure.  
 
Staff at both Intervention and Control sites displayed a widespread wish to 
modernise and improve services, and there was frustration at the inability to 
do more. Much modernisation was possible at no cost, such as changes to 
service processes. Well-motivated staff and innovative ideas were 
recognised as facilitating such changes. However, lack of senior 
The ENIGMA study 
©NCCSDO 2008 Page 289 
management support, financial constraints or perceived inappropriate 
allocation of funding (such as the provision of additional funding for staff 
without extra equipment) were a cause for frustration. Changes to work 
processes and patterns were beneficial for staff, despite ongoing tensions 
among specific groups within endoscopy units. 
 
The findings are summarised in tabular form in Tables 70-72 (a, b and c), 
using a three-layer matrix (MATRICS) to illustrate which specific target 
variables for each of the three perspectives were investigated (layer 1), 
which methods were used for each variable (layer 2), and the findings (layer 
3). An alpha-numeric code links the effect sought, method used and 
findings, which are also displayed from three perspectives: the patient; 
endoscopy services; NHS and society. Thus the effect (layer 1) on patient 
quality of life (1), was measured (layer 2) using the SF-36 (B), EQ-5D (C) 
and GSRQ (D), and found (layer 3) no difference between Intervention and 
Control groups, but overall improvement over time (1B, 2C, 1D).  
 
Table 70.   Effects1 that were sought (layer 1)  
 
 
1Outcomes defined specifically for each perspective, according to Aims and 
Objectives. 
 
Effects on patients Effects on endoscopy 
services 
Effects on the rest of 
the NHS and society 
1 -  Patient Quality of Life  
[B, D] 
6 - Cost of modernisation 
[H] 
14 – Time off work [I] 
2 - Total health benefit 
[C] 
7 – Service performance 
[A] 
 
3 - Patient experience of 
referral process  
[E] 
8 – Organisation, 
function and process of 
service delivery [E, F, G, 
J] 
4 – Patient satisfaction 
with endoscopy [L] 
9 – Accessibility to 
services [E, F, K] 
5 – Waiting times [E, M] 10 – Appropriateness and 
acceptability of services 
[F, G, K] 
 11 – Reliability and 
availability of routinely 
collected process data 
[A] 
12 – Patient use of drugs 
[I] 
13 – Patient use of 
primary and secondary 
care resources [I] 
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Table 71.   Methods used (layer 2) 
 
 
Table 72 (a). Effects on patients (layer 3) 
 
Code Effects on patients  
3E, 9F, 5E, 
9E, 8E 
 
 
Access to and acceptability of endoscopy services have improved with 
shorter waiting times, greater throughput, more patient information, more 
responsiveness to patient views and better communication between 
reception staff and patients. 
3E ‘Urgent’ patients are satisfied with waiting time. Majority of non-urgent 
patients satisfied with waiting time. 
Fewer patients saying they would like procedure sooner 
3E No change in experience for patients who had had previous endoscopy  
3E Patients are satisfied with treatment and care received 
9F, 10F There is greater commitment to patient satisfaction and involvement 
10F Difficult to assess if patients are at the centre of ‘quality agenda’ or benefit 
as units strive to reach targets 
10G External/government targets implemented through Trusts and management 
force clinicians to concentrate predominantly on meeting targets rather than 
focussing on patient care. 
1B Patients had improved SF-36 MCS and PCS following endoscopy but there 
was no significant difference between Intervention and Control groups. 
1D Patients had fewer GI symptoms as measured by GRSQ following endoscopy 
but there were no significant differences between Intervention and Control 
groups 
2C Patients had improved EQ-5D following endoscopy but there were no 
significant differences between Intervention and Control groups 
4L There were no differences between Intervention and Control groups in 
patient satisfaction as measured by the GESQ following endoscopy  
5M There were significant differences in patient waiting times between 
Intervention and Control groups. These favoured the Intervention group for 
the first four waves of recruitment and the Control group for Wave 5. 
 
Code Method 
A [7, 11] Process data analysis 
B [1] Analysis of Short Form 36 (SF-36) scores  
C [2] Analysis of Euroqol 5D (EQ-5D) scores 
D [1] Analysis of Gastrointestinal Symptom Rating Questionnaires 
(GSRQ) scores 
E [3, 5, 8, 10] Semi-structured patient interviews 
F[8, 9, 10] Interviews with professionals and key people 
G[8, 10] Focus groups 
H [6] Health economic site visits 
I [12, 13, 14] Health economic patient reported resource use 
J [8] Innovations form 
K [9, 10] General Practitioner (GP) questionnaire 
L [4] Gastrointestinal Endoscopy Satisfaction Questionnaires 
(GESQ) (patient satisfaction questionnaire) 
M [5] Analysis of time difference between referral and procedure 
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Table 72 (b). Effects on endoscopy services (layer 3 continued)  
 
Code  Effects on endoscopy services 
10F MES Programme training offered too early by ill prepared teachers and 
project staff lacked credibility. 
10F MES ToolkitTM strongly disliked but data collection recognised as important 
to support change 
9F Some Government targets helped put endoscopy in spotlight. Others impact 
negatively on some patients 
10F Working relationships of staff sharing endoscopy improving but still some 
resistance from clinicians 
10F Strong leadership, communication, staff ownership important in introducing 
change 
8F Training important to update staff and ensure appropriate skill mix but 
time, sparse financial resources and insufficient staff impede this 
10F Staff respond positively, are supportive and co-operative and welcome the 
challenge of new ways of working 
9K There was no significant difference between GPs who referred patients to 
Intervention and Control sites regarding perception of accessibility to 
services 
10K There was no significant difference between the GPs who referred to the 
Intervention and Control sites regarding appropriateness and acceptability 
of services  
8F Ongoing financial constraints that lead to crisis management, ad hoc 
change, and make forward planning difficult 
9F Lack of resources impacts on staffing, equipment, information technology 
and facilities 
8F Some change processes are cost neutral  
8G Discord between members of staff from various specialties using endoscopy 
units. 
8G, 10G Welsh units see themselves as lagging behind their English counterparts, 
but are learning from the successes and mistakes. 
8G Changes to improve processes, such as pooled lists, did not require 
additional resources. 
8G Lack of recognition and appreciation of professionals by management and 
Trusts lead to disillusionment amongst senior clinicians; an erosion of 
professional self-identity. 
8G, 10G Resource deficits and allocation of funds based on poorly informed 
decisions.  
8G, 10G Lack of management involvement and/ or interest in clinical processes and 
patient care 
7A There was no statistically significant improvement in the delivery of 
endoscopy services in Intervention sites 
7A There was no statistically significant improvement in the delivery of 
endoscopy services in Control sites 
7A There was no significant difference between the endoscopy services of the 
Intervention and Control sites at any time 
11A Process data was not routinely collected by many endoscopy units, but 
especially not by the Intervention sites 
11A The majority of routinely collected process data from endoscopy units and 
Trusts was highly comparable with the equivalent Hospital Episode 
Statistics (HES) datasets 
12I Overall resource investments in modernisation in terms of one-off costs, 
investments which produce a flow of benefits and increase in annual 
revenue costs.  
13I Tendency toward lower use of drugs by patients in Intervention sites 
14I Some tendency toward reduction in primary and secondary NHS resource 
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use 
8J There was no significant difference in the average number of innovations 
introduced by Intervention and Control sites 
6H All sites made major investments in modernisation: in staff, training, 
equipment and modernisation activities. 
6H The Intervention did not significantly affect overall levels of investment in 
modernisation. 
 
Table 72 (c). Effects on the rest of the NHS and society (layer 3 
 continued) 
 
Code Effects on the rest of the NHS and society 
8F, 8G Change due to natural realignment and evolution of services rather than as 
a response to specific innovations.  
8F External body can be a catalyst for change. 
8F The nature of change is ad-hoc rather than specific. 
13I Tendency toward less time off work by patients meaning less lost 
productivity to industry. 
8F There have been some successes in getting funding, with Global Rating 
Scale (GRS) and National Bowel Cancer Screening Programme (NBCSP) 
useful leverage tools. 
10G GRS and NBCSP help raise the political visibility and image of endoscopy 
units within the Trusts affecting targets and funding allocation. 
 
There is no universally accepted definition of either innovation in, or 
modernisation of health services. We found a wide variety of initiatives that 
were undertaken to change services for the better. While we were not able 
to show any significant difference between Intervention and Control sites 
(i.e. any effect of the MES programme) apart from shorter waiting lists and 
a decrease in the number of patients waiting, we have shown a qualitative 
improvement in patient perceptions of their care and time spent waiting, 
communication with patients, physical surroundings and staff skill mix. 
Patients are satisfied with the service they receive and the majority are 
content with waiting times, including for routine procedures. 
 
The approaches to modernisation in the participating sites were many and 
diverse, but tended to be ad hoc and opportunist, rather than strategic and 
co-ordinated. They were initiated and led by staff in the units themselves 
where strong leadership, communication and staff ownership were 
important in achieving effective change. Centrally initiated targets were felt 
to be helpful in drawing attention to endoscopy services at a local level but 
paradoxically were often felt to affect patients negatively by distorting 
priorities. This view is supported by a review of the literature on the impact 
of the Two-Week-Rule (TWR), which was implemented to speed referral of 
suspected colorectal cancer patients (CRC), but lacks the sensitivity to be 
effective: only 9.4% of patients referred via the TWR were subsequently 
diagnosed with CRC, and only 32% of all CRC patients were referred via 
TWR (Thorne, Hutchings and Elwyn 2006).  
 
The primary purpose of such initiatives is to reduce delay between referral 
and action, but there is a complex interaction between the numbers waiting 
for a procedure and the time individuals spend on a waiting list. The data we 
received from sites were not sufficiently robust enough to enable us to 
explore this in depth but it is likely that the decrease in numbers waiting is 
the result of more effective attempts by Intervention sites to influence and 
manage demand (e.g. by new referral procedures, validation of referrals, 
guidelines and triage), while stable average waiting times reflect less 
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successful innovations designed to improve departmental capacity or 
efficiency. 
 
We identified several barriers to innovation and change. Our qualitative 
research revealed staff issues such as low morale and discordance between 
professional groups that impacted on the effectiveness of innovations or 
modernisation. We also identified deficiencies relating to data management 
and the use of data to provide evidence on which to improve services. An 
analysis of the availability of such process and activity data indicated that it 
was routinely collected in only eight of 19 sites, and of these, only two (both 
Control sites) were able to provide all five service process measures that are 
pertinent to ongoing monitoring of service performance. Furthermore, we 
found HES to be unreliable with regard to endoscopic activity, confirming 
concerns that have been expressed previously (Williams 1999; Williams and 
Mann 2002). The problem appears to be mainly due to lack of consistent 
application of data dictionary definitions by Trust Information Departments, 
leading at times to gross underreporting of activity. 
 
Focus groups with professionals elicited frustration at the lack of Trust or 
hospital management systems in place, at the more senior levels of 
management, to encourage units to implement identified change or seek 
finances necessary to promote change.  Professionals also emphasised the 
lack of understanding to support the work and ambition of the units and 
suggested management at the more senior levels were not acting effectively 
to make a difference to unit working.  This was exacerbated by the 
professionals’ sense that units lacked visibility within Trusts. This meant 
that units were unable to make appropriate long-lasting changes to service 
delivery and organisation and that decisions about modernisation were 
made by ill-informed management without scientific or clinical experience, 
and without an evidence-based approach to change.   
 
Focus group participants also suggested the culture of management was 
problematic, with a cultural gulf between consultants and managers.  The 
higher managerial echelons within the Trust were seen to be working in an 
ad-hoc manner, making decisions without consultation or knowledge of the 
work on the ground.  Furthermore, managerial decisions were enforced 
without clarity of structure or process so that the rules of engagement 
between unit staff and management were a moving feast.  Consequently, it 
was difficult for consultants and clinicians to know how and when to engage 
with management or to recognise the processes necessary to engage 
effectively. This was exacerbated by a general sense of resource deficit. 
Focus groups with health professionals who had modernised their units 
independently of the MES programme suggested that to achieve long-lasting 
positive effects management should actively support innovations, 
particularly by considering staff morale and appropriate funding. 
 
The MES programme thus does not appear to have been a major factor in 
bringing about change. Indeed the ‘ToolkitTM’ introduced by the programme 
was disliked and not sustained. This study found that very few study sites of 
either Site type were actively collecting any service-related data, a finding 
that has been expanded upon elsewhere (Thorne, Hutchings and Elwyn 
2008).  From this we concluded that the Toolkit™ failed to introduce a data 
collection culture in the Control sites, and more surprisingly in the 
Intervention sites.  There could be a number of reasons for this, each of 
which will be discussed below: 
 
 Many site contacts commented during interviews that they saw the 
Toolkit™ as too rigorous.  They understood the aims of the Toolkit™ 
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in promoting data collection and analysis to better understand and 
monitor services, but they thought that the level of detail for the 
data was too fine.  For example, counting activity by measuring the 
length of time taken for each appointment in minutes was 
impractical, and extremely time and resource-intensive.  Whilst the 
data was exceptional at highlighting service processes and problems, 
it was not practical to collect this data on a daily basis. 
 The strict data collection regime may have been too exhaustive.  
Data had to be collected daily and uploaded to the MES programme 
on a monthly basis – yet another deadline to be met in an already 
busy unit. 
 As already mentioned, sites appeared to understand the necessity for 
data collection practices to be implemented and many predicted their 
intention to develop their own, less comprehensive but less resource-
intensive version of a data collection toolkit.  We have shown that 
most did not follow up their intention with implementation of data 
collection practices, most probably due to time constraints but also 
possibly due to a lack of experience in understanding what variables 
needed to be collected and analysed for effective service monitoring. 
 Many sites had a change of personnel following the close of the MES 
programme, especially fin the Intervention sites who tended to “lose” 
their change agent as they moved on to other modernisation 
programmes within the Trust.  In many cases, these were the people 
to dealt with the Toolkit in the Intervention sites and with their move 
came a loss of data capture motivation.  The same may be true for 
the Control sites to a lesser extent, since NHS personnel often have a 
short-term contract within departments. 
 Data collection was often driven by local targets and the need to 
develop bids for funding from the Trust.  This led to ad hoc data 
collection that was usually short-lived and not applied to service 
delivery. 
 
The MES programme may have initiated a more innovative culture which 
was receptive to the introduction of the GRS. This was introduced in spring 
2005, towards the end of our study, to improve the quality of endoscopy 
services and was quickly identified as a stronger driver for change and 
innovation than the MES programme. It requires sites to monitor the quality 
of their clinical care and of their patients’ experience themselves. 
Professionals have welcomed the GRS because it has raised the profile of 
endoscopy services with Trust management and it makes their work more 
visible. Notwithstanding the apparent failure of the MES programme, 
interviews with professionals indicated that it had encouraged change and 
facilitated the subsequent implementation of the GRS.  
 
Thus the factors driving modernisation are complex, and modest investment 
plays little role. There is a perception that the GRS now improves both 
quality and activity. Hence there is a need to evaluate its effect on patient 
outcomes and departmental performance, especially as it may be adopted 
more widely, including overseas.  
11.2   Internal validity 
 
At the start to chapter 2 we discussed the methodological challenges in 
setting up this study. We used mixed methods, including patient and 
professional views, documentation of activity, health economics and patient 
outcomes measured in five waves from 2004 to 2006. We have thus 
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assessed the impact of the NHSMA MES programme from a wide variety of 
perspectives leading to concordant results. However the absence of a widely 
accepted definition of innovation or modernisation made our task more 
difficult. We therefore sought examples of local innovation through 
interviews with staff and then shared these widely with all study sites, thus 
helping them to complete the list of changes they had made. However, it 
was often difficult for them to identify the exact timing of the innovation, 
not least because there was little reliable data. 
  
We used a quasi-experimental approach to assess patient outcomes. A 
randomised controlled trial (RCT) was not possible because the intervention 
we were assessing (support from the NHSMA MES) started before our 
evaluation. We used validated instruments to collect outcome data from 
patients in five waves over two years. Our original intention was to use an 
interrupted time series approach, but the timing of innovations by the sites 
were too imprecise to draw inferences. We therefore monitored progress 
over time, and compared Intervention and Control sites. Such an approach 
is weaker than an RCT, but the findings from our mix of methods are largely 
concordant.  
 
One hundred patients were invited to participate by each site in each wave, 
identified from the referrals received in the month of recruitment, with 
recruitment limited to 20 patients each day to distribute allocation 
throughout the week. Of 9154 considered for the study, 3818 (41%) 
consented to take part and completed a Baseline Questionnaire (BQ). The 
Post Procedure Questionnaires (PPQ) was returned by 76.9% of those, and 
67.8% returned the 12 month Post Procedure Questionnaire (12M PPQ). 
Though the response rate from patients was disappointing, it was consistent 
across waves and sites, thus facilitating inference, and yielded 2587 
evaluable responses. There was imbalance in patient characteristics at 
baselines, with more urgent requests in the Control group, and more routine 
requests in the Intervention group. As we were able to control for such 
potential biases, however, we doubt that this has distorted our findings. 
  
The intervention we studied was the active support and funding given to 
study sites by the NHSMA MES programme. The investment was small 
(£30k) and made in early 2003. By March 2005 the programme had ceased 
and the NHSMA itself was disbanded. We sought effects over a 33 month 
period from April 2004 to January 2007, and were thus looking at the 
impact of a programme more than a year after it started, and for two years 
after the host organisation was disbanded. This timescale is appropriate to 
assess the impact of innovations introduced, but means that our baseline 
data were collected after the intervention had been applied. This may 
explain why Intervention sites already had shorter waiting times than 
Control sites at the beginning of our evaluation. 
 
The relative lack of analysable activity data from study sites is regrettable, 
and limits the depth of conclusions that can be drawn, but the findings we 
do have are concordant with the conclusions we have drawn from the data 
from patients.  
 
We took a rigorous approach to the qualitative aspects of the study, 
obtaining views from patients by telephone interview, and using both face to 
face interviews and focus groups to seek the views of professionals. The 
response to our questionnaire to GPs was poor (35%), and reduces 
confidence in our finding that more GPs working in the locality of Control 
sites thought the changes introduced produced better results than those 
working near Intervention sites. 
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11.3   External validity 
 
This study has looked in depth at 18 sites. These included small and large, 
rural and urban, district general and teaching hospitals (Table 2). We 
believe they are generally representative of endoscopy units in England. Our 
quantitative findings are in tune with the slow pace of modernisation of 
endoscopy services across the country at the time of the study, and are 
supported by the qualitative observations of both patients and professionals. 
The improvement in patient outcome after a procedure reflects our previous 
experience in the MINuET study (Williams, Russell, Durai, Cheung, Farrin, 
Bloor et al. 2006). The problems we encountered with routinely collected 
data from study sites also reflects our previous experience (Williams 1999; 
Williams and Mann 2002).  
 
We are not aware of any previous systematic evaluation of endoscopy 
service modernisation using a mixed methods approach, but we have shown 
that this is feasible though difficult, both methodologically and practically. 
Robust service data is crucial, but not yet available in spite of the attempts 
of the NHSMA to promote this in the MES programme. 
11.4   Wider implications 
 
Modernisation of endoscopy services does not appear to affect patient’s use 
of other NHS resources. It is not therefore a mechanism for reducing 
demand on other NHS services. Relatively small financial incentives (such as 
those made by the NHSMA) are unlikely to have a measurable effect. Other 
funding sources can compensate those denied funding from a specific 
programme, and potential sources should be exploited. Even so, funding 
itself and promotion of data collection, is unlikely to produce major 
improvements in services. We judge that future initiatives should 
concentrate on quality improvement and it will be important to engender a 
strong sense of local ownership, raise the profile of services, and engage the 
support of Trust management. 
 
Better systems are needed to capture data, not only about activity, but also 
about demand, and patient outcomes, both administrative and clinical.  
Patient-focused clinical systems that support both individual patient 
management and departmental processes in one integrated approach, is the 
logical way to achieve this. It is hoped that the wider capture of electronic 
patient focused data will also enable the routine measurement of patient 
outcomes, either directly (Ali, Gaze, Russell, Russell and Williams 2008) or 
by proxy (Hutchings, Cheung, Williams, Cohen, Longo and Russell 2005).  
 
11.5 Learning Points   
11.5.1 Policy makers 
 
 Policy should focus on improving quality, not attaining activity 
targets. 
 Data collection to monitor both quality and activity should be 
embedded in the process of care and, wherever possible, not 
collected as a parallel activity. 
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 If a major initiative is to be evaluated, this should be built in ab 
initio. 
 New initiatives should clearly define the issues they are addressing.  
For example, there should be clear distinctions defined between 
modernisation, innovation, improvement and change. 
11.5.2 NHS Trusts 
 
 Senior management should listen more closely to the views of the 
clinicians who work in their Trusts and aim to facilitate the changes 
that are proposed. 
 Professionals are frusteated by their inability to change, which they 
perceive as due to a lack of support, as well as a lack of funding. 
 Much change can be achieved with a facilitated, bottom-up approach. 
 There is a need for senior management to work more closely with 
professional leaders at a Trust level, and to respect their views and 
aspirations. 
 A more structured approach to liaison is needed. 
11.5.3 Professionals 
 
 Tribalism amongst professional groups remains a serious problem 
and an inhibition to positive change. 
 Strong leadership is an essential requirement for effective change. 
 More investment and effort should be made to fulfil the training 
requirements of units, particularly with routine tasks such as data 
capture and reporting. 
 Improvements should be directed primarily at quality. 
 Rigorous data collection is an essential activity if units are to be 
managed effectively, and needs to be recognised as the responsibility 
of staff at all levels. 
11.5.4 Research funders 
 
 There should be strong links between policy makers and research 
funders to ensure that evaluation is built in ab initio. 
 A mixed-methods approach involving quasi-experimental methods is 
an effective but expensive way to evaluate complex interventions. 
 A mechanism should be found to facilitate the continuation of studies 
that identify new issues so that the opportunities for further learning 
are not lost. 
11.6 Need for further research 
 
1. The MES programme was a catalyst to modernisation during a period 
of wider policy pressures to modernise services. The evaluation of 
future initiatives should be planned from the beginning so as to 
identify the intrinsic effects and isolate them from other trends. 
 
2. Many of our sites identified the GRS as a strong driver for improving 
services, and this now needs to be rigorously evaluated.  
 
3. Further research is needed regarding the role of management in 
relation to endoscopy unit staff requests for financial or unit support 
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and the relationship between management and the change culture of 
endoscopy units.  This would include a clearer understanding of how 
management are perceived by endoscopy unit staff and how 
management themselves view their roles in relation to 
gastroenterology service developments.  Additional research would 
explore current structures and processes in place for managerial 
decision making within the Trusts in relation to endoscopy units and 
changes to managerial functioning in respect of service delivery and 
organisation. 
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12 Conclusion                                                            
We have drawn several conclusions from this large and complex study. 
12.1   There were substantial changes in the 
services delivered by endoscopy units during the 
timescale of this study 
 
This included changed roles and responsibilities and many new working 
practices to manage demand and increase capacity.  
12.2   Small financial incentives do not 
themselves trigger innovation in services 
 
Modernisation has occurred both with and without the direct influence and 
funding of the NHSMA MES programme. 
12.3   Modernisation to reduce endoscopy 
waiting lists does not improve patient outcomes 
 
The number of patients waiting for an endoscopy fell at Intervention sites, 
but average waiting times did not. In sites that did not receive funding from 
the MES average waiting times lengthened until the end of the study when a 
fall was noted. The known improvement in patient quality of life after 
endoscopy was confirmed, but patient outcomes were unaffected by 
modernisation or investment. 
12.4   Endoscopy activity and process data 
needs substantial improvement 
 
The availability of process and activity data from sites is poor. HES data are 
unreliable for monitoring endoscopic activity. 
12.5   Patients are largely content with 
services 
 
Patients saw little change in services, and are satisfied with their treatment 
and care, and with waiting times, which they perceived as falling.  
12.6   Endoscopy staff must be at the heart of 
improvement 
 
Professional morale is low, but the ambition to improve services is strong. 
Staff saw the MES programme as a driver for change, but were frustrated by 
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lack of senior management support for clinically led change, and a perceived 
lack of investment. The importance of strong leadership, staff commitment, 
teamwork and good communication is confirmed.  
12.7   Modernisation should be more patient-
focused 
 
Modernisation of endoscopy services may reduce numbers on waiting lists 
but, if it is to improve patient outcomes, it should focus on quality-based 
goals rather than activity targets. The recent introduction of the GRS has 
focussed attention on quality and its effectiveness should be evaluated. 
 
12.8   A mixed method approach which 
includes a quasi-experimental component is 
feasible and valuable in the evaluation of the 
delivery of services 
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Appendix 1 – Full Proposal 
SECTION 1. SUMMARY OF THE PROPOSAL 
 
Scientific summary of the research proposal: no more than 500 words covering 
the following topics: aims of the research, type and location, methods of working, 
measure of outcome if appropriate. 
 
Aims of the research 
 
 To evaluate innovations in service delivery and organisation initiated by 
the Modernising Endoscopy Service (MES) of the NHS Modernisation 
Agency (NHSMA). 
 To compare the accessibility and acceptability of the resulting models of 
service delivery with other new models. 
 Also to compare effectiveness and cost-effectiveness in improving 
outcomes assessed by patients and professionals. 
 
Type and location of innovations 
 
We shall use 25 sites across the UK. The NHSMA has selected 29 ‘pilot sites’ in 
England to receive funding, training and support to analyse and redesign their 
current GE services. From these we shall select a stratified sample of ten 
‘experimental sites’. A further 70 ‘independent sites’ applied to take part but were 
unsuccessful. From these we shall select a stratified sample of ten ‘MES Control 
sites’ keen to redesign their services with training and support but no extra 
funding. Thirteen British sites committed to genuinely independent redesign of 
their GE services responded to our circular to the British Society of 
Gastroenterology (BSG). From these we shall select a stratified sample of five 
‘BSG Control sites’. 
 
Methods of evaluation 
The 29 pilot sites aim to analyse their services during 2003 and redesign them 
during 2004. In collaboration with the NHSMA we shall invite our 10 MES Control 
sites to analyse their services by July 2003. We shall ask all 15 Control sites to 
redesign their services by July 2004. Even so we expect both types of site to vary 
in their speed of innovation. This differential timetable reflects the Control sites’ 
lack of earmarked funding, which is likely to inhibit progress as they seek 
alternative resources for innovation (though not evaluation), and will enable us to 
infer from Control sites what would have happened in experimental sites in the 
absence of MES recognition and funding. Thus our basic research design is that of 
an interrupted time series design, simplified where appropriate to a controlled 
before-and-after study. 
 
Measurement of outcome 
To measure time between significant events in the patient journey, we shall 
collect data from our 25 sites over three years. To gather patients’ assessments of 
their own outcomes (both generic through EQ-5D, and specific to the digestive 
tract), the quality of communication, and the extent of their own contributions 
and costs, we shall draw stratified samples of 40 patients per site in the spring 
and autumn of 2003, the spring and autumn of 2004, and the spring of 2005. We 
shall ask these 5000 patients to complete questionnaires at their first hospital 
appointment and by post 12 months later. To explore patients’ views and 
preferences in more detail, we shall interview a 5% stratified random sample of 
respondents over two years from the spring of 2003. We shall interview stratified 
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random samples of ten health care professionals per site over the same period. To 
estimate the incremental cost per quality-adjusted life year of the MES, we shall 
estimate the NHS and societal costs of innovative models and compare them with 
changes in patients’ EQ-5D scores. 
 
 
SECTION 1. SUMMARY OF THE PROPOSAL (CONTINUED) 
 
Plain language summary of the research proposal: in no more than 500 words 
please summarise your proposal in non-scientific language, using words and 
terms that can be easily understood by non-research communities. Do not use 
acronyms or abbreviations. Your summary must include a clear statement of the 
purpose of your research, how it will build on existing evidence where available, 
and its intended benefits to patients and the public. It must also describe how the 
research will be conducted and how patients and the public will be involved. 
 
Introduction 
The NHS Modernisation Agency has set up a national project to modernise 
gastroenterology services. These services investigate patients with digestive and 
bowel symptoms. An important role is to identify or eliminate cancer. In Phase 2 
of that project 29 ‘pilot sites’ in England are receiving funding, training and 
support to analyse their current services and redesign them. 
 
Purpose of the research 
Working with the NHS we shall evaluate whether the changes initiated by the 
national project are acceptable to patients and professionals, improve access to, 
and outcomes of, gastroenterology services, and provide good value for money. 
Existing evidence on redesigning services in this field, to which applicants have 
contributed, relates to specific or local projects, rather than generic and national. 
Nevertheless our previous work provides a rigorous basis for the proposed 
evaluation. 
 
Research design 
To compare the national project with other approaches to redesigning services, 
we shall sample representative sites – ten national project sites and 15 ‘Control 
sites’. Ten of the Control sites will be unsuccessful applicants to the national 
project who nevertheless chose to adopt the methods of the project without extra 
funding. Another five controls will have existing commitments to redesign their 
services independently of the national project. National project sites (both those 
who were successful and received funding, and those who were unsuccessful) 
should analyse their services during 2003 and redesign them during 2004. We 
shall ask Control sites to analyse their services by July 2003 and redesign them 
by July 2004. This differential timetable allows Control sites to seek alternative 
resources for redesign. More important it enables us to infer from Control sites 
what would have happened in pilot sites in the absence of their national project 
 
Research methods 
To compare services between pilot and Control sites over three years from the 
beginning of 2003, we shall extend data bases designed for the national project to 
cover all 25 evaluation sites. We shall also sample 200 patients per site over two 
years from April 2003. We shall ask these 5000 patients to complete 
questionnaires about their experiences, outcomes, costs (e.g. travel, time off 
work) and recent use of NHS resources at their first hospital appointment and by 
post 12 months later. To explore patients’ views and preferences in more detail, 
we shall interview a sample of 250 respondents over two years from April 2003. 
We shall also interview samples of ten health care professionals per site over the 
same period. To assess the value for money of redesigning services we shall 
compare extra benefits to patients with extra costs to NHS, patients and society. 
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Public involvement in research 
Thus we shall collect a wide range of data from representative samples of 
patients. We shall also build on our previous experience of public involvement by 
including representatives of patient organisations in the management of our 
research. 
 
SECTION 2. DETAILS OF THE RESEARCH PROPOSAL  
 
(This section must have a MAXIMUM of 10 sides of A4 paper and a minimum font 
of 10 points, you may LENGTHEN or SHORTEN any part from A – J ONLY) 
 
A. Aims & Objectives 
Aims 
 
 To evaluate, both quantitatively and qualitatively, innovative models of 
delivery and organisation of gastroenterology (GE) services in general, and 
endoscopy services in particular, initiated and co-ordinated by the 
Modernising Endoscopy Service (MES) of the NHS Modernisation Agency 
(NHSMA). 
 To compare the accessibility and acceptability to patents and professionals 
of the resulting models of service delivery and organisation with those of 
other new models. 
 To compare the effectiveness and cost-effectiveness of the resulting 
models in improving outcomes assessed by patients and professionals with 
those of other new models. 
 
Objectives 
 
 To describe new models of service delivery designed to improve the 
assessment and management, mainly but not exclusively in secondary 
care, of patients with new and continuing gastro-intestinal (GI) disorders. 
While many of these models will arise in experimental sites directly from 
the MES, others will arise in Control sites, either indirectly from the MES or 
independently of the MES. While some will focus narrowly on endoscopy 
services, others will cover GE services in general. 
 To estimate for both experimental and Control models of service delivery: 
 accessibility and other measures of the quality of the process of care; 
 acceptability to patients and professionals in primary and secondary care, 
and their perception of the value of these models; 
 outcome as assessed by patients and professionals in primary and 
secondary care; 
 resources consumed by NHS, patients and society in general; and 
 effects on other aspects of the NHS. 
 To develop methods to evaluate complex heterogeneous interventions 
designed with a common purpose. 
 
B. Relevance to SDO Call for Proposals 
 
Our proposal is relevant to the call for proposals from the NHS SDO R&D 
Programme in three main ways. First it evaluates new models of service delivery 
and organisation before their national adoption. Specifically it compares models of 
delivering GE services directly initiated and co-ordinated by the MES of the 
NHSMA with models generated in other ways, some indirectly by the MES and 
others independently of the MES. More generally it will yield important insights 
into effective ways of developing models of service delivery and organisation in 
other fields.  
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Secondly our proposal addresses three of the five exemplary issues specified in 
the commissioning brief: 
 
 Service redesign to improve booking for outpatient or day case 
appointments; 
 Innovations at the interface between primary and secondary care; and 
 Substitution of professions. Our proposal can address this issue only if one 
or more of the emerging models substitute one profession for another. 
Nevertheless our preliminary survey of members of the British Society of 
Gastroenterology (BSG) has established that the use of clinical nurse 
specialists to enhance GE services by prioritising referrals, undertaking 
endoscopies and contributing to follow-up is fast increasing and thus 
certain to feature in emerging models of service delivery at many of the 25 
evaluation sites. 
 
These three issues are central to current NHS priorities and thus the 
implementation of the NHS Plan. 
 
Thirdly the brief mentions the desirability of methodological development to 
complement research into substantive issues. Our third objective is to develop 
methods to evaluate complex heterogeneous interventions designed with a 
common purpose (Section A). To this end we have developed a common portfolio 
of process and outcome measures to cover all 25 sites under the umbrella of a 
multiple interrupted time series. 
 
Finally our proposal also addresses the issue of access. Since our focus is on the 
organisation and management of services, however, it complements rather than 
replicates the SDO access programme. 
 
C. Background, including NHS context and relevant literature 
 
Background 
 
The NHS is changing, in response to political, social and economic pressures, and 
to advances in diagnosis and treatment. Improving access to care is a high 
priority, highlighted in the NHS Plan in general and the NHS Cancer Plan in 
particular, and reinforced by National Service Frameworks. Roles are also 
changing. Nurses are undertaking many tasks traditionally undertaken by doctors. 
This is especially true of gastroenterology – a busy inter-professional specialty 
that cares for disorders of the gut, liver and pancreas. As in many other 
specialties, workload is rising and hospitals are experiencing increasing difficulty 
in offering patients timely and appropriate care. There is a heavy demand for 
rapid access to diagnostic facilities for patients with symptoms that raise the 
possibility of cancer. Cancers of the GI tract (oesophagus, stomach, pancreas, 
colon and rectum) are commoner than in any other organ system and most need 
endoscopy or the upper or lower gut for diagnosis. Endoscopy also has a major 
role in the diagnosis and treatment of benign disease. As a result, referrals are 
increasing and gastroenterology units have increasing difficulty maintaining 
appropriate, timely assessment of all patients. 
 
National data on waiting lists for endoscopy are not available. However the NHS 
Modernisation Agency estimate that about one million patients are currently 
waiting, some for more than a year. Furthermore many benign GI disorders (e.g. 
oesophagitis, coeliac disease, liver disorders, Crohn’s Disease and ulcerative 
colitis) require continuing follow-up because of the need for powerful therapy to 
control the disease, the likelihood of relapse, and the risk of developing cancer or 
other dangerous sequelae. Hence it is proving difficult to maintain rapid, 
appropriate and fair access to consultations and investigations, both for newly 
The ENIGMA study 
©NCCSDO 2008 Page 308 
referred patients and for those under follow-up. There is increasing recognition of 
the need to inform patients better and involve them more in decision making. 
However these trends increase consultation times, and reduce the number of 
patients seen at each clinic. 
 
In response to these pressures many GE units have devised new methods for 
assessing patients referred from primary care, and for following up those who 
remain under surveillance. For referrals these methods include: novel booking 
systems, also the focus of the NHSMA National Bookings Programme0; 
assessment and triage by nurses; and ‘one-stop’ clinics that combine clinical 
assessment and diagnostic procedures in one visit. For follow-up there is a trend 
towards telephone appointments with nurses rather than booked appointments 
with specialist doctors. Unfortunately the evaluation of these innovations has 
been piecemeal, with few rigorous studies. Randomised trials have shown that 
both patient-initiated follow-up1 and open access follow-up2 are effective, 
maintain patients’ Quality of Life, and enjoy the support of patients and general 
practitioners3. However most reports have been in abstract4-12 and focus on 
benefits rather than problems. Few assess effects on secondary and primary care 
or the preferences of patients and professionals. Hence there is an urgent need 
for rigorous evaluation of the effect of these innovations on patients, 
professionals, workload in primary and secondary care, and NHS resource 
consumption. 
 
Organisational change in the NHS reflects a growing recognition of the benefits of 
a systems approach to health care delivery and reorganisation13. Publications on 
the systems approach in clinical journals show increasing professional interest13-15 
in the application of business process re-engineering (BPR) to health care16. The 
Department of Health funded two projects to test the application of BPR to health 
care in the early 1990s and since then, the number and scale of different types of 
‘redesign’ initiatives have grown rapidly. These initiatives all seek to improve 
quality of care through redesign of the patient process or pathway17. The NHS Plan 
has emphasised that redesign will play a key role in the modernisation of the NHS 
but there are relatively few well-conducted empirical studies on the effectiveness 
of the different models for redesign in health care18 and even fewer have assessed 
the impact of these models on patients’ Quality of Life with validated outcome 
measures.  
 
The Modernising Endoscopy Service (MES) 
 
Eight NHS Trusts in England are already taking part in the first, developmental 
phase of the MES. Of the remaining 161 current NHS Trusts 99 applied for the 
second, pilot phase of the MES. Using simple explicit criteria the NHSMA selected 
29 of these 99 as ‘pilot sites’ in Phase 2, launched on 4 September 2002. These 
29 will receive earmarked funding of £10 000 for using the MES Management 
ToolkitTM to analyse their current endoscopy services over the last three months of 
2002, together with training and support from the MES itself. The ToolkitTM uses 
the principles of service improvement and redesign to enable pilot sites to assess 
current services in response to seven ‘challenges’. Those pilot sites who use it 
successfully will receive further earmarked funding of £30 000 for redesigning 
their services over the calendar year 2003 in response to the eighth and final 
‘challenge’ – that of promoting new ways of working. Together these 29 pilot sites 
epitomise the complex intervention19 to create new models of service delivery and 
organisation in GE that this project seeks to evaluate. 
 
Though the 70 unsuccessful sites will receive no funding, they are eligible to use 
the ToolkitTM outside the remit of the MES. In particular they can apply to attend a 
one-day training course in the autumn of 2002 and thereafter receive support 
from the NHSMA. Thus these 70 ‘independent sites’ represent one form of control 
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for the 29 pilot sites – similar in many ways, but lacking earmarked resources to 
develop their services. 
 
In addition our outline application aimed to evaluate genuinely independent 
“innovations in GE at the interface between primary and secondary care”. In 
preparing that outline we wrote to all members of the British Society of 
Gastroenterology. Seventeen replied to say that they had developed, or were 
developing, new ways of managing patients newly referred to GE. Most of these, 
and two others, had also developed, or were developing, new ways of following up 
patients seen in GE clinics. However all 19 respondents were willing in principle to 
contribute to a project funded by the NHS SDO R&D Programme to evaluate 
innovations in managing GE referrals. We still regard the effective but efficient 
follow-up of patients with chronic, relapsing disease as an important issue in 
modernising GE services. However follow-up is not prominent in the MES 
ToolkitTM. Given the opportunity to collaborate with the NHSMA to evaluate the 
MES initiatives focusing on the referral process, therefore, we have deferred our 
plans for a randomised trial of flexible nurse-led follow-up versus conventional 
doctor-led follow-up, as outlined in our outline application. 
 
Of the 19 sites identified through the BSG, two are taking part in Phase 1 of the 
MES and another four in Phase 2. These six are thus ineligible to act as controls 
for the MES. Of the remaining 13 sites, four are in Scotland or Wales, 7 are 
among the 70 quasi-independent suites and the remaining 2 are among the 62 
sites who did not apply to join the MES. Thus these 13 sites represent another 
form of control for the 29 pilot sites in that they have developed initiatives in GE 
independently of the MES. 
 
In principle the proposed evaluation will compare a representative random sample 
of ten of the 29 MES ‘pilot sites’ with a comparable random sample comprising ten 
of the 70 MES ‘independent sites’ and five of the ‘genuinely independent sites’ 
identified through the BSG. Our preliminary survey of BSG members strongly 
suggests that, despite the link between the 10 independent sites and the MES, 
these 25 evaluative sites will generate a wide range of innovations covering the 
spectrum of outpatient and day case services, including but not limited to 
endoscopy services. Thus we expect new models of service delivery and 
organisation to address both the assessment of new patients and the surveillance 
of existing patients. In particular evaluative sites are likely to use a variety of 
approaches to improve the speed and appropriateness of referral and assessment, 
potentially including decision support systems, joint clinics between primary and 
secondary care, nurse-led consultations, nurse-led triage, one-stop assessments, 
on-line booking and rapid access clinics. In contrast those sites that seek to 
improve the efficiency of follow-up, if only to release resources for primary 
assessment, are likely to adopt the model of nurse-led telephone surveillance. 
 
The contrast between the predicted heterogeneity of new models to deliver 
assessment services for newly referred patients and the predicted homogeneity of 
new models to deliver follow-up services for continuing patients has two 
implications for research design. First our methods of evaluation need to be 
sufficiently generic to provide a comprehensive comparison of the ten pilot sites 
and the 15 Control sites, covering both primary assessment and follow-up for 12 
months after referral. Secondly there is real scope for a conventional randomised 
trial of flexible nurse-led follow-up versus conventional doctor-led follow-up, as 
outlined in our outline application. To focus on the challenging task of developing 
and implementing a generic evaluation package, however, we have deferred our 
plans for a randomised trial to evaluate the nurse-led model of GE follow-up. 
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D Plan of investigation 
 
Research questions 
 
The aims and objectives defined in Section 2A imply ten distinct research 
questions: 
 
1. What new models of service delivery and organisation have stemmed from 
the Modernising Endoscopy Service (MES) and other current initiatives to 
improve the process of referral and follow-up for patients with serious or 
chronic gastrointestinal disorders? 
2. What issues do these models create, and how do patients and 
professionals address these issues? 
3. What is the effect of these models on speed of access from primary to 
secondary care, and other measures of the quality of the process of care? 
4. How acceptable are these models to patients and professionals in primary 
and secondary care? 
5. To what extent do patients and professionals in primary and secondary 
care value these models? 
6. What is the effect of these models on outcome, as assessed by patients & 
professionals in primary and secondary care? 
7. What resources do these models use from the NHS, patients and society in 
general? 
8. What is the effect of these models on other health services? 
9. Taking all these criteria into account, are these new models better on 
balance for patients?  Are they better on balance for the NHS? 
10. Again taking all these criteria into account, are the models initiated and 
co-ordinated by the MES better on balance than other new models for 
gastroenterology services? 
 
Type and location of innovations 
 
We shall use 25 sites in England, Scotland and Wales, representing three distinct 
approaches to innovation in GE services. The NHSMA has selected 29 ‘pilot sites’ 
in England to receive funding, training and support from Phase 2 of the MES. They 
will use a ToolkitTM developed by the MES to analyse and redesign their current 
GE services, notably endoscopy. From these 29, we shall select a stratified 
random sample of ten ‘experimental sites’ keen to contribute to evaluation. A 
further 70 ‘independent sites’ (NHSMA terminology) in England applied to take 
part in Phase 2 but were unsuccessful. From these we shall select a stratified 
random sample of ten ‘MES Control sites’ keen to use the ToolkitTM with training 
and support but no extra funding, and to contribute to evaluation. A further 13 
sites committed to genuinely independent redesign of their GE services, including 
four in Scotland and Wales, responded to our circular to members of the British 
Society of Gastroenterology (BSG). From these we shall select a further stratified 
random sample of five ‘BSG Control sites’ keen to contribute to evaluation. 
 
Design of evaluation 
 
The NHSMA has specified that the 29 pilot sites, including our ten experimental 
sites, should complete their use of the MES ToolkitTM during 2003 and redesign 
their services during 2004. In collaboration with the NHSMA we plan to invite our 
10 MES Control sites to complete their use of the ToolkitTM by July 2003 and to 
ask all 15 (MES and BSG) Control sites to redesign their services by July 2004. 
This differential timetable reflects the Control sites’ lack of earmarked funding, 
which is likely to inhibit progress as they seek alternative resources for 
innovation, though not evaluation. Thus it allows them to seek alternative 
resources for redesign. More important it enables us to infer from Control sites 
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what would have happened in experimental sites in the absence of the national 
project, which gives them both official recognition and funding. 
 
Thus our basic research design is that of a multiple interrupted time series design, 
in which the MES initiative ‘interrupts’ secular trends in the ten experimental 
sites, in principle from the start of 2003. In the 15 Control sites, in contrast, less 
formal innovations will interrupt secular trends, in principle from the second half 
of 2003. In practice, however, both types of site are sure to vary in their speed of 
innovation. This has implications for research design. First we shall use the 
various measures of referral performance being collected from the 29 pilot sites 
by the NHSMA – to identify the period of innovation in each of the ten 
experimental sites. Secondly we shall work with the NHSMA to extend the 
collection of these measures to the 15 Control sites. Similarly we shall use them 
to identify the period of innovation in each of the Control sites. In this way we 
shall plot the degree of overlap between the typical period of innovations in each 
type of site. This plot will assess the feasibility and power of using time series 
analysis to compare the effects of the MES initiative with those of the more 
heterogeneous control innovations. If time series analysis proves difficult to 
conduct or to report (more likely), we shall fall back on the simpler, though less 
powerful, design of a controlled before-and-after study. The main challenge of the 
simpler design would be to use the plots just mentioned to identify a time, 
perhaps towards the end of 2003, when the majority of experimental sites were 
well advanced in implementing their service redesigns while the majority of 
Control sites were not. 
 
Measurement of outcome 
 
To measure time between significant events in the referral process, we shall use 
data collected in collaboration with NHSMA from our 25 sites over three years 
from 2003 through 2005. To gather patients’ assessments of their own outcomes 
(both generic through EQ-5D20 and SF3621, and specific to the GI tract), the 
quality of communication, and the extent of their own contributions and costs, we 
shall draw stratified samples of 40 patients per site in the spring and autumn of 
2003, the spring and autumn of 2004, and the spring of 2005. We shall ask these 
5000 patients to complete questionnaires at their first hospital appointment and 
by post 12 months later. To explore patients’ views and preferences in more 
detail, we shall interview a 5% stratified random sample of respondents over two 
years from the spring of 2003. We shall interview stratified random samples of 
ten health care professionals per site over the same period. To estimate the 
incremental cost per quality-adjusted life year of the MES, we shall estimate the 
NHS and societal costs of innovative models and compare them with changes in 
patients’ EQ-5D scores. 
 
E. Methods (including the plan of analysis) 
 
QUANTITATIVE METHODS 
 
Study population and sample 
 
All newly referred patients will be eligible for recruitment. We shall draw samples 
of 40 patients per site, stratified by age, sex and presenting complaint on five 
separate occasions – the spring and autumn of 2003, the spring and autumn of 
2004, and the spring of 2005. We shall ask these 5000 patients to complete 
questionnaires at their first hospital appointment and by post 12 months later. 
Previously this research team has consistently followed up 75% of patients 
recruited to trials after one year2,22,23. If, as we expect, 25 centres participate in 
this phase, this could yield 3750 analysable patients. Given the Quasi-
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experimental nature of the trial design, however, it is prudent to base power 
calculations on a responding sample of only 3000 patients. 
 
Outcome measures 
 
We shall measure time to consultation and diagnosis, and patient outcome as 
assessed by two widely used generic measures – EQ-5D20 and SF3621 – and the 
condition-specific UK Gastrointestinal Symptom Rating Questionnaire (GSRQ). 
The GSRQ, currently being validated in the MINuET study (HTA 97/37/09), covers 
the full range of GI symptoms and their effect on patients’ Quality of Life. We 
shall assess the effect of changes to models of service delivery on GE services in 
general through median waiting times, for example for outpatient consultation 
and open access endoscopy, and other indicators like percentage of referrals ‘fast 
tracked’ and the outcomes of these referrals. Given the limitations of assessing 
patient ‘satisfaction’24, we shall assess the experience of both patients and 
general practitioners (GPs) through an instrument we are currently developing to 
map patients’ pathways from the point of referral to communicated action plan. 
This will assess how administrative systems communicate with patients and GPs 
about appointments and procedures. Key items will include acknowledgement of 
referral and the timely provision of information about the proposed management 
plan to both patient and referrer. This instrument goes beyond ‘satisfaction’ of 
patient or GP to examine the critical aspects of a referral primarily intended for 
investigation. It should provide a valuable secondary research outcome of this 
study. 
 
Statistical power 
To calculate the power of this complex design at all accurately needs good 
information, notably about auto-correlation within time series and correlation 
between patients within sites. To simplify the calculation one can eschew possible 
gains in power from the time series analysis and possible losses from the 
heterogeneity of new service models, since both are likely to have much smaller 
effects than probable losses from intra-site correlations. There is little information 
in the literature, gastroenterological or more general, about the likely size of such 
correlations. We therefore rely on the accumulated experience of the many 
triallists within the MRC Health Services Research Collaboration, notably in 
Aberdeen, Bristol, York and Wales. This suggests that intra-cluster correlation 
rarely exceeds 0.01 for outcome measures. Since the total target size for each 
site is 200, the effective sample size is therefore unlikely to fall below 1000, viz 
3000 / (1 + 200 x 0.01). Using a 5% significance level this would yield 80% 
power of detecting a standardised difference of 0.2 between the 10 experimental 
sites and the 15 Control sites in EQ5D, SF36 or GSRQ. In our judgement such a 
difference is the least that would be clinically important. 
 
What will be the method of analysis? 
 
Primary analysis will be by ‘intention to treat’. We shall include all patients 
properly recruited even if they did not receive their intended pathway. We shall 
use multilevel modelling to take account of site effects, in particular of systematic 
differences between the models of service delivery adopted by each centre. As the 
basic design is Quasi-experimental, there is a danger that multi-collinearity (i.e. 
unintended correlation between service models and other patient characteristics) 
will prevent unequivocal quantitative conclusions. That is one reason why we 
have included a substantial qualitative component. 
 
Economic Evaluation 
 
Direct Service Costs 
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We shall estimate the NHS cost of each model of service delivery by identifying 
the resources consumed at each participating site using specially designed data 
collection forms. These will include all staff time, whether professional or 
administrative, devoted to managing and delivery the service. The health 
economic researcher will visit each site to identify a link person for each site and 
brief him or her on the data we are seeking and our preferred format. We shall 
value resources in monetary terms using standard methods25 and derive a cost 
per patient referred. We shall compare the costs of the various models to the NHS 
and patients using methods tested in recent2 and current trials22,23 conducted by 
this research team.  
 
Cost Utility Analysis (CUA) 
 
In collaboration with the NHS Modernisation Agency we shall ask 200 patients per 
site, 5000 in total, to complete the EQ5D at their first hospital appointment and 
again 12 months later. The EQ5D is a global utility-based measure of health-
related Quality of Life commonly used in cost utility analyses20. It comprises five 
dimensions – mobility, self care, usual activities, pain, and anxiety & depression. 
As different models of service delivery can affect resource use in other parts of 
the NHS, patients will simultaneously record NHS resource use in primary and 
secondary care and medication, over the previous three months. Patient recording 
is reliable means of collecting resource use data over this time period26. We shall 
also validate the most expensive contacts through clinical and administrative 
information systems in secondary care. Unless any model is dominant (i.e. 
achieves significantly better outcomes while costing significantly less), we shall 
estimate the incremental cost per quality adjusted life year (QALY) by comparing 
changes in EQ5D scores with NHS costs. 
 
Cost Effectiveness Analysis 
 
Thus CUA will compare general models of service delivery, rather than its 
commoner use in assessing specific interventions for well-defined patient groups. 
Accordingly while CUA should capture major differences in EQ5D scores, patient 
heterogeneity suggests that non-significant differences in this relatively 
insensitive measure may be more likely than in randomised trials. Accordingly we 
shall also conduct a cost effectiveness analysis. So patients will also complete the 
condition-specific GSRQ. As different models of service delivery may also affect 
travel and other costs borne by patients and their families, we shall also ask them 
to record these costs. We shall estimate cost effectiveness by comparing total 
societal costs (i.e. to NHS and patients) with changes in the principal symptom 
score on the GSRQ, that is the symptom that has the greatest effect on Quality of 
Life as measured by the EQ5D. 
 
QUALITATIVE METHODS 
 
We shall use qualitative methods to observe the processes of care and to assess 
the acceptability to patients and professionals in primary and secondary care of 
innovative models of referral, diagnosis and follow-up, and their perceptions of 
the value of these models. We shall use qualitative methods for four main 
reasons: 
 
Models to improve the speed and appropriateness of referral are varied. They 
include decision support systems, joint primary-secondary care clinics, nurse-led 
consultations, nurse-led triage, on-line booking, one-stop assessments, and rapid 
access clinics. The views and experiences of those who have a stake in the models 
are potentially diverse. Factors affecting the success of these models are complex. 
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The breadth of issues to be addressed in evaluating innovations remains to be 
identified. Where centres use specialist nurses with telephones to reduce demand 
on resources, for example, they do so in different ways, including telephone 
clinics, telephone help-lines and telephone support. Information relating not only 
to outcome but also to structure and process will be important to determine. 
 
The methodological framework – case studies and stakeholder analysis 
 
A case study design will permit exploration in-depth and the identification of local 
differences while being sensitive to common issues and concerns. Those who have 
a stake in service delivery models include patients, consultants, GPs, specialist 
nurses and other professionals. The potential diversity of their experiences and 
views indicate the desirability of a stakeholder analysis27,28. This has the capacity 
to: 
 
 accommodate the diversity of experiences and views; 
 allow the researchers to remain relatively impartial by recognising that 
different stakeholders may have different success criteria; 
 identify similarities and differences between and within stakeholder 
groups; and 
 explore the attributed reasons for outcomes, which are experienced and 
perceived as success or failure, strength or weakness. 
 
Sampling strategy 
 
We shall draw random samples of patients from the same sampling frames as the 
quantitative patient survey. To ensure that we sample the full range of issues for 
patients, their questions will include: 
 
 What are their views on the novel systems?  
 How do they experience speed of access? If there are benefits, what form 
do they take?  If there are costs, what form do they take? 
 How do past experiences influence patients’ present experiences of seeking 
advice on symptoms that raise the possibility of cancer? 
 How do they compare and contrast their relationships with doctors and 
nurses? 
 How confident are patients about consulting a nurse? 
 What are the benefits and costs of nurse-led advice and consultation?  
 
We shall identify the other stakeholder groups and cover the full range of issues 
relevant to them. We shall seek to establish the frequency and depth of concerns 
and to extrapolate directly from these samples to the populations from which they 
come. We shall sample professionals strategically to include those who can 
provide answers to questions such as: 
 
 What are their views of all the models of service delivery they experience? 
 What issues have they encountered in setting up new models?  How have 
they and others overcome difficulties? 
 What are their views of substitution as a means of improving access and 
speed of referral? 
 How have lines of accountability changed? 
 How have clinical, professional, legal and administrative responsibilities 
changed? 
 Are there areas of overlap and ambiguity?  How have they and others 
addressed these? 
 
Data collection and analysis 
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Semi-structured tape-recorded interviews will be the main instruments of data 
collection. A few focus group interviews will enable patients to explore issues of 
importance to them as a group, using their own vocabulary, generating their own 
questions and pursuing their own priorities29. They can also generate aspects of a 
topic not contemplated by the researchers. In exploring the views of professionals 
through focus groups, experience suggests that profession-specific groups provide 
most useful data. In contrast individual interviews allow for the exploration at 
length and in depth of private concerns and issues. However this potential 
strength can be a weakness if interviewees feel they have revealed information 
that makes them vulnerable. The applicants are aware of these potential 
problems, and experienced in the ethical conduct of research and handling 
sensitive issues. In particular we shall seek written informed consent from all 
interviewees. 
 
We shall transcribe tape-recorded interviews and subject them to rigorous textual 
analysis, both manually and where appropriate through a text analysis software 
package like NUDIST. Analysis will describe patients’ and professionals’ 
assessments of innovation. We shall also use SPSS to expedite the analysis of 
demographic data collected. We shall identify, link and categorise themes running 
through the data. Glaser and Strauss30 argue that coding is essential in 
minimising subjectivity in the analysis of qualitative data. May31 provides a useful 
practical guide to the coding of qualitative coding based on the principles of rigour 
and explicitness. We shall discuss the resulting themes in relation to published 
studies on innovations in health care delivery to see how far they confirm or 
challenge other published findings. 
 
To provide contextual data, we shall observe processes of care at each site. While 
interviews and questionnaires yield accounts of what respondents do in principle 
and why, observation offers researchers an opportunity to see what people do in 
practice. The tradition of participant observation stems from the discipline of 
social anthropology and contributes widely to sociological research32-35. 
Collectively these qualitative methods of data collection are known as 
ethnography. This style of research seeks to understand the social meanings and 
activities of people in given settings. To this end it uses close association with, 
and often participation in, those settings35. 
 
CONCLUSION 
 
This study will build on our current experience of working with gastroenterology 
services in a 25-centre trial of nurses undertaking upper and lower endoscopy 
(MINuET). Our experience in that and other multi-centre trials e.g. 2,22,23 strongly 
suggests that the proposed study is feasible and potentially very valuable. 
 
Please state the benefits of this research to the NHS 
 
This study will yield greater understanding of the benefits and costs, to patients, 
professionals and the NHS, of new approaches to delivering secondary care to 
patients, using a specialty in which many different professionals work together, 
including physicians, surgeons, radiologists, pathologists, nurses, and dieticians. 
It will identify new models of service delivery and organisation that achieve 
improvements in clinical and cost effectiveness. It will disseminate these for 
uptake in other hospitals and disciplines, with advice on designing, preparing and 
implementing new models of service delivery and organisation. It will give 
valuable insights into the management of change within the NHS, notably change 
initiated by the NHS Modernisation Agency and analogous bodies. It will advance 
the evaluation of complex heterogeneous interventions designed with a common 
purpose and contribute to methodological development in this difficult field. 
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Please outline your proposals for the involvement of stakeholders 
throughout the project. This should include service users and those who 
plan, manage & deliver services 
 
We plan to involve patients throughout the project. In this and many other ways 
we shall work closely with the NHS Modernisation Agency, who have particular 
responsibility for involving both patients and health professionals. One of the 
applicants (GE) has considerable research and clinical experience of 
communicating with patients and sharing decisions with them. So we are 
especially keen that patients contribute to the project team. We shall also seek 
the views and preferences of large representative samples of patients, through 
both interviews in depth and questionnaires validated for self-completion. 
 
We shall also interview in depth representative samples of those responsible for 
planning and managing new services, and of health care professionals responsible 
for service delivery. 
 
H. Plans for the dissemination of results 
 
We shall disseminate the findings of this study energetically and extensively. We 
shall communicate them to the NHS through the NHS Modernisation Agency and 
associated bodies. We shall also make them accessible to the scientific community 
through peer-reviewed publication. In the first instance we shall submit them to a 
general medical journal like the BMJ. We shall also present them to the annual 
meeting of the British Society of Gastroenterology (BSG), which is attended by 
physicians, surgeons, radiologists, pathologists, clinical scientists, nurses and 
dieticians working in gastroenterology. We shall summarise the findings on the 
Society’s website and in its newsletter. We shall also disseminate them to patients 
through the National Association for Colitis and Crohn’s Disease, the Coeliac 
Society, and analogous bodies. We shall circulate an appropriate press release to 
the national press. We shall also encourage all collaborating centres to publicise 
the findings locally. 
 
I. Justification of costs, including the time spent on the project by each 
researcher (even if they are being funded from an alternative source). 
 
This complex multi-centre study will require two research assistants (Grade 2 pt 
11) to coordinate the data collection from the study sites and to undertake the 
primary analysis required. One will have a quantitative background, be familiar 
with routine data, electronic handling of study data and its analysis; the other will 
be primarily responsible for organising, collecting and analysing the data collected 
through qualitative approaches (patient interviews, focus groups etc). A 0.25 FTE 
health economist will be retained to initiate and oversee the economic appraisal of 
the new models of service delivery resulting from the study sites. 
 
The study will be supported by two clerical posts – a 0.5 FTE Grade 3 clerical 
assistant, who will be responsible for the quantitative data and its validation; and 
a full-time Grade 3 will be the main point of contact for the study sites and 
provide the link to the research team and steering group and will also assist with 
the transcription of the qualitative data collected. Both posts will be involved in 
the distribution of study materials to the sites and mailings to participants. 
 
A substantial allowance for travel will be needed, as the study sites will require 
visits from the researchers at the beginning of the study, and patient interviews 
and focus groups will require travel costs to be reimbursed to researchers and 
participants. Regular steering group and project team meetings will also mean 
that the trial costs of participants are met. 
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5,000 questionnaires, with follow-ups and return envelopes will be required 
(printing and postage). A budget of £5,000 per study site has been set to offset 
the costs of data collection. Laptop computers will be required for the research 
assistants (who will have to be fully mobile) and desktop PCs for the clerical 
officers. Allowances for general stationery costs, audio recorder and tapes, and 
venue and catering costs for focus groups have also been included. 
 
The Modernisation Agency has agreed to be fully involved in the organisation of 
the trial and to support this work through the involvement of its co-applicants and 
other members of its teams. 
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Appendix 2 – Innovation form proforma 
Instruction sheet for the completion of the 
ENIGMA Innovations Form 
 
Please follow the instructions below to complete the Innovations Form. 
 
1. Indicate which of the innovations listed have taken place at the [NAME] 
endoscopy unit by ticking either the “Yes” or “No” column.  
2. Indicate the approximate year when the innovation took place by ticking the 
“2000 – 2002” column, the “2003” column or the “2004 – 2005” column.  
3. If any innovations that have taken place in your department are not listed, 
please list these in the blank table on page 4. 
4. Where relevant, please complete the “Comments” section on page 4 quoting 
the reference number of the innovation and any additional information. 
Continue on a separate sheet if necessary. 
 
Notes: 
Some changes may be applicable to more than one category of innovations listed. 
Please tick as many as apply and make a note in the Comments section. 
 
Where changes have occurred that were not part of the endoscopy unit’s 
modernisation plans, we would still like to know about them if they impacted on the 
endoscopy services. Please include them when completing the form and make notes 
in the comments section. 
 
If you have any queries on the completion of the Innovations Form, please contact 
Kym Thorne on 01792 602062. 
 
(…Cont’d) 
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(…Cont’d) 
List of innovations  
Implemented? Timeframe 
Yes No “2000 – 2002” “2003” “2004 - 2005” 
NEW / ADDITIONAL STAFF: 
1. Nurse Endoscopists       
2. GP Endoscopists      
3. Consultants      
4. Link / escort nurses      
5. Health care assistants      
6. Receptionist / other clerical staff      
7. New management / leadership       
8. Data collection staff      
ALTERATIONS OF STAFF ROLES: 
9. Changing roles of medical staff      
10. Changing roles of clerical staff      
11. Clerical duties taken from nurses      
NEW NURSE RESPONSIBILITIES: 
12. Nurse led clinic(s)       
13. Nurse led consent      
14. Nurses performing cannulations      
15. PEG nurses      
16. Training nurses to be nurse 
Endoscopists  
     
NEW WORKING PRACTICES: 
17. New referral procedure(s) into the 
unit 
     
18. Validation of referrals      
19. New guideline(s) / protocols      
20. Triage of emergency patients      
21. Pre-assessment clinics      
22. DNA strategies      
23. Cancellation strategies      
24. “6-week notice period for leave” 
policy 
     
25. New procedure(s) performed      
26. Introducing dedicated training list(s)      
 
(…Cont’d) 
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List of innovations  
Implemented? Timeframe 
Yes No “2000 – 2002” “2003” “2004-005” 
INCREASING ACTIVITY: 
27. Extra slots for emergency bleeds, etc      
28. Scheduling extra list(s) (Mon  Fri)      
29. Increasing the length of the working 
day 
     
30. Weekend / out of hours working      
WAITING LIST MANAGEMENT: 
31. Validation of waiting lists      
32. Pooling waiting lists      
33. Waiting list initiative sessions      
CHANGES IN BOOKING PATIENTS APPOINTMENTS: 
34. Open access booking      
35. Full booking       
36. Partial booking      
STRUCTURAL CHANGES TO THE UNIT: 
37. New hospital / unit      
38. Structural alterations to current unit      
39. Increasing capacity in recovery area      
40. Centralising admin in one place      
41. Moving some endoscopy externally      
42. Refurbishment of reception / 
endoscopy suite 
     
ANALYSIS OF WORKING PRACTICES: 
43. New / improved in-house data 
collection 
     
44. Demand and capacity studies       
45. Audits      
46. Process mapping      
47. Patient surveys      
IMPROVING THE PATIENTS’ EXPERIENCE: 
48. New information leaflets for patients       
49. Improving patient privacy & dignity      
50. Home bowel preps      
51. Improving experience of inpatients      
(…Cont’d) 
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(…Cont’d) 
 
List of innovations  
Implemented? Timeframe 
Yes No “2000 – 2002” “2003” “2004 - 2005” 
52. Improving experience of diabetic 
patients 
     
53. Improving experience of patients 
with other comorbidities 
     
IMPROVING STAFF EXPERIENCE: 
54. Staff training / development       
55. “Protected time” for staff to meet / 
train 
     
56. Surveying staff on changes wanted      
57. New / improved staffroom      
58. Endoscopy groups / staff meetings      
59. Improving staff communication       
MISCELLANEOUS CHANGES: 
60. New medical equipment      
61. New IT equipment / software      
62. Raising the profile of endoscopy       
63. Advice or help from within the Trust       
64. Advice or help from external 
agencies 
     
65. Open days for hospital staff / 
patients  
     
OTHER INNOVATIONS NOT INCLUDED IN THE LIST: 
  66.      
  67.      
  68.      
  69.      
  70.      
 
 Comments 
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Evaluating Innovations in Gastroenterology
for the NHS Modernisation Agency
(ENIGMA) study
Baseline Questionnaire
A questionnaire for people with digestive and bowel disorders
Please complete this questionnaire at home as soon as you have time and
return to us using the prepaid envelope enclosed.
PLEASE DO NOT WAIT UNTIL YOU RECEIVE YOUR
APPOINTMENT TO COMPLETE THIS.
CONFIDENTIAL
Study Number
Appendix 3 – Baseline Questionnaire 
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Please read all the instructions before completing this questionnaire.
Thank you for agreeing to take part in this study.  The answers you give in this questionnaire
will help us to find out if the treatments you receive are helpful for your condition.
The information you provide will be completely confidential and will not affect your treatment in
any way.
Please answer all the questions.  Although it may seem that some questions are asked more
than once, it is still important that you answer every one.  If you find it difficult to answer a
question, please do the best you can.
Please follow the instructions for each section of the questionnaire carefully.
For each section, if you are asked to put a cross in the box, please use a cross, as if you were
filling out a ballot paper, rather than a tick.
For example in the following question, if your answer is yes, you should place a cross firmly in
the corresponding box.
  Yes    No
Do you drive a car?
Please use a black or blue pen.  Do not use a pencil or any other coloured pen.
Please complete the questionnaire fully and return it in the FREEPOST envelope provided as
soon as possible.  Please do not wait until your appointment to complete it.
2
The ENIGMA study 
©NCCSDO 2008 Page 324 
Evaluating Innovations in Gastroenterology
for the NHS Modernisation Agency (ENIGMA)
Consent
Please complete your name and address so that we can send you the second questionnaire and the
name and address of your GP so that we can notify him/her of your inclusion in the study.
Name & address GP Name & address
.......................................................................... .......................................................................
.......................................................................... .......................................................................
.......................................................................... .......................................................................
.......................................................................... .......................................................................
Postcode  ......................................................... Postcode .......................................................
Please sign below if you do not want your General Practitioner to be notified.
I do not wish my General Practitioner to be notified that I am taking part in this study.
Signature Date
3
I have received the patient information sheet, understand the study and agree to
participate.
I understand that I will be asked to complete questions about my health, feelings
and quality of life and views about the service.
I understand that my participation is voluntary and that I can withdraw from the
study at any time, and this will not affect my medical care.
I understand that my General Practitioner will be notified of my participation in this
study, unless I request that this does not happen.
I understand that the study team may look at my medical notes.  I give permission
for the study team to access my medical notes for the purposes of this research.
Please cross each box
to show that you agree
with the statement
Signature    Date
Name in capitals
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A4. In the last 2 weeks, how often have you experienced bitter bile
or acid reflux (from the stomach into the throat)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A5. In the last 2 weeks, how often have you experienced a feeling
of nausea or sickness without actually vomiting?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A6. In the last 2 weeks, how often have you retched or heaved
without actually vomiting?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A7. In the last 2 weeks, how often have you actually vomited?
Not at all
Once a week
Two or three times a week
Most days
Everyday
6
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Yes
No
Not applicable
A8. If you have vomited in the last 2 weeks, have you seen any blood
in the vomit?
If you have not had any of the symptoms or problems described in questions A4 to A8, skip
question A9 and go directly to question A10
A9. In the last 2 weeks, how much have the symptoms described in
question A4 to question A8 prevented you from doing your usual
activities?
Not at all
A little
Moderately
A lot
Extremely
A10. In the last 2 weeks, how often have you been bothered by a lot
of belching or burping (release of wind from the stomach by the
mouth)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A11. In the last 2 weeks, how often have you been bothered by passing
a lot of wind from the back passage?
Not at all
Once a week
Two or three times a week
Most days
Everyday
7
The ENIGMA study 
©NCCSDO 2008 Page 329 
A12. In the last 2 weeks, how often have you experienced bloatedness,
and or a feeling of trapped wind in your stomach?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A13. In the last 2 weeks, how often have you experienced loud gurgling
noises from your stomach?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A10 to A13, skip
question A14 and go straight to question A15 over the page
A14. In the last 2 weeks, how much have the symptoms described in
question A10 to question A13 prevented you from doing your
usual activities?
Not at all
A little
Moderately
A lot
Extremely
8
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A15. In the last 2 weeks, how often have you felt that your food sticks
on the way down your gullet (through the chest into your stomach)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A16. In the last 2 weeks, how often have your eating habits been
restricted because of your condition (examples might be having
to eat more slowly, having to take smaller portions or having
to eat different foods)? Not at all
Once a week
Two or three times a week
Most days
Everyday
A17. In the last 2 weeks have you had a lack of appetite?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A15 to A17, skip
question A18 and go to question A19 over the page
A18. In the last 2 weeks, how much have the symptoms described
in question A15 to question A17 prevented you from doing your
usual activities? Not at all
A little
Moderately
A lot
Extremely
9
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A19. Have you noticed any change in weight (not due to a change
in your diet) over the last 3 months?
No, my weight has been stable
Yes, I have been gaining weight
Yes, I have been loosing weight
A20. In the last 2 weeks, how often have you been bothered by too
 frequent emptying of your bowels?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A21. In the last 2 weeks, how often have you been bothered by
loose stools?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A22. In the last 2 weeks, how often have you been bothered by
hard stools?
Not at all
Once a week
Two or three times a week
Most days
Everyday
10
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A23. In the last 2 weeks, how often have you been bothered by
constipation (constipation means difficulty in emptying your bowels)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A24. In the last 2 weeks, how often have you had an urgent need to
empty your bowels (this urgent need is often associated with a
feeling that you are not in full control)? Not at all
Once a week
Two or three times a week
Most days
Everyday
A25. In the last 2 weeks, how often have you had a feeling of not
completely emptying your bowels?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A26. In the last 2 weeks, have you had bleeding through your back
passage (signs of bleeding include fresh blood, staining of toilet
tissue, blood mixed with stools)?
Not at all
A little
Moderately
A lot
Extremely
11
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If you have not had any of the symptoms or problems described in questions A20 to A26, skip
question A27 and go straight to question A28
Not at all
A little
Moderately
A lot
Extremely
A28. Compared with 2 weeks ago, how would you now rate your
symptoms in general?
Much better now than 2 weeks ago
Somewhat better now than 2 weeks ago
About the same as 2 weeks ago
Somewhat worse now than 2 weeks ago
Much worse now than 2 weeks ago
A29. In the last 2 weeks, how often have your symptoms caused you
difficulties in getting to sleep?
Not at all
Once a week
Two or three times a week
Most nights
Every night
A30. In the last 2 weeks, how often have your symptoms caused
you to wake up?
Not at all
Once a week
Two or three times a week
Most nights
Every night
12
A27. In the last 2 weeks, how much have the symptoms described
in question A20 to question A26 prevented you from doing your
usual activities?
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This section asks for your views about your health, how you feel and how well you are able to do
your usual activities.
Answer every question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
B1. In general, would you say your health is:
B2. Compared to 1 year ago, how would you rate your health in general now?
B3. The following questions are about activities you might do during a typical day.  Does
your health now limit you in these activities?  If so, how much? (cross a box on each line)
13
Much better
now than one
year ago
Somewhat
better now than
one year ago
Somewhat
worse now than
one year ago
About the
same as one
year ago
Much worse
now than one
year ago
Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports
Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling or playing golf
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling or stooping
Walking more than a mile
Walking several hundred yards
Walking one hundred yards
Bathing or dressing yourself
Yes, limited
a lot
Yes, limited
a little
No, not
limited at all
Excellent Very good Good Fair Poor
SECTION B
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14
B4. During the past 4 weeks, how much of the time have you had any of the following problems
with your work or other regular daily activities as a result of your physical health?
Cut down on the
amount of time you
spent on work or other
activities
Accomplished less
than you would like
Were limited in the
kind of work or other
activities
Had difficulty
performing the work or
other activities (for
example, it took extra
effort)
All of the
time
Most of
the time
Some of
the time
A little of
the time
None of
the time
B5. During the past 4 weeks, how much of the time have you had any of the following problems
with your work or other regular daily activities as a result of any emotional problems (such as
feeling depressed or anxious)?
Cut down on the
amount of time you
spent on work or other
activities
Accomplished less
than you would like
Did work or activities
less carefully than
usual
All of the
time
Most of
the time
Some of
the time
A little of
the time
None of
the time
B6. During the past 4 weeks, to what extent has your physical health or emotional problems
interfered with your normal activities with family, friends, neighbours, or groups?
Not at all Slightly Moderately Quite a bit Extremely
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B7. How much bodily pain have you had during the past 4 weeks?
B8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)?
B9. These questions are about how you feel and how things have been with you during the 
past 4 weeks.  For each question, please give ONE answer that comes closest to the
way you have been feeling.
How much of the time during the past 4 weeks ..........
15
Did you feel full of life?
Have you been very nervous?
Have you felt so down in the
dumps that nothing could
cheer you up?
Have you felt calm and
peaceful?
Did you have a lot of energy?
Have you felt downhearted
and depressed?
Did you feel worn out?
Have you been happy?
Did you feel tired?
All of the
time
Most of
the time
Some of
the time
A little of
the time
None of
the time
None Very mild Mild Moderate Severe Very severe
ExtremelyQuite a bitModeratelySlightlyNot at all
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B10. During the past 4 weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting friends, relatives, etc)?
B11. How TRUE or FALSE is each of the following statements for you?
I seem to get sick a little
easier than other people
I am as healthy as
anybody I know
I expect my health to
get worse
My health is excellent
16
Definitely
true
Mostly
true
Don't
know
Mostly
false
Definitely
false
Most of
the time
All of
the time
Some of
the time
A little of
the time
None of
the time
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This section asks about your health in general.  Please indicate which statement best describes
your own health state today.
Answer each question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
I have no problems in walking about
I have some problems in walking about                                      
I am confined to bed
C1. Mobility
C2. Self care
I have no problems with self-care
I have some problems with self-care                                           
I am unable to wash or dress myself
C3. Usual Activities
I have no problems with performing my usual activities
I have some problems with performing my usual activities          
I am unable to perform my usual activities
C4. Pain / Discomfort
I have no pain or discomfort
I have moderate pain or discomfort                                             
I have extreme pain or discomfort
C5. Anxiety/Depression
I am not anxious or depressed
I am moderately anxious or depressed                                        
I am extremely anxious or depressed
17
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To help people say how good or bad their health state is, we have
drawn a scale (rather like a thermometer) on which the best state
you can imagine is marked 100 and the worst state you can imagine
is marked 0.
We would like you to indicate on this scale how good or bad your
own health is today, in your opinion.  Please do this by drawing a
line from the black box below to whichever point on the scale
indicates how good or bad your health state is today.
 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst 
imaginable 
health state 
0 
Best  
imaginable 
health state 
 
Your own 
health state 
today 
18
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This section is about the health care you have had in the last 3 months.  Please read
each question carefully.  For each question, if you have had no treatment or visits enter '0'
as indicated.
We would like to know about visits to health professionals for any reason, not just your
digestive or bowel symptoms.
D1. How often have you consulted, for any reason, any of the following at your GP's surgery in
the last 3 months?
Your own or another GP
If none enter '0'
Nurse
If none enter '0'
Other (please specify)
If none enter '0'
D2. How often have you consulted, for any reason, any of the following at home in the last
3 months?
Your own or another GP
If none enter '0'
Nurse
If none enter '0'
Other (please specify)
If none enter '0'
D3. How often have you been admitted, for any reason, to a hospital (NHS or private) as an 
emergency in the last 3 months?
If none enter '0'
D4. How often have you been admitted, for any reason, to a hospital (NHS or private) NOT as 
an emergency in the last 3 months?
If none enter '0'
19
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D5. How many times have you been seen, for any reason at a hospital outpatient clinic in the 
last 3 months?
By a Doctor
If none enter '0'
By a Nurse Practitioner
If none enter '0'
By a Dietician
If none enter '0'
By anyone else (please specify)
If none enter '0'
D6. How many times have you been admitted as a day case for upper or lower endoscopy in 
the last 3 months?
Upper endoscopy
If none enter '0'
Lower endoscopy
If none enter '0'
D7. If you are in work, how many days work have you lost due to illness or in order to see any
health professional in the last 3 months?
If none enter '0'
20
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Look at the list of medications below.  If you take any of the medications listed below, please
enter the dose of each tablet (this will be written on the tablet box or bottle) and the number of
tablets you take each day.  Answer 'yes' or 'no' to whether you are taking the drug regularly and
if you answer 'no' please enter the average number of tablets you take each month.
21
Indigestion medication
Nexium (Esomeprazole)
 
Losec (Omeprazole)
 
Zoton (Lansoprazole)
 
Protium (Pantoprazole)
 
Pariet (Rabeprazole)
 
Zantac (Ranitidine)
 
Pepcid (Famotidine)
 
Axid (Nizatidine)
 
Tagamet (Cimetidine)
 
Maxolon (Metoclopramide)
 
Motilium (Domperidone)
Medication for irritable bowel
Spasmonal (Alverine)
 
Merbentyl (Dicycloverine)
 
Buscopan (Hyoscine)
 
Colpermin
 
Colofac (Mebeverine)
 
Fybogel
Anti-diarrhoeal medication
Imodium (Loperamide)
 
Codeine Phosphate
 
Questran (Colestyramine)
 
Lomotil (Co-phenetrope)
Each tablet
dose in mg
Number of
tablets per
day
Regular? If not regularly,
average number
of tablets taken
per month
SECTION E
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
The ENIGMA study 
©NCCSDO 2008 Page 343 
If not regularly, average
number per month
22
Medication for Colitis
Asacol or Pentasa or Salofalk
(Mesalazine)
 
Colazide (Balsalazide)
 
Dipentum (Olsalazine)
 
Salazopyrin (Sulfasalazine)
 
Entocort or
Budenofalk(Budesonide)
 
Prednisolone (by mouth)
 
Predsol or Predfoam or
Predenema (enemas)
Each tablet
dose in mg
Number of
tablets per
day
Regular? If not regularly,
average number
of tablets taken
per month
If you take any other tablets/liquids for your digestive or bowel symptoms, that are not listed,
please write the details in the list below.  Please include any prescriptions and medicines you buy
over the counter from the chemist or supermarket (examples include antacids and laxatives)
Name of medicine On prescription Dose in mg
or ml
How many times
taken per week
If you wish to add any comments regarding your medication, please enter them in the box below.
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Number
per day
Regular?
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Are you happy to take part in a telephone interview with one of our researchers?  
Yes       No               
Please enter your date of birth below
/ /
Please enter your sex below
Male Female        
23
Please enter your initials in the box below
What test are you having? (please write in the box below)
If you are not sure what test you are having, please cross this box.
  D       D              M      M              Y       Y      Y      Y
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Thank you for completing this questionnaire.
If you have any general comments about your digestive or bowel treatment, or this questionnaire,
please write them below.
Once you have completed the questionnaire please return it in the FREEPOST envelope provided,
or send it to
ENIGMA Study Team
Swansea Clinical School
University of Wales Swansea
Singleton Park
Swansea
SA2 8PP
If you have any concerns about your symptoms please consult your GP or hospital doctor.
YOUR COMMENTS
24
The ENIGMA study 
©NCCSDO 2008 Page 346 
 
Appendix 4 – Post Procedure Questionnaire 
 
Evaluating Innovations in Gastroenterology
for the NHS Modernisation Agency
(ENIGMA) study
Post Procedure Questionnaire
A questionnaire for people with digestive and bowel disorders
Please complete this questionnaire at home and return to us
using the prepaid envelope enclosed
CONFIDENTIAL
Study Number
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Please read all the instructions before completing this questionnaire.
When you agreed to take part in this study, you kindly completed a questionnaire about your
health and treatment.  We would now like to repeat this following your recent procedure or test.
The answers you give in this questionnaire will help us to find out if the treatments you receive
are helpful for your condition.
The information you provide will be completely confidential and will not affect your treatment in
any way.
Please answer all the questions.  Although it may seem that some questions are asked more
than once, it is still important that you answer every one.  If you find it difficult to answer a
question, please do the best you can.
Please follow the instructions for each section of the questionnaire carefully.
For each section, if you are asked to put a cross in the box, please use a cross, as if you were
filling out a ballot paper, rather than a tick.
For example in the following question, if your answer is yes, you should place a cross firmly in
the corresponding box.
  Yes    No
Do you drive a car?
Please use a black or blue pen.  Do not use a pencil or any other coloured pen.
Please complete the questionnaire fully and return it in the FREEPOST envelope provided as
soon as possible.
2
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3
Please enter the date you are completing this questionnaire below
/ /
This section asks about your symptoms.  When answering the questions about the effect on your
life, consider how these symptoms prevented you from doing your usual activities over the last 2
weeks.
Answer every question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
A1. In the last 2 weeks, how often have you experienced heartburn
(a burning sensation behind your breast bone)? Not at all
Once a week
Two or three times a week
Most days
Everyday
A2. In the last 2 weeks, how often have you had any discomfort
in your upper abdomen (above your belly button and below
your ribs)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A1 and A2, skip
question A3 and go straight to question A4 over the page.
A3. In the last 2 weeks, how much have the symptoms described
in questions A1 and A2 prevented you from doing your usual activities?
Not at all
A little
Moderately
A lot
Extremely
  D       D              M      M              Y       Y      Y      Y
SECTION A
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A4. In the last 2 weeks, how often have you experienced bitter bile
or acid reflux (from the stomach into the throat)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A5. In the last 2 weeks, how often have you experienced a feeling
of nausea or sickness without actually vomiting?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A6. In the last 2 weeks, how often have you retched or heaved
without actually vomiting?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A7. In the last 2 weeks, how often have you actually vomited?
Not at all
Once a week
Two or three times a week
Most days
Everyday
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A8. If you have vomited in the last 2 weeks, have you seen any blood
in the vomit?
If you have not had any of the symptoms or problems described in questions A4 to A8, skip
question A9 and go directly to question A10.
A9. In the last 2 weeks, how much have the symptoms described in
question A4 to question A8 prevented you from doing your usual
activities?
Not at all
A little
Moderately
A lot
Extremely
A10. In the last 2 weeks, how often have you been bothered by a lot
of belching or burping (release of wind from the stomach by the
mouth)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A11. In the last 2 weeks, how often have you been bothered by passing
a lot of wind from the back passage?
Not at all
Once a week
Two or three times a week
Most days
Everyday
Yes
No
Not applicable
5
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A12. In the last 2 weeks, how often have you experienced bloatedness,
and or a feeling of trapped wind in your stomach?
Not at all
Once a week
Two or three times a week
Most days
Everyday
Not at all
Once a week
Two or three times a week
Most days
Everyday
A13. In the last 2 weeks, how often have you experienced loud gurgling
noises from your stomach?
If you have not had any of the symptoms or problems described in questions A10 to A13, skip
question A14 and go straight to question A15 over the page.
A14. In the last 2 weeks, how much have the symptoms described
in question A10 to question A13 prevented you from doing your
usual activities?
Not at all
A little
Moderately
A lot
Extremely
6
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A15. In the last 2 weeks, how often have you felt that your food sticks
on the way down your gullet (through the chest into your stomach)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A16. In the last 2 weeks, how often have your eating habits been
restricted because of your condition (examples might be having
to eat more slowly, having to take smaller portions or having
to eat different foods)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A17. In the last 2 weeks have you had a lack of appetite?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A15 to A17, skip
question A18 and go to question A19 over the page.
A18. In the last 2 weeks, how much have the symptoms described in
question A15 to question A17 prevented you from doing your usual
activities? Not at all
A little
Moderately
A lot
Extremely
7
The ENIGMA study 
©NCCSDO 2008 Page 353 
A19. Have you noticed any change in weight (not due to a change
in your diet) over the last 3 months?
No, my weight has been stable
Yes, I have been gaining weight
Yes, I have been loosing weight
A20. In the last 2 weeks, how often have you been bothered by
too frequent emptying of your bowels?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A21. In the last 2 weeks, how often have you been bothered by
loose stools?
Not at all
Once a week
Two or three times a week
Most days
Everyday
Not at all
Once a week
Two or three times a week
Most days
Everyday
A22. In the last 2 weeks, how often have you been bothered by
hard stools?
8
Yes, I have b en l i  i t
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A23. In the last 2 weeks, how often have you been bothered by
constipation (constipation means difficulty in emptying your bowels)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A24. In the last 2 weeks, how often have you had an urgent need to
empty your bowels (this urgent need is often associated with a
feeling that you are not in full control)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A25. In the last 2 weeks, how often have you had a feeling of not
completely emptying your bowels?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A26. In the last 2 weeks, have you had bleeding through your back
passage (signs of bleeding include fresh blood, staining of toilet
tissue, blood mixed with stools)?
Not at all
A little
Moderately
A lot
Extremely
9
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If you have not had any of the symptoms or problems described in questions A20 to A26,
skip question A27 and go straight to question A28.
Not at all
A little
Moderately
A lot
Extremely
A28. Compared with 2 weeks ago, how would you now rate your
symptoms in general?
Much better now than 2 weeks ago
Somewhat better now than 2 weeks ago
About the same as 2 weeks ago
Somewhat worse now than 2 weeks ago
Much worse now than 2 weeks ago
A29. In the last 2 weeks, how often have your symptoms caused you
difficulties in getting to sleep?
A30. In the last 2 weeks, how often have your symptoms caused you
to wake up?
Not at all
Once a week
Two or three times a week
Most nights
Every night
Not at all
Once a week
Two or three times a week
Most nights
Every night
10
A27. In the last 2 weeks, how much have the symptoms described 
in question A20 to question A26 prevented you from doing your
usual activities?
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This section asks for your views about your health, how you feel and how well you have been
able to do your usual activities since your test.
Answer every question by putting a cross in the corresponding box.  Do not cross more
than one box in each group.  If you are unsure about how to answer a question, please give
the best answer you can.
B1. In general, would you say your health is:
B2. Compared with before your test, how would you rate your health in general now?
About the
same as one
year ago
Much better
now than one
year ago
Somewhat better
now than one
year ago
Somewhat
worse now than
one year ago
Much worse
now than one
year ago
B3. The following questions are about activities you might do during a typical day.  Does
your health now limit you in these activities?  If so, how much? (cross a box on each line)
Yes, limited
a lot
Yes, limited
a little
No, not
limited at all
Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports
Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling or playing golf
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling or stooping
Walking more than a mile
Walking several hundred yards
Walking one hundred yards
Bathing or dressing yourself
11
Excellent Very good Good PoorFair
SECTION B
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B4. Since your test, how much of the time have you had any of the following problems with
your work or other regular daily activities as a result of your physical health?
All of
the time
Most of
the time
Some of
the time
A little of
the time
None of
the time
Cut down on the
amount of time you
spent on work or other
activities
Accomplished less
than you would like
Were limited in the
kind of work or other
activities
Had difficulty
performing the work or
other activities (for
example, it took extra
effort)
B5. Since your test, how much of the time have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)?
None of
the time
A little of
the time
Some of
the time
Most of
the time
All of
the time
Cut down on the
amount of time you
spent on work or other
activities
Accomplished less
than you would like
Did work or activities
less carefully than
usual
B6. Since your test, to what extent has your physical health or emotional problems interfered
with your normal activities with family, friends, neighbours or groups?
ExtremelyQuite a bitSlightly ModeratelyNot at all
12
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B7. How much bodily pain have you had since your test?
B8. Since your test, how much did pain interfere with your normal work (including both work 
outside the home and housework)?
B9. These questions are about how you feel and how things have been with you since your 
test.  For each question, please give ONE answer that comes closest to the way you
have been feeling.
How much of the time since your test  ..........
Did you feel full of life?
Have you been very nervous?
Have you felt so down in the
dumps that nothing could
cheer you up?
Have you felt calm and
peaceful?
Did you have a lot of energy?
Have you felt downhearted
and depressed?
Did you feel worn out?
Have you been happy?
Did you feel tired?
All of the
time
Most of
the time
Some of
the time
None of
the time
A little of
the time
13
None Very mild Mild Moderate Severe Very severe
Not at all Slightly Moderately Quite a bit Extremely
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B10. Since your test, how much of the time has your physical health or emotional problems
interfered with your social activities (like visiting friends, relatives, etc)?
B11. How TRUE or FALSE is each of the following statements for you?
Definitely
true
Don't
know
Mostly
true
Mostly
false
Definitely
false
I seem to get sick a little
easier than other people
I am as healthy as
anybody I know
I expect my health to
get worse
My health is excellent
14
All of
the time
Most of
the time
Some of
the time
A little of
the time
None of
the time
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This section asks about your health in general.  Please indicate which statement best describes
your own health state today.
Answer every question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
I have no problems in walking about
I have some problems in walking about                                      
I am confined to bed
C1. Mobility
C2. Self care
I have no problems with self-care
I have some problems with self-care                                           
I am unable to wash or dress myself
C3. Usual Activities
I have no problems with performing my usual activities
I have some problems with performing my usual activities         
I am unable to perform my usual activities
C4. Pain / Discomfort
I have no pain or discomfort
I have moderate pain or discomfort                                             
I have extreme pain or discomfort
C5. Anxiety/Depression
I am not anxious or depressed
I am moderately anxious or depressed                                       
I am extremely anxious or depressed
SECTION C
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To help people say how good or bad their health state is, we have drawn
a scale (rather like a thermometer) on which the best state you can
imagine is marked 100 and the worst state you can imagine is marked 0.
We would like you to indicate on this scale how good or bad your own
health is today, in your opinion.  Please do this by drawing a line from
the black box below to whichever point on the scale indicates how good
or bad your health state is today.
 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst 
imaginable 
health state 
0 
Best  
imaginable 
health state 
 
Your own 
health state 
today 
For office use only
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This section is about the health care you have had in the last 3 months.  Please read each
question carefully.  For each question, if you have had no treatment or visits enter '0' as
indicated.
We would like to know about visits to health professionals for any reason, not just your
digestive or bowel symptoms.
D1. How often have you consulted, for any reason, any of the following at your GP's surgery 
in the last 3 months?
Your own or another GP
If none enter '0'
Nurse
If none enter '0'
Other (please specify)
If none enter '0'
D2. How often have you consulted, for any reason, any of the following at home in the last
3 months?
Your own or another GP
If none enter '0'
Nurse
If none enter '0'
Other (please specify)
If none enter '0'
D3. How often have you been admitted, for any reason, to a hospital (NHS or private) as an 
emergency in the last 3 months?
If none enter '0'
D4. How often have you been admitted, for any reason, to a hospital (NHS or private) NOT as 
an emergency in the last 3 months?
If none enter '0'
17
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D5. How many times have you been seen, for any reason at a hospital outpatient clinic in the 
last 3 months?
By a Doctor
If none enter '0'
By a Nurse Practitioner
If none enter '0'
By a Dietician
If none enter '0'
By anyone else (please specify)
If none enter '0'
D6. How many times have you been admitted as a day case for upper or lower endoscopy in 
the last 3 months?
Upper endoscopy
If none enter '0'
Lower endoscopy
If none enter '0'
D7. If you are in work, how many days work have you lost due to illness or in order to see any
health professional in the last 3 months?
If none enter '0'
18
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Look at the list of medications below.  If you take any of the medications listed below, please
enter the dose of each tablet (this will be written on the tablet box or bottle) and the number of
tablets you take each day.  Answer 'yes' or 'no' to whether you are taking the drug regularly and
if you answer 'no' please enter the average number of tablets you take each month.
Each tablet
dose in mg
Number of
tablets per
day
Regular? If not regularly,
average number
of tablets taken
per monthIndigestion medication
Nexium (Esomeprazole)
 
Losec (Omeprazole)
 
Zoton (Lansoprazole)
 
Protium (Pantoprazole)
 
Pariet (Rabeprazole)
 
Zantac (Ranitidine)
 
Pepcid (Famotidine)
 
Axid (Nizatidine)
 
Tagamet (Cimetidine)
 
Maxolon (Metoclopramide)
 
Motilium (Domperidone)
Medication for irritable bowel
Spasmonal (Alverine)
 
Merbentyl (Dicycloverine)
 
Buscopan (Hyoscine)
 
Colpermin
 
Colofac (Mebeverine)
 
Fybogel
Anti-diarrhoeal medication
Imodium (Loperamide)
 
Codeine Phosphate
 
Questran (Colestyramine)
 
Lomotil (Co-phenetrope)
19
SECTION E
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
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Each tablet
dose in mg
Medication for Colitis
Asacol or Pentasa or Salofalk
(Mesalazine)
 
Colazide (Balsalazide)
 
Dipentum (Olsalazine)
 
Salazopyrin (Sulfasalazine)
 
Entocort or Budenofalk
(Budesonide)
 
Prednisolone (by mouth)
 
 
Predsol or Predfoam or
Predenema (enemas)
 
Number of
tablets per
day
Regular? If not regularly,
average number
of tablets taken
per month
If you take any other tablets/liquids for your digestive or bowel symptoms, that are not listed,
please write the details in the list below.  Please include any prescriptions and medicines you buy
over the counter from the chemist or supermarket (examples include antacids and laxatives).
How many times
taken per week
Dose in
mg or ml
On prescriptionName of medicine
If you wish to add any comments regarding your medication, please enter them in the box below.
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Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Number
per day
Yes No
Regular? If not regularly, average
number per month
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This section aims to obtain YOUR personal views based on YOUR experience of having a test.
Your answers will be treated in a confidential manner, and they will not affect your treatment in any
way.  The information provided will be used to find out how satisfied people are with their test, and
to improve the hospital service.
Answer every question by putting a cross in the corresponding box.  Do not cross more than one
box in each group.  If you are unsure about how to answer a question, please give the best answer
you can.
EnoughA bit too muchFar too much A little None
F7. Before you had your test, how much explanation did you receive about what would happen
during your test?
If you did not receive an explanation, then please go directly to question F10.
NoneLimitedReasonableGoodVery good
F6. Before you had your test, how much opportunity did you have to ask questions about the test?
Very useful Useful Fair Not very useful Not at all useful
F5. Was the information sent to you before your test useful in answering your questions?
EasyVery easy Fair Difficult Very difficult
F4. How easy to understand was the information that was sent to you before your test?
A bit too muchFar too much Enough A little None
F3. How much information was sent to you before your test?
21
F1. What test did you have?
/ /F2. Date of the test
SECTION F
If no information was sent to you, then please go directly to question F6.
The ENIGMA study 
©NCCSDO 2008 Page 367 
None Mild Moderate Severe Very severe
F13. How much discomfort did you experience during your test?
PoorFairGoodVery good Very poor
F12. How would you rate the communication skills (eg. courtesy, respect, sensitivity,
friendliness) of the other staff involved?
Very poorPoorFairGoodVery good
F11. How would you rate the technical skills (eg. thoroughness, carefulness, competence) 
of the person who performed your test?
Very good Good Fair Poor Very poor
F10. How would you rate the communication skills (eg. courtesy, respect, sensitivity,
friendliness) of the person who performed your test?
FairUsefulVery useful Not very useful Not at all useful
F9. Was the explanation given to you before your test useful in answering your questions?
Easy Fair Difficult Very difficultVery easy
F8 . How easy to understand was the explanation given to you before the test?
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F14. How much pain did you experience during your test?
F15. How much discomfort did you experience in the rest of the day, after your test?
F16. How much pain did you experience in the rest of the day, after your test?
F17. After you had your test, how much opportunity did you have to ask questions about 
the findings?
F18. After you had your test, how much explanation of the findings did you receive?
F19. How easy to understand was the explanation given to you after your test?
If you did not receive an explanation, then please go directly to question F21.
None Mild Moderate Severe Very severe
None Mild Moderate Severe Very severe
None Mild Moderate Very severeSevere
Far too much A bit too much Enough A little None
Very good Good Reasonable Limited None
Very easy Easy Fair Difficult Very difficult
23
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F20. Was the explanation given to you after your test useful in answering your questions?
F21. How would you rate the comfort of the recovery area, if applicable?
F22. Overall, how satisfied are you with your test?
F23. If, in the future, you have another test of this sort, how satisfied would you be to have it
done by the same person?
F24. Overall, how would you rate the care you received at the hospital for the test?
Very useful Useful Fair Not very useful Not at all useful
Very good Good Fair Poor Very poor
Very satisfied Satisfied Neither satisfied
nor dissatisfied
Dissatisfied Very dissatisfied
Very good Good Fair Poor Very poor
Very dissatisfiedDissatisfiedNeither satisfied
nor dissatisfied
SatisfiedVery satisfied
24
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Before the appointment
G1. Overall, from the time you were first told you needed the test to the
time you went to the hospital, how long did you wait for the test?
Up to 1 month
More than 1 month but no more than 3 months
More than 3 months but no more than 5 months
More than 5 months but no more than 12 months
More than 12 months but no more than 18 months
More than 18 months
I went to the hospital without an appointment
Don't know / Can't remember
G2. Before your appointment for the test, did you know the reason for
the test?
Yes, definitely
Yes, to some extent
No
G3. Before your test, did you know who to contact if your symptoms or
condition got worse?
Yes
No
G4. Was the date for your test changed by the hospital?
No
Yes, once
Yes, 2 or 3 times
Yes, 4 times or more
25
This section relates to your experience regarding the appointment for the test you told us
about on page 21.
Answer every question by putting a cross in the corresponding box.  Do not cross more
than one box in each group.  If you are unsure about how to answer a question, please give
the best answer you can.
SECTION G
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Waiting
G5. How long after the stated appointment time did the procedure start?
Seen on time, or early
Waited up to 5 minutes
Waited 6-15 minutes
Waited 16-30 minutes
Waited 31-60 minutes
Waited more than 1 hour but no more than 2 hours
Waited more than 2 hours
Don't know / Can't remember
Not given a stated test time
G6. Were you told how long you would have to wait?
Yes, but the wait was shorter
Yes, and I had to wait about as long as was told
Yes, but the wait was longer
No, I was not told
Don't know / Can't remember
G7. Were you told why you had to wait?
Yes
No, but I would have liked an explanation
No, but I didn't mind
Don't know / Can't remember
26
If you were seen on time, then please go directly to question G8 over the page.
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Information
G8. Did a member of staff tell you about what danger signals regarding
your illness or test to watch for after you went home?
Yes, completely
Yes, to some extent
No
I did not need this type of information
G9 Did hospital staff tell you who to contact after you got home if you 
were worried about your condition or test?
Yes, they told me to contact my GP
Yes, they told me to contact the practice nurse at my local health centre
Yes, they told me to contact NHS Direct
Yes, I was told to dial 999
Yes, they told me to contact a hospital doctor or nurse
Yes, I was told to contact someone else
No, I was not told who to contact
I did not need this type of information
Don't know / Can't remember
27
G10. If you had a biopsy (ie sample taken away for testing) how long did
you wait for your results?
Up to 1 month
More than 1 month but no more than 3 months
More than 3 months but no more than 5 months
More than 5 months but no more than 12 months
More than 12 months but no more than 18 months
More than 18 months
Don't know / Can't remember
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Any other comments
If there is anything else you would like to tell us about your experiences in the hospital for the test,
please do so here.
Was there anything particularly good about your visit to the hospital?
Was there anything that could have been improved?
Any other comments?
Are you happy to take part in a telephone interview with one of our researchers?
(Please cross appropriate box)
Thank you very much for your help.
Please check that you answered all the questions that apply to you.
Please post this questionnaire back in the FREEPOST envelope provided.
No stamp is needed.
Yes No
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Appendix 5 – 12 month Post Procedure 
Questionnaire 
Study Number
Evaluating Innovations in Gastroenterology
for the NHS Modernisation Agency
(ENIGMA) study
12 month post procedure questionnaire
A questionnaire for people with digestive and bowel disorders
Please complete this questionnaire at home as soon as you have time and
return to us using the prepaid envelope enclosed.
CONFIDENTIAL
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Please read all the instructions before completing this questionnaire.
Thank you for agreeing to take part in this study.  The answers you give in this questionnaire
will help us to find out if the treatments you receive are helpful for your condition.
The information you provide will be completely confidential and will not affect your treatment in
any way.
Please answer all the questions.  Although it may seem that some questions are asked more
than once, it is still important that you answer every one.  If you find it difficult to answer a
question, please do the best you can.
Please follow the instructions for each section of the questionnaire carefully.
For each section, if you are asked to put a cross in the box, please use a cross, as if you were
filling out a ballot paper, rather than a tick.
For example in the following question, if your answer is yes, you should place a cross firmly in
the corresponding box.
  Yes    No
Do you drive a car?
Please use a black or blue pen.  Do not use a pencil or any other coloured pen.
Please complete the questionnaire fully and return it in the FREEPOST envelope provided as
soon as possible.
2
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Please enter the date you are completing this questionnaire below
/ /
This section asks about your symptoms.  When answering the questions about the effect on your
life, consider how these symptoms prevented you from doing your usual activities over the last 2
weeks.
Answer each question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
Not at all
Once a week
Two or three times a week
Most days
Everyday
A1. In the last 2 weeks, how often have you experienced heartburn
(a burning sensation behind your breast bone)?
A2. In the last 2 weeks, how often have you had any discomfort
in your upper abdomen (above your belly button and below
your ribs)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A1 and A2, skip
question A3 and go straight to question A4 over the page
A3. In the last 2 weeks, how much have the symptoms described in
questions A1 and A2 prevented you from doing your usual activities?
Not at all
A little
Moderately
A lot
Extremely
  D       D              M      M              Y       Y      Y      Y
SECTION A
3
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A4. In the last 2 weeks, how often have you experienced bitter bile
or acid reflux (from the stomach into the throat)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A5. In the last 2 weeks, how often have you experienced a feeling
of nausea or sickness without actually vomiting?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A6. In the last 2 weeks, how often have you retched or heaved
without actually vomiting?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A7. In the last 2 weeks, how often have you actually vomited?
Not at all
Once a week
Two or three times a week
Most days
Everyday
4
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Yes
No
Not applicable
A8. If you have vomited in the last 2 weeks, have you seen any blood
in the vomit?
If you have not had any of the symptoms or problems described in questions A4 to A8, skip
question A9 and go directly to question A10
A9. In the last 2 weeks, how much have the symptoms described in
question A4 to question A8 prevented you from doing your usual
activities?
Not at all
A little
Moderately
A lot
Extremely
A10. In the last 2 weeks, how often have you been bothered by a lot
of belching or burping (release of wind from the stomach by the
mouth)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A11. In the last 2 weeks, how often have you been bothered by passing
a lot of wind from the back passage?
Not at all
Once a week
Two or three times a week
Most days
Everyday
5
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A12. In the last 2 weeks, how often have you experienced bloatedness,
and or a feeling of trapped wind in your stomach?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A13. In the last 2 weeks, how often have you experienced loud gurgling
noises from your stomach?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A10 to A13, skip
question A14 and go straight to question A15 over the page
A14. In the last 2 weeks, how much have the symptoms described in
question A10 to question A13 prevented you from doing your
usual activities?
Not at all
A little
Moderately
A lot
Extremely
6
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A15. In the last 2 weeks, how often have you felt that your food sticks
on the way down your gullet (through the chest into your stomach)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A16. In the last 2 weeks, how often have your eating habits been
restricted because of your condition (examples might be having
to eat more slowly, having to take smaller portions or having
to eat different foods)? Not at all
Once a week
Two or three times a week
Most days
Everyday
A17. In the last 2 weeks have you had a lack of appetite?
Not at all
Once a week
Two or three times a week
Most days
Everyday
If you have not had any of the symptoms or problems described in questions A15 to A17, skip
question A18 and go to question A19 over the page
A18. In the last 2 weeks, how much have the symptoms described
in question A15 to question A17 prevented you from doing your
usual activities? Not at all
A little
Moderately
A lot
Extremely7
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A19. Have you noticed any change in weight (not due to a change
in your diet) over the last 3 months?
No, my weight has been stable
Yes, I have been gaining weight
Yes, I have been losing weight
A20. In the last 2 weeks, how often have you been bothered by too
 frequent emptying of your bowels?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A21. In the last 2 weeks, how often have you been bothered by
loose stools?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A22. In the last 2 weeks, how often have you been bothered by
hard stools?
Not at all
Once a week
Two or three times a week
Most days
Everyday
8
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A23. In the last 2 weeks, how often have you been bothered by
constipation (constipation means difficulty in emptying your bowels)?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A24. In the last 2 weeks, how often have you had an urgent need to
empty your bowels (this urgent need is often associated with a
feeling that you are not in full control)? Not at all
Once a week
Two or three times a week
Most days
Everyday
A25. In the last 2 weeks, how often have you had a feeling of not
completely emptying your bowels?
Not at all
Once a week
Two or three times a week
Most days
Everyday
A26. In the last 2 weeks, have you had bleeding through your back
passage (signs of bleeding include fresh blood, staining of toilet
tissue, blood mixed with stools)?
Not at all
A little
Moderately
A lot
Extremely
9
The ENIGMA study 
©NCCSDO 2008 Page 383 
If you have not had any of the symptoms or problems described in questions A20 to A26, skip
question A27 and go straight to question A28
Not at all
A little
Moderately
A lot
Extremely
A28. Compared with 2 weeks ago, how would you now rate your
symptoms in general?
Much better now than 2 weeks ago
Somewhat better now than 2 weeks ago
About the same as 2 weeks ago
Somewhat worse now than 2 weeks ago
Much worse now than 2 weeks ago
A29. In the last 2 weeks, how often have your symptoms caused you
difficulties in getting to sleep?
Not at all
Once a week
Two or three times a week
Most nights
Every night
A30. In the last 2 weeks, how often have your symptoms caused
you to wake up?
Not at all
Once a week
Two or three times a week
Most nights
Every night
A27. In the last 2 weeks, how much have the symptoms described
in question A20 to question A26 prevented you from doing your
usual activities?
10
The ENIGMA study 
©NCCSDO 2008 Page 384 
This section asks for your views about your health, how you feel and how well you are able to do
your usual activities.
Answer every question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
B1. In general, would you say your health is:
B2. Compared to 1 year ago, how would you rate your health in general now?
B3. The following questions are about activities you might do during a typical day.  Does
your health now limit you in these activities?  If so, how much? (cross a box on each line)
Much better
now than one
year ago
Somewhat
better now than
one year ago
Somewhat
worse now than
one year ago
About the
same as one
year ago
Much worse
now than one
year ago
Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports
Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling or playing golf
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling or stooping
Walking more than a mile
Walking several hundred yards
Walking one hundred yards
Bathing or dressing yourself
Yes, limited
a lot
Yes, limited
a little
No, not
limited at all
Excellent Very good Good Fair Poor
SECTION B
11
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B4. During the past 4 weeks, how much of the time have you had any of the following problems
with your work or other regular daily activities as a result of your physical health?
Cut down on the
amount of time you
spent on work or other
activities
Accomplished less
than you would like
Were limited in the
kind of work or other
activities
Had difficulty
performing the work or
other activities (for
example, it took extra
effort)
All of the
time
Most of
the time
Some of
the time
A little of
the time
None of
the time
B5. During the past 4 weeks, how much of the time have you had any of the following problems
with your work or other regular daily activities as a result of any emotional problems (such as
feeling depressed or anxious)?
Cut down on the
amount of time you
spent on work or other
activities
Accomplished less
than you would like
Did work or activities
less carefully than
usual
All of the
time
Most of
the time
Some of
the time
A little of
the time
None of
the time
B6. During the past 4 weeks, to what extent has your physical health or emotional problems
interfered with your normal activities with family, friends, neighbours, or groups?
Not at all Slightly Moderately Quite a bit Extremely
12
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B7. How much bodily pain have you had during the past 4 weeks?
B8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)?
B9. These questions are about how you feel and how things have been with you during the 
past 4 weeks.  For each question, please give ONE answer that comes closest to the
way you have been feeling.
How much of the time during the past 4 weeks ..........
Did you feel full of life?
Have you been very nervous?
Have you felt so down in the
dumps that nothing could
cheer you up?
Have you felt calm and
peaceful?
Did you have a lot of energy?
Have you felt downhearted
and depressed?
Did you feel worn out?
Have you been happy?
Did you feel tired?
All of the
time
Most of
the time
Some of
the time
A little of
the time
None of
the time
None Very mild Mild Moderate Severe Very severe
ExtremelyQuite a bitModeratelySlightlyNot at all
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B10. During the past 4 weeks, how much of the time has your physical health or emotional
problems interfered with your social activities (like visiting friends, relatives, etc)?
B11. How TRUE or FALSE is each of the following statements for you?
I seem to get sick a little
easier than other people
I am as healthy as
anybody I know
I expect my health to
get worse
My health is excellent
Definitely
true
Mostly
true
Don't
know
Mostly
false
Definitely
false
Most of
the time
All of
the time
Some of
the time
A little of
the time
None of
the time
14
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This section asks about your health in general.  Please indicate which statement best describes
your own health state today.
Answer each question by putting a cross in the corresponding box.  Do not cross more than
one box in each group.  If you are unsure about how to answer a question, please give the best
answer you can.
I have no problems in walking about
I have some problems in walking about                                      
I am confined to bed
C1. Mobility
C2. Self care
I have no problems with self-care
I have some problems with self-care                                           
I am unable to wash or dress myself
C3. Usual Activities
I have no problems with performing my usual activities
I have some problems with performing my usual activities          
I am unable to perform my usual activities
C4. Pain / Discomfort
I have no pain or discomfort
I have moderate pain or discomfort                                             
I have extreme pain or discomfort
C5. Anxiety/Depression
I am not anxious or depressed
I am moderately anxious or depressed                                        
I am extremely anxious or depressed
SECTION C
15
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To help people say how good or bad their health state is, we have
drawn a scale (rather like a thermometer) on which the best state
you can imagine is marked 100 and the worst state you can imagine
is marked 0.
We would like you to indicate on this scale how good or bad your
own health is today, in your opinion.  Please do this by drawing a
line from the black box below to whichever point on the scale
indicates how good or bad your health state is today.
 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst 
imaginable 
health state 
0 
Best  
imaginable 
health state 
 
Your own 
health state 
today 
For office use
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This section is about the health care you have had in the last 3 months.  Please read
each question carefully.  For each question, if you have had no treatment or visits enter '0'
as indicated.
We would like to know about visits to health professionals for any reason, not just your
digestive or bowel symptoms.
D1. How often have you consulted, for any reason, any of the following at your GP's surgery in
the last 3 months?
Your own or another GP
If none enter '0'
Nurse
If none enter '0'
Other (please specify)
If none enter '0'
D2. How often have you consulted, for any reason, any of the following at home in the last
3 months?
Your own or another GP
If none enter '0'
Nurse
If none enter '0'
Other (please specify)
If none enter '0'
D3. How often have you been admitted, for any reason, to a hospital (NHS or private) as an 
emergency in the last 3 months?
If none enter '0'
D4. How often have you been admitted, for any reason, to a hospital (NHS or private) NOT as 
an emergency in the last 3 months?
If none enter '0'
SECTION D
17
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D5. How many times have you been seen, for any reason at a hospital outpatient clinic in the 
last 3 months?
By a Doctor
If none enter '0'
By a Nurse Practitioner
If none enter '0'
By a Dietician
If none enter '0'
By anyone else (please specify)
If none enter '0'
D6. How many times have you been admitted as a day case for upper or lower endoscopy in 
the last 3 months?
Upper endoscopy
If none enter '0'
Lower endoscopy
If none enter '0'
D7. If you are in work, how many days work have you lost due to illness or in order to see any
health professional in the last 3 months?
If none enter '0'
18
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Look at the list of medications below.  If you take any of the medications listed below, please
enter the dose of each tablet (this will be written on the tablet box or bottle) and the number of
tablets you take each day.  Answer 'yes' or 'no' to whether you are taking the drug regularly and
if you answer 'no' please enter the average number of tablets you take each month.
Indigestion medication
Nexium (Esomeprazole)
 
Losec (Omeprazole)
 
Zoton (Lansoprazole)
 
Protium (Pantoprazole)
 
Pariet (Rabeprazole)
 
Zantac (Ranitidine)
 
Pepcid (Famotidine)
 
Axid (Nizatidine)
 
Tagamet (Cimetidine)
 
Maxolon (Metoclopramide)
 
Motilium (Domperidone)
Medication for irritable bowel
Spasmonal (Alverine)
 
Merbentyl (Dicycloverine)
 
Buscopan (Hyoscine)
 
Colpermin
 
Colofac (Mebeverine)
 
Fybogel sachets
Anti-diarrhoeal medication
Imodium (Loperamide)
 
Codeine Phosphate
 
Questran (Colestyramine)
 
Lomotil (Co-phenetrope)
Each tablet
dose in mg
Number of
tablets per
day
Regular? If not regularly,
average number
of tablets taken
per month
SECTION E
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
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If not regularly, average
number per month
Medication for Colitis
Asacol or Pentasa or Salofalk
(Mesalazine)
 
Colazide (Balsalazide)
 
Dipentum (Olsalazine)
 
Salazopyrin (Sulfasalazine)
 
Entocort or
Budenofalk(Budesonide)
 
Prednisolone (by mouth)
 
Predsol or Predfoam or
Predenema (enemas)
Each tablet
dose in mg
Number of
tablets per
day
Regular? If not regularly,
average number
of tablets taken
per month
If you take any other tablets/liquids for your digestive or bowel symptoms, that are not listed,
please write the details in the list below.  Please include any prescriptions and medicines you buy
over the counter from the chemist or supermarket (examples include antacids and laxatives)
Name of medicine On prescription Dose in mg
or ml
How many times
taken per week
If you wish to add any comments regarding your medication, please enter them in the box below.
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Yes No
Number
per day
Regular?
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Yes       No               
/ /
Please enter your sex below
Male Female        
Please enter your initials in the box below
  D       D              M      M              Y       Y      Y      Y
If YES, please complete questions F2 and F3.
F2. How long did you wait for the treatment?
Up to 1 month
More than 1 month but no more than 3 months
More than 3 months but no more than 5 months
More than 5 months but no more than 12 months
More than 12 months but no more than 18 months
More than 18 months
Don't know / Can't remember
Yes       No               
21
SECTION F
F1. Thinking back to your test/endoscopy a year ago did you require any treatment after it?
F3. Did you know the reason for the treatment?
If YES, please describe briefly.
Please enter your date of birth below
If you would like to see a summary of the overall results of the study when it is complete, please
place a cross in this box.
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Thank you for completing this questionnaire.
If you have any general comments about your digestive or bowel treatment, or this questionnaire,
please write them below.
Once you have completed the questionnaire please return it in the FREEPOST envelope provided,
or send it to
ENIGMA Study Team
Swansea Clinical School
University of Wales Swansea
Singleton Park
Swansea
SA2 8PP
If you have any concerns about your symptoms please consult your GP or hospital doctor.
YOUR COMMENTS
22
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Appendix 6 – 12 month Post Referral 
Questionnaire 
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Appendix 7 – The TIS Form proforma 
 
FORM 1: 
 
Number of referrals received for endoscopy 
  
Month 
requested 
Referral type 
FLEXIBLE 
SIGMOIDOSCOPY  
COLONOSCOPY 
GASTROSCOPY 
/ OGD 
TOTAL 
MM/YY 
Day case / outpatient          
2 week (cancer)         
Inpatient         
Follow-up 
(surveillance)         
Emergency         
Total         
 
  FORM 2: Origin of referrals 
received  
 
 
 
Month 
requested 
Referral 
source 
Number of procedures requested per month 
FLEXIBLE 
SIGMOIDOSCOPY  
COLONOSCOPY 
GASTROSCOPY 
/ OGD 
TOTAL 
MM/YY 
GP          
Consultant         
Private         
Total         
The ENIGMA study 
©NCCSDO 2008 Page 421 
 
 
FORM 3: 
 
Waiting list information  
   
Month 
requested 
No. patients waiting 
for… 
FLEXIBLE 
SIGMOIDOSCOPY  
COLONOSCOPY 
GASTROSCOPY 
/ OGD 
TOTAL 
MM/YY 
> 1 month         
> 3 months         
> 6 months         
> 12 months         
Total         
 
 
FORM 4: Cancellations / DNAs  
 
Month 
requested Reason for lost slot 
Number lost 
MM/YY 
Patient cancellation   
Patient DNA'd   
Hospital Cancellation    
Total   
 
 
FORM 5: 
 
Number of endoscopies performed  
  
Month requested 
FLEXIBLE 
SIGMOIDOSCOPY  
COLONOSCOPY 
GASTROSCOPY / 
OGD 
TOTAL 
MM/YY         
MM/YY = Month/Year 
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Appendix 8 – Total procedures data submitted by highest ranking source for 
each site 
Data 
variable Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Referrals T0 292   287 408   370 379 727 429   638   175 268 5     872 507   
T1 334   463 391   337 311 614 456   585   242 251 1     853 555   
T2 130 647 332 438   391 311 654 520   674 342 385 198 52 361 729 672 534   
T3 336 469 309 325 418 449 280 586 184   619 315 379 260 88 366 678 796 494   
T4 337 724 344 376 402 255 347 585 356   683 365 402 273 60 289 836 628 599 484 
T5 396 630 333 337 409 269 371 573     619 347 474 218 257 276 641 798 565 337 
T6 287 856 316 328 448 278   560     597 419 528     303 818 456 582 305 
T7 336 564 281 280   287   289     589   548       604 380   303 
Wait >3m T0     202 282 39 6   85     1043   1586 353 3     248 53   
T1     88 433 172 0   27     808   1117 418 7     180 41   
T2   77 4 461 60 0   55     889   1010 30 4     112 28   
T3   82 36 388 56 0 110 40     1020   1113 340 3     118 51   
T4   39 30 306 65 92 63 40     1063   1143 807 24     162 26 45 
T5   85 13 347 15 6 91 81     1265   1070 1090 6     178 11 0 
T6   14 5 239 26   28 79     2109   1080         103 8 0 
T7   52 6 128       49         1787         517 0 0 
Snapshot T0 1148       93     699 995         685      941 482   
T1 1180       289     630 2024         733      457 425   
T2 675 818     97     683 1889     996   324      27900 469 433   
T3 477 890     97     588 2006 440   952   840      39540 789 554   
T4 456 487     165     773 2122 657   803   1296      38085 597 477   
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(…Cont’d) 
 
Data 
variable 
Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Snapshot T5 484 588      25     654 2183 940   963   1511      47295 652 402   
T6 414 572     43     631 2723     1208          38085 421 421   
T7 300 567             2648                 1234     
Lost slots T0 94   69     21     216   53   64 64 1 104   240 29   
T1 81   67     26     138   34   134 63 6 244   300 29   
T2 71 13 52     92     106   54   146 29 2 203 75 322 26   
T3 99 21 47   38 112     142   64   192 33 121 232 82 258 21   
T4 70 18 62   67 20     134   64   141 46 136 203 121 253 34   
T5 75 26 64   54 26     151   50   102 40 135   97 311 26   
T6 70 29 52   98 114     141   36   167       84 406 52   
T7 32 21 56     17     138   28   40       65 161     
Activity T0 376 479 376 369   352 473 727 382 308 541   483 203 111 210   682 342 122 
T1 448 506 392 324   225 298 614 401 316 499   652 267 88 492   816 374 171 
T2 332 506 405 336   285 408 654 359 286 414 250 603 130 80 499 562 722 292 170 
T3 366 504 383 252 419 257 412 586 314 266 518 299 559 186 248 544 515 723 358 182 
T4 488 518 442 280 418 281 458 585 320 276 515 311 675 208 301 530 773 763 424 294 
T5 409 539 392 290 415 359 449 573 334 260 444 277 544 157 397   714 828 347 362 
T6 409   405 310 405 325 430 560 335 318 490 323 506       725 862     
T7 278   269 303 362 255 331 334 289 287 476   371       604 424     
 
Cells shaded in grey indicate datasets subsequently excluded due to irregularities. 
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Appendix 9 – Data submitted from highest ranking source for FS procedures 
only 
 
Variable Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Referrals T0 7   12 53   72 121 188 6   97   14   0     81     
T1 28   43 66   76 91 147 4   94   17   0     60     
T2 6 44 33 49   69 97 193 6   97 45 82   0 52 153 7     
T3 18 45 32 34 115 99 87 144 3   113 66 94   1 81 177 14     
T4 18 76 30 41 119 53 114 153 16   120 73 116   0 54 220 1   151 
T5 10 58 40 53 128 80 96 169     113 68 130   10 45 216 11   73 
T6 17 76 46 67 137 74   170     110 86 135     57 188 12   67 
T7 20 49 28 48   68   113     167   136       182 2   63 
Wait 
>3m 
T0     18 40   0   65     29   252 15 0     0 4   
T1     5 60   0   9     18   87 13 0     0 13   
T2   3 0 62   0   20     45   97 0 0     2 14   
T3   10 0 36   0 24 13     49   120 6 0     7 20   
T4   3 3 38   16 3 19     76   110 30 0     4 4 0 
T5   50 2 14   2 16 29     105   119 23 0     4 2 0 
T6   5 0 20     3 20     426   124         0 4 0 
T7   16 0 17       22         152         7 0 0 
Snapshot T0 57             297 3         26      87 160   
T1 65             260 14         20       66 151   
T2 84 72           272 19     144   8     4665 7 152   
T3 51 80           243 27 49   128   34      7230 13 189   
T4 47 64           352 34 122   95   59      7695 6 150   
T5 57 60           221 96 155   94   39      8760 7 119   
T6 42 89           238 101     165          9105 2 132   
T7 29 70             74                 10     
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(…Cont’d) 
 
Activity T0 35 36 25 55   66   188 4 60 61   117   9 0   49 121 13 
T1 43 28 31 45   48   147 3 71 58   203   16 12   65 115 30 
T2 36 30 44 42   56   193 11 60 35 44 150   5 3 121 23 71 28 
T3 54 55 32 32 106 32   144 7 54 72 56 111   10 11 132 16 85 29 
T4 65 60 45 31 100 48   153 11 48 68 88 161   9 29 188 1 98 9 
T5 51 55 37 36 131 106   169 15 48 56 65 131   17   160 10 78 11 
T6 61  45 50 106 64   170 13 61 58 54 128       182 11     
T7 29   30 46 110 64 97 129 16 41 87   106       182 2     
 
Cells shaded in grey indicate datasets subsequently excluded due to irregularities. 
The ENIGMA study 
©NCCSDO 2008 Page 426 
Appendix 10 – Data submitted from highest ranking source for Colonoscopy 
procedures only 
Variable Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Referrals T0 62   84 104   76 65 110 97   137   72   4     342     
T1 73   142 108   89 88 113 149   140   35   1     507     
T2 21 149 94 148   79 83 100 187   120 127 103   4 113 182 323     
T3 71 125 75 92 57 115 68 86 102   108 127 97   7 132 165 396     
T4 86 194 104 145 71 50 107 119 93   154 143 118   11 105 214 371   114 
T5 97 196 88 94 43 94 143 114     108 154 149   80 107 156 397   80 
T6 64 262 84 90 71 84   94     100 176 146     131 278 250   61 
T7 88 155 73 86   73   63     137   147       170 142   65 
Wait 
>3m 
T0     117 90   0   13     944   708 281 3     223 17   
T1     67 174   0   11     714   432 355 7     174 11   
T2   44 4 148   0   20     764   465 24 4     96 1   
T3   53 31 133   0 18 17     884   478 200 3     98 14   
T4   36 23 135   40 16 6     884   578 488 1     129 13 8 
T5   33 4 145   4 42 17     1082   628 680 1     153 3 0 
T6   9 2 123     25 15     1259   719         90 1 0 
T7   33 3 74       13         1299         188 0 0 
Snapshot T0 478             123 644         453       350 68   
T1 458             120 1049         538       233 67   
T2 354 302           131 1070     350   175     12450  164 87   
T3 242 296           123 1146 107   368   451      16740 394 122   
T4 186 205           110 1221 140   337   731      19350 230 123   
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(…Cont’d) 
 
Variable Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Snapshot T5 179 260           105 1160 189   383   875      25800 265 94   
T6 191 239           97 1232     491          21870 195 111   
T7 133 229             1250                 359     
Activity T0 81 97 55 99   48   110 88 51 153   85   21 150   293 37 40 
T1 88 95 91 96   60   113 76 47 126   139   23 354   357 46 73 
T2 63 109 56 83   61   100 74 40 91 120 111   21 358 145 376 43 63 
T3 96 79 65 67 56 35   86 59 48 120 113 102   80 364 140 363 65 78 
T4 131 88 84 86 61 61   119 74 40 141 112 152   103 330 210 362 87 137 
T5 110 117 85 97 58 75   114 88 34 104 98 122   182   232 436 65 253 
T6 126   99 80 75 67   94 79 48 120 136 66       235 494     
T7 62   60 82 85 52 103 67 80 50 142   80       170 230     
 
Cells shaded in grey indicate datasets subsequently excluded due to irregularities. 
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Appendix 11 – Data submitted from highest ranking source for UGE 
procedures only 
Variable Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Referrals T0 223   191 251   222 193 429 326   404   89   1     449     
T1 233   278 217   172 132 354 303   351   190   0     286     
T2 103 454 205 241   243 131 361 327   457 170 200   48 196 394 342     
T3 247 299 202 199 246 235 125 356 79   398 122 188   80 153 336 386     
T4 233 454 210 190 212 152 126 313 247   409 149 168   49 130 402 256   219 
T5 289 376 205 190 238 95 132 290     398 125 195   167 124 269 390   184 
T6 206 518 186 171 240 121   296     387 157 247     115 352 194   177 
T7 228 360 180 146   146   113     285   265       252 236   175 
Wait 
>3m 
T0     67 152   6   7     70   626 57 0     25 32   
T1     16 199   0   7     76   598 50 0     6 17   
T2   30 0 251   0   15     80   448 6 0     14 13   
T3   19 5 219   0 68 10     87   515 134 0     13 17   
T4   0 4 133   36 44 15     103   455 289 23     29 9 37 
T5   2 7 188   0 33 35     78   323 387 5     21 6 0 
T6   0 3 96     0 44     424   237         13 3 0 
T7   3 3 37       14         336         322 0 0 
Snapshot T0 613             279 348         206       504 254   
T1 657             250 961         175       158 207   
T2 237 444           280 800     502   141     10785  298 194   
T3 184 514           222 834 284   456   355      15570 382 243   
T4 223 218           311 867 395   371   506      11040 361 204   
T5 248 268           328 927 596   486   597      12735 380 189   
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Variable Time 
Hospital ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Snapshot T6 181 244           296 1390     552          7110 224 178   
T7 138 268             1324                 865     
Activity T0 260 346 296 215   238   429 290 197 327   281   81 60   340 184 69 
T1 317 383 270 183   117   354 322 198 315   310   49 126   394 213 68 
T2 233 367 305 211   168   361 274 186 288 86 342   54 138 296 323 178 79 
T3 216 370 286 153 257 190   356 248 164 326 130 346   158 169 243 344 209 75 
T4 292 370 313 163 257 172   313 235 188 306 111 362   189 171 375 400 239 148 
T5 248 367 270 157 226 178   290 231 178 284 114 291   198   322 382 204 98 
T6 222  261 180 224 194   296 243 209 312 133 312       308 357     
T7 187   179 175 167 139 131 138 193 196 247   185       252 192     
 
Cells shaded in grey indicate datasets subsequently excluded due to irregularities.
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Appendix 12 – Costing assumptions and unit 
costs 
Resources devoted to modernisation were gleaned from the two interviews 
held at each site. The level of detail that could be provided varied. The 
methods below were used to value each resource. 
 
Staff 
 
Grade/Band Reported 
Interviews were held shortly after the implementation of ‘Agenda for 
Change’ in the NHS whereby staff posts were changed from Grades to 
Bands. Where the relevant grade or band was reported, average costs were 
taken from  
 
http://www.geniushealth.com/info/nhs-pay/nursing-pay-rates.html (grades)  
 
http://www.nhscareers.nhs.uk/details/Default.aspx?Id=767 (bands) 
 
Titles Reported: 
Where the job title was reported the following assumptions were made 
 
Junior Nurse = Grade F 
Nurse Endoscopist = Grade G 
Senior Nurse= grade H 
Sister = Grade H 
Nurse Specialist = grade H 
Nurse Consultant = grade H 
Manager = 8b 
Unit manager = 8b 
Project manager/ modernisation manager = 8b 
General manager = 8b 
Service manager/ Clinical service manager = 8b 
Senior manager = 8d 
Directorate manager = 8d 
Junior manager = 8a 
A&C = 5 
 
Job Description Reported 
During some interviews, the interviewee was unable to specify the grade of 
staff involved in a particular activity. It was often the case, however, that 
the job description could be specified. In these cases staff cost were 
estimated by finding jobs advertised on www.jobs.NHS.uk which most 
closely related to the job of the staff member and using the middle point of 
the advertised scale.  
 
Equipment 
 
Equipment costs were those incurred by the sites. Where cost was unknown, 
the most frequently incurred cost for similar equipment by other sites was 
used.  
 
 
Training 
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For training courses, actual costs incurred were used where reported. Where 
not known, the cost for the relevant course were as follows from  
http://www.bsg.org.uk/bsgdisp1.php?id=d82d268e18ad5db9500c&h=1&m
=00022#training 
- Basic Skills in Colonoscopy - 3 Days -£1000 
- Basic Skills in GI Endoscopy - 3 Days - £900 
- Basic Skills in Therapeutic GI Endoscopy - 3 Days - £1000 
- Basic Skills in Flexible Sigmoidoscopy - 3 Days - £900 
- Training the Trainers - 2 Days -£700 
- Basic Skills in ERCP Training - 3 Days £1200 
- Basic Skills in Radial Endoscopic Ultrasound  - 3 Days -£1000 
 
The opportunity cost of the time of the person being trained (see above) 
was added to these costs of the courses.  
 
 
Unit Costs and sources 
 
Data item £ Unit 
cost 
Source 
GP (surgery visit) £21 1 
Nurse (surgery visit) £8 1 
GP (home visit) £60 1 
Nurse (home visit) £11 1 
Social services/ Social worker £60 1 
Support worker £11 1 
Consultant £73 1 
Dietician/ Nutritional nurse/ 
Nutritional therapy session 
£35 2 
Physiotherapist session £36 2 
Paramedics/ Ambulance £161 2 
Chiropodist/ Podiatrist £31 2 
Occupational therapist £36 2 
Chiropodist /Podiatrist £31 2 
Day case endoscopy £457 4 
Colonoscopy £352 2 
Flexible sigmoidoscopy £279 2 
Gastroscopy £275 2 
Inpatient per day: medical £269 3 
Endoscopy slot £2727 6 
Outpatient episode £96 3 
Avg. weekly earnings male £105   5 
Avg. weekly earnings female £81.20 5 
Drugs * 7 
 
* = individual drug costs from (7) 
1 = Curtis L, Netten A. Costs of health and social care 2006. PSSRU 
2 = Dept. of Health. NHS Reference costs 2005/6 
3 = Netten & Curtis 2002* inflated to 2005/2006 using DH Pay and Prices 
Index 
4 = 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publications
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PolicyAndGuidance/DH_062884  2005-2006. Day cases. Appendix NSRC1 
(TDC) 
5 =  
http://www.statistics.gov.uk/downloads/theme_labour/LFSHQS/Table36.xls 
(2006) 
6 = Slot is made up of 12 points. Slot cost based on assumed ½ session for 
colonoscopy (2 points per procedure) and ½ session for 
sigmoidoscopy/gastroscopy (1 point each per procedure).  
 British National Formulary 2007. 
   
Endoscopy Sessions: 
Costs based on NHS Reference costs 2005 
Colonoscopy=2 points £352 
flexible sigmoidoscopy=1 £279 
gastroscopy=1 £275 
 
Points taken from Melaine Marchette, Singleton Hospital 
Session/slot= 12 points 
 
flexible sigmoidoscopy= £279*12 = 3384 
gastroscopy= £275*12 (points)= £3300  
Total average= (£3384+£3300)/2=£3342 
 
Assumption 1/2 session is for colonoscopy 3(points)*352 (average cost of 
colonoscopy, NHS reference cost 2005)=£1056  
1/2 session for flexible sigmoidoscopy and gastroscopy= £3342/2=£1671 
 
Cost of per slot/session= £1056+£1671=£2727 
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Appendix 13 – Patient Interview Schedule 
 
Question 
 
 
Probe 
1. I’d like to talk to you about  
 the way you were referred for 
 your endoscopy, the xxx you 
 had on xxx at xxx Hospital 
 
 
2. Can you tell me how long 
 after seeing your GP that you 
 had the endoscopy? 
 
 
3. Were there any good points 
 about  the way you were 
 referred? 
 
Speed of access 
Amount of information given about 
process 
 - length of wait 
 - acknowledgement  
Referral route – OPs, direct from GP 
Choice of date 
 
4. Do you have any suggestions 
 for improvement about the 
 way you were referred? 
 
Speed of access 
Information about process 
Referral route 
Choice of date 
Bad experiences 
 
5. Can I ask whether you have 
 been referred for an 
 endoscopy before the xxx 
 (type of procedure) in xxx 
 (date)? 
 
What did you have then and how long 
ago? 
Check if same hospital 
Flexi / Colon / Gastro 
6. Have you noticed any 
 changes since your last 
 referral? 
 
 
7. Do you have any other 
 comments? 
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Appendix 14 – Clinician / Key person first 
round interview schedule 
Question Prompt 
1. How did you become 
 involved in innovation / 
 changes in endoscopy  
 
Prompt  - background 
    - previous skills 
2. Can you describe the way 
the endoscopy services ran 
(run) before any innovations 
/ changes were made? 
 (last 2 years) 
 
Prompt  - what problems were you / are  
     you trying to address 
    - opinions 
WHY/HOW 
Either: 
3a.  Can you clarify what I  
  innovations / changes  
  have contributed to the  
  way the unit currently  
  runs? 
Or: 
3b. What innovations /   
  changes do you hope to  
  make? 
Prompt - innovations - booking system 
        - reduction in waiting  
         times 
WHY/HOW     - improvement in DNA 
        - Nurse Endoscopist 
        - increased staffing 
        - alteration of staff   
         responsibilities 
        - change of leadership 
        - staff training 
        - changes in staff    
         responsibilities 
        - equipment 
        - relocation /     
         restructuring of    
         building 
        - process differences 
  - why chose one innovation over another 
  - which one successful in your view 
  - opinions 
 
4. Can you identify any 
problems / issues in 
implementing the 
innovations / changes? 
Or: 
Do you envisage any 
problems / issues in 
implementing the 
innovations / changes? 
Prompt  - funding 
  - staff resistance 
WHY/HOW - staff numbers 
 
Either: 
5a.  Where did you get funding 
   for innovation/changes?  
Or: 
5b. Where will you get funding 
 for innovations / changes? 
Prompt - (Intervention) 
 Which innovations / changes resulted directly 
from MA funding? 
 Would you have made changes without MA 
 funding? 
WHY/HOW 
Prompt - (Control) 
Reaction to not receiving funding? 
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(…Cont’d) 
 
6. How have staff responded to
 innovations/changes? 
 
Prompt - working as team 
   - to your leadership 
WHY/HOW 
 
7. What impact has the arrival 
of the MA had? 
Prompt   - ToolkitTM - still 
     - Training / support from MA 
WHY/HOW 
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Appendix 15 – Clinician / Key person second 
round interview schedule 
Question Prompt 
1. Can you clarify what 
innovations / changes in the 
last two years have 
contributed to the way the 
unit currently runs? 
 
Are they moving the service 
forward? 
 
Ask if they have completed 
the GRS and for their scores 
Prompt – innovations –  booking system 
 -  reduction in waiting times 
WHY/HOW - improvement in DNA 
 - Nurse Endoscopist 
 increased staffing 
 alteration of staff responsibilities 
 change of leadership 
 staff training 
 changes in staff responsibility 
 equipment 
 relation / restructuring of building 
 process differences 
 -  why choose one innovation over another 
 - which one successful in your view 
 - opinions 
 
Data collection 
Are they moving the service forward? 
What problems still facing? 
2. Why was change 
introduced? 
Improve services for patient  
Efficiency of provision 
3. Can you identify any 
problems / issues in 
implementing the new 
innovations / changes? 
Prompt   - funding 
     - staff resistance 
WHY/HOW  - staff numbers 
 
4. Where did you get funding 
for the new innovation / 
changes? 
 
Has funding situation 
changed since we last met? 
Mention aware that seen by DC/SM but interested 
in their views on how funding is impacting on 
change 
5. How have staff responded 
to innovations / changes? 
Prompt 
 
Why/how 
6. Do you think the service is 
now more accessible to 
patients as a result of the 
innovations you described?  
Example 
Example 
7. Do you think the service is 
now more acceptable to 
patients as a result of the 
innovations you described?  
Example 
Example 
8. If you were to have an 
endoscopy in this unit, what 
would you want to change? 
 
WHY 
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Appendix 16 – Individual analysts’ 
summative paragraphs for all four focus 
groups 
FG1 
 
(AW)  
The speech meanders through a number of important issues. These include issues 
around power and threats to autonomy (e.g. between medical colleagues, nursing 
and medical colleagues, clinicians and managers and between teaching hospitals 
and DGHs). These in turn are linked to everyday, practical difficulties and 
opportunities around who should be scoping, making referrals, and managing the 
scoping environment – including new roles/ ways of working. The extract reflects 
tussles around who should be leading on strategy in relation to innovations. 
Clearly the feeling is that Government driven initiatives and associated funding 
opportunities may undermine moving forward on local needs. Conversely – at 
least to a degree – there appears to be some agreement that targets, for example 
waiting list targets, may act as facilitators for innovation. Communication is a key 
issue throughout, particularly between managers and clinicians – and this links 
with perceived eroded autonomy – although this is experienced differently by 
nurses and doctors. The latter point links up with the issue of how power is 
experienced. Better networking between units is mentioned as a potentially useful 
facilitator and of benefit to patients. Interestingly, patients are very much on the 
periphery of this focus group discussion – one notable exception is the point that 
in order to pull in resources patients are potentially inconvenienced. You will know 
where in the transcript reference is made to this. The issue of whether or not 
funding on the one hand or better management on the other would expedite 
better patient service is ever present between the lines and the text suggests 
both are key concerns. 
 
Key issues include: power, autonomy, practicalities, strategy, funding, 
management, targets, new and changing roles/ways of working and 
communication.  
 
(WYC) 
The discussion has highlighted several barriers to changes, including conflict 
between clinical needs, Government directives and management agenda; 
resistance to changes in working practice, lack of capacity and insufficient IT 
support. However, it was also suggested that management agenda and 
Government targets could be used to facilitate changes. 
 
Changes mentioned in the discussion included introducing pooled list, 
management and referral guidelines, vetting lists, getting additional staff, 
additional sessions and even building new units. Uncertainties about the 
sustainability of the changes were mentioned. Inpatient referrals and the liaison 
with surgeons were repeatedly mentioned as sticky points. There were also some 
concerns expressed about the way to handle patients with more complex needs 
such as those who needed PEG and sedation. 
 
Some changes were perceived to require funding. These included staffing, IT and 
equipment. A difference between the participants in the understanding of the cost 
of providing a service could be seen, as exemplified by the discussion about 
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capsule endoscopy. The need to give people incentive to put the effort to 
introduce changes was also mentioned. 
 
Differences between doctors and nurses in their response to changes were 
highlighted. Doctors were perceived to be more resistant to changes, especially to 
those introduced by management. Several reasons were suggested by the 
participants with clinician autonomy being perceived as the underlying factor of 
this medical resistance. 
 
Participants admitted that changes introduced in their units seemed to be 
working, but some seemed to admit this with reluctance. Low staff morale, 
especially among doctors was mentioned as a downside of the changes 
introduced. 
 
Participants were open about bad relationship with management or trying to out-
manoeuvre managers. They also suggested the impact of the big environment 
which included the new contract, Trust deficits, differences between teaching 
hospitals and district general hospital and merger of Trusts.  
 
(AS) 
Resource issues are a common problem when introducing changes with a lack of 
funding, lack of staff and inadequate IT systems being highlighted. However, not 
all change requires funding, such as changing work practices and finding ways to 
redeploy funds and all participants described changes in their units, indicating an 
understanding of the need and desire to improve endoscopy services. The 
changes aim to reduce waiting times by managing demand and increasing list 
utilisation to increase capacity, but there is a sense of frustration that 
improvements are limited by inadequate funding to sustain and increase staffing 
and improve IT systems. This is compounded in areas where Trusts have financial 
deficits and funding is generally not forthcoming unless attached to a Government 
target. There has been some staff resistance but it was felt that while nurses 
could be persuaded of the benefits of introducing new ways of working, 
consultants were not so easily swayed particularly if they felt they were being 
dictated to by management. However, the cause of consultant resistance relates 
to a change in the expectations of the role of a consultant - their traditional role 
as an autonomous, independent decision-maker, is being challenged and they feel 
that while retaining the responsibility of the role, they no longer have any 
authority. This perceived change in role combined with the continuous demands 
for change in the NHS is seen as causing resistance among consultants and 
contributes to tension in the relationship between consultants and managers. In 
spite of some resistance, the group felt the changes that had been introduced in 
their units had worked well but there was disappointment that the effects had 
been limited and had not resulted in significant improvements in staff morale with 
nurses continuing to be under pressure. However, while recruitment continues to 
be difficult, retention of staff has improved. 
 
(FR) 
Focus group participants’ emphasised barriers to change over and above 
facilitators to change, highlighting in particular a lack of resources, underpinned 
by a lack of understanding by managers of what is needed to progress service 
delivery. This is exacerbated by a slow rate of change. Some changes, however 
have been well received, including: centralised waiting list management, trained 
Nurse Endoscopists and new guidelines for referral and management of patients. 
Although acquiring funds is crucial for progress, as important is the clever re-
deployment of funds which appears lacking, resulting in de-motivated staff. 
Moreover, the Trusts are seen to be managing resources unwisely and it is 
essential that if change is to be successful, management must come on board and 
work closely with Units according to their requirements. Until that happens, Units 
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will continue to try to manipulate the system to serve their individual needs. As 
for engagement of staff in modernisation interventions, doctors were considered 
the most difficult group, resisting change in keeping with the notion that they are 
overburdened, all powerful and autonomous. For improvements to progress, there 
needs to be better retention of staff, greater nurse engagement, less staff 
pressure and stress and fewer challenges to doctors’ authority from out-of-touch 
management. Implementation programmes for innovations have neither run 
smoothly nor been well received. This has led to low staff morale which has 
worsened since the introduction of MES innovations. Ironically, this is tempered 
by greater efficiency. However, although people might be working more quickly, 
they are seen to be achieving less, perceiving themselves to have all the 
responsibility but no authority and Trusts to be dysfunctional.  
 
(JGW) 
There is a strong sense that, with possibly one exception, the participants are 
keen to improve their services through change. They are, however, frustrated by 
the system, particularly lack of resources and a poor relationship with 
management, who they see as resistant to the changes they wish to make. There 
is, however, an acknowledgement among the doctors of their own medical 
arrogance and resistance to change initiated by others. The sense of frustration 
and failure to affect improvement is strong, although it is clear that some changes 
have been initiated with good effect. It appears that much can be achieved within 
existing resources through greater efficiency (driven by targets, audit and 
guidelines) and changing roles, notwithstanding a feeling that funding is the main 
barrier. There is clearly a problem with staff morale and with change fatigue, 
though a hint that strong leadership and the application of change management is 
key to progress.  
 
(ITR) 
 I begin with a caveat. The conclusions I draw from the transcript depend on what 
I know about the 5 participants: are they typical, at the good end of the 
performance spectrum, or al the poor end of that spectrum? To make progress I 
assume that they are typical.  
 
1. That said the first question about facilitators and barriers elicited many more 
barriers, with the Government, management and resources all coming in for 
criticism. More refreshing was the member who focused on traditional working 
patterns. and the one who remembered to say at the end that the "national 
endoscopy project had facilitated the process", In aggregate, however, this group 
perceived the state of the endoscopy service as 'half empty' rather than 'half full'.  
 
2. Responses to the second question, about changes since 2002, were more 
encouraging. Reported changes included increases in the number of Nurse 
Endoscopists refusing inpatient referrals for endoscopy, and pooling waiting lists 
(which operational researchers have been demanding ever since they failed to 
reduce deaths from horse-kicks In the Prussian cavalry).  
 
3. There was general agreement in response to the third question that funding 
was critical in achieving change. Examples included the appointment of extra 
staff, the purchase of new health technology and Information technology, the 
replacement of old equipment, the payment of incentives, and the perception of 
perverse incentives to refurbish car parks before Increasing support staff.  
 
4. There was also general consensus about staff response to change. Members 
saw doctors as resistant to change, while nurses were more compliant, though not 
universally so. In different ways members recognised the potential for good 
management to facilitate change and poor management to discourage it, even to 
prevent it.  
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5. The final question led to general agreement that the changes had been 
effective, but generated a range of qualifications: two members asserted that the 
changes had been at the expense of morale, manifest in failure to recognise 
Improvements or the feeling of being under attack.  
 
6 Subject to my initial caveat I conclude that this focus group was convinced that 
modernising endoscopy had been generally successful. At the same time they 
cited a lot of anecdotal evidence about weak management and missed 
opportunities.  
 
FG2 
 
(AS) 
Participants acknowledged that change was needed, in particular to reduce 
waiting lists to avoid the late detection of cancers. While further changes are 
needed, they (nurses in particular) reported some improvements and that staff 
are motivated by seeing the positive outcomes. Nursing staff instigate a lot of the 
changes; they are patient focused and, being in the unit all the time, see what 
changes are needed. However, it was acknowledged that endoscopy is a unit used 
by other specialties and there are differences between physicians and surgeons 
and their reasons for doing endoscopy. This can result in concern by physicians 
over the quality of scoping by surgeons and reluctance by surgeons to scope 
medical patients. Improving communication between groups was highlighted by 
one participant as an important step in introducing change. Resources for 
modernising endoscopy services have been limited, due in part to the lack of an 
NSF and targets. Nevertheless, cost neutral changes, while needing time and 
commitment, have been made and it is anticipated that the GRS and Colorectal 
Cancer (CRC) Screening, could bring additional resources but there is concern 
about how units will cope with the additional work. There is a sense of community 
within gastroenterology in South Wales and while WAG has been supportive in 
funding training, more financial support is needed to continue improving services. 
The fact that modernisation in Wales lags behind England was viewed positively in 
that participants felt they had learnt from the experiences, good and bad, of their 
colleagues elsewhere. 
 
 (HH) 
There were two Nurse Endoscopists and one doctor involved in the focus group 
session. All were keen to participate and fully discuss issues relating to 
modernisation of endoscopy services both in terms of what they had done locally 
and what could be done long-term. There appears to be a great deal of 
camaraderie within endoscopy services generally with most personnel happy to 
instigate or accept change. The main driver for change appeared to be improving 
the patient experience. The nurses appear to be driving many of the changes and 
were very highly regarded. Difficulties were encountered where ‘outside’ 
personnel were involved. All the participants commented on successful changes 
that had been achieved predominantly by re-evaluating the service rather than 
providing financial support. Long-term however it was recognised that money 
would be the main driver to maintenance and improvement of the service. There 
was a general consensus that Wales could learn from English sites and that good 
relationships existed across borders. The main issues that arose relating to 
improvement of services were reduction of waiting times, backfilling, improving 
relationships and management issues. 
 
(IC) 
The informants were positive about the effects of the changes in endoscopy 
services made through the management of throughput. The changes highlighted 
included: validation of waiting lists, backfilling and pooling the lists. The impact of 
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delayed endoscopy on patient prognosis was highlighted as the main driver for 
change and  nurses played an important part in the introduction of those changes. 
The impact of the changes on the work pattern of the endoscopy team especially 
the booking clerk was highlighted. Some challenges were mentioned, including 
the lack of investment, the need to bring senior executives on board and 
persuade some surgeons to work with the physicians. The need to ensure 
adequate information from GP referral to prioritise patients was also mentioned. 
These changes had been resource-neutral so far but informants had referred to 
the need of putting more resources into the services to maintain the momentum 
and took the service forward and to meet the standards set in GRS (Global Rating 
Scale?). 
 
(FR) 
Welsh Gastroenterology Units have been keen to make changes to address a 
range of issues including: long waiting lists, lack of communication between staff 
particularly surgeons and physicians, and poor performance. This has engendered 
pooled lists, a drop in waiting times and less territoriality over patients. 
Instigators for change are patient focused, spurred on by seeing late cancers and 
a recognition of ineffective management. Change has been predominantly nurse-
led however with motivation most staff groups are willing to embraced change, 
seeing the potential for improved patient care. In spite of barriers such as funding 
and lack of resources, innovations have been a success and have led to re-
organised nurses’ work, mapped pathways and pooled lists. Funds are now 
needed to deal with the influx of extra cases and the GRS. Welsh units are proud 
of the changes they have made, looking to English Units for guidance and 
direction. However they see little financial support or understanding from the 
Trusts or from external sources such as the Welsh Assembly Government. 
 
(JGW) 
The transcript indicates general agreement between the three who participated 
(two nurses and a doctor). The changes instigated in the modernisation process 
appear to be modest and conventional (improving work flow, changing roles, 
validating waiting lists, collaborating better, and pooling endoscopy lists). These 
changes have been facilitated by better management and nurse-led change. The 
Global Rating Scale has clearly been a very significant driver and it would appear 
that there has been little money made available. In spite of this there was a 
feeling that this lack of money was a barrier to change, as was senior managerial 
inertia. Surprisingly, it was felt that the biggest achievement in these changes 
was a reduction in waiting lists and there was little mention of quality of care or 
patient benefit. 
 
(GJ) 
Changes within the participants’ units were process- and staff related, such as 
validating, pooling and backfilling of lists, identifying problems, promoting intra-
organisational collaboration and re-organising staff; with nurses being the main 
initiators of change. Changes appeared to be reactive rather than proactive, in 
response to external factors such as audits, the Global Rating Scale (GRS) and 
seeing late cancers. Organisational factors posed barriers to changes, as well as 
the ‘lack of belongingness’ of GI units within the wider health care context. Very 
little or no funding was required so far, however financial support will be needed 
to make improvements sustainable. The consideration of the support, which the 
English units have received through the NHSMA initiative, is characterised by 
positive reframing; emphasis is placed on support from within the Welsh 
community and the opportunity to observe mistakes as a learning experience.  
 
(ITR) 
The three participants reported wide variations in performance in reducing 
waiting for endoscopy: Hospital N (FG2.1) is very proud of keeping their waiting 
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time below one month for 2 years; Hospital S  (FG1.3) has reduced waiting time 
through 'backfilling' but not to the same extent; but Hospital C (FG2.2) has 
apparently had little success.  
 
These variations seem to reflect variations in approach to modernisation: 
in Hospital N senior managers persuaded surgeons and physicians to work 
together, notably by sharing lists (FG2.1); in Hospital S the main driver was a 
rigorous internal assessment leading to changes in the management of waiting 
lists (FG2.3); but, though Hospital C has 'done lots of audits', there is real 
opposition to change (FG2.2) with the result that 'conscious sedation' and a 
revised referral form (FG2.2) are the main changes.  
 
Facilitators and barriers: it was the transition to become a screening unit 
that facilitated the greatly improved performance of Hospital N, despite the lack of 
a gastroenterology NSF and uninterested gastroenterologists (FG2.1); in Hospital 
S the main incentive seemed to be the desire to become a CRC screening unit 
(FG2.3.) with nurses facilitating progress and surgeons reluctant to lose their 
patients providing the main barrier (FG2.3); in Hospital C financial incentives 
seemed to facilitate and the absence of such incentives left inertial barriers in 
place (FG2.2).  
 
FG3 
 
(FR) 
Many more barriers than facilitators to change were mentioned in FG3 – a focus 
group comprising 6 gastroenterology physicians and surgeons. Barriers included 
lack of training especially among nursing staff, organisational barriers and 
differences between professional group functioning. Innovation is also impeded by 
lack of a National Service Framework, labyrinthine management systems and lack 
of positive steer from the Welsh Assembly Government resulting from a political 
agenda that restricts the flow of funding to endoscopy. The implementation of the 
GRS was instrumental in ensuring changes did take place to services, raising 
morale and strengthening team spirit somewhat, however while pressure 
continues from management to move forward, the process of modernisation lacks 
leadership, co-ordination and the necessary finances. In addition there is the need 
for additional staff training, closer collaboration between staff and support for 
nurses. Change is at a slower pace in Wales than in English units, with Welsh 
units lagging behind in terms of strategic vision, resource availability, 
Governmental and Trust support and good management. 
 
(HH) 
The FG produced a lot of discussion about the current status of GI services in 
Wales. Although changes were highlighted, a number of clinicians were keen to 
point out that the changes were not always positive. Some of the changes made 
included increased staffing, reducing waiting times, changes in the way services 
were delivered, increasing the numbers and types of services, the introduction of 
specialisation and pooling of lists. It was though that the bowel cancer screening 
programme (NBCSP) and Trust mergers would have further unknown implications 
on services. Specialisation and MDT were thought to have made improvements 
particularly in managing cancer patients but that specialisation in itself led to its 
own problems particularly with respect to finding the right people out of hours 
and the time impact of attending MDT meetings. There was general agreement 
that the complexity of work had increased along with the volume as well as a 
requirement for more accurate reporting. There seemed to be a general 
consensus among the group that the relationship between Trust management and 
clinicians was a barrier to change with managers and politicians dictating the 
changes. The changes were thought of as ‘target led’ and did not necessarily 
result in improved patient outcome. It was recognised that new equipment was a 
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major requirement but acquiring funding for it was difficult. It was perceived that 
relationships between junior staff and consultants were also difficult. The major 
facilitator for change was thought to be forward thinking, pro-active staff who 
were willing to share knowledge and ideas. Better communication, IT, literature 
and medical education were also mentioned as facilitators. Fragmentation of 
departments was mentioned as a barrier, as was training and research 
curtailment and lack of funding to increase staffing. It was recognised that 
changes in the NHS were slow and this led to low staff morale. Lack of funding 
was highlighted on several occasions and some participants mentioned that they 
had received external funds from pharmaceutical companies or charities in order 
to buy equipment or fund staff. There were several comments regarding low staff 
morale due to changing roles. It was also perceived that there were too many 
frequent targets to achieve and that this was likely to affect patient outcomes. It 
was perceived that there were no major differences with England and that English 
units were not significantly better than Wales in terms of GI outcomes. It was 
thought that waiting times and cancer screening programmes may have suffered 
in Wales. It was also thought that Wales had lacked resources compared with 
England. Despite this it was felt that there were no major differences with 
England in terms of clinical outcomes.  
 
(AS)  
Interviewees reported changes initiated from within units (some at little cost) that 
had been effective particularly in reducing waiting lists, such as more consultants 
and Endoscopists, pooling of lists and ensuring appropriateness of referrals. In 
contrast, change forced by Government, considered to be too much, too often and 
not evidence based, was not as effective and was leading to changes in the way 
clinicians and nurses work that are not good for patients; clinicians were said to 
be losing autonomy, becoming less flexible and feeling disengaged and nurses 
were spending less time caring for patients. While two clinicians felt that funding 
was not a major issue, the remainder voiced concerns about resources for 
gastroenterology equipment, research, personnel and training. It was felt that 
something had to be a political priority to gain support from Trusts. The clinicians 
did not feel that the MA work in England had created a big difference between the 
two countries. However, some felt that Wales lacks resources and lags behind 
England in terms of waiting times, colorectal screening and technical 
development. 
 
(GJ)  
Six gastroenterology consultants and surgeons, representing Welsh units, 
participated in this group. Changes in participants’ units included the expansion of 
units and staff, and increased specialisation including a focus on multi-disciplinary 
team work (MDT). Politicians setting targets and Trusts making badly informed 
financial decisions are considered as root causes of the problems that are being 
experienced. Two paradoxes emerged: 1) the new consultant contract essentially 
increases pay for reduced working hours, reducing the perceived quality of patient 
care considerably; 2) targets drive clinicians to treat patients on the waiting list 
on the expense of urgent cases. This creates, as one participant phrased it, a 
‘depressing atmosphere’ and leads health care services to ‘lose the plot in basic 
patient care’. Nurses and doctors are merely seen as employees and this change 
in professional self-identity causes frustration; management decisions are being 
made without consultation with the affected parties. Changes are considered to be 
more effective if they come from within. Participants noted that changes imposed 
by management should be evidence-based as it is expected within clinical 
practice.  
 
(JGW) 
This Focus Group had a good mix of specialists but all were doctors. The most 
dominant theme to emerge was the distrust and dislike of management, and the 
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perceived adverse influence on change. This seemed to be manifest mainly as 
inertia but in some instances as negative. There was felt to be a loss of clinical 
freedom, autonomy, influence and morale among clinicians. There was also an 
evolving change in roles and perception of roles with loss of conventional 
functions which had could have an adverse effect. 
 
The changes described were diverse and there was no particular theme. Quite a 
lot was said about specialisation and the impact that this has had, both positive 
and negative. The discussants seemed fairly ambivalent about funding. In some 
instances there had been considerable investment in new units and more people 
but others described difficulty getting equipment. Overall the impression was that 
funding was not perceived as a huge catalyst for change and reorganisation was 
also important. Virtually nothing was said about the patient experience and there 
was very little about real change for the better. However, when asked for 
differences between England and Wales there was a general consensus that Wales 
was not worse off and possibly better off from the medical perspective than 
England, although some initiatives such as colorectal cancer screening were 
delayed and it was acknowledged that waiting lists were probably longer. There 
was an implication that less research was being done. The lack of evidence for 
change and the lack of consultation by management to seek professional views 
were highlighted 
 
(ITR) 
The transcript suggests that this was a coherent group who saw recent changes in 
gastroenterology as generally for the worse. To test this negative impression, I 
undertook a crude form of content analysis. The six members made a total of 22 
comments identifying changes since 2002 – increased specialisation (FG3.3, 
FG3.5, FG3.2, FG3.1), more human resources (FG3.4, FG3.3, FG3.1), reduced 
waiting times (FG3.4, FG3.6, FG3.3), new or expanded endoscopy unit (FG3.4, 
FG3.1), introduction of referral criteria (FG3.4, FG3.3), more multi-disciplinary 
teams [MDTs] (FG3.5, FG3.2), more colonoscopies (FG3.4), merger of NHS Trusts 
(FG3.4), changes due to Innovations in Care (FG3.6), pooled lists (FG3.3), better 
investigation (FG3.2) and centralised training (FG3.1). 
 
The group made nine comments identifying facilitators of change – clinical 
colleagues (FG3.5, FG3.6), scientific advance (FG3.1), the internet (FG3.2), video 
technology (FG3.2), access to literature (FG3.2), better communication (FG3.2), 
investment (FG3.3), political support (FG3.6), commercial funding (FG3.2) and 
‘bottom up’ innovation (FG3.1). In contrast they made 14 comments identifying 
barriers to change – funding (FG3.2, FG3.5, FG3.6), target-driven NHS (FG3.5, 
FG3.3), European Time Directive (FG3.1), bureaucracy (FG3.2), loss of clinical 
autonomy (FG3.3), loss of morale (FG3.3), slowness of NHS to change (FG3.6), 
political interference (FG3.6), loss of continuity of care (FG3.4), difficulty of 
providing out-of-hours care (FG3.4), increased specialisation (FG3.4), difficulty in 
recruitment (FG3.2) and ‘top down’ innovation (FG3.1). 
 
The group identified three changes not needing extra resources – rationalising 
open access (FG3.4), pooled lists (FG3.3) and specialised wards (FG3.1). In 
contrast they made six comments identifying changes needing resources – 
technological equipment (FG3.4, FG3.6, FG3.3), more MDTs (FG3.5, FG3.2) and 
more human resources (FG3.5). 
 
The group identified one positive staff response to change, namely some staff 
welcome specialisation (FG3.2). In contrast they identified seven negative staff 
responses: nurses rarely nurse (FG3.1); junior doctors are unhappy with training 
and appraisal (FG3.1); some staff do not like specialisation (FG3.2); loss of 
professionalism and commitment (FG3.5); change has been overwhelming 
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(FG3.3); frustration at pace of change (FG3.6); and diversification is reducing 
quality of patient care (FG3.4). 
 
Three comments classified the changes as successful – ‘tremendous 
improvement’ (FG3.3), ‘they have worked’ (FG3.5), ‘good overall’ (FG3.1). In 
contrast seven comments classified them as adverse: centralisation questions 
future role of DGH (FG3.4); NHS targets have taken control (FG3.6); more risk-
taking (FG3.5); inappropriate merger (FG3.2); consultants’ loss of autonomy 
(FG3.2) few changes are evidence-based e.g. MDTs & pooled lists (FG3.1); and 
imposed changes have been distressing (FG3.1). 
 
The group identified three advantages that gastroenterology in Wales enjoys over 
England – better pay (FG3.2), fewer changes (FG3.1) and no independent 
treatment centres (FG3.6). However they also identified three disadvantages – 
fewer jobs (FG3.1), longer waiting times (FG3.6) and fewer resources (FG3.3). 
 
In conclusion I judge that this content analysis confirms the impression of a 
coherent (or well chaired?) group who saw recent changes in gastroenterology as 
generally for the worse. 
 
FG4  
 
(FR)  
FG4 comprised six gastroenterology surgeons and physicians who described a 
number of positive aspects to change that had taken place in their units, 
including: a greater number of consultant appointments, reduced waiting times, 
pooled lists and new inpatient referral systems. However, this has led to more 
complex working arrangements and a greater volume of work. Barriers and 
facilitators to change were mentioned in equal measure. Barriers included: new 
political and managerial directives, target driven workloads, lack of training and 
decrease in research. Facilitators included: greater sub-specialism in surgeons 
and better science. Bureaucracy has grown, affected by change to managerial and 
political functioning which has challenged working practices and led to large 
amounts of legislation and paperwork. As a consequence of a “depressing 
atmosphere” and “distressing times”, stress levels among staff are high. Many 
changes have been undertaken without funding, such as pooled lists, however 
Welsh endoscopy lacks necessary funding and lags behind its English counterparts 
in this respect as well as in the number of jobs that have been created, but not in 
terms of good clinical practice.  
 
(AS) 
The major barrier related to the management of endoscopy. Problems included 
convincing Trust management of the importance of endoscopy, an inability to pull 
together the different specialties using endoscopy, difficulty getting through the 
layers of management - “enormous and complex labyrinth management systems” 
(106) and crisis management. Other barriers included the low profile of 
endoscopy, lack of NSF, insufficient staff and funding and the problems of 
geography, population and capacity that create issues with training programmes. 
Few facilitators were mentioned but included by-passing management, specialty 
based services facilitating additional staff and the need for motivated people. 
Some changes were described (pooling, specialist clinics, additional staff) but 
there was a greater sense of what they were working towards and the problems 
experienced. While endoscopy staff were dedicated and supportive and work as a 
team, there was concern about low morale and described as like “people clinging 
to a life raft” (465). It was seen as important to raise the profile of endoscopy and 
anticipated that Bowel Cancer Screening and GRS would help with this. There was 
frustration that Wales was lagging behind England but it was felt that progress 
was being made. 
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(HH) 
The original innovations introduced in Wales in 2004 were mentioned as major 
facilitators for change although it was felt that things had faltered in more recent 
years. Barriers to change in Welsh units included changes to the GI training 
programmes which appear to have faltered at the expense of devolution. The 
Trust management also were perceived as a barrier and passing through the 
management structure to get changes approved and funded was complex. There 
also appeared to be a lack of communication between the surgical and medical 
specialties which made consolidation of services difficult. It was also felt that 
there was poor management of different specialties within endoscopy and that 
each one had its own agenda so there was a lack of cohesion. It was thought that 
GI services had lost out to other specialties because they were not high profile 
enough. It was also mentioned that gastroenterology may have suffered for a 
number of years because it did not have a National Service Framework. It was 
however recognised that the introduction of bowel cancer screening would have 
an impact. Running GI units effectively was difficult due to staffing deficits and 
the increased workload. Units appeared to be running without their full 
complement of staff with no major drives to recruit additional staff. Lack of time 
to communicate with colleagues also slowed progress. Changes appear to be 
Assembly led. Some of the changes were the appointment of specialist nurses, 
endoscopy user groups, engaging with GPs regarding referrals, previous Trust 
mergers, changes to endoscopy services, pooled lists and dedicated clinics. The 
implementation of the global rating score was also felt to have made an impact 
and has provided a template for change. It was felt that politicians had not 
acknowledged the extent of the changes required within gastroenterology in order 
to implement cancer screening and the GRS. Also it was felt that although 
changes had been made they did not always lead to improvement. For example 
increased facilities could not be utilised fully due to staff shortages. It was felt 
that changes that were deemed necessary by management were funded but that 
clinical changes were not. It also appeared that some of the participants were 
unsure if funding was given or not. Some funding was obtained from external 
sources initially but was eventually Trust funded. It was recognised that 
consultant funding had been funded but that other staff funding was not always in 
place. It was felt that staffing levels in general were quite low in gastroenterology 
and that although training existed for doctors this was not the case for nurses. 
Costs for this type of training appeared to rely on external funding. Despite 
working in difficult conditions it was felt that there was a strong sense of 
teamwork. However it was recognised that the staff did not feel appreciated by 
the management and that general morale was low. It was commented that there 
was a lack of leadership at some levels. It was generally felt that Wales lagged 
behind England in terms of changes. Issues that were mentioned were lack of 
funding for training, development of the English cancer network, lack of 
resources, geographical issues. It was felt however that progress was now being 
made in Wales. Increasing the profile of gastroenterology was thought to be the 
major factor in improving it long term. 
 
(GJ) 
Six gastroenterology consultants and surgeons, representing Welsh units, 
participated in this group. Changes included the expansion of units, the 
implementation of endoscopy unit user groups, and changes to the referral and 
booking system. Prioritization in Trust management conflicts with priorities set by 
the service group management, leading to decisions that are not based on clinical 
or medical expertise. Unstructured investment (such as the employment of 
additional consultants without the additional provision of equipment) leads to a 
deterioration in waiting times, and management decisions were noted to be 
reactive rather than proactive. Staff morale was considered to be an indicator of 
perceived support by Trust management. High levels of staff absence and 
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turnover as well as intra-organisational discord indicate a low morale. The 
development of team cliques and considerable diversity in levels of commitment 
were also noted. Slow and traditional change was considered preferable and 
rather than ‘window-dressing’ to appear to comply with targets, honesty about 
performance will be of more benefit. Welsh units lagging behind innovations in 
English units appeared to be cause for frustration.  
 
(JGW) 
This was a difficult group to summarise as a lot of the discussion was not very 
articulate. It would appear that all the group were doctors and there was more 
diversity of view than in other groups. Much of the discussion was negative, 
highlighting difficulties and problems rather than summarising modernisation. 
Management again was felt to be a barrier to change – not in tune with needs, 
reactionary and distrusted. If supportive, then change was effected but this was 
often in the context of crisis management. It was felt that endoscopy was 
disadvantaged by being a low priority, both in terms of gastroenterology and 
specifically endoscopy. The specialty suffers from not having a National Service 
Framework. Under-staffing is an issue, both in terms of nurses and consultants, 
and expansion has been helpful. The main changes have been the Global Rating 
Scale, better team work and more nurse specialists. Training was highlighted as 
important but inadequate for nurses. The Agenda for Change has been very 
negative.  
 
Wales is clearly seen as lagging behind across a range of issues including training, 
modernisation, Global Rating Scale, and suffers by being a small country. There 
was a feeling that Wales is catching up and is perhaps less unencumbered by 
other aspects of change.  
 
(ITR) 
The transcript suggests that this was a disappointed group who saw recent 
changes in gastroenterology as predominantly for the worse. To test this negative 
impression, I undertook a crude form of content analysis. Between them the six 
members identified two facilitators of change – senior Trust management (FG4.4) 
and the innovations in 2004 (FG4.1). In contrast they made 16 comments 
identifying barriers to change – management of endoscopy service (FG4.4, FG4.3, 
FG4.5), training in endoscopy (FG4.6), size of Wales (FG4.6), ‘gastroenterology 
spans medicine and surgery’ (FG4.4), lack of NSF in gastroenterology (FG4.3), 
staffing deficits (FG4.4), generic management system (FG4.2), ‘all Trusts trying 
to do everything’ (FG4.2), ‘2004 innovations petered out’ (FG4.1), clinical 
workload (FG4.5), secretarial support (FG4.5), ‘gastroenterology is politically 
invisible’ (FG4.6) and epidemiological trends e.g. in alcoholic liver disease 
(FG4.6). 
 
The six members made a total of 15 comments identifying real changes since 
2002 –introduction of the Global Rating Scale [GRS] (FG4.3, FG4.6), increasing 
nurse endoscopy (FG4.4, FG4.6), endoscopy users group (FG4.1), dyspepsia 
guidelines & workshops (FG4.1), teamwork leading to the introduction of special 
clinics (FG4.3), substitution of clinical nurse specialists for Specialist Registrars 
(FG4.3), merger of NHS Trusts (FG4.4), pooled lists (FG4.4), centralised booking 
(FG4.4), more consultants (FG4.6), second endoscopy room (FG4.6), reduced 
waiting times (FG4.6) and flexible training (FG4.6). Sadly two members hardly 
contributed to this topic, offering wishful thoughts about appointing clinical nurse 
specialists (FG4.5) or creating a nutrition team (FG4.5), or else waffle about ‘the 
sort of work coming in’ (FG4.2) and ‘the sort of things we can do’ (FG4.2).  
 
The group identified only one change not needing extra resources – pooled lists – 
and three needing such resources, all relating to new posts (FG4.5, FG4.1, 
FG4.2). Similarly the group identified only one positive staff response to change, 
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namely dedication during staff shortage (FG4.3). In contrast they identified four 
negative staff responses – unhappiness caused by Agenda for Change (FG4.4), 
loss of support caused by unhelpful environment (FG4.2), unreliability of junior 
staff (FG4.2) and low morale due to stress (FG4.1). The fact that members who 
identified many changes were slow to elaborate on them in response to these two 
follow-up questions also suggests low morale. 
 
The group identified three advantages that gastroenterology in Wales enjoys over 
England – no payment by results (FG4.4) or private sector commissioning 
(FG4.4), thus maintaining a traditional integrated health service (FG4.6). 
However they also identified six disadvantages – fewer resources (FG4.5, FG4.3), 
Wales ‘slower off the mark’ especially with training (M), fewer innovations 
(FG4.1), weaker management of cancer (FG4.1), later implementation of GRS and 
thus later improvement in standards (FG4.3), geography difficult for local services 
(FG4.6) and difficulty in maintaining strong research (FG4.6). 
 
In conclusion I judge that this content analysis confirms the impression of a 
disappointed, even depressed, group who saw recent changes in gastroenterology 
as predominantly for the worse. 
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Appendix 17 - Focus group schedule 
 
Scripted introduction … 
 
 
i. What do you see as facilitators and barriers to change in endoscopy 
services?  
 
ii. What changes have you made in your unit since 2002? 
 
iii. Was funding necessary? 
 
iv. How have staff responded to change / lack of change?  
   
v. How well do you think changes have worked? 
 
 
 
In addition Welsh Focus Groups explored: 
 
• Responses to the MA’s support for English Endoscopy units 
• The impact that changes to English units made on Welsh units  
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Appendix 18 – GP Questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Cont…) 
  
HAS CHANGE OCCURRED IN THE FOLLOWING AREAS (QUESTIONS 1-5
BELOW AND 6-9 OVERLEAF):
1. The way referrals are made to the endoscopy unit
If YES, has the change led to a better or worse service compared to 4 years ago?
2. a. Your understanding of the way referrals are prioritised when
received by the hospital
If YES, has the change led to a better or worse service compared to 4 years ago?
b. Outcome of the prioritisation process for your individual patient
If YES, has the change led to a better or worse service compared to 4 years ago?
3. Speed of referral in terms of access to services
If YES, has the change led to a better or worse service compared to 4 years ago?
4. Information back from secondary care following your referral request
If YES, has the change led to a better or worse service compared to 4 years ago?
5. The % of patients requesting further GP appointments whilst waiting
for their endoscopy
If YES, has the change led to a better or worse service compared to 4 years ago?
      
      
Better
     
Neither better
nor worse
When referring patients to the endoscopy unit at xxx
Hospital, have you noticed any of the following changes in the
last 4 years?
Please answer each question by putting a cross in the corresponding box.
GP Questionnaire
NO
DON'T
KNOW
YES
      
      
Neither better
nor worse
Better
WorseNeither better
nor worse
Better
      
      
Neither better
nor worse
Better
     
Neither better
nor worse
Better
      
Neither better
nor worse
Better
Worse
Worse
Worse
Worse
Worse
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(Cont…) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HAS CHANGE OCCURRED IN THE FOLLOWING AREAS (QUESTIONS 6-9):
6. Communication from secondary care about the outcome of the
endoscopy
If YES, has the change led to a better or worse service compared to 4 years ago?
7. Communication from secondary care about the final diagnosis
If YES, has the change led to a better or worse service compared to 4 years ago?
8. Communication from secondary care about any complications
If YES, has the change led to a better or worse service compared to 4 years ago?
9. Communication from secondary care about any treatment initiated
If YES, has the change led to a better or worse service compared to 4 years ago?
IN SUMMARY:
10.Do you think the service is better or worse than 4 years ago?
11.Overall, are your patients getting a good deal from the service?      
      
      
      
NO DON'T
KNOW
YES
      
      
      
Neither better
nor worse
WorseBetter
Neither better
nor worse
WorseBetter
Neither better
nor worse
WorseBetter
      
Better Neither better
nor worse
Worse
WorseBetter Neither better
nor worse
Thank you for completing the questions.  If you would like to elaborate on how the current service is better or
worse compared to four years ago please use the space below.
If you have any queries please contact Anne Seagrove (01792 513411) or Kym Thorne (01792 602062), Research Assistants.
Please return in the FREEPOST envelope provided to: ENIGMA, School of Medicine, University of Wales
Swansea, FREEPOST SWC4951, Swansea, SA2 8ZZ.
      
      
Better Neither better
nor worse
Worse
For office use only
2
If you would like a summary of the overall results, please place a cross in this box      
